View Filing Data

Print Document View Excel Document

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
Document and Entity Information - USD ($) $ in Millions	Dec. 31, 2015	Mar. 08, 2016	Jun. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	VECTOR GROUP LTD
Entity Central Index Key	0000059440
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Common Stock, Shares Outstanding		123,792,329
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 1,979

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 240,368	$ 326,365
Investment securities available for sale	181,976	269,100
Accounts receivable - trade, net	23,889	23,328
Inventories	86,516	90,323
Income taxes receivable, net	2,841	3,282
Restricted assets	9,195	2,595
Other current assets	38,954	36,404
Total current assets	583,739	751,397
Property, plant and equipment, net	75,632	84,112
Real estate held for sale, net	23,318	10,643
Long-term investments	62,726	52,723
Investments in real estate ventures	217,168	163,460
Restricted assets	12,303	12,013
Goodwill and other intangible assets, net	263,959	269,972
Prepaid pension costs	20,650	25,032
Other assets	51,261	53,902
Total assets	1,310,756	1,423,254
Current liabilities:
Current portion of notes payable and long-term debt	8,919	52,640
Current portion of fair value of derivatives embedded within convertible debt	0	884
Current payments due under the Master Settlement Agreement	29,241	26,322
Current portion of employee benefits	915	931
Income taxes payable, net	96	1,743
Litigation accruals	22,904	3,149
Other current liabilities	154,217	126,755
Total current liabilities	216,292	212,424
Notes payable, long-term debt and other obligations, less current portion	886,249	860,711
Fair value of derivatives embedded within convertible debt	144,042	168,502
Non-current employee benefits	55,055	49,314
Deferred income taxes, net	79,429	95,904
Payments due under the Master Settlement Agreement	20,094	25,809
Litigation accruals	24,718	25,700
Other liabilities	7,038	5,570
Total liabilities	1,432,917	1,443,934
Commitments and contingencies (Notes 10 and 15)
Stockholders' deficiency:
Preferred stock, par value $1.00 per share, 10,000,000 shares authorized	0	0
Common stock, par value $0.10 per share, 250,000,000 and 250,000,000 shares authorized, 123,792,329 and 118,646,261 shares issued and 123,792,329 and 114,501,014 shares outstanding	12,379	11,450
Accumulated deficit	(210,113)	(97,009)
Accumulated other comprehensive loss	(8,313)	(1,343)
Treasury shares, at cost, 0 and 4,145,247	0	(12,857)
Total Vector Group Ltd. stockholders' deficiency	(206,047)	(99,759)
Non-controlling interest	83,886	79,079
Total stockholders' deficiency	(122,161)	(20,680)
Total liabilities and stockholders' deficiency	$ 1,310,756	$ 1,423,254

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 1.00	$ 1.00
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Common stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common Stock, shares authorized (in shares)	250,000,000	250,000,000
Common stock, shares issued (in shares)	123,792,329	118,646,261
Common stock, shares outstanding (in shares)	123,792,329	114,501,014
Common stock in treasury, shares (in shares)	0	4,145,247

Consolidated Statements of Operations - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Revenues:

Tobacco

^[1]

$ 1,017,761

$ 1,021,259

$ 1,014,341

Real estate

641,406

561,467

65,580

E-Cigarettes

(1,970)

8,589

Total revenues

1,657,197

1,591,315

1,079,921

Cost of sales:

Tobacco

^[1]

697,900

735,725

729,393

Real estate

410,287

354,028

37,638

E-Cigarettes

1,540

7,307

Total cost of sales

1,109,727

1,097,060

767,031

Operating, selling, administrative and general expenses

320,221

279,342

113,598

Litigation, settlement and judgment expense

20,072

2,475

88,106

Restructuring charges

7,257

Operating income

199,920

212,438

111,186

Other income (expenses):

Interest expense

(120,691)

(160,991)

(132,147)

Loss on extinguishment of debt

(21,458)

Changes in fair value of derivatives embedded within convertible debt

24,455

19,409

18,935

Acceleration of interest expense related to debt conversion

(5,205)

(12,414)

Equity in (losses) earnings from investments

(2,681)

3,140

3,126

Gain (loss) on sale of investment securities available for sale

11,138

(11)

5,152

Equity in earnings from real estate ventures

2,001

4,103

22,925

Impairment of investment securities available for sale

(12,846)

Gain on acquisition of Douglas Elliman

60,842

Other, net

6,409

9,396

4,573

Income before provision for income taxes

107,705

82,279

60,720

Income tax expense

41,233

33,165

23,672

Net income

66,472

49,114

37,048

Net (income) loss attributed to non-controlling interest

(7,274)

(12,258)

252

Net income attributed to Vector Group Ltd.

$ 59,198

$ 36,856

$ 37,300

Per basic common share:

Net income applicable to common shares attributed to Vector Group Ltd. (in dollars per share)

$ 0.49

$ 0.33

$ 0.36

Per diluted common share:

Net income applicable to common shares attributed to Vector Group Ltd. (in dollars per share)

0.49

0.33

0.36

Cash distributions declared per share (in dollars per share)

$ 1.54

$ 1.47

$ 1.40

[1]	Revenues and cost of goods sold include federal excise taxes of $439,647, $446,086 and $456,703 for the years ended December 31, 2015, 2014 and 2013, respectively.

Consolidated Statements of Operations (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Statement [Abstract]
Tax portion of revenues and cost of goods sold	$ 439,647	$ 446,086	$ 456,703

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Statement of Comprehensive Income [Abstract]
Net income	$ 66,472	$ 49,114	$ 37,048
Net unrealized (losses) gains on investment securities available for sale:
Change in net unrealized (losses) gains	(12,710)	2,095	19,632
Net unrealized losses (gains) reclassified into net income	1,708	11	(5,152)
Net unrealized (losses) gains on investment securities available for sale	(11,002)	2,106	14,480
Net unrealized gains (losses) on long-term investments accounted for under the equity method:
Change in net unrealized gains (losses)	1,190	(1,784)	98
Net unrealized losses reclassified into net income	1,624	0	0
Net unrealized gains (losses) on long-term investments accounted for under the equity method	2,814	(1,784)	98
Net change in forward contracts	61	64	62
Net change in pension-related amounts
Net (loss) gain arising during the year	(8,620)	(4,698)	9,513
Amortization of gain	4,200	1,015	2,099
Net change in pension-related amounts	(4,420)	(3,683)	11,612
Other comprehensive (loss) income	(12,547)	(3,297)	26,252
Income tax effect on:
Change in net unrealized (losses) gains on investment securities	5,650	(866)	(7,971)
Net unrealized losses (gains) reclassified into net income on investment securities	(702)	(5)	2,092
Change in net unrealized gains (losses) on long-term investments accounted for under the equity method	(484)	738	(40)
Net unrealized losses reclassified into net income on long-term investments accounted for under the equity method	(672)	0	0
Forward contracts	(25)	(27)	(25)
Pension-related amounts	1,810	1,523	(4,714)
Income tax benefit (provision) on other comprehensive (loss) income	5,577	1,363	(10,658)
Other comprehensive (loss) income, net of tax	(6,970)	(1,934)	15,594
Comprehensive income	59,502	47,180	52,642
Comprehensive (income) loss attributed to non-controlling interest	(7,274)	(12,258)	252
Comprehensive income attributed to Vector Group Ltd.	$ 52,228	$ 34,922	$ 52,894

Consolidated Statement of Stockholders' Deficiency - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ (20,680)	$ (50,605)	$ (89,070)
Net income	66,472	49,114	37,048
Change in net loss and prior service cost, net of income taxes	(2,610)	(2,160)	6,898
Forward contract adjustments, net of income taxes	36	37	37
Unrealized gain on long-term investment securities accounted for under the equity method, net of income taxes	1,658	(1,046)	58
Change in net unrealized gain on investment securities, net of income taxes	(7,060)	1,229	11,661
Net unrealized gains reclassified into net income, net of income taxes	1,006	6	(3,060)
Unrealized gain on investment securities, net of income taxes	(6,054)	1,235	8,601
Total other comprehensive income	(6,970)	(1,934)	15,594
Comprehensive income	59,502	47,180	52,642
Distributions and dividends on common stock	(189,838)	(166,898)	(146,056)
Restricted stock grant	120	100	0
Surrender of shares in connection with restricted stock vesting	(2,083)
Effect of stock dividend	0	0	0
Note conversion, net of income taxes	25,522	132,021	53,654
Beneficial conversion feature of notes payable, net of income taxes		14,648
Exercise of stock options	1,321	$ 5,051	$ 544
Cancellation of treasury shares	$ 0
Exercise of stock options (in shares)	115,531	442,740	44,293
Tax benefit of options exercised	$ 821	$ 1,178	$ 38
Stock based compensation	5,621	3,251	2,519
Deemed contribution (dividend) from subsidiary			0
Acquisition of Douglas Elliman Realty, LLC			85,703
Contributions to non-controlling interest	813	2,733	1,955
Distributions to non-controlling interest	(3,280)	(9,339)	(12,534)
Ending balance	(122,161)	(20,680)	(50,605)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ 11,450	$ 9,748	$ 8,989
Beginning balance (in shares)	114,501,014	97,482,998	89,898,411
Restricted stock grant	$ 120	$ 100	$ 8
Restricted stock grant (in shares)	1,200,000	1,000,000	77,500
Surrender of shares in connection with restricted stock vesting	$ (8)
Surrender of shares in connection with restricted stock vesting (in shares)	(83,411)
Effect of stock dividend	$ 584	$ 520	$ 450
Effect of stock dividend (in shares)	5,837,144	5,195,856	4,498,579
Note conversion, net of income taxes	$ 223	$ 1,041	$ 297
Note conversion, net of income taxes (in shares)	2,227,552	10,417,384	2,970,168
Exercise of stock options	$ 10	$ 41	$ 4
Exercise of stock options (in shares)	110,030	404,776	38,340
Ending balance	$ 12,379	$ 11,450	$ 9,748
Ending balance (in shares)	123,792,329.000	114,501,014	97,482,998
Additional Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ 0	$ 0	$ 0
Distributions and dividends on common stock	(18,120)	(155,067)	(57,891)
Restricted stock grant			(8)
Surrender of shares in connection with restricted stock vesting	(2,075)
Note conversion, net of income taxes	25,299	130,980	53,357
Beneficial conversion feature of notes payable, net of income taxes		14,648
Exercise of stock options	1,311	5,010	540
Cancellation of treasury shares	(12,857)
Tax benefit of options exercised	821	1,178	38
Stock based compensation	5,621	3,251	2,519
Deemed contribution (dividend) from subsidiary			1,445
Ending balance	0	0	0
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(97,009)	(121,514)	(70,199)
Net income	59,198	36,856	37,300
Distributions and dividends on common stock	(171,718)	(11,831)	(88,165)
Effect of stock dividend	(584)	(520)	(450)
Ending balance	(210,113)	(97,009)	(121,514)
Other Comprehensive Income (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(1,343)	591	(15,003)
Change in net loss and prior service cost, net of income taxes	(2,610)	(2,160)	6,898
Forward contract adjustments, net of income taxes	36	37	37
Unrealized gain on long-term investment securities accounted for under the equity method, net of income taxes	1,658	(1,046)	58
Change in net unrealized gain on investment securities, net of income taxes	(7,060)	1,229	11,661
Net unrealized gains reclassified into net income, net of income taxes	1,006	6	(3,060)
Ending balance	(8,313)	(1,343)	591
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(12,857)	(12,857)	(12,857)
Cancellation of treasury shares	12,857
Ending balance	0	(12,857)	(12,857)
Non-controlling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	79,079	73,427	0
Net income	7,274	12,258	(252)
Deemed contribution (dividend) from subsidiary			(1,445)
Acquisition of Douglas Elliman Realty, LLC			85,703
Contributions to non-controlling interest	813	2,733	1,955
Distributions to non-controlling interest	(3,280)	(9,339)	(12,534)
Ending balance	$ 83,886	$ 79,079	$ 73,427

Consolidated Statement of Stockholders' Equity Deficiency (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income taxes on note conversion	$ 367	$ 300	$ 7,242
Income taxes on beneficial conversion feature of notes payable		$ 10,327

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net income	$ 66,472	$ 49,114	$ 37,048
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	25,654	24,499	12,631
Non-cash stock-based expense	5,621	3,251	2,519
Acceleration of interest expense related to debt conversion	0	5,205	12,414
Loss (gain) on sale of assets	77	(540)	170
Deferred income taxes	(13,195)	22,026	466
Distributions from long-term investments	1,258	1,416	2,011
Equity in (losses) earnings from long-term investments	2,681	(3,140)	(3,126)
(Gain) loss on sale of investment securities available for sale	(11,138)	11	(5,152)
Equity in earnings from real estate ventures	(2,001)	(4,103)	(22,925)
Distributions from investments in real estate ventures	5,894	5,152	4,251
Non-cash interest expense	6,504	35,584	22,995
Non-cash interest income	0	0	(90)
Gain on acquisition of Douglas Elliman	0	0	(60,842)
Impairment of investment securities	12,846	0	0
Impairment of long-term investments	811	0	0
Impairment of real estate held for sale	230	0	0
Changes in assets and liabilities:
Receivables	(1,414)	(11,197)	5,975
Inventories	3,806	3,173	6,897
Accounts payable and accrued liabilities	37,936	5,708	41,047
Payments due under the Master Settlement Agreement	(2,796)	(925)	(32,690)
Other assets and liabilities, net	5,233	(27,858)	28,427
Net cash provided by operating activities	144,479	107,376	52,026
Cash flows from investing activities:
Sale of investment securities	270,576	154,615	117,021
Maturities of investment securities	5,491	930	27
Purchase of investment securities	(214,146)	(305,731)	(170,463)
Proceeds from sale or liquidation of long-term investments	1,303	2,416	10,927
Purchase of long-term investments	(10,000)	(12,000)	(5,501)
(Increase) decrease in restricted assets	(6,889)	(872)	1,081
Investments in real estate ventures	(70,272)	(40,916)	(75,731)
Distributions from investments in real estate ventures	17,563	7,309	3,142
Issuance of notes receivable	(4,410)	(8,250)	(8,600)
Cash acquired in Douglas Elliman consolidation	0	0	116,935
Proceeds from sale of fixed assets	4	4	48
Capital expenditures	(10,977)	(23,404)	(13,275)
Increase in cash surrender value of life insurance policies	(1,742)	(484)	(628)
Purchase of subsidiaries	0	(750)	(67,616)
Repayment of notes receivable	4,000	4,850	0
Purchase of preferred securities	0	(1,000)	0
Pay down of investment securities	8,739	1,849	681
Proceeds from sale of preferred securities	1,000	0	0
Investments in real estate held for sale	(12,603)	0	0
Net cash used in investing activities	(22,363)	(221,434)	(91,952)
Cash flows from financing activities:
Proceeds from issuance of debt	2,105	413,914	457,767
Repayments of debt	(6,684)	(12,601)	(422,581)
Deferred financing charges	(624)	(12,360)	(11,750)
Borrowings under revolver	153,361	886,130	978,788
Repayments on revolver	(167,915)	(898,788)	(977,794)
Dividends and distributions on common stock	(188,151)	(167,328)	(144,711)
Distributions to non-controlling interest	(3,280)	(9,339)	(11,764)
Contributions from non-controlling interest	813	0	0
Proceeds from exercise of Vector options	1,441	5,151	544
Tax benefit of options exercised	821	1,178	38
Net cash (used in) provided by financing activities	(208,113)	205,957	(131,463)
Net (decrease) increase in cash and cash equivalents	(85,997)	91,899	(171,389)
Cash and cash equivalents, beginning of year	326,365	234,466	405,855
Cash and cash equivalents, end of year	$ 240,368	$ 326,365	$ 234,466

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(a) Basis of Presentation:

The consolidated financial statements of Vector Group Ltd. (the “Company” or “Vector”) include the accounts of VGR Holding LLC (“VGR Holding”), Liggett Group LLC (“Liggett”), Vector Tobacco Inc. (“Vector Tobacco”), Liggett Vector Brands LLC (“Liggett Vector Brands”), Zoom E-Cigs LLC (“Zoom”), New Valley LLC (“New Valley”) and other less significant subsidiaries. New Valley includes the accounts of Douglas Elliman Realty, LLC (“Douglas Elliman”) and other less significant subsidiaries. All significant intercompany balances and transactions have been eliminated.

Liggett and Vector Tobacco are engaged in the manufacture and sale of cigarettes in the United States. Zoom is engaged in the sale of electronic cigarettes in the United States. New Valley is engaged in the real estate business.

Revisions to December 31, 2014 Consolidated Balance Sheet. The Company has revised its December 31, 2014 Consolidated Balance Sheet, which originally presented deferred income tax assets and liabilities (current and noncurrent) on a gross basis, rather than a net basis by jurisdiction. The revisions conform to ASC 740-10-45-6 which states all current deferred tax liabilities and assets within the same tax jurisdiction shall be offset and presented as a single amount and all noncurrent deferred tax liabilities and assets shall be offset and presented as a single amount. The Company assessed the materiality of this error on previously issued consolidated financial statements and concluded that the error was immaterial. In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes” (“ASU 2015-17”), which requires deferred tax liabilities and assets to be classified as noncurrent in a classified statement of financial position. The guidance is effective for financial statements issued for annual periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018. Earlier application is permitted for all entities as of the beginning of an interim or annual reporting period. This amendment may be applied either prospectively or retrospectively to all periods presented. The Company adopted the provisions of this ASU retrospectively in the fourth quarter of 2015, and adjusted all prior periods accordingly. The adoption of this ASU will simplify the presentation of deferred income taxes and reduce complexity without decreasing the usefulness of information provided to users of financial statements. The adoption of ASU 2015-17 did not have a significant impact on the Company's financial position, results of operations and cash flows.”

The cumulative impact of the revisions and application of the new ASU are presented in the table below:



	December 31, 2014
	As Previously Reported		Revision			ASU Adoption			As Revised

Deferred income taxes	$	29,192	$	(29,192	)	$	—		$	—
Total current assets	857,846		(29,192		)	—			828,654

Deferred income taxes	51,129		(51,129		)	—			—
Total assets	$	1,573,392	$	(80,321	)	$	—		$	1,493,071

Deferred income taxes, net	$	57,671	$	(29,192	)	$	(28,479	)	$	—
Total current liabilities	270,095		(29,192		)	(28,479		)	212,424

Deferred income taxes, net	145,639		(51,129		)	28,479			122,989
Total liabilities	1,551,340		(80,321		)	—			1,471,019
Total stockholders' equity	22,052					—			22,052
Total liabilities and stockholders' equity	$	1,573,392	$	(80,321	)	$	—		$	1,493,071

Adoption of Equity Method. The Company adopted the equity method of accounting for its investments in Ladenburg Thalmann Financial Services Inc. (“LTS”) and Castle Brands Inc. (“Castle”) in 2015 because the Company determined that it had significant influence due to the evolution of the relationships with each company. In accordance with ASC 323-35-33, the Company has adjusted its consolidated financial statements, retroactively, on a step-by-step basis as if the equity method had been in effect since inception.

The cumulative impact of the revisions and application of the equity method of accounting for the two investments are presented in the tables below:



	December 31, 2014
	As Previously Reported			(1)	Revision			As Revised

Investment securities available for sale	$	346,043			$	(76,943	)	$	269,100
Other current assets	36,718				(314		)	36,404
Total current assets	828,654				(77,257		)	751,397

Long-term investments	40,292				12,431			52,723
Other assets	58,893				(4,991		)	53,902
Total assets	$	1,493,071			$	(69,817	)	$	1,423,254


Deferred income taxes, net	$	122,989			$	(27,085	)	$	95,904
Total liabilities	1,471,019				(27,085		)	1,443,934
Accumulated deficit	(90,160		)		(6,849		)	(97,009		)
Accumulated other comprehensive income	34,540				(35,883		)	(1,343		)
Total Vector Group Ltd. stockholders' deficiency	(57,027		)		(42,732		)	(99,759		)
Total stockholders' equity (deficiency)	22,052				(42,732		)	(20,680		)
Total liabilities and stockholders' equity (deficiency)	$	1,493,071			$	(69,817	)	$	1,423,254

(1) The amounts shown in the “As Previously Reported” column reflect the impact of the deferred tax adjustments presented in the preceding table.



	Year ended								Year ended
	December 31, 2014								December 31, 2013
	As Previously Reported		Revision			As Revised			As Previously Reported		Revision			As Revised

Operating, selling, administrative and general expenses	$	278,392	$	950		$	279,342		$	112,748	$	850		$	113,598
Operating income	213,388		(950		)	212,438			112,036		(850		)	111,186

Equity in earnings from investments	1,242		1,898			3,140			2,066		1,060			3,126
Other, net	10,552		(1,156		)	9,396			7,550		(2,977		)	4,573
Income before provision for income taxes	82,487		(208		)	82,279			63,487		(2,767		)	60,720
Income tax expense	33,251		(86		)	33,165			24,795		(1,123		)	23,672
Net income	49,236		(122		)	49,114			38,692		(1,644		)	37,048

Net income attributed to Vector Group Ltd.	36,978		(122		)	36,856			38,944		(1,644		)	37,300

Other comprehensive income (loss), net of tax	11,680		(13,614		)	(1,934		)	33,128		(17,534		)	15,594

Comprehensive income	60,916		(13,736		)	47,180			71,820		(19,178		)	52,642

Comprehensive income attributed to Vector Group Ltd.	$	48,658	$	(13,736	)	$	34,922		$	72,072	$	(19,178	)	$	52,894

(b) Estimates and Assumptions:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Significant estimates subject to material changes in the near term include valuation of intangible assets, inventory valuation, promotional accruals, sales returns and allowances, actuarial assumptions of pension plans, the estimated fair value of embedded derivative liabilities, settlement accruals, valuation of investments, including other-than-temporary impairments to such investments, and litigation and defense costs. Actual results could differ from those estimates.

Cash includes cash on hand, cash on deposit in banks, money market accounts and cash equivalents, comprised of short-term investments which have an original maturity of 90 days or less. Interest on short-term investments is recognized when earned. The Company places its cash and cash equivalents with large commercial banks. The Federal Deposit Insurance Corporation (“FDIC”) and Securities Investor Protection Corporation (“SIPC”) insure these balances, up to $250 and $500, respectively. Substantially all of the Company’s cash balances at December 31, 2015 are uninsured.

(d) Financial Instruments:

The carrying value of cash and cash equivalents, restricted assets and short-term loans approximate their fair value.

The fair value of the senior secured notes and the variable interest senior convertible debentures for the years ended December 31, 2015 and 2014 was estimated based on current market quotations.

As required by authoritative guidance, derivatives embedded within the Company’s convertible debt are recognized on the Company’s balance sheet and are stated at estimated fair value at each reporting period. Changes in the fair value of the embedded derivatives are reflected quarterly as “Changes in fair value of derivatives embedded within convertible debt.”

The estimated fair values for financial instruments presented herein are not necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair values.

(e) Investment Securities:

The Company classifies investments in debt and marketable equity securities as available for sale. Investments classified as available for sale are carried at fair value, with net unrealized gains and losses included as a separate component of stockholders’ deficiency. The cost of securities sold is determined based on average cost. Investments in marketable equity securities represent less than a 20 percent interest in the investees and the Company does not exercise significant influence over such entities.

Gains are recognized when realized in the Company’s consolidated statements of operations. Losses are recognized as realized or upon the determination of the occurrence of an other-than-temporary decline in fair value. The Company’s policy is to review its securities on a periodic basis to evaluate whether any security has experienced an other-than-temporary decline in fair value. If it is determined that an other-than-temporary decline exists in one of the Company’s marketable securities, it is the Company’s policy to record an impairment charge with respect to such investment in the Company’s consolidated statements of operations.

(f) Significant Concentrations of Credit Risk:

Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and trade receivables. The Company places its temporary cash in money market securities (investment grade or better) with what management believes are high credit quality financial institutions.

Liggett’s customers are primarily candy and tobacco distributors and large grocery, drug and convenience store chains. Two customers, accounted for 19% and 10% of Liggett's revenues in 2015 and 18% and 10% in 2013. One customer accounted for 19% of Liggett's revenues in 2014. Concentrations of credit risk with respect to trade receivables are generally limited due to the large number of customers, located primarily throughout the United States, comprising Liggett’s customer base. Liggett’s two largest customers represented approximately 4% and 1%, respectively, of net accounts receivable at December 31, 2015 and 5% and 1%, respectively, at December 31, 2013. Liggett’s largest customer represented approximately 11% of net accounts receivable at December 31, 2014. Ongoing credit evaluations of customers’ financial condition are performed and, generally, no collateral is required. Liggett maintains reserves for potential credit losses and such losses, in the aggregate, have not exceeded management’s expectations.

(g) Accounts Receivable:

Accounts receivable-trade are recorded at their net realizable value. The allowance for doubtful accounts and cash discounts was $479 and $452 at December 31, 2015 and 2014, respectively. Uncollectible accounts are written off when the likelihood of collection is remote and when collection efforts have been abandoned.

(h) Inventories:

Tobacco inventories are stated at the lower of cost or market and are determined primarily by the last-in, first-out (LIFO) method at Liggett and Vector Tobacco. Although portions of leaf tobacco inventories may not be used or sold within one year because of the time required for aging, they are included in current assets, which is common practice in the industry. It is not practicable to determine the amount that will not be used or sold within one year.

(i) Restricted Assets:

Current restricted assets of $9,195 and $2,595 at December 31, 2015 and 2014, respectively, consist primarily of certificates of deposits and supersedeas bonds. Long-term restricted assets of $12,303 and $12,013 at December 31, 2015 and 2014, respectively, consist primarily of certificates of deposit which collateralize letters of credit, supersedeas bonds and deposits on long-term debt. The certificates of deposit mature at various dates from February 2016 to August 2020.

(j) Property, Plant and Equipment:

Property, plant and equipment are stated at cost. Property, plant and equipment are depreciated using the straight-line method over the estimated useful lives of the respective assets, which are 20 to 30 years for buildings and 3 to 10 years for machinery and equipment.

Repairs and maintenance costs are charged to expense as incurred. The costs of major renewals and betterments are capitalized. The cost and related accumulated depreciation of property, plant and equipment are removed from the accounts upon retirement or other disposition and any resulting gain or loss is reflected in operations.

The cost of leasehold improvements is amortized over the lesser of the related leases or the estimated useful lives of the improvements. Costs of major additions and betterments are capitalized, while expenditures for routine maintenance and repairs are charged to expense as incurred.

(k) Investments in Real Estate Ventures:

In accounting for its Investments in real estate ventures, the Company identified its participation in Variable Interest Entities (“VIE”), which are defined as entities in which the equity investors have not provided enough equity to finance its activities or the equity investors (1) cannot directly or indirectly make decisions about the entity’s activities through their voting rights or similar rights; (2) do not have the obligation to absorb the expected losses of the entity; (3) do not have the right to receive the expected residual returns of the entity; or (4) have voting rights that are not proportionate to their economic interests and the entity’s activities involve or are conducted on behalf of an investor with a disproportionately small voting interest.

The Company's interest in VIEs is primarily in the form of equity ownership. The Company examines specific criteria and uses judgment when determining if the Company is the primary beneficiary of a VIE. Factors considered include risk and reward sharing, experience and financial condition of other partner(s), voting rights, involvement in day-to-day capital and operating decisions, representation on a VIE's executive committee, existence of unilateral kick-out rights exclusive of protective rights or voting rights and level of economic disproportionality between the Company and its other partner(s).

Accounting guidance requires the consolidation of VIEs in which the Company is the primary beneficiary. The guidance requires consolidation of VIEs that an enterprise has a controlling financial interest. A controlling financial interest will have both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.

The Company's maximum exposure to loss in its investments in unconsolidated VIEs is limited to its investment in the unconsolidated VIEs which is the carrying value. The Company's maximum exposure to loss in its investment in its consolidated VIEs is limited to its investment which is the carrying value of the investment net of the non-controlling interest. Creditors of the consolidated VIEs have no recourse to the general credit of the primary beneficiary.

(l) Goodwill and Other Intangible Assets:

Goodwill from acquisitions represents the excess of the purchase price over the fair value of the underlying acquired net tangible and intangible assets. Factors that contribute to the recognition of goodwill in the Company’s acquisitions include (i) expected growth rates and profitability of the acquired companies, (ii) securing buyer-specific synergies that increase revenue and profits and are not otherwise available to market participants, (iii) significant cost savings opportunities, (iv) experienced workforce and (v) the Company’s strategies for growth in sales, income and cash flows.

Goodwill is tested for impairment at least annually as of October 1and monitored for interim triggering events on an on-going basis. Other intangible assets with indefinite useful lives are not amortized, but rather, are tested for impairment at least annually. In evaluating goodwill for impairment, the Company has the option to first assess qualitative factors to determine whether further impairment testing is necessary. Among other relevant events and circumstances that affect the fair value of reporting units, the Company considers individual factors such as macroeconomic conditions, changes in the industry and the markets in which the Company operates as well as the historical and expected future financial performance. If we conclude that it is more likely than not that fair value is less than its carrying value, recoverability of goodwill is evaluated using a two-step process. The first step involves a comparison of the fair value of the reporting unit to the Company’s carrying amount. Fair value is determined based on an income approach and a market approach that are equally weighted. If the carrying amount of the reporting unit, including the goodwill, exceeds the fair value of the reporting unit, the second step is performed. The second step involves a comparison of the implied fair value and carrying value of the goodwill of the reporting unit. To the extent that the carrying amount exceeds the implied fair value of the goodwill, an impairment loss is recognized.

To determine the implied fair value of the Company’s indefinite-lived intangible asset, trademark, it utilizes the relief from royalty method, pursuant to which the asset is valued by reference to the amount of royalty income it would generate if licensed in an arm’s length transaction. Under the relief from royalty method, similar to the discounted cash flow method, estimated net revenues expected to be generated by the asset during its life are multiplied by a benchmark royalty rate and then discounted by the estimated weighted average cost of capital associated with the asset. The resulting capitalized royalty stream is an indication of the value of owning the asset. To the extent that the carrying amount exceeds the implied fair value of the intangible asset, an impairment loss is recognized.

The fair value of the intangible asset associated with the benefit under the Master Settlement Agreement (“MSA”) is calculated using discounted cash flows. This approach involves two steps: (i) estimating future cash savings due to the payment exemption under the MSA and (ii) discounting the resulting cash flow savings to determine fair value. This fair value is then compared with the carrying value of the intangible asset associated with the benefit under the MSA. To the extent that the carrying amount exceeds the implied fair value of the intangible asset, an impairment loss is recognized.

Intangible assets with finite lives are amortized over their respective estimated useful lives. Identifiable intangible assets that are subject to amortization are evaluated for impairment using a process similar to that used to evaluate long-lived assets described below.

(m) Impairment of Long-Lived Assets:

The Company reviews long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. The Company performs a test for recoverability, comparing projected undiscounted cash flows to the carrying value of the asset group to determine if impairment exists. If impairment is determined to exist, any related impairment loss is calculated based on fair value of the asset on the basis of discounted cash flow. Impairment losses on assets to be disposed of, if any, are based on the estimated proceeds to be received, less costs of disposal.

(n) Pension, Postretirement and Postemployment Benefits Plans:

The cost of providing retiree pension benefits, health care and life insurance benefits is actuarially determined and accrued over the service period of the active employee group. The Company recognizes the funded status of each defined benefit pension plan, retiree health care and other postretirement benefit plans and postemployment benefit plans on the balance sheet.

(o) Stock Options:

The Company accounts for employee stock compensation plans by measuring compensation cost for share-based payments at fair value. The fair value is recognized as compensation expense over the vesting period on a straight-line basis. The terms of certain stock options awarded under the 2014 Management Incentive Plan in February 2014 and under the 1999 Plan in November 2013, February 2013, December 2009 and January 2001 provide for common stock dividend equivalents (paid in cash at the same rate as paid on the common stock) with respect to the shares underlying the unexercised portion of the options. The Company recognizes payments of the dividend equivalent rights on these options on the Company consolidated balance sheet as reductions in additional paid-in capital until fully utilized and then accumulated deficit ($5,566, $4,612 and $4,007 net of income taxes, for the years ended December 31, 2015, 2014 and 2013, respectively), which are included as “Distributions and dividends on common stock” in the Company’s consolidated statement of changes in stockholders’ equity.

(p) Income Taxes:

The Company accounts for income taxes under the liability method and records deferred taxes for the impact of temporary differences between the amounts of assets and liabilities recognized for financial reporting purposes and the amounts recognized for tax purposes as well as tax credit carryforwards and loss carryforwards. These deferred taxes are measured by applying currently enacted tax rates. A valuation allowance reduces deferred tax assets when it is deemed more likely than not that some portion or all of the deferred tax assets will not be realized. A current tax provision is recorded for income taxes currently payable.

The Company accounts for uncertainty in income taxes by recognizing the financial statement impact of a tax position when it is more likely than not that the position will be sustained upon examination. If the tax position meets the more-likely-than-not recognition threshold, the tax effect is recognized at the largest amount of the benefit that is greater than 50% likely of being realized upon ultimate settlement. The guidance requires that a liability created for unrecognized deferred tax benefits shall be presented as a liability and not combined with deferred tax liabilities or assets.

(q) Distributions and Dividends on Common Stock:

The Company records distributions on its common stock as dividends in its consolidated statement of stockholders’ deficiency to the extent of retained earnings. Any amounts exceeding retained earnings are recorded as a reduction to additional paid-in-capital to the extent paid-in-capital is available. The Company’s stock dividends are recorded as stock splits and given retroactive effect to earnings per share for all years presented.

(r) Revenue Recognition:

Tobacco and E-Cigarettes sales: Revenues from sales are recognized upon the shipment of finished goods when title and risk of loss have passed to the customer, there is persuasive evidence of an arrangement, the sale price is fixed or determinable and collectibility is reasonably assured. The Company provides an allowance for expected sales returns, net of any related inventory cost recoveries (e.g. federal excise taxes). Certain sales incentives, including promotional price discounts, are classified as reductions of net sales. The Company includes federal excise taxes on tobacco sales in revenues and cost of goods sold. Since the Company’s primary line of business is tobacco, the Company’s financial position and its results of operations and cash flows have been and could continue to be materially adversely affected by significant unit sales volume declines at the Company and industry levels, regulation, litigation and defense costs, increased tobacco costs or reductions in the selling price of cigarettes in the near term.

Tobacco Shipping and Handling Fees and Costs: Shipping and handling fees related to sales transactions are neither billed to customers nor recorded as revenue. Shipping and handling costs, which were $5,488 in 2015, $5,585 in 2014 and $5,559 in 2013 are recorded as operating, selling, administrative and general expenses.

Real estate sales: Revenue is recognized only when persuasive evidence of an arrangement exists, the price is fixed or determinable, the transaction has been completed and collectibility of the resulting receivable is reasonably assured. Real estate commissions earned by the Company’s real estate brokerage businesses are recorded as revenue on a gross basis upon the closing of a real estate transaction as evidenced when the escrow or similar account is closed, the transaction documents have been recorded and funds are distributed to all appropriate parties. Commissions expenses are recognized concurrently with related revenues. Property management fees and rental commissions earned are recorded as revenue when the related services are performed.

(s) Advertising:

Tobacco and E-Cigarettes advertising costs, which are expensed as incurred and included within operating, selling, administration and general expenses, were $5,097, $9,493 and $4,839 for the years ended December 31, 2015, 2014 and 2013, respectively.

Real estate advertising costs, which are expensed as incurred and included within operating, selling, administration and general expenses, were $25,657, $14,952 and $1,298 for the years ended December 31, 2015 and 2014 and 2013, respectively.

(t) Comprehensive Income:

The Company presents net income and other comprehensive income in two separate, but consecutive, statements. The items are presented before related tax effects with detailed amounts shown for the income tax expense or benefit related to each component of other comprehensive income.

The components of accumulated other comprehensive (loss) income, net of income taxes, were as follows:



	December 31, 2015			December 31, 2014			December 31, 2013
Net unrealized gains on investment securities available for sale, net of income taxes of $7,758, $12,706 and $11,528, respectively	$	12,048		$	18,102		$	16,867
Net unrealized losses on long-term investment accounted for under the equity method, net of income tax benefits of $0, $1,156, and $418, respectively	—			(1,658		)	(612		)
Forward contracts adjustment, net of income taxes of $11, $36, and $63, respectively	(19		)	(55		)	(92		)
Pension-related amounts, net of income taxes of $13,977, $12,167, and $10,644, respectively	(20,342		)	(17,732		)	(15,572		)
Accumulated other comprehensive (loss) income	$	(8,313	)	$	(1,343	)	$	591

(u) Fair Value of Derivatives Embedded within Convertible Debt:

The Company has estimated the fair market value of the embedded derivatives based principally on the results of a valuation model. The estimated fair value of the derivatives embedded within the convertible debt is based principally on the present value of future dividend payments expected to be received by the convertible debt holders over the term of the debt. The discount rate applied to the future cash flows is estimated based on a spread in the yield of the Company’s debt when compared to risk-free securities with the same duration; thus, a readily determinable fair market value of the embedded derivatives is not available. The valuation model assumes future dividend payments by the Company and utilizes interest rates and credit spreads for secured to unsecured debt, unsecured to subordinated debt and subordinated debt to preferred stock to determine the fair value of the derivatives embedded within the convertible debt. The valuation also considers other items, including current and future dividends and the volatility of Vector’s stock price. At December 31, 2015, the range of estimated fair market values of the Company’s embedded derivatives was between $143,422 and $144,660. The Company recorded the fair market value of its embedded derivatives at the midpoint of the inputs at $144,042 as of December 31, 2015. At December 31, 2014, the range of estimated fair market values of the Company’s embedded derivatives was between $167,593 and $171,215. The Company recorded the fair market value of its embedded derivatives at the midpoint of the inputs at $169,386 as of December 31, 2014. The estimated fair market value of the Company’s embedded derivatives could change significantly based on future market conditions. (See Note 9.)

(v) Capital and Credit Markets:

The Company has performed additional assessments to determine the impact, if any, of market developments, on the Company’s consolidated financial statements. The Company’s additional assessments have included a review of access to liquidity in the capital and credit markets, counterparty creditworthiness, value of the Company’s investments (including long-term investments, mortgage receivable and employee benefit plans) and macroeconomic conditions. The volatility in capital and credit markets may create additional risks in the upcoming months and possibly years and the Company will continue to perform additional assessments to determine the impact, if any, on the Company’s consolidated financial statements. Thus, future impairment charges may occur.

On a quarterly basis, the Company evaluates its investments to determine whether an impairment has occurred. If so, the Company also makes a determination of whether such impairment is considered temporary or other than temporary. The Company believes that the assessment of temporary or other-than-temporary impairment is facts-and-circumstances driven. However, among the matters that are considered in making such a determination are the period of time the investment has remained below its cost or carrying value, the likelihood of recovery given the reason for the decrease in market value and the Company’s original expected holding period of the investment.

(w) Contingencies:

The Company records Liggett’s product liability legal expenses as operating, selling, administrative and general expenses as those costs are incurred. As discussed in Note 15, legal proceedings covering a wide range of matters are pending or threatened in various jurisdictions against Liggett and the Company.

The Company and its subsidiaries record provisions in their consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except as disclosed in Note 15: (i) management has concluded that it is not probable that a loss has been incurred in any of the pending tobacco-related cases; or (ii) management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome of any of the pending tobacco-related cases and, therefore, management has not provided any amounts in the consolidated financial statements for unfavorable outcomes, if any. Legal defense costs are expensed as incurred.

Adverse verdicts have been entered against Liggett in 15 state court Engle progeny cases and several of these verdicts have been affirmed on appeal and satisfied by Liggett. In certain cases, the judgments entered have been joint and several with other defendants. In four of these cases, punitive damages were awarded against Liggett. The Company's potential range of loss in the remaining cases on appeal is between $0 and $12,674 in the aggregate, plus accrued interest and attorneys’ fees. In determining the range of loss, we consider potential settlements as well as future appellate relief. Except as discussed in Note 15, management is unable to estimate the possible loss or range of loss from remaining Engle progeny cases as there are currently multiple defendants in each case and discovery has not occurred or is limited. As a result, the Company lacks information about whether plaintiffs are, in fact, Engle class members (non-class members’ claims are generally time-barred), the relevant smoking history, the nature of the alleged injury and the availability of various defenses, among other things. Further, plaintiffs typically do not specify their demand for damages. Litigation is subject to many uncertainties, and it is possible that the Company’s consolidated financial position, results of operations or cash flows could be materially adversely affected by an unfavorable outcome in any such tobacco-related litigation.

(x) Other Income:

Other income, net consists of:



	Year Ended
	December 31,
	2015			2014		2013
Interest and dividend income	$	7,038		$	5,803	$	4,381
Out-of-period adjustment	—			1,231		—
Acceleration of closing fee related to termination of Douglas Elliman joint venture	—			2,335		—
Impairment of real estate held for sale	(230		)	—		—
Loss on sale of assets	(78		)	—		—
Gain on long-term investment	390			—		189
Impairment of long-term investments	(811		)	—		—
Other income	100			27		3
Other income, net	$	6,409		$	9,396	$	4,573

The out-of-period adjustment related to a non-accrual of a receivable from Douglas Elliman in the fourth quarter of 2013 and would have increased the Company's gain on acquisition of Douglas Elliman in 2013. The Company assessed the materiality of this error on all previously issued consolidated financial statements and concluded that the error was immaterial to all previously issued consolidated financial statements. The impact of correcting this error in 2014 was not material to the Company's 2014 consolidated financial statements.

(y) Other Current Liabilities:

Other current liabilities consists of:



	December 31, 2015		December 31, 2014
Accounts payable	$	19,639	$	10,856
Accrued promotional expenses	24,816		20,191
Accrued excise and payroll taxes payable, net	26,556		23,172
Accrued interest	28,147		28,321
Commissions payable	11,008		9,523
Accrued salaries and benefits	20,134		16,009
Other current liabilities	23,917		18,683
Total other current liabilities	$	154,217	$	126,755

(z) New Accounting Pronouncements:

In February 2016, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-17, Leases. The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The new standard is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the effect that this guidance will have on its consolidated financial statements.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments--Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, which amends the guidance in U.S. GAAP on the classification and measurement of financial instruments. Changes to the current guidance primarily affects the accounting for equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. In addition, the ASU clarifies guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017, and upon adoption, an entity should apply the amendments by means of a cumulative-effect adjustment to the balance sheet at the beginning of the first reporting period in which the guidance is effective. Early adoption is not permitted except for the provision to record fair value changes for financial liabilities under the fair value option resulting from instrument-specific credit risk in other comprehensive income. The Company is evaluating the effect that this guidance will have on its consolidated financial statements.

In September 2015, the FASB issued ASU 2015-16, Business Combination (Topic 805): Simplifying the Accounting for Measurement Period Adjustments (“ASU 2015-16”), which requires adjustments to provisional amounts initially recorded in a business combination that are identified during the measurement period to be recognized in the reporting period in which the adjustment amounts are determined. This includes any effect on earnings of changes in depreciation, amortization, or other income effects as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date. ASU 2015-15 also requires the disclosure of the nature and amount of measurement-period adjustments recognized in the current period, including separately the amounts in current-period income statement line items that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. The guidance is effective for the Company beginning January 1, 2016. The Company will apply the guidance prospectively for all business combinations that occur subsequent to the adoption date.

In August 2015, FASB issued ASU 2015-15, Interest - Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measure of Debt Issuance Costs Associated with Line-of-Credit Arrangements (Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting), which codifies an Securities and Exchange Commission staff announcement that entities are permitted to defer and present debt issuance costs related to line-of-credit arrangement as assets. Given the absence of authoritative guidance within ASU 2015-03 for debt issuance costs related to line-of-credit arrangements, ASU 2015-15 clarifies that the Securities and Exchange Commission staff would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. This guidance is effective immediately and will be applied prospectively to any line-of-credit arrangements entered into subsequent to the effective date. In April 2015, FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”), which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected. Upon adoption, the Company will apply the new guidance on a retrospective basis and adjust the balance sheet of each individual period presented to reflect the period-specific effects of applying the new guidance. This guidance is effective for the Company beginning January 1, 2016. The Company is evaluating the effect that this guidance will have on its consolidated financial statements.

In February 2015, FASB issued ASU 2015-02, Consolidation: Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 amends the consolidation requirements and significantly changes the consolidation analysis required. ASU 2015-02 requires management to reevaluate all legal entities under a revised consolidation model specifically (1) modify the evaluation of whether limited partnership and similar legal entities are VIEs, (2) eliminate the presumption that a general partner should consolidate a limited partnership, (3) affect the consolidation analysis of reporting entities that are involved with VIEs particularly those that have fee arrangements and related party relationships, and (4) provide a scope exception from consolidation guidance for reporting entities with interests in legal entities that are required to comply with or operate in accordance with requirements that are similar to those in Rule 2a-7 of the Investment Act of 1940 for registered money market funds. The guidance is effective for the Company beginning January 1, 2016. The Company is evaluating the effect that this guidance will have on its consolidated financial statements.

In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40)-Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). ASU 2014-15 provides guidance to U.S. GAAP about management’s responsibility to evaluate whether there is a substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. Specifically, ASU 2014-15 (1) defines the term substantial doubt, (2) requires an evaluation of every reporting period including interim periods, (3) provides principles for considering the mitigating effect of management’s plan, (4) requires certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) requires an express statement and other disclosures when substantial doubt is not alleviated, and (6) requires an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this update are effective for annual periods beginning after December 15, 2016 and interim periods within those reporting periods. Earlier adoption is permitted.

In May 2014, FASB issued ASU 2014-9, Revenue from Contracts with Customers (Topic 606), (“ASU 2014-9”). ASU 2014-9 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The new standard is effective for annual reporting periods beginning after December 15, 2018, with early adoption permitted for annual reporting periods beginning subsequent to December 15, 2016. The new standard is required to be applied retrospectively to each prior reporting period presented or with the cumulative effect of initially applying it recognized at the date of initial application. The Company has not yet selected a transition method and it has not determined the impact of the new standard on its consolidated financial statements.

Earnings Per Share

12 Months Ended

Dec. 31, 2015

Earnings Per Share [Abstract]

EARNINGS PER SHARE

Information concerning the Company’s common stock has been adjusted to give effect to the 5% stock dividends paid to Company stockholders on September 29, 2015, September 26, 2014 and September 27, 2013. The dividends were recorded at par value of $584 in 2015, $520 in 2014 and $450 in 2013, since the Company did not have retained earnings in each of the aforementioned years. In connection with the 5% stock dividends, the Company increased the number of shares subject to outstanding stock options by 5% and reduced the exercise prices accordingly.

For purposes of calculating basic earnings per share (“EPS”), net income available to common stockholders attributed to Vector Group Ltd. for the period are reduced by the contingent interest and the non-cash interest expense associated with the discounts created by the beneficial conversion features and embedded derivatives related to the Company’s convertible debt issued. The convertible debt issued by the Company are participating securities due to the contingent interest feature and had no impact on EPS for the years ended December 31, 2015, 2014 and 2013 as the dividends on the common stock reduced earnings available to common stockholders so there were no unallocated earnings.

As discussed in Note 14, the Company has stock option awards which provide for common stock dividend equivalents at the same rate as paid on the common stock with respect to the shares underlying the unexercised portion of the options. These outstanding options represent participating securities under authoritative guidance. The Company recognizes payments of the dividend equivalent rights ($5,566, net of income taxes of $211, and $4,612, net of income taxes of $306, and $4,007, net of income taxes of $91, for the years ended December 31, 2015, 2014 and 2013, respectively) on these options as reductions in additional paid-in capital on the Company’s consolidated balance sheet. As a result, in its calculation of basic EPS for the years ended December 31, 2015, 2014 and 2013, respectively, the Company has adjusted its net income for the effect of these participating securities as follows:



	2015			2014			2013
Net income attributed to Vector Group Ltd.	$	59,198		$	36,856		$	37,300
Income attributable to participating securities	(1,752		)	(1,024		)	(1,023		)
Net income available to common stockholders attributed to Vector Group Ltd.	$	57,446		$	35,832		$	36,277

Basic EPS is computed by dividing net income available to common stockholders attributed to Vector Group Ltd. by the weighted-average number of shares outstanding, which includes vested restricted stock.

Diluted EPS includes the dilutive effect of non-vested restricted stock grants, stock options and convertible securities. Diluted EPS is computed by dividing net income available to common stockholders by the diluted weighted-average number of shares outstanding, which includes dilutive non-vested restricted stock grants, stock options and convertible securities.

Basic and diluted EPS were calculated using the following shares for the years ended December 31, 2015, 2014 and 2013:



	2015	2014	2013
Weighted-average shares for basic EPS	117,760,538	108,075,400	100,886,113
Plus incremental shares related to stock options and non-vested restricted stock	32,030	66,732	261,837
Weighted-average shares for diluted EPS	117,792,568	108,142,132	101,147,950

The following non-vested restricted stock and shares issuable upon the conversion of convertible debt were outstanding during the years ended December 31, 2015, 2014 and 2013 but were not included in the computation of diluted EPS because the exercise prices of the options and the per share expense associated with the restricted stock were greater than the average market price of the common shares during the respective periods, and the impact of common shares issuable under the convertible debt were anti-dilutive to EPS.



	Year Ended December 31,
	2015		2014		2013
Weighted-average shares of non-vested restricted stock	N/A		N/A		30,319
Weighted-average expense per share	N/A		N/A		$	15.10
Weighted-average number of shares issuable upon conversion of debt	25,113,350		32,216,245		30,862,794
Weighted-average conversion price	$	19.55	$	16.83	$	13.81

The Company’s convertible debt was anti-dilutive in 2015, 2014 and 2013.

Investment Securities Available for Sale

12 Months Ended

Dec. 31, 2015

Available-for-sale Securities [Abstract]

INVESTMENT SECURITIES AVAILABLE FOR SALE

The components of investment securities available for sale at December 31, 2015 were as follows:



	Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Marketable equity securities	$	47,502	$	19,833	$	(62	)	$	67,273
Mutual funds invested in fixed income securities	20,126		—		(15		)	20,111
Marketable debt securities	94,540		52		—			94,592
Total investment securities available for sale	$	162,168	$	19,885	$	(77	)	$	181,976

The components of investment securities available for sale at December 31, 2014 were as follows:



	Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Marketable equity securities	$	46,695	$	32,018	$	(1,104	)	$	77,609
Mutual funds invested in fixed income securities	61,485		—		(1,659		)	59,826
Marketable debt securities	130,111		2,470		(916		)	131,665
Total investment securities available for sale	$	238,291	$	34,488	$	(3,679	)	$	269,100

The table below summarizes the maturity dates of marketable debt securities at December 31, 2015.



Investment Type:	Fair Value		Under 1 Year		1 Year up to 5 Years		More than 5 Years
U.S. Government securities	$	28,132	$	—	$	28,132	$	—
Corporate securities	41,561		2,154		39,347		60
U.S. mortgage-backed securities	5,790		636		5,003		151
Commercial mortgage-backed securities	8,728		5,739		715		2,274
U.S. asset-backed securities	8,276		2,342		5,934		—
Index-linked U.S. bonds	2,105		—		2,105		—
Total marketable debt securities by maturity dates	$	94,592	$	10,871	$	81,236	$	2,485

The available-for-sale investment securities with continuous unrealized losses for less than 12 months and 12 months or greater and their related fair values were as follows:



	In loss position for
	Less than 12 months					12 months or more
	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses			Total Fair Value		Total Unrealized Losses
December 31, 2015
Marketable equity securities	$	5,938	$	(62	)	$	—	$	—		$	5,938	$	(62	)
Mutual funds invested in fixed income securities	10,053		(15		)						10,053		(15		)
	$	15,991	$	(77	)	$	—	$	—		$	15,991	$	(77	)

December 31, 2014
Marketable equity securities	$	6,599	$	(138	)	$	3,534	$	(966	)	$	10,133	$	(1,104	)
Mutual funds invested in fixed income securities	59,826		(1,659		)	—		—			59,826		(1,659		)
Marketable debt securities
U.S. Government securities	22,375		(18		)	—		—			22,375		(18		)
Corporate securities	30,896		(204		)	7,224		(131		)	38,120		(335		)
U.S. mortgage-backed securities	3,370		(26		)	—		—			3,370		(26		)
Commercial mortgage-backed securities	11,332		(46		)	5,176		(432		)	16,508		(478		)
U.S. asset-backed securities	15,228		(29		)	—		—			15,228		(29		)
Index-linked U.S. bonds	2,098		(30		)	—		—			2,098		(30		)
	$	151,724	$	(2,150	)	$	15,934	$	(1,529	)	$	167,658	$	(3,679	)

Unrealized losses from fixed-income securities are primarily attributable to changes in interest rates. Unrealized losses

from equity and debt securities are due to market price movements. The Company believes the unrealized losses associated with the Company's equity securities will be recovered in the future.

Gross realized gains and losses on available-for-sale investment securities were as follows:



	Year Ended December 31,
	2015			2014			2013
Gross realized gains on sales	$	13,727		$	275		$	5,538
Gross realized losses on sales	(2,589		)	(286		)	(386		)
Gains (losses) on sale of investment securities available for sale	$	11,138		$	(11	)	$	5,152

Gross realized losses on other-than-temporary impairments	$	(12,846	)	$	—		$	—

The Company recorded an “Other-than-temporary-impairment” charge of $12,846 for the year ended December 31, 2015. The largest component of this total charge was $6,895 related to Morgans Hotel Group Co., a company where Vector's President and Chief Executive Officer also serves as Chairman of the Board of Directors.

Although management generally does not have the intent to sell any specific securities at the end of the period, in the ordinary course of managing the Company's investment securities portfolio, management may sell securities prior to their maturities for a variety of reasons, including diversification, credit quality, yield and liquidity requirements and the funding of obligations of the Company.

Proceeds from investment securities sales totaled $270,576, $154,615 and $117,021 and proceeds from early redemptions by issuers totaled $14,230, $2,779 and $708 for the years ended December 31, 2015, 2014 and 2013, respectively, mainly from sales of Corporate securities and U.S. Government securities.

- Definition

The entire disclosure for investments in certain debt and equity securities.

+ References + Details

Inventories

12 Months Ended

Dec. 31, 2015

Inventory, Net [Abstract]

INVENTORIES

Inventories consist of:



	December 31, 2015			December 31, 2014
Leaf tobacco	$	49,856		$	49,948
Other raw materials	3,578			3,532
Work-in-process	789			879
Finished goods	61,493			62,876
E-Cigarettes	80			3,079
Inventories at current cost	115,796			120,314
LIFO adjustments	(29,280		)	(29,991		)
	$	86,516		$	90,323

All of the Company’s inventories, excluding amounts related to prepaid MSA cost and federal excise taxes, at December 31, 2015 and 2014 have been reported under the LIFO method. The $29,280 LIFO adjustment as of December 31, 2015 decreases the current cost of inventories by $19,863 for leaf tobacco, $643 for other raw materials, $33 for work-in-process, $8,736 for finished goods and $5 for E-Cigarettes. The $29,991 LIFO adjustment as of December 31, 2014 decreased the current cost of inventories by $19,941 for leaf tobacco, $861 for other raw materials, $39 for work-in-process, $9,054 for finished goods and $96 for E-Cigarettes. Cost of goods sold was reduced by $1,703 for the year ended December 31, 2015 due to liquidations of LIFO inventories.

The Company has a leaf inventory management program whereby, among other things, it is committed to purchase certain quantities of leaf tobacco. The purchase commitments are for quantities not in excess of anticipated requirements and are at prices, including carrying costs, established at the commitment date. At December 31, 2015, Liggett had tobacco purchase commitments of approximately $15,466. The Company has a single source supply agreement for fire safe cigarette paper through 2019.

The Company capitalizes the incremental prepaid cost of the MSA and federal excise taxes in ending inventory. Each year, the Company capitalizes in inventory that portion of its MSA liability that relates to cigarettes shipped to the public warehouses but not sold. The amount of capitalized MSA cost in “Finished goods” inventory was $15,796 and $14,369 at December 31, 2015 and 2014, respectively. Federal excise tax in inventory was $23,455 at December 31, 2015 and $22,642 at December 31, 2014.

Property, Plant and Equipment

12 Months Ended

Dec. 31, 2015

Property, Plant and Equipment [Abstract]

PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consist of:



	December 31, 2015			December 31, 2014
Land and improvements	$	1,442		$	1,442
Buildings	15,908			15,418
Machinery and equipment	178,131			167,090
Leasehold improvements	21,142			17,212
	216,623			201,162
Less accumulated depreciation and amortization	(140,991		)	(117,050		)
	$	75,632		$	84,112

Depreciation and amortization expense related to property, plant and equipment for the years ended December 31, 2015, 2014 and 2013 was $20,423, $17,843 and $11,063, respectively.

Future machinery and equipment purchase commitments at Liggett were $832 and $3,266 at December 31, 2015 and 2014, respectively.

Long Term Investments

12 Months Ended

Dec. 31, 2015

Long-term Investments [Abstract]

LONG-TERM INVESTMENTS

Long-term investments consist of the following:



	December 31, 2015		December 31, 2014
Investments accounted at cost	$	41,231	$	32,239
Investments accounted under the equity method	21,495		20,484
	$	62,726	$	52,723

(a) Cost-Method Investments:

Long-term investments consist of the following investments accounted for at cost:



	December 31, 2015				December 31, 2014
	Carrying Value		Fair Value		Carrying Value		Fair Value
Investment partnerships	$	40,730	$	44,217	$	31,541	$	38,039
Real estate partnership	501		552		698		1,108
	$	41,231	$	44,769	$	32,239	$	39,147

The principal business of the investment partnerships is investing in investment securities and real estate. The estimated fair value of the investment partnerships was provided by the partnerships based on the indicated market values of the underlying assets or investment portfolio. The investments in these investment partnerships are illiquid and the ultimate realization of these investments is subject to the performance of the underlying partnership and its management by the general partners. In the future, the Company may invest in other investments, including limited partnerships, real estate investments, equity securities, debt securities, derivatives and certificates of deposit, depending on risk factors and potential rates of return.

If it is determined that an other-than-temporary decline in fair value exists in long-term investments, the Company records an impairment charge with respect to such investment in its consolidated statements of operations. The Company will continue to perform additional assessments to determine the impact, if any, on the Company’s consolidated financial statements. Thus, future impairment charges may occur.

The Company has accounted for these investments using the cost method of accounting because the investments did not meet the requirements for equity method accounting.

The Company invested an aggregate $5,000 in three additional investment partnerships in 2015. The principal business of these investment partnerships is investing in investment securities. The Company also invested $5,000 in a reinsurance company in 2015. The Company received cash distributions of $587, $549 and $769 from limited partnerships in 2015, 2014 and 2013, respectively.

The long-term investments are carried on the consolidated balance sheet at cost. The fair value determination disclosed above

would be classified as Level 3 under fair value hierarchy disclosed in Note 18 if such assets were recorded on the consolidated balance sheet at fair value. The fair value determinations disclosed above were based on company assumptions, and information obtained from the partnerships based on the indicated market values of the underlying assets of the investment portfolio.

(b) Equity-Method Investments:

Long-term investments consist of the following investments accounted for under the equity method:



	December 31, 2015		December 31, 2014
Indian Creek Investors LP	$	4,989	$	8,053
Boyar Value Fund	7,302		—
Ladenburg Thalmann Financial Services Inc.	9,204		12,173
Castle Brands, Inc.	—		258
	$	21,495	$	20,484

The Company's investments accounted for under the equity method include the following: Indian Creek Investors LP (“Indian Creek”), Boyar Value Fund (“Boyar”), Ladenburg Thalmann Financial Services Inc. (“LTS”) and Castle Brands Inc. (“Castle”). At December 31, 2015, the Company's ownership percentages in Indian Creek, Boyar, LTS and Castle were 19.93%, 29.92%, 7.84% and 7.99%, respectively. The Company accounted for Indian Creek and Boyar interests as equity-method investments because the Company's ownership percentage meets the threshold for equity-method accounting. The Company accounted for the LTS and Castle interests as equity-method investments because the Company has the ability to exercise significant influence over their operating and financial policies.

The Company's investments under the equity method include an investment in the common stock of Boyar. As of December 31, 2015, the Company owned approximately 30% of the outstanding stock of Boyar. The value of the investment based on the quoted market price as of December 31, 2015 was $7,302, equal to its carrying value. Ladenburg Thalmann Fund Management, LLC, an indirect subsidiary of “LTS”, is the manager of Boyar.

At December 31, 2015, the aggregate values of the LTS and Castle investments based on the quoted market price were $39,167 and $15,585, respectively. The difference between the amount at which the LTS and Castle investments are carried and the amount of underlying equity in net assets was $21,463 and $1,848, respectively. This basis difference represents goodwill and is being accounted for as part of the equity investment.

The principal business of Indian Creek is investing in investment securities. Fair value approximates carrying value. The estimated fair value of the investment partnership was provided by the partnership based on the indicated market values of the underlying assets or investment portfolio. The investment in the investment partnership is illiquid and the ultimate realization of the investment is subject to the performance of the underlying partnership and its management by the general partners.

The Company received cash distributions of $2,364, $3,283 and $12,358 from the Company's investments in long-term investments under the equity method in 2015, 2014 and 2013, respectively. The 2013 distribution was primarily related to the repayment of a note from LTS. The Company recognized equity in losses in long-term investments under the equity method of $2,681 in 2015. The Company recognized equity in earnings in long-term investments under the equity method of $3,140 and $3,126 in 2014 and 2013, respectively. The Company has suspended its recognition of equity losses in Castle to the extent such losses exceed its basis.

The long-term investments are carried on the consolidated balance sheet at cost under the equity method of accounting. The fair value determination disclosed above would be classified as Level 3 under fair value hierarchy disclosed in Note 18 if such assets were recorded on the consolidated balance sheet at fair value.

Pursuant to Rule 4-08(g), the following summarized financial data for unconsolidated subsidiaries includes information for Indian Creek and Boyar Value Fund.



	December 31, 2015		December 31, 2014
Investment securities	$	40,676	$	71,331
Cash and cash equivalents	101		309
Other assets	8,664		32
Total assets	$	49,441	$	71,672

Other liabilities	$	408	$	6,571
Total liabilities	408		6,571
Partners' capital	49,033		65,101
Total liabilities and partners' capital	$	49,441	$	71,672



	Year Ended December 31,
	2015			2014			2013
Investment income	$	565		$	3,314		$	565
Expenses	(868		)	(1,298		)	(839		)
Net investment (loss) income	(303		)	2,016			(274		)
Total net realized (loss) gain and net change in unrealized depreciation from investments	(14,809		)	(168		)	16,496
Net (decrease) increase in partners' capital resulting from operations	$	(15,112	)	$	1,848		$	16,222

Pursuant to Rule 4-08(g) is the following summarized financial data for LTS. The Company has elected a three-month lag reporting period for LTS.



	September 30, 2015			September 30, 2014
Cash and cash equivalents	$	114,548		$	94,952
Receivables from clearing brokers, note receivable and other receivable, net	115,334			123,947
Goodwill and intangible assets, net	269,774			211,862
Other assets	63,634			62,571
Total assets	$	563,290		$	493,332

Accrued compensation, commissions and fees payable	$	72,936		$	61,205
Accounts payable and accrued liabilities	24,615			22,328
Notes payable, net of $1,655 and $951 unamortized discount in 2015 and 2014, respectively	59,184			62,131
Other liabilities	21,487			32,802
Total liabilities	178,222			178,466
Preferred stock	1			1
Common stock	19			18
Additional paid-in capital	517,988			452,263
Accumulated deficit	(132,952		)	(137,406		)
Total controlling shareholders' equity	385,056			314,876
Non-controlling interest	12			(10		)
Total shareholders' equity	385,068			314,866
Total liabilities and shareholders' equity	$	563,290		$	493,332

(1) The table above presents the nature and amounts of the major components of assets and liabilities, along with information regarding redeemable stock and non-controlling interest.



	Twelve Months Ended September 30,
	2015			2014			2013
Revenues	$	1,122,735		$	867,756		$	753,840
Expenses	(1,132,010		)	(856,072		)	(756,988		)
Gross (loss) profit	(9,275		)	11,684			(3,148		)
Change in fair value of contingent consideration	31			12			(121		)
(Loss) income from continuing operations	(9,244		)	11,696			(3,269		)
Net income (loss)	$	4,396		$	22,482		$	(5,389	)

Pursuant to Rule 4-08(g) is the following summarized financial data for Castle. The Company has elected a three-month lag reporting period for Castle.



	September 30, 2015		September 30, 2014
Current assets	$	36,922	$	31,121
Non-current assets	9,845		9,834
Total assets	$	46,767	$	40,955

Current liabilities	$	9,947	$	8,703
Non-current liabilities	13,696		12,028
Total liabilities	23,643		20,731
Total controlling shareholders' equity	19,978		17,490
Non-controlling interest	3,146		2,734
Total shareholders' equity	23,124		20,224
Total liabilities and shareholders' equity	$	46,767	$	40,955



	Twelve Months Ended September 30,
	2015			2014			2013
Revenues	$	67,143		$	51,426		$	43,484
Expenses	(41,317		)	(32,495		)	(28,117		)
Gross profit	25,826			18,931			15,367
Other expenses	(25,920		)	(20,399		)	(19,176		)
Loss from continuing operations	(94		)	(1,468		)	(3,809		)
Net loss	$	(2,946	)	$	(4,845	)	$	(8,604	)

New Valley LLC

12 Months Ended

Dec. 31, 2015

Schedule of Investments [Abstract]

NEW VALLEY LLC

(a) Residential Brokerage Business Acquisition.

New Valley is engaged in the real estate business and is seeking to acquire additional real estate properties and operating companies. On December 13, 2013, an affiliate of New Valley acquired an additional 20.59% interest in Douglas Elliman from Prudential Real Estate Financial Services of America, Inc. for a purchase price of $60,000 in cash. The acquisition increased the Company’s ownership position in Douglas Elliman from 50% to 70.59%.

As of December 31, 2012, the Company owned a 50% interest in Douglas Elliman, and the Company accounted for its 50% using the equity method of accounting. The Company consolidated Douglas Elliman on December 13, 2013 and recognized a gain of $60,842 to account for the difference between the carrying value and the fair value of the previously held 50% interest. The fair value of the equity interest immediately prior to the acquisition was $84,859. The Company used a combination of a discounted cash flow analysis and market-based valuation methodologies, which represent Level 3 fair value measurements, to measure the fair value of Douglas Elliman and to perform its preliminary purchase price allocation.

In 2014, the Company reassessed its initial purchase accounting allocations. The following table reconciles initial allocation to final allocation of acquired assets and liabilities:



	Preliminary December 13, 2013		Measurement Period Adjustments			Final December 13, 2013
	Preliminary December 13, 2013		Measurement Period Adjustments			Final December 13, 2013
Cash and cash equivalents	$	116,935	$	—		$	116,935
Other current assets	12,647		—			12,647
Property, plant and equipment, net	20,275		—			20,275
Goodwill	72,135		(1,729		)	70,406
Trademarks	80,000		—			80,000
Other intangible assets, net	12,928		5,856			18,784
Other non-current assets	3,384		—			3,384
Total assets acquired	$	318,304	$	4,127		$	322,431

Notes payable - current	$	201	$	—		$	201
Other current liabilities	26,247		105			26,352
Notes payable - long term	420		—			420
Other long-term liabilities	—		4,022			4,022
Total liabilities assumed	$	26,868	$	4,127		$	30,995

Net assets acquired	$	291,436	$	—		$	291,436

Non-controlling interest	$	85,703	$	—		$	85,703

Revenues of the acquired operations from December 13, 2013 through December 31, 2013 were $20,482 and net income was $732.

Equity Method of Accounting. Prior to December 13, 2013, New Valley accounted for its 50% interest in Douglas Elliman under the equity method of accounting. New Valley’s equity income from Douglas Elliman was $22,974 for the period of January 1 through December 13, 2013.

Summarized financial information for the period January 1 through December 13, 2013 for Douglas Elliman is presented below. Included in the results was a management fee paid to the Company of $2,204 for the period of January 1 through December 13, 2013.



	January 1 through December 13,
	2013
Revenues	$	416,453
Costs and expenses	369,852
Depreciation expense	3,790
Amortization expense	213
Other income (expense)	(22		)
Interest expense, net	23
Income tax expense	996
Net income	$	41,557

Douglas Elliman’s current operations are primarily located in the New York, Miami and Los Angeles metropolitan areas. Local and regional economic and general business conditions in these markets could differ materially from prevailing conditions in other parts of the country.

(b) Investments in real estate ventures.

New Valley also holds equity investments in various real estate projects domestically and internationally.

The components of “Investments in real estate ventures” were as follows:



	December 31, 2015		December 31, 2014

Land Development - Milanosesto Holdings (Sesto Holdings)	$	—	$	5,037

10 Madison Square Park (1107 Broadway)	11,391		6,383
The Marquand (11 East 68th Street)	13,900		12,000
11 Beach Street	13,209		12,328
20 Times Square (701 Seventh Avenue)	14,985		12,481
111 Murray Street	25,567		27,319
160 Leroy Street	3,952		1,467
215 Chrystie Street	5,592		3,300
The Dutch (25-19 43rd Avenue)	1,077		733
Queens Plaza (23-10 Queens Plaza South)	16,177		11,082
87 Park (8701 Collins Avenue)	8,658		6,144
125 Greenwich Street	9,750		9,308
West Hollywood Edition (9040 Sunset Boulevard)	10,510		5,604
76 Eleventh Avenue	17,967		—
Monad Terrace	6,608		—
Takanasee	4,680		—
Condominium and Mixed Use Development	164,023		108,149

Maryland Portfolio	—		3,234
ST Portfolio	15,754		15,283
Apartment Buildings	15,754		18,517

Park Lane Hotel	19,697		19,341
Hotel Taiwana	7,069		7,629
Coral Beach and Tennis Club	3,159		2,816
Hotels	29,925		29,786

The Plaza at Harmon Meadow	5,449		—
Commercial	5,449		—

Other	2,017		1,971

Investments in real estate ventures	$	217,168	$	163,460

Land Development:

Milanosesto Holdings. In October 2010, New Valley acquired a 7.2% interest in Sesto Holdings S.r.l. (“Sesto”) for $5,000. Sesto holds a 42% interest in an entity that has purchased a land plot of approximately 322 acres in Milan, Italy. Sesto intended to develop the land plot as a multi-parcel, multi-building mixed use urban regeneration project. During the fourth quarter of 2015, New Valley exercised a put and recovered its entire investment. Sesto is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for Sesto under the equity method of accounting. New Valley had no exposure to loss as a result of its investment in Sesto at December 31, 2015. The investment has concluded.

Condominium and Mixed Use Development:

10 Madison Square Park . During 2011, New Valley invested $5,489 for an approximate indirect 5% interest in MS/WG 1107 Broadway Holdings LLC. In September 2011, MS/WG 1107 Broadway Holdings LLC acquired the 1107 Broadway property in Manhattan, NY. The joint venture is converting a 260,000-square-foot office building into a luxury residential condominium in the Flatiron District / NoMad neighborhood of Manhattan. MS/WG 1107 Broadway Holdings LLC is a variable interest entity; however, New Valley is not the primary beneficiary. During 2015, all partners in the joint venture contributed pro-rata amounts to the joint venture, and New Valley’s portion was $3,217. New Valley accounts for MS/WG 1107 Broadway Holdings LLC under the equity method of accounting. New Valley received distributions of $2,449 for the year ended December 31, 2014 and recognized equity income of $1,010 for the year ended December 31, 2015 and equity income of $2,254 for the year ended December 31, 2014. New Valley’s maximum exposure to loss as a result of its investment in MS/WG 1107 Broadway Holdings LLC was $10,610 at December 31, 2015.

The Whitman. In February 2011, New Valley invested $900 for an approximate 12% interest in Lofts 21 LLC. Lofts 21 LLC acquired an existing property in Manhattan to develop into a luxury residential condominium which was marketed as The Whitman. The property is located in the Flatiron District / NoMad neighborhood. Construction had been completed and three of the four units were sold in 2013 and the remaining unit was sold in 2014.

The investment in Lofts 21 LLC is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for Lofts 21 LLC under the equity method of accounting. New Valley received distributions of $1,717 for the year ended December 31, 2014, and recorded equity income of $552 and $525 for the years ended December 31, 2014 and 2013, respectively. . The investment concluded in 2014.

The Marquand. In December 2011, New Valley invested $7,000 for an approximate 18% interest in a condominium conversion project. The building is a 12-story, 105,000 square foot residential rental building located on 68th Street between Fifth Avenue and Madison Avenue in Manhattan. Of the 29 units available for sale, five units were sold in 2015 and eight units were sold in 2014.

The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley recorded equity income of $1,900 and $5,000 for the years ended December 31, 2015 and 2014, respectively. New Valley’s maximum exposure to loss as a result of its investment in The Marquand was $13,900 at December 31, 2015.

11 Beach Street. New Valley invested $9,642 in June 2012 and $1,519 in 2013 for an approximate 49.5% interest in 11 Beach Street Investor LLC (the “Beach JV”). Beach JV plans to renovate and convert an existing office building in Manhattan into a luxury residential condominium. During 2014, all partners in the joint venture contributed pro-rata amounts to the joint venture, and New Valley’s portion was $2,178. During 2014, all partners in the joint venture received pro-rata amounts from the joint venture for contributions in excess of need, and New Valley’s portion was $1,010. Beach JV is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for its interest in Beach JV under the equity method of accounting. New Valley recorded equity loss of $521 for the year ended December 31, 2015. New Valley’s maximum exposure to loss on its investment in Beach JV was $11,807 at December 31, 2015.

20 Times Square. In August and September 2012, New Valley invested a total of $7,800 for an approximate 11.5% interest in a joint venture that acquired property located at 701 Seventh Avenue in Times Square in Manhattan. The joint venture plans to redevelop the property for retail space and signage, as well as a site for a hotel. The investment closed in October 2012 and New Valley invested an additional $1,507 at closing. All partners in the joint venture contributed pro-rata amounts to the joint venture, and New Valley’s portion was $1,035 and $2,421 in 2015 and 2014, respectively. All partners in the joint venture received pro-rata amounts from the joint venture for contributions in excess of need, and New Valley’s portion was $1,088 for the year ended December 31, 2014.

New Valley may have additional future capital contributions of approximately $14,000. The property is located on the northeast corner of Seventh Avenue and 47th Street. The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley recorded equity loss of $9 for the year ended December 31, 2015. New Valley’s maximum exposure to loss as a result of its investment in NV 701 Seventh Avenue was $13,507 at December 31, 2015.

111 Murray Street. In May 2013, New Valley acquired a 25% interest in a joint venture, which had the rights to acquire a 15-story building on a 31,000 square-foot lot in the TriBeCa neighborhood of Manhattan. In July 2013, the joint venture closed on the acquisition of the property. The joint venture is building a mixed-use property that includes both commercial space and a 157-unit, luxury condominium building on the building’s site. Development began in 2014 and is expected to be completed by September 2018. New Valley had invested $27,319 in the joint venture as of December 31, 2014 in the form of capital contributions and a loan bearing interest at 12% per annum, compounded quarterly, to the joint venture partner. All partners in the joint venture contributed pro-rata amounts to the joint venture, and New Valley’s portion was $9,617 for the year ended December 31, 2015. During 2015, all partners in the joint venture received pro-rata amounts from the joint venture for contributions in excess of need, and New Valley’s portion was $11,204. In 2015, a new partner was admitted into the joint venture. As a result of this admission, New Valley recognized a gain of $344 and New Valley's ownership in the project decreased to 9.5%. The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley recorded equity loss of $165 for the year ended December 31, 2015. New Valley’s maximum exposure to loss as a result of its investment was $25,567 as of December 31, 2015.

160 Leroy Street. In March 2013, a subsidiary of New Valley, NV Leroy LLC, invested $1,150 for an approximate 5% interest in a development site in the West Greenwich Village neighborhood of Manhattan. The site is being developed as a high-rise condominium that will face the Hudson River. Subsequent to its initial investment, New Valley acquired a 50% partner in its investment in NV Leroy LLC. The investment in NV Leroy LLC is a variable interest entity and New Valley is the primary beneficiary. As a result of the consolidation of NV Leroy LLC, New Valley carries its investment at $3,952 and non-controlling interest of $1,924 related to the investment. All partners in the joint venture contributed pro-rata amounts to the joint venture, and New Valley’s portion was $702 and $317 in 2015 and 2014, respectively. In 2015, a new partner was admitted into the joint venture. As a result of this admission, New Valley recognized a gain of $1,680 and New Valley's ownership in the project decreased to 3.1%. NV Leroy LLC interest in the development project is a variable interest entity; however, NV Leroy LLC is not the primary beneficiary. NV Leroy LLC accounts for this investment under the equity method of accounting. New Valley’s maximum exposure to loss as a result of its investment in 160 Leroy Street was $1,925 at December 31, 2015.

215 Chrystie Street. In December 2012, New Valley invested $1,973 for an approximate 49% interest in WG Chrystie LLC (“Chrystie Street”) which owns a 37.5% ownership interest in 215 Chrystie Venture LLC which, through its affiliate, owns a condominium conversion project located in Manhattan. The joint venture plans to develop the property into a 29-story mixed-use property with PUBLIC, an Ian Schrager-branded boutique hotel, and luxury condominium residences. All partners in the joint venture contributed pro-rata amounts to the joint venture, and New Valley’s portion was $1,997 and $1,252 in 2015 and 2014, respectively. The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley recorded equity loss of $194 for the year ended December 31, 2015. New Valley’s maximum exposure to loss as a result of its investment in Chrystie Street was $5,103 at December 31, 2015.

25-19 43rd Avenue - The Dutch LIC. In May 2014, New Valley invested $733 for an approximate 9.9% interest in 43rd Avenue Investors LLC. The joint venture plans to develop 87,000 square feet of residential condominium units in Long Island City, New York. Construction of the 86-unit building commenced in September 2014. In 2015, all partners in the venture contributed pro-rata amounts to the venture, and New Valley’s portion was $247. New Valley’s investment percentage did not change. The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley’s maximum exposure to loss as a result of its investment in 43rd Avenue Investors LLC was $980 at December 31, 2015.

Queens Plaza South. In December 2012 and August 2013, New Valley invested $7,350 for an approximate 45.4% interest in QPS 23-10 Venture LLC which through its affiliate owns a condominium conversion project, 23-10 Queens Plaza South, located in Queens, New York. All partners in the venture contributed pro-rata amounts to the venture, and New Valley’s portion was $3,630 and $4,532 in 2015 and 2014, respectively. During 2014, all partners in the venture received pro-rata amounts from the venture for contributions in excess of need, and New Valley’s portion was $1,508. New Valley’s investment percentage did not change. The joint venture plans to develop a new apartment tower with 472,574 square feet of residential space. The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley recorded equity loss of $2 for the year ended December 31, 2015. New Valley’s maximum exposure to loss as a result of its investment in Queens Plaza South was $14,710 at December 31, 2015.

87 Park. In December 2013, New Valley invested $3,750 in a joint venture to acquire a 15% interest in an oceanfront development site in Miami Beach, Florida, which will be developed into a residential condominium building. In 2015 and 2014, all partners in the venture contributed pro-rata amounts to the venture, and New Valley’s portion was $2,275 and $2,250, respectively. New Valley’s investment percentage did not change. The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley recorded equity loss of $584 for the year ended December 31, 2015 and equity income of $100 for the year ended December 31, 2014. New Valley’s maximum exposure to loss as a result of its investment in 87 Park was $7,835 at December 31, 2015.

125 Greenwich Street. In August 2014, New Valley invested $7,308 for an approximate 78.5% interest in NV Greenwich LLC. The investment in NV Greenwich is a variable interest entity and New Valley is the primary beneficiary. As a result of the consolidation of NV Greenwich LLC, New Valley carries its investment at $9,750 and has non-controlling interest of $1,916 related to the investment. In 2015, all partners in the venture contributed pro-rata amounts to the venture, and New Valley’s portion was $6,359. During 2015, all partners in the joint venture received amounts from the joint venture and New Valley’s portion was $7,348. NV Greenwich LLC ultimately owns 13.3% 125 Greenwich JV LLC. The joint venture plans to develop a residential condominium tower in lower Manhattan. The investment in 125 Greenwich JV LLC is a variable interest entity; however, NV Greenwich LLC is not the primary beneficiary. NV Greenwich LLC accounts for this investment under the equity method of accounting. New Valley recorded equity income of $600 for the year ended December 31, 2015. New Valley's maximum exposure to loss as a result of its investment in 125 Greenwich Street was $7,003 at December 31, 2015.

West Hollywood Edition. In October 2014, New Valley invested $5,604 for an approximate 48.5% interest in 9040 Sunset Boulevard. In 2015, all partners in the venture contributed pro-rata amounts to the venture, and New Valley’s portion was $4,123. New Valley’s investment percentage did not change. The joint venture plans to develop a hotel and condominium complex. The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley recorded equity loss of $89 for the year ended December 31, 2015. New Valley’s maximum exposure to loss as a result of its investment in 9040 Sunset Boulevard was $9,638 at December 31, 2015. New Valley and its partner have jointly and severally guaranteed approximately $50,000 of a construction loan. Each partner has agreed to indemnify the other for their respective percentage share. The guarantee is automatically reduced for all additional capital contributions New Valley and its partner contribute to the investment, and for any additional equity raised for the project. If New Valley is required to make a payment under the guarantee, the payment would constitute a capital contribution and increase New Valley's investment in the venture.

76 Eleventh Avenue. In May 2015, New Valley invested $17,000 for an approximate 5.1% interest in HFZ 76 Eleventh Holdco LLC. The joint venture plans to develop luxury residential condominium building in the Chelsea neighborhood of Manhattan, NY. The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley’s maximum exposure to loss as a result of its investment in 76 Eleventh Avenue was $17,000 at December 31, 2015.

Monad Terrace. In May 2015, New Valley invested $6,200 for an approximate 31.3% interest in Monad Terrace LLC. The joint venture plans to develop luxury residential condominium building in Miami Beach, FL. The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley recorded equity loss of $196 for the year ended December 31, 2015. New Valley’s maximum exposure to loss as a result of its investment in Monad Terrace was $6,242 at December 31, 2015.

Takanasee. In December 2015, New Valley invested $4,428 for an approximate 22.8% interest in Takanasee Developers LLC. The joint venture plans to develop a luxury oceanfront community composed of single and multi family homes in Long Branch, NJ. The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley’s maximum exposure to loss as a result of its investment in Takanasee was $4,428 at December 31, 2015.

New Valley capitalized $9,928 of interest expense into the carrying value of its ventures whose projects were currently under development during the year ended December 31, 2015.

Douglas Elliman has been engaged by the developers as the sole broker or the co-broker for several of the real estate development projects that New Valley owns an interest in through its joint venture investments. Douglas Elliman had gross commissions of approximately $3,077 for the year ended December 31, 2015 from these projects.

Apartment & Office Buildings:

Maryland Portfolio. In July 2012, New Valley invested $5,000 for an approximate 30% interest in a joint venture that owns a 25% interest in a portfolio of approximately 5,500 apartment units primarily located in Baltimore County, Maryland. The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley received distributions of $2,059 and $613 for the years ended December 31, 2015 and 2014, respectively. New Valley recorded equity loss of $1,175, equity income of $349 and equity loss of $542 for the years ended December 31, 2015, 2014, and 2013, respectively. New Valley’s maximum exposure to loss as a result of its investment in NV Maryland was $0 at December 31, 2015. New Valley has suspended its recognition of equity losses in Maryland Portfolio to the extent such losses exceed its basis.

ST Portfolio. In November 2013, New Valley invested $16,365 for an approximate 16.4% interest in a joint venture that owns two Class A multi-family rental assets in partnership with Winthrop Realty Trust. The two buildings are located in Houston, Texas and Stamford, Connecticut. The buildings include 488 apartment units and approximately 20,000 square feet of retail space.The Phoenix, Arizona and San Pedro, California buildings were sold in 2015 and 2014, respectively, and the proceeds were used to pay down debt. The investment is not a variable interest entity. New Valley accounts for this investment under the equity method of accounting. New Valley received a distribution of $1,231 and $693 for the years ended December 31, 2015 and 2014, respectively, and recorded equity income of $1,702 and an equity loss of $8 and $381 for the years ended December 31, 2015, 2014 and 2013, respectively. New Valley’s maximum exposure to loss as a result of its investment in ST Portfolio was $15,754 at December 31, 2015.

Hotels:

Park Lane Hotel. In November 2013, New Valley acquired an approximate 5% interest in a joint venture that acquired the Park Lane Hotel, which is presently a 47-story, 605-room independent hotel. The joint venture is developing plans for a future use. The development is estimated to take approximately 30 months from commencement of construction. New Valley had invested $19,341 in the joint venture as of December 31, 2014. New Valley contributed an additional of $1,895 in 2015, along with the contributions of additional capital of the investment partners. New Valley's ownership percentage did not change.

The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley recorded an equity loss of $1,539 and $2,643 for the years ended December 31, 2015 and 2014 and income of $183 for the years ended December 31, 2013, related to the hotel operations. New Valley’s maximum exposure to loss as a result of its investment in Park Lane Hotel was $19,697 at December 31, 2015.

Hotel Taiwana. In October 2011, New Valley invested $2,658 for an approximate 17% interest in Hill Street Partners LLP (“Hill”). Hill purchased a 37% interest in Hill Street SEP (“Hotel Taiwana”) which owned a portion of a hotel located in St. Barthelemy, French West Indies. The hotel consists of 30 suites, 6 pools, a restaurant, lounge and gym. New Valley contributed additional capital of $514 in 2014, along with contributions of additional capital by the other investment partners of Hill Street Partners LLP (“Hill”). New Valley’s investment percentage did not change. Hill used the contributions to purchase the remaining interest in Hotel Taiwana and make improvements to the property. The purpose of the investment is to renovate and the sell the hotel in its entirety or as hotel-condos.

The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. New Valley recorded an equity loss of $560 and $313 for the years ended December 31, 2015 and 2014, respectively, related to the hotel operations. New Valley recorded no equity income for the year ended December 31, 2013. New Valley’s maximum exposure to loss as a result of its investment in Hotel Taiwana was $7,069 at December 31, 2015.

Coral Beach. In December 2013, New Valley invested $3,030 to acquire a 49% interest in a joint venture that acquired a 52-acre private club in Bermuda. In 2015, all partners in the venture contributed pro-rata amounts to the venture, and New Valley’s portion was $1,377. New Valley’s investment percentage did not change. The property consists of the Horizons cottages, which includes 39 units, and Coral Beach and Tennis Club, which includes 62 hotel and cottage units. Renovation began on the Coral Beach and Tennis Club in 2014.

The investment is not a variable interest entity. New Valley accounts for this investment under the equity method of accounting. New Valley recorded an equity loss of $1,034, $1,299 and $66 for the years ended December 31, 2015, 2014 and 2013, respectively, related to the hotel operations. New Valley’s maximum exposure to loss as a result of its investment in Coral Beach was $3,159 at December 31, 2015.

Commercial:

Harmon Meadow. In March 2015, New Valley invested $5,931 to acquire a 49.0% in CSV-NV Harmon Meadow GP LLC. The purpose of the joint venture is to own and operate the Harmon Meadow retail shopping center in Secaucus, NJ. The investment is a variable interest entity; however, New Valley is not the primary beneficiary. New Valley accounts for this investment under the equity method of accounting. During 2015, New Valley received distributions of $480 and recorded equity loss of $2. New Valley’s investment percentage did not change. New Valley’s maximum exposure to loss as a result of its investment in Harmon Meadow was $5,449 at December 31, 2015.

Consolidated Variable Interest Entities:

It was determined that New Valley is the primary beneficiary of the NV Leroy LLC and NV Greenwich LLC entities as New Valley controls the activities that most significantly impact economic performance of the entities. Therefore, New Valley consolidates these VIEs.

The carrying amount of VIEs' assets that consolidated were $13,702 and $10,775 for the years ended December 31, 2015 and 2014, respectively. Those assets are owned by the VIEs, not the Company. Neither of the consolidated VIEs had non-recourse liabilities as of December 31, 2015 and 2014. A VIE's assets can only be used to settle obligations of that VIE. The VIEs are not guarantors of the Company's senior notes and other debts payable.

Pursuant to Rule 4-08(g), the following summarized financial data for unconsolidated subsidiaries includes information for the following entities: Land Development (Milanosesto Holdings), Condominium and Mixed Use Development (10 Madison Square Park, The Marquand, 11 Beach Street, 160 Leroy Street, 215 Chrystie Street, Queens Plaza South, 111 Murray Street, 87 Park, 20 Times Square, 25-19 43rd Avenue - The Dutch LIC, 76 Eleventh Avenue, Monad Terrace, West Hollywood Edition and 125 Greenwich Street) Apartment Buildings (ST Portfolio and Maryland Portfolio), Hotels (Coral Beach, Park Lane Hotel, and Hotel Taiwana) and Commercial (Harmon Meadow). New Valley has elected a one-month lag reporting period for 10 Madison Square Park, Hotel Taiwana, 11 Beach Street, Maryland Portfolio, 20 Times Square, 160 Leroy Street, 215 Chrystie Street, 87 Park, 125 Greenwich Street, Harmon Meadow,Monad Terrace, Park Lane Hotel, ST Portfolio, Coral Beach, and West Hollywood Edition. New Valley has elected a three-month lag reporting period for The Marquand, Queens Plaza South, 111 Murray Street, 25-19 43rd Avenue - The Dutch LIC and 76 Eleventh Avenue.

Land Development:



	December 31, 2015		December 31, 2014
Balance Sheets
Investment in real estate	$	—	$	759,038
Total assets	—		789,107
Total debt	—		520,760
Total liabilities	$	—	$	609,066

Condominium and Mixed Use Development:



	Year Ended December 31,
	2015		2014		2013
Income Statement
Revenue	$	141,884	$	182,635	$	39,120
Cost of Goods Sold	92,837		96,993		11,938
Other Expenses	10,672		6,798		22,375
Income from continuing operations	$	38,375	$	78,844	$	4,807



	December 31, 2015		December 31, 2014
Balance Sheets
Investment in real estate	$	2,921,611	$	1,617,397
Total assets	3,237,835		1,894,670
Total debt	2,014,682		1,121,099
Total liabilities	2,195,940		1,301,223
Non controlling interest	535,573		364,560

Apartment & Office Buildings:



	Year Ended December 31,
	2015		2014			2013
Income Statement
Revenue	$	83,871	$	85,704		$	59,917
Other Expenses	75,384		86,153			64,643
Income from continuing operations	$	8,487	$	(449	)	$	(4,726	)



	December 31, 2015			December 31, 2014
Balance Sheets
Investment in real estate	$	590,331		$	632,753
Total assets	626,513			669,368
Total debt	512,479			498,330
Total liabilities	529,692			511,027
Non controlling interest	(4,463		)	49,170

Hotels:



	Year Ended December 31,
	2015			2014			2013
Income Statement
Revenue	$	83,324		$	82,899		$	22,090
Cost of Goods Sold	3,837			3,064			3,691
Other Expenses	112,069			133,258			35,164
Loss from continuing operations	$	(32,582	)	$	(53,423	)	$	(16,765	)



	December 31, 2015		December 31, 2014
Balance Sheets
Investment in real estate	$	824,753	$	777,157
Total assets	894,447		903,677
Total debt	511,029		506,655
Total liabilities	538,426		540,706
Non controlling interest	294,470		295,051

Commercial:



	Year Ended December 31,
	2015			2014		2013
Income Statement
Revenue	$	5,638		$	—	$	—
Other Expenses	5,642			—		—
Loss from continuing operations	$	(4	)	$	—	$	—



	December 31, 2015		December 31, 2014
Balance Sheets
Investment in real estate	$	65,398	$	—
Total assets	67,343		—
Total debt	55,624		—
Total liabilities	56,415		—

Other:



	Year Ended December 31,
	2015		2014		2013
Income Statement
Revenue	$	3,030	$	2,714	$	2,558
Other Expenses	1,049		1,019		927
Income from continuing operations	$	1,981	$	1,695	$	1,631



	December 31, 2015		December 31, 2014
Balance Sheets
Total assets	$	5,157	$	4,786
Total liabilities	$	1,022	$	766

(d) Real Estate Held for Sale, net:

The components of “Real Estate Held for Sale, net” were as follows:



	December 31, 2015		December 31, 2014
Escena, net	$	10,716	$	10,643
Sagaponack	12,602		—
Investment in consolidated real estate businesses, net	$	23,318	$	10,643

Escena. In March 2008, a subsidiary of New Valley purchased a loan collateralized by a substantial portion of a 450-acre approved master planned community in Palm Springs, California known as “Escena.” In April 2009 New Valley completed the foreclosure process and took title to the collateral which consisted of 867 residential lots with site and public infrastructure, an 18-hole golf course, a substantially completed clubhouse, and a seven-acre site approved for a 450-room hotel.

The assets have been classified as an “Real estate held for sale, net” on the Company’s consolidated balance sheet and the components are as follows:



	December 31, 2015			December 31, 2014
Land and land improvements	$	8,907		$	8,953
Building and building improvements	1,875			1,865
Other	1,923			1,568
	12,705			12,386
Less accumulated depreciation	(1,989		)	(1,743		)
	$	10,716		$	10,643

The Company recorded an operating loss of $789, $760 and $1,184 for the years ended December 31, 2015, 2014 and 2013, respectively, from Escena. The operating loss recorded for the year ended December 31, 2015 includes an impairment charge of $230 related to the golf course.

In October 2013, the Company sold 200 of the 867 residential lots for approximately $22,700, net of selling costs. The remaining project consists of 667 residential lots, consisting of both single family and multi-family lots, an 18-hole golf course, clubhouse restaurant and golf shop, and a seven-acre site approved for a 450-room hotel.

Investment in Indian Creek. In March 2013, New Valley invested $7,616 for an 80% interest in Timbo LLC (“Indian Creek”) which owns a residential real estate project located on Indian Creek, Florida. As a result of the 80% ownership interest, the consolidated financial statements of the Company include the results of Indian Creek.

In May 2014, the Indian Creek property was sold for $14,400 and New Valley received a distribution of approximately $7,100. New Valley recognized income of approximately $2,400 from the sale for the year ended December 31, 2014. The project has concluded.

Investment in Sagaponack. In April 2015, New Valley invested $12,502 in a residential real estate project located in Sagaponack, NY. The project is wholly owned and the balances of the project are included in the consolidated financial statements of the Company. As of December 31, 2015, the assets of Sagaponack consist of land and land improvements of $12,602.

Real Estate Market Conditions. Because of the risks and uncertainties of the real estate markets, the Company will continue to perform additional assessments to determine the impact of the markets, if any, on the Company’s consolidated financial statements. Thus, future impairment charges may occur.

Goodwill and Other Intangible Assets

12 Months Ended

Dec. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS

The components of Goodwill and other intangible assets, net were as follows:



	December 31, 2015		December 31, 2014
Goodwill	$	70,791	$	70,791

Indefinite life intangibles:
Intangible asset associated with benefit under the MSA	107,511		107,511
Trademark - Douglas Elliman	80,000		80,000

Intangibles with a finite life, net	5,657		11,670

Total goodwill and other intangible assets, net	$	263,959	$	269,972

Goodwill is evaluated for impairment annually or whenever we identify certain triggering events or circumstances that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Events or circumstances that might indicate an interim evaluation is warranted include, among other things, unexpected adverse business conditions, macro and reporting unit specific economic factors (for example, interest rate and foreign exchange rate fluctuations, and loss of key personnel), supply costs, unanticipated competitive activities, and acts by governments and courts.

The Company follows ASC 350, Intangibles -- Goodwill and Other, included in ASU 2011-08, Testing Goodwill for Impairment. The Company performed the quantitative assessment for the year ended December 31, 2015 and determined that performing the second step of the two-step impairment test was unnecessary.

Other intangible assets and contract liabilities assumed were as follows:



	Useful Lives in Years	December 31, 2015			December 31, 2014
Intangible asset associated with benefit under the MSA	Indefinite	$	107,511		$	107,511

Trademark - Douglas Elliman	Indefinite	80,000			80,000

Favorable leases	1 - 10	13,444			13,444
Other intangibles	1 - 5	5,691			5,690
		19,135			19,134
Less: Accumulated amortization on amortizable intangibles		(13,478		)	(7,464		)
Other intangibles, net		$	5,657		$	11,670

Contract liabilities assumed:

Unfavorable leases	1 - 10	$	4,022		$	4,022
Less: Accumulated amortization on amortizable intangibles		(1,591		)	(808		)
Unfavorable leases, net		$	2,431		$	3,214

The intangible asset associated with the benefit under the MSA relates to the market share payment exemption of The Medallion Company Inc. (now known as Vector Tobacco Inc.), acquired in April 2002, under the MSA, which states payments under the MSA continue in perpetuity. As a result, the Company believes it will realize the benefit of the exemption for the foreseeable future.

The fair value of the intangible asset associated with the benefit under the MSA is calculated using discounted cash flows. This approach involves two steps: (i) estimating future cash savings due to the payment exemption under the MSA and (ii) and discounting the resulting cash flow savings to determine fair value. This fair value is then compared with the carrying value of the intangible asset associated with the benefit under the MSA. To the extent that the carrying amount exceeds the implied fair value of the intangible asset, an impairment loss is recognized. The Company performed its impairment test for the year ended December 31, 2015 and no impairment was noted.

The trademark intangible is attributed to the acquisition of the Douglas Elliman Realty brand name which the Company plans to continue using for the foreseeable future. The fair value of the intangible asset associated with the Douglas Elliman trademark is calculated using a “relief from royalty payments” method. This approach involves two steps: (i) estimating reasonable royalty rates for its trademark associated with the Douglas Elliman trademark and (ii) applying these royalty rates to a net sales stream and discounting the resulting cash flows to determine fair value. This fair value is then compared with the carrying value of the trademark. The Company performed its impairment test for the year ended December 31, 2015 and no impairment was noted.

The fair value of the other intangibles with finite lives includes favorable leases arising from leases with terms that are less than market value assumed in the business combination. Other intangibles with finite lives also includes backlog and listing inventory for Development sales.

The unfavorable leases were from lease terms that exceeded market and gave rise to a liability that were assumed in the business combination. The unfavorable leases are grouped with long-term Other liabilities.

Amortization of other intangibles was $5,080 and $5,088 for the years ended December 31, 2015 and 2014, respectively. For the years ended December 31, 2015 and 2014, respectively, $1,925 and $1,768 were taken as an offset to revenue, which relate to amortization of backlog and listing inventory intangible assets, $3,730 and $4,034 were taken as rent expense for amortization of favorable leases, $783 and $783 were taken as offsets to rent expense for amortization of unfavorable leases, and $208 and $69 were taken as other amortization expense. Amortization expense is estimated to be $1,573, $932, and $833, and amortization income from unfavorable lease contracts of $166, and $22 during the five years ended December 31, 2016 through 2020, respectively, and amortization expense of $75 thereafter.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

Notes Payable, Long Term Debt and Other Obligations

12 Months Ended

Dec. 31, 2015

Debt Disclosure [Abstract]

NOTES PAYABLE, LONG-TERM DEBT AND OTHER OBLIGATIONS

Notes payable, long-term debt and other obligations consist of:



	December 31, 2015			December 31, 2014
Vector:
7.75% Senior Secured Notes due 2021, including premium of $8,014 and $9,275	$	608,014		$	609,275
6.75% Variable Interest Senior Convertible Note due 2015 (as amended), net of unamortized discount of $0 and $0*	—			25,000
5.5% Variable Interest Senior Convertible Debentures due 2020, net of unamortized discount of $86,136 and $98,831*	172,614			159,919
7.5% Variable Interest Senior Convertible Notes due 2019, net of unamortized discount of $132,119 and $146,634*	97,881			83,366
Liggett:
Revolving credit facility	3,213			17,767
Term loan under credit facility	3,269			3,589
Equipment loans	9,716			13,966
Other	461			469
Total notes payable, long-term debt and other obligations	895,168			913,351
Less:
Current maturities	(8,919		)	(52,640		)
Amount due after one year	$	886,249		$	860,711

_____________________________

The fair value of the derivatives embedded within the 6.75% Variable Interest Senior Convertible Note ($0 at December 31, 2015 and $884 at December 31, 2014, respectively), the 5.50% Variable Interest Senior Convertible Debentures ($71,959 at December 31, 2015 and $80,864 at December 31, 2014, respectively), and the 7.5% Variable Interest Senior Convertible Debentures ($72,083 at December 31, 2015 and $87,638 at December 31, 2014, respectively) is separately classified as a derivative liability in the consolidated balance sheets.

Senior Secured Notes - Vector:

11% Senior Secured Notes due 2015:

On January 29, 2013, the Company announced a cash tender offer with respect to any and all of its outstanding $415,000 principal amount of its 11% Senior Secured Notes due 2015. The Company retired $336,315 of the 11% Senior Secured Notes at a premium of 104.292%, plus accrued and unpaid interest on February 12, 2013. The remaining $78,685 of the 11% Senior Secured Notes were called and retired on March 14, 2013 at a redemption price of 103.667% plus accrued and unpaid interest. The Company recorded a loss on the extinguishment of the debt of $21,458 for the year ended December 31, 2013. The loss included premium and tender costs of $17,820 and non-cash interest expense of $3,638 related to the write-off of net unamortized debt discount and deferred finance costs.

7.75% Senior Secured Notes due 2021:

In February 2013, the Company issued $450,000 of its 7.75% Senior Secured Notes due 2021 in a private offering to qualified institutional investors in accordance with Rule 144A of the Securities Act of 1933. The aggregate net proceeds from the issuance of the 7.75% Senior Secured Notes were approximately $438,250 after deducting offering expenses. The Company used the net proceeds of the issuance for a cash tender offer announced on January 29, 2013, with respect to any and all of its outstanding 11% Senior Secured Notes due 2015.

The 7.75% Senior Secured Notes pay interest on a semi-annual basis at a rate of 7.75% per year and mature on February 15, 2021. The Company may redeem some or all of the 7.75% Senior Secured Notes at any time prior to February 15, 2016 at a make-whole redemption price. On or after February 15, 2016, the Company may redeem some or all of the 7.75% Senior Secured Notes at a premium that will decrease over time, plus accrued and unpaid interest and liquidated damages, if any, to the redemption date. At any time prior to February 15, 2016, the Company may on any one or more occasions redeem up to 35% of the aggregate principal amount of the 7.75% Senior Secured Notes with the net proceeds of certain equity offerings at 107.75% of the aggregate principal amount thereof, plus accrued and unpaid interest and liquidated damages, if any, to the redemption date. In the event of a change of control, as defined in the indenture governing the 7.75% Senior Secured Notes, each holder of the 7.75% Senior Secured Notes may require the Company to repurchase some or all of its 7.75% Senior Secured Notes at a repurchase price equal to 101% of their aggregate principal amount plus accrued and unpaid interest and liquidated damages, if any to the date of purchase.

The 7.75% Senior Secured Notes are guaranteed subject to certain customary automatic release provisions on a joint and several basis by all of the 100% owned domestic subsidiaries of the Company that are engaged in the conduct of the Company’s cigarette businesses. (See Note 21.) In addition, some of the guarantees are collateralized by second priority or first priority security interests in certain collateral of some of the subsidiary guarantors, including their common stock, pursuant to security and pledge agreements.

In connection with the issuance of the 7.75% Senior Secured Notes, the Company entered into a Registration Rights Agreement. The Company agreed to consummate a registered exchange offer for the 7.75% Senior Secured Notes within 360 days after the date of the initial issuance of the 7.75% Senior Secured Notes. In June 2013, the Company completed an offer to exchange the 7.75% Senior Secured Notes issued in February 2013 for an equal amount of newly issued 7.75% Senior Secured Notes due 2021. The new 7.75% Senior Secured Notes have substantially the same terms as the original notes, except that the new 7.75% Senior Secured Notes have been registered under the Securities Act.

The indenture contains covenants that restrict the payment of dividends by the Company if the Company’s consolidated earnings before interest, taxes, depreciation and amortization, as defined in the indenture, for the most recently ended four full quarters is less than $75,000. The indenture also restricts the incurrence of debt if the Company’s Leverage Ratio and its Secured Leverage Ratio, as defined in the indenture, exceed 3.0 and 1.5, respectively. The Company’s Leverage Ratio is defined in the indenture as the ratio of the Company’s and the guaranteeing subsidiaries’ total debt less the fair market value of the Company’s cash, investments in marketable securities and long-term investments to Consolidated EBITDA, as defined in the indenture. The Company’s Secured Leverage Ratio is defined in the indenture in the same manner as the Leverage Ratio, except that secured indebtedness is substituted for indebtedness.

On April 15, 2014, the Company completed the sale of an additional $150,000 principal amount of its 7.75% Senior Secured Notes due 2021 for a price of 106.750% in a private offering to qualified institutional investors in accordance with Rule 144A of the Securities Act of 1933. The Company received net proceeds of approximately $158,670 after deducting underwriting discounts, commissions, fees and offering expenses. The Company will amortize the deferred costs and debt premium related to the additional Senior Secured Notes over the estimated life of the debt.

In August 2014, the Company completed an offer to exchange the 7.75% senior secured notes issued in April 2014 for an equal amount of newly issued 7.75% senior secured notes due 2021. The new 7.75% senior secured notes have substantially the same terms as the original notes, except that the new 7.75% senior secured notes have been registered under the Securities Act.

Variable Interest Senior Convertible Debt — Vector:

Vector has outstanding two series of variable interest senior convertible debt. Both series of debt pay interest on a quarterly basis at a stated rate plus an additional amount of interest on each payment date. The additional amount is based on the amount of cash dividends paid during the prior three-month period ending on the record date for such interest payment multiplied by the total number of shares of its common stock into which the debt would be convertible on such record date (the “Additional Interest”).

6.75% Variable Interest Senior Convertible Note due 2015, as amended:

On May 11, 2009, the Company issued in a private placement the 6.75% Note in the principal amount of $50,000. The purchase price was paid in cash ($38,225) and by tendering $11,005 principal amount of the 5% Notes, valued at 107% of principal amount. The note paid interest (“Total Interest”) on a quarterly basis at a rate of 3.75% per annum plus additional interest, which was based on the amount of cash dividends paid during the prior three-month period ending on the record date for such interest payment multiplied by the total number of shares of its common stock into which the debt would be convertible on such record date. Notwithstanding the foregoing, however, the interest payable on each interest payment date should have been the higher of (i) the Total Interest and (ii) 6.75% per annum. The note was convertible into the Company’s common stock at the holder’s option.

On March 14, 2014, the holder of the 6.75% Variable Interest Senior Convertible Note due 2014 converted $25,000 principal balance of the $50,000 Note into 2,338,930 of the Company's common shares. The Company recorded non-cash accelerated interest expense related to the converted debt of $3,679 for the year ended December 31, 2014. The debt conversion resulted in a reduction of debt and an increase to equity in the amount of $25,000.

On November 14, 2014, the Note was amended whereby the stated maturity date of the Note was extended from November 15, 2014 to February 15, 2015. On February 3, 2015, the holder of the 6.75% Variable Interest Senior Convertible Note due 2014 converted the remaining $25,000 principal balance of the $50,000 Note into 2,338,930 of our common stock. The outstanding principal balance as of December 31, 2015 was $0.

The purchaser of the 6.75% Note was an entity affiliated with Dr. Phillip Frost, who reported, after the consummation of the sale, beneficial ownership of approximately 11.7% of the Company’s common stock. Dr. Frost has reported that entities affiliated with him had beneficial ownership of approximately 15.3% of the Company’s common stock following the purchase of additional shares in a privately-negotiated transaction with an existing stockholder.

6.75% Variable Interest Senior Convertible Exchange Notes due 2014:

The 6.75% Variable Interest Senior Convertible Exchange Notes due 2014 (the “6.75% Exchange Notes”) paid interest (“Total Interest”) on a quarterly basis beginning August 15, 2009 at a rate of 3.75% per annum plus additional interest, which was based on the amount of cash dividends paid during the prior three-month period ending on the record date for such interest payment multiplied by the total number of shares of its common stock into which the debt would be convertible on such record date. Notwithstanding the foregoing, however, the interest payable on each interest payment date was the higher of (i) the Total Interest and (ii) 6.75% per annum.

In 2014, holders of the 6.75% Exchange Notes converted all of the $107,530 notes into a total of 8,867,443 of the Company's common shares. The Company recorded non-cash accelerated interest expense related to the converted debt of $1,526 for the year ended December 31, 2014. The debt conversion resulted in a reduction of debt and an increase to equity in the amount of $107,530.

3.875% Variable Interest Senior Convertible Debentures due 2026:

The 3.875% Variable Interest Senior Convertible Debentures due 2026 (the “Debentures”) paid interest on a quarterly basis at a rate of 3.875% per annum plus Additional Interest (the “Debenture Total Interest”). Notwithstanding the foregoing, however, the interest payable on each interest payment date was the higher of (i) the Debenture Total Interest and (ii) 5.75% per annum. The debentures were convertible into the Company’s common stock at the holder’s option.

The Debentures had an original principal amount of $110,000 when issued in 2006. Holders of the Debentures chose to convert an aggregate of $11,000 principal amount in 2011 and an aggregate of $55,778 principal in 2012 into the Company's common stock. On October 29, 2013, the Company issued a Notice of Optional Redemption to each remaining holder of the Debentures. Pursuant to the Notice of Optional Redemption, the Company intended to redeem all of the remaining Debentures outstanding under the Indenture on November 29, 2013. In November 2013, holders of the remaining debentures converted an aggregate of $43,222 principal amount of the debentures into 3,274,610 shares of the Company’s common stock in November 2013. The Company recorded non-cash accelerated interest expense related to the converted debt of $12,414 for the year ended December 31, 2013. The conversion of the remaining outstanding debt in 2013 resulted in a reduction of debt and an increase to equity in the amount of $43,222.

7.5% Variable Interest Senior Convertible Notes due 2019:

In November 2012, the Company sold $230,000 of its 7.5% variable interest senior convertible notes due 2019 (the “2019 Convertible Notes”) in a public offering registered under the Securities Act. The 2019 Convertible Notes are the Company's senior unsecured obligations and are effectively subordinated to any of its secured indebtedness to the extent of the assets securing such indebtedness. The 2019 Convertible Notes are also structurally subordinated to all liabilities and commitments of the Company's subsidiaries. The aggregate net proceeds from the sale of the 2019 Convertible Notes were approximately $218,900 after deducting underwriting discounts, commissions, fees and offering expenses.

The 2019 Convertible Notes pay interest (“Total Interest”) on a quarterly basis beginning January 15, 2013 at a rate of 2.5% per annum plus additional interest, which is based on the amount of cash dividends paid during the prior three-month period ending on the record date for such interest payment multiplied by the total number of shares of its common stock into which the debt will be convertible on such record date. Notwithstanding the foregoing, however, the interest payable on each interest payment date shall be the higher of (i) the Total Interest and (ii) 7.5% per annum. The notes are convertible into the Company’s common stock at the holder’s option. The conversion price at December 31, 2015 was $15.98 per share (approximately 62.5743 shares of common stock per $1,000 principal amount of the note), is subject to adjustment for various events, including the issuance of stock dividends. The notes will mature on January 15, 2019. If a fundamental change (as defined in the indenture) occurs, the Company will be required to offer to repurchase the notes at 100% of their principal amount, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

Share Lending Agreement:

In connection with the offering of its 2019 Convertible Notes in November 2012, the Company lent Jefferies & Company (“Jefferies”), the underwriter for the offering, a total of 7,077,720 shares of the Company’s common stock under the Share Lending Agreement. Jefferies is entitled to offer and sell such shares and use the sale to facilitate the establishment of a hedge position by investors in the notes and will receive all proceeds from the common stock offerings and lending transactions under the Share Lending Agreement. The Company received a nominal lending fee of $0.10 per share for each share of common stock that the Company lent pursuant to the Share Lending Agreement.

The Share Lending Agreement requires that the shares borrowed be returned upon the maturity of the related debt, January 2019, or earlier, including the redemption of the notes or the conversion of the notes to shares of common stock pursuant to the terms of the indenture governing the notes. Borrowed shares are issued and outstanding for corporate law purposes and, accordingly, the holders of the borrowed shares will have all of the rights of a holder of the Company’s outstanding shares. However, because the share borrower must return to the Company all borrowed shares (or identical shares), the borrowed shares are not considered outstanding for purposes of computing and reporting the Company’s earnings per share in accordance with U.S. GAAP. Jefferies agreed to pay to the Company an amount equal to any dividends or other distributions that the Company pays on the borrowed shares.

The Company received a nominal fee for the loaned shares and determined the fair value of the Share Lending Agreement was $3,204 at the date of issuance based on the present value of the future cash flows attributed to an estimated reduction in stated interest due to the presence of the Share Lending Agreement. The $3,204 fair value was recognized as a debt financing charge and is being amortized to interest expense over the term of the notes. In November 2012, 3,538,860 shares were returned but no cash was exchanged. As of December 31, 2015, 3,538,859 shares were outstanding on the Share Lending Agreement and $286 had been amortized to interest expense.

5.5% Variable Interest Senior Convertible Notes due 2020 - Vector:

On March 24, 2014, the Company completed the sale of $258,750 of its 5.5% Variable Interest Convertible Senior Notes due 2020 (the “2020 Convertible Notes”). The 2020 Convertible Notes are the Company's senior unsecured obligations and are effectively subordinated to any of its secured indebtedness to the extent of the assets securing such indebtedness. The 2020 Convertible Notes are also structurally subordinated to all liabilities and commitments of the Company's subsidiaries.

The aggregate net proceeds from the sale of the 2020 Convertible Notes were approximately $250,300 after deducting underwriting discounts, commissions, fees and offering expenses. The net proceeds were used for general corporate purposes, including for additional investments in real estate and in the Company's tobacco business.

The 2020 Convertible Notes pay interest (“Total Interest”) on a quarterly basis beginning April 15, 2014 at a rate of 1.75% per annum plus additional interest, which is based on the amount of cash dividends paid during the prior three-month period ending on the record date for such interest payment multiplied by the total number of shares of its common stock into which the debt will be convertible on such record date. Notwithstanding the foregoing, however, the interest payable on each interest payment date after April 15, 2014 shall be the higher of (i) the Total Interest and (ii) 5.5% per annum with the interest payment on April 15, 2014 being based on 5.5% per annum. The notes are convertible into the Company’s common stock at the holder’s option. The conversion price at December 31, 2015 was $24.64 per share (approximately 40.5891 shares of common stock per $1,000 principal amount of the note), and is subject to adjustment for various events, including the issuance of stock dividends. The notes will mature on April 15, 2020. If a fundamental change (as defined in the indenture) occurs, the Company will be required to offer to repurchase the notes at 100% of their principal amount, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

Embedded Derivatives on the Variable Interest Senior Convertible Debt:

The portion of the interest on the Company’s convertible debt which is computed by reference to the cash dividends paid on the Company’s common stock is considered an embedded derivative within the convertible debt, which the Company is required to separately value. In accordance with authoritative guidance on accounting for derivatives and hedging, the Company has bifurcated these embedded derivatives and estimated the fair value of the embedded derivative liability including using a third party valuation. The resulting discount created by allocating a portion of the issuance proceeds to the embedded derivative is then amortized to interest expense over the term of the debt using the effective interest method. Changes to the fair value of these embedded derivatives are reflected quarterly in the Company’s consolidated statements of operations as “Change in fair value of derivatives embedded within convertible debt.” The value of the embedded derivative is contingent on changes in interest rates of debt instruments maturing over the duration of the convertible debt as well as projections of future cash and stock dividends over the term of the debt.

A summary of non-cash interest expense associated with the amortization of the debt discount created by the embedded derivative liability associated with the Company’s variable interest senior convertible debt is as follows:



	Year Ended December 31,
	2015		2014		2013
6.75% note	$	—	$	6,097	$	5,914
6.75% exchange notes	—		13,570		11,799
3.875% convertible debentures	—		—		155
7.5% convertible notes	8,777		5,553		3,614
5.5% convertible notes	9,752		6,851		—
Interest expense associated with embedded derivatives	$	18,529	$	32,071	$	21,482

A summary of non-cash changes in fair value of derivatives embedded within convertible debt is as follows:



	Year Ended December 31,
	2015			2014		2013
6.75% note	$	(5	)	$	3,212	$	5,075
6.75% exchange notes	—			8,990		9,625
3.875% convertible debentures	—			—		(1,417		)
7.5% convertible notes	15,555			5,296		5,652
5.5% convertible notes	8,905			1,911		—
Gain on changes in fair value of derivatives embedded within convertible debt	$	24,455		$	19,409	$	18,935

The following table reconciles the fair value of derivatives embedded within convertible debt:



	6.75% Note			6.75% Exchange Notes			3.875% Convertible Debentures			7.5% Convertible Notes			5.5% Convertible Notes			Total
Balance at January 1, 2013	$	11,682		$	22,146		$	39,714		$	98,586		$	—		$	172,128
Conversion of $43,222 of 3.875% Variable Interest Senior Convertible Debentures due June 15, 2016	—			—			(41,131		)	—			—			(41,131		)
(Gain) loss from changes in fair value of embedded derivatives	(5,075		)	(9,625		)	1,417			(5,652		)	—			(18,935		)
Balance at December 31, 2013	6,607			12,521			—			92,934			—			112,062
Issuance of 5.5% Note	—			—			—			—			82,775			82,775
Conversion of $25,000 of 6.75% Variable Interest Senior Convertible Note due February 15, 2015	(2,511		)	—			—			—			—			(2,511		)
Conversion of $107,530 of 6.75% Variable Interest Senior Convertible Exchange Notes due November 15, 2014	—			(3,531		)	—			—			—			(3,531		)
Gain from changes in fair value of embedded derivatives	(3,212		)	(8,990		)	—			(5,296		)	(1,911		)	(19,409		)
Balance at December 31, 2014	884			—			—			87,638			80,864			169,386
Conversion of $25,000 of 6.75% Variable Interest Senior Convertible Note due February 15, 2015	(889		)	—			—			—			—			(889		)
Loss (gain) from changes in fair value of embedded derivatives	5			—			—			(15,555		)	(8,905		)	(24,455		)
Balance at December 31, 2015	$	—		$	—		$	—		$	72,083		$	71,959		$	144,042

Beneficial Conversion Feature on Variable Interest Senior Convertible Debt:

After giving effect to the recording of the embedded derivative liability as a discount to the convertible debt, the Company’s common stock had a fair value at the issuance date of the debt in excess of the conversion price resulting in a beneficial conversion feature. The accounting guidance on debt with conversion and other options requires that the intrinsic value of the beneficial conversion feature be recorded to additional paid-in capital and as a discount on the debt. The discount is then amortized to interest expense over the term of the debt using the effective interest method. The beneficial conversion feature has been recorded, net of income taxes, as an increase to stockholders’ deficiency.

A summary of non-cash interest expense associated with the amortization of the debt discount created by the beneficial conversion feature on the Company’s variable interest senior convertible debt is as follows:



	Year Ended December 31,
	2015		2014		2013
Amortization of beneficial conversion feature:
6.75% note	$	—	$	5,317	$	5,157
6.75% exchange notes	—		8,386		7,294
3.875% convertible debentures	—		—		82
7.5% convertible notes	5,738		3,631		2,363
5.5% convertible notes	2,943		2,067		—
Interest expense associated with beneficial conversion feature	$	8,681	$	19,401	$	14,896

Unamortized Debt Discount on Variable Interest Senior Convertible Debt:

The following table reconciles unamortized debt discount within convertible debt:



	6.75% Note			6.75% Exchange Notes			3.875% Convertible Debentures			7.5% Convertible Notes			5.5% Convertible Notes			Total
Balance at January 1, 2013	$	30,383		$	45,038		$	36,107		$	161,795		$	—		$	273,323
Conversion of $43,222 of 3.875% Variable Interest Senior Convertible Debentures due June 15, 2016	—			—			(35,870		)	—			—			(35,870		)
Amortization of embedded derivatives	(5,914		)	(11,799		)	(155		)	(3,614		)	—			(21,482		)
Amortization of beneficial conversion feature	(5,157		)	(7,294		)	(82		)	(2,363		)	—			(14,896		)
Balance at December 31, 2013	19,312			25,945			—			155,818			—			201,075
Conversion of $107,530 of 6.75% Variable Interest Senior Convertible Exchange Notes due November 15, 2014	—			(3,989		)	—			—			—			(3,989		)
Conversion of $25,000 of 6.75% Variable Interest Senior Convertible Note due February 15, 2015	(7,898		)	—			—			—			—			(7,898		)
Issuance of convertible notes - embedded derivative	—			—			—			—			82,775			82,775
Issuance of convertible notes - beneficial conversion feature	—			—			—			—			24,974			24,974
Amortization of embedded derivatives	(6,097		)	(13,570		)	—			(5,553		)	(6,851		)	(32,071		)
Amortization of beneficial conversion feature	(5,317		)	(8,386		)	—			(3,631		)	(2,067		)	(19,401		)
Balance at December 31, 2014	—			—			—			146,634			98,831			245,465
Amortization of embedded derivatives	—			—			—			(8,777		)	(9,752		)	(18,529		)
Amortization of beneficial conversion feature	—			—			—			(5,738		)	(2,943		)	(8,681		)
Balance at December 31, 2015	$	—		$	—		$	—		$	132,119		$	86,136		$	218,255

Revolving Credit Facility — Liggett:

On January 14, 2015, Liggett and 100 Maple LLC ("Maple"), a subsidiary of Liggett, entered into a Third Amended and Restated Credit Agreement (the “Credit Agreement”), with Wells Fargo Bank, National Association (“Wells Fargo”), as agent and lender. The Credit Agreement governs a $60,000 credit facility (the “Credit Facility”) that consists of a revolving credit facility of up to $60,000 borrowing capacity (the “Revolver”) and a $3,600 term loan (the “Term Loan”) that is within the $60,000 commitment under the Credit Facility and reduces the amount available under the Revolver. All borrowings under the Credit Facility (other than the Term Loan) are limited to a borrowing base equal to roughly (1) the lesser of (a) 85% of the net amount of eligible accounts receivable and (b) $10,000 plus (2) the lesser of (a) the sum of (I) 80% of the value of eligible inventory consisting of packaged cigarettes plus (II) the lesser of (x) 60% multiplied by Liggett’s eligible cost of eligible inventory consisting of leaf tobacco and (y) 85% of the net orderly liquidation value of eligible inventory consisting of leaf tobacco and (b) $60,000, less (3) certain reserves against accounts receivable, inventory, bank products or other items which Wells Fargo, as agent, may establish from time to time in its permitted discretion. The obligations under the Credit Facility are collateralized on a first priority basis by all inventories, receivables and certain other personal property of Liggett and Maple, a mortgage on Liggett’s manufacturing facility and certain real property of Maple, subject to certain permitted liens. The Credit Facility amended and restated Liggett’s previous $50,000 credit facility with Wells Fargo and Maple’s existing $3,600 term loan with Wells Fargo.

The term of the Credit Facility expires on March 31, 2020. Prime rate loans under the Credit Facility bear interest at a rate equal to the greatest of (i) the Federal Funds rate plus 0.50%, (ii) LIBOR plus 1.0% and (ii) the prime rate of Wells Fargo. LIBOR rate loans under the Credit Facility bear interest at a rate equal to LIBOR plus 2.25%. The interest rate applicable to this Credit Facility at December 31, 2015 was 2.70%.

The Credit Facility permits the guaranty of the 7.75% Senior Secured Notes due 2021 by each of Liggett and Maple and the pledging of certain assets of Liggett and Maple on a subordinated basis to secure their guarantees. The credit facility also grants to Wells Fargo a blanket lien on all the assets of Liggett and Maple, excluding any equipment pledged to current or future purchase money or other financiers of such equipment and excluding any real property, other than the Mebane Property and other real property to the extent its value is in excess of $5,000. Wells Fargo, Liggett, Maple and the collateral agent for the holders of our 7.75% senior secured notes have entered into an intercreditor agreement, pursuant to which the liens of the collateral agent on the Liggett and Maple assets will be subordinated to the liens of Wells Fargo on the Liggett and Maple assets.

The Credit Facility contains customary affirmative and negative covenants, including covenants that limit Liggett’s, Maple’s and their subsidiaries’ ability to incur, create or assume certain indebtedness, to incur or assume certain liens, to purchase, hold or acquire certain investments, to declare or make certain dividends and distributions and to engage in certain mergers, consolidations and asset sales. The Credit Facility also requires the Company to comply with specified financial covenants, including that Liggett's earnings before interest, taxes, depreciation and amortization, as defined under the Credit Facility, on a trailing twelve month basis, shall not be less than $100,000 if Liggett's excess availability, as defined under the Credit Facility, is less than $20,000. The covenants also require that annual capital expenditures, as defined under the Credit Facility (before a maximum carryover amount of $10,000), shall not exceed $20,000 during any fiscal year. The Credit Facility also contains customary events of default. The Credit Facility requires Liggett’s compliance with certain financial and other covenants including a restriction on Liggett’s ability to pay cash dividends unless Liggett’s borrowing availability, as defined, under the credit facility for the 30-day period prior to the payment of the dividend, and after giving effect to the dividend, was at least $5,000 and no event of default had occurred under the agreement, including Liggett’s compliance with the covenants in the credit facility. Liggett was in compliance with these covenants as of December 31, 2015.

Term Loan under Credit Facility — Liggett:

Within the commitment under the Credit Facility, Wells Fargo holds a mortgage on Liggett’s manufacturing facility through a Term Loan with Maple. The outstanding balance under the Term Loan is $3,269 as of December 31, 2015. The Term Loan bears an interest rate equal to LIBOR + 2.25%. Monthly principal payments of $25 are due under the Term Loan on the first day of each month with the unpaid principal balance of approximately $2,000 due at maturity on March 1, 2020.

As of December 31, 2015, a total of $6,482 was outstanding under the revolving and term loan portions of the credit facility. Availability as determined under the facility was approximately $51,452 based on eligible collateral at December 31, 2015.

Equipment Loans — Liggett:

In 2015, Liggett entered into two financing agreements for a total of $1,765 related to the purchase of equipment. The weighted average interest rate of the outstanding debt is 4.79% per annum and the interest rates on the two notes are from 4.49% to 4.85%. Total monthly installments are approximately $33.

In 2014, Liggett entered into three financing agreements for a total of $5,115 related to the purchase of equipment. The weighted average interest rate of the outstanding debt is 5.02% per annum and the interest rates on the three notes are from 4.98% to 5.04%. Total monthly installments are approximately $95. Liggett also refinanced $2,843 of debt related to equipment purchased in 2011. The refinanced debt had an interest rate of 5.63% and a remaining term of 21 months. The refinanced debt carries an interest rate of 4.99% and a term of 36 months.

In 2013, Liggett entered into two financing agreements for a total of $6,580 related to the purchase of equipment. The weighted average interest rate of the outstanding debt is 4.49% per annum and the interest rates on the two notes are 3.28% and 4.93%. Total monthly installments are approximately $181.

Each of these equipment loans is collateralized by the purchased equipment.

Fair Value of Notes Payable and Long-Term Debt:

The estimated fair value of the Company’s notes payable and long-term debt are as follows:



	December 31, 2015				December 31, 2014
	Carrying Value		Fair Value		Carrying Value		Fair Value
Notes payable and long-term debt	$	895,168	$	1,297,875	$	913,351	$	1,313,711

Notes payable and long-term debt are carried on the balance sheet at amortized cost. The fair value determination disclosed above would be classified as Level 2 under the fair value hierarchy disclosed in Note 18 if such liabilities were recorded on the consolidated balance sheet at fair value. The estimated fair value of the Company’s notes payable and long-term debt has been determined by the Company using available market information and appropriate valuation methodologies including the evaluation of the Company’s credit risk as described in Note 1. The Company used the quoted market prices as of December 31, 2015 to determine the fair value of its publicly traded notes and debentures. The carrying value of the credit facility and term loan is equal to the fair value. The fair value of the equipment loans and other obligations was determined by calculating the present value of the required future cash flows. However, considerable judgment is required to develop the estimates of fair value and, accordingly, the estimate presented herein are not necessarily indicative of the amount that could be realized in a current market exchange.

Scheduled Maturities:

Scheduled maturities of long-term debt are as follows:



	Principal		Unamortized Discount/ (Premium)			Net
Year Ending December 31:
2016	$	8,919	$	—		$	8,919
2017	2,254		—			2,254
2018	2,001		—			2,001
2019	231,160		132,119			99,041
2020	261,075		86,136			174,939
Thereafter	600,000		(8,014		)	608,014
Total	$	1,105,409	$	210,241		$	895,168

Commitments

12 Months Ended

Dec. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments

COMMITMENTS

Certain of the Company’s subsidiaries lease facilities and equipment used in operations under both month-to-month and fixed-term agreements. The aggregate minimum rentals under operating leases with non-cancelable terms of one year or more as of December 31, 2015 are as follows:



	Lease Commitments
Year Ending December 31:
2016	$	25,463
2017	21,064
2018	18,928
2019	14,912
2020	11,835
Thereafter	72,888
Total	$	165,090

The Company’s rental expense for the years ended December 31, 2015, 2014 and 2013 was $24,446, $22,516 and $6,523, respectively.

Employee Benefit Plans

12 Months Ended

Dec. 31, 2015

Compensation and Retirement Disclosure [Abstract]

EMPLOYEE BENEFIT PLANS

Defined Benefit Plans and Postretirement Plans:

Defined Benefit Plans. The Company sponsors three defined benefit pension plans (two qualified and one non-qualified) covering virtually all individuals who were employed by Liggett on a full-time basis prior to 1994. Future accruals of benefits under these three defined benefit plans were frozen between 1993 and 1995. These benefit plans provide pension benefits for eligible employees based primarily on their compensation and length of service. Contributions are made to the two qualified pension plans in amounts necessary to meet the minimum funding requirements of the Employee Retirement Income Security Act of 1974. The plans’ assets and benefit obligations were measured at December 31, 2015 and 2014, respectively.

The Company also sponsors a Supplemental Retirement Plan (“SERP”) where the Company will pay supplemental retirement benefits to certain key employees, including certain executive officers of the Company. The plan meets the applicable requirements of Section 409A of the Internal Revenue Code and is intended to be unfunded for tax purposes. Payments under the SERP will be made out of the general assets of the Company. The SERP is a defined benefit plan. Under the SERP, the benefit payable to a participant at his normal retirement date is a lump sum amount which is the actuarial equivalent of a predetermined annual retirement benefit set by the Company’s board of directors. Normal retirement date is defined as the January 1 following the attainment by the participant of the latter of age 60 or the completion of eight years of employment following January 1, 2002 with the Company or a subsidiary.

The SERP provides the Company’s President and Chief Executive Officer with an additional benefit under the SERP equal to a $736 lifetime annuity beginning January 1, 2013. In addition, in the event of a termination of his employment under the circumstances where he is entitled to severance payments under his employment agreement, he will be credited with an additional 36 months of service towards vesting under the SERP.

At December 31, 2015, the aggregate lump sum equivalents of the annual retirement benefits payable under the Amended SERP at normal retirement dates occurring during the following years is as follows: 2016 – $0; 2017 – $0; 2018 – $0; 2019 – $0; 2020 – $7,111 and 2021 to 2025 – $47,586. In the case of a participant who becomes disabled prior to his normal retirement date or whose service is terminated without cause, the participant’s benefit consists of a pro-rata portion of the full projected retirement benefit to which he would have been entitled had he remained employed through his normal retirement date, as actuarially discounted back to the date of payment. A participant who dies while working for the Company or a subsidiary (and before becoming disabled or attaining his normal retirement date) will be paid an actuarially discounted equivalent of his projected retirement benefit; conversely, a participant who retires beyond his normal retirement date will receive an actuarially increased equivalent of his projected retirement benefit.

Postretirement Medical and Life Plans. The Company provides certain postretirement medical and life insurance benefits to certain employees and retirees. Substantially all of the Company’s manufacturing employees as of December 31, 2015 are eligible for postretirement medical benefits if they reach retirement age while working for Liggett or certain affiliates. Retirees are required to fund 100% of participant medical premiums and, pursuant to union contracts, Liggett reimburses approximately 219 hourly retirees, who retired prior to 1991, for Medicare Part B premiums. In addition, the Company provides life insurance benefits to approximately 164 active employees and 402 retirees who reach retirement age and are eligible to receive benefits under one of the Company’s defined benefit pension plans. The Company’s postretirement liabilities are comprised of Medicare Part B and life insurance premiums.

The following table provides a reconciliation of benefit obligations, plan assets and the funded status of the pension plans and other postretirement benefits:



	Pension Benefits						Other Postretirement Benefits
	2015			2014			2015			2014
Change in benefit obligation:
Benefit obligation at January 1	$	(150,199	)	$	(150,911	)	$	(9,031	)	$	(8,899	)
Service cost	(532		)	(523		)	(8		)	(9		)
Interest cost	(4,992		)	(6,196		)	(371		)	(430		)
Plan settlement	17,047			—			—			—
Special termination benefits	(3,831		)	—			—			—
Benefits paid	9,879			10,207			522			552
Expenses paid	490			322			—			—
Actuarial (gain) loss	(1,368		)	(3,098		)	454			(245		)
Benefit obligation at December 31	$	(133,506	)	$	(150,199	)	$	(8,434	)	$	(9,031	)
Change in plan assets:
Fair value of plan assets at January 1	$	134,017		$	137,036		$	—		$	—
Actual return on plan assets	(327		)	7,162			—			—
Plan settlement	(17,047		)	—			—			—
Expenses paid	(490		)	(322		)	—			—
Contributions	346			348			522			552
Benefits paid	(9,879		)	(10,207		)	(522		)	(552		)
Fair value of plan assets at December 31	$	106,620		$	134,017		$	—		$	—
Unfunded status at December 31	$	(26,886	)	$	(16,182	)	$	(8,434	)	$	(9,031	)
Amounts recognized in the consolidated balance sheets:
Prepaid pension costs	$	20,650		$	25,032		$	—		$	—
Other accrued liabilities	(320		)	(324		)	(595		)	(607		)
Non-current employee benefit liabilities	(47,216		)	(40,890		)	(7,839		)	(8,424		)
Net amounts recognized	$	(26,886	)	$	(16,182	)	$	(8,434	)	$	(9,031	)



	Pension Benefits									Other Postretirement Benefits
	2015			2014			2013			2015			2014			2013
Service cost — benefits earned during the period	$	532		$	523		$	1,170		$	8		$	9		$	16
Interest cost on projected benefit obligation	4,992			6,196			5,518			371			430			418
Expected return on assets	(7,378		)	(8,518		)	(7,915		)	—			—			—
Settlement loss	3,214			—			244			—			—			—
Special termination benefit recognized	3,831			—			—			—			—			—
Amortization of net loss (gain)	1,083			1,075			1,918			(97		)	(60		)	(64		)
Net expense (income)	$	6,274		$	(724	)	$	935		$	282		$	379		$	370

The following table summarizes amounts in accumulated other comprehensive loss that are expected to be recognized as components of net periodic benefit cost for the year ending 2016.



	Defined Benefit Pension Plans		Post- Retirement Plans			Total
Actuarial loss (gain)	$	1,855	$	(75	)	$	1,780

As of December 31, 2015, accumulated other comprehensive (loss) income, before income taxes, consists of the following:



	Defined Benefit Pension Plans			Post- Retirement Plans			Total
Accumulated other comprehensive (loss) income as of January 1, 2015	$	(30,481	)	$	582		$	(29,899	)
Amortization of gain (loss)	4,297			(97		)	4,200
Net (loss) gain arising during the year	(9,074		)	454			(8,620		)
Accumulated other comprehensive (loss) income as of December 31, 2015	$	(35,258	)	$	939		$	(34,319	)

As of December 31, 2014, accumulated other comprehensive (loss) income, before income taxes, consisted of the following:



	Defined Benefit Pension Plans			Post- Retirement Plans			Total
Accumulated other comprehensive (loss) income as of January 1, 2014	$	(27,102	)	$	886		$	(26,216	)
Amortization of gain (loss)	1,075			(60		)	1,015
Net loss arising during the year	(4,454		)	(244		)	(4,698		)
Accumulated other comprehensive (loss) income as of December 31, 2014	$	(30,481	)	$	582		$	(29,899	)

As of December 31, 2015, two of the Company’s four defined benefit plans experienced accumulated benefit obligations in excess of plan assets, for which in the aggregate the projected benefit obligation, accumulated benefit obligation and fair value of plan assets were $47,535, $47,535 and $0, respectively. As of December 31, 2014, two of the Company’s four defined benefit plans experienced accumulated benefit obligations in excess of plan assets, for which in the aggregate the projected benefit obligation, accumulated benefit obligation and fair value of plan assets were $41,214, $41,214 and $0, respectively.



	Pension Benefits			Other Postretirement Benefits
	2015	2014	2013	2015	2014	2013
Weighted average assumptions:
Discount rates — benefit obligation	3.75% - 4.50%	2.75% - 4.00%	3.00% - 4.75%	4.75%	4.25%	5.00%
Discount rates — service cost	2.75% - 4.25%	3.00% - 4.75%	2.25% - 4.00%	4.25%	5.00%	4.25%
Assumed rates of return on invested assets	6.00%	6.50%	6.50%	—%	—%	—%
Salary increase assumptions	N/A	N/A	N/A	3.00%	3.00%	3.00%

Discount rates were determined by a quantitative analysis examining the prevailing prices of high quality bonds to determine an appropriate discount rate for measuring obligations. The aforementioned analysis analyzes the cash flow from each of the Company’s four benefit plans as well as a separate analysis of the cash flows from the postretirement medical and life insurance plans sponsored by Liggett. The aforementioned analyses then construct a hypothetical bond portfolio whose cash flow from coupons and maturities match the year-by-year, projected benefit cash flow from the respective pension or retiree health plans. The Company uses the lower discount rate derived from the two independent analyses in the computation of the benefit obligation and service cost for each respective retirement liability. The Company uses the discount rate derived from the analysis in the computation of the benefit obligation and service cost for all the plans respective retirement liability.

The Company considers input from its external advisors and historical returns in developing its expected rate of return on plan assets. The expected long-term rate of return is the weighted average of the target asset allocation of each individual asset class. The Company’s actual 10-year annual rate of return on its pension plan assets was 6.0%, 6.6% and 7.2% for the years ended December 31, 2015, 2014 and 2013, respectively, and the Company’s actual five-year annual rate of return on its pension plan assets was 6.3%, 9.8% and 13.6% for the years ended December 31, 2015, 2014 and 2013, respectively.

Gains and losses resulted from changes in actuarial assumptions and from differences between assumed and actual experience, including, among other items, changes in discount rates and changes in actual returns on plan assets as compared to assumed returns. These gains and losses are only amortized to the extent that they exceed 10% of the greater of Projected Benefit Obligation and the fair value of assets. For the year ended December 31, 2015, Liggett used a 16.16-year period for its Hourly Plan and a 15.99-year period for its Salaried Plan to amortize pension fund gains and losses on a straight line basis. Such amounts are reflected in the pension expense calculation beginning the year after the gains or losses occur. The amortization of deferred losses negatively impacts pension expense in the future.

Plan assets are invested employing multiple investment management firms. Managers within each asset class cover a range of investment styles and focus primarily on issue selection as a means to add value. Risk is controlled through a diversification among asset classes, managers, styles and securities. Risk is further controlled both at the manager and asset class level by assigning excess return and tracking error targets. Investment managers are monitored to evaluate performance against these benchmark indices and targets.

Allowable investment types include equity, investment grade fixed income, high yield fixed income, hedge funds and short term investments. The equity fund is comprised of common stocks and mutual funds of large, medium and small companies, which are predominantly U.S. based. The investment grade fixed income fund includes managed funds investing in fixed income securities issued or guaranteed by the U.S. government, or by its respective agencies, mortgage backed securities, including collateralized mortgage obligations, and corporate debt obligations. The high yield fixed income fund includes a fund which invests in non-investment grade corporate debt securities. The hedge funds invest in both equity, including common and preferred stock, and debt obligations, including convertible debentures, of private and public companies. The Company generally utilizes its short term investments, including interest-bearing cash, to pay benefits and to deploy in special situations.

The Liggett Employee Benefits Committee has established the following target assets allocation to equal 50.0% equity investments, 30.0% investment grade fixed income, 10.0% high yield fixed income, 5.0% alternative investments (including hedge funds and private equity funds) and 5.0% short-term investments, with a rebalancing range of approximately plus or minus 5% around the target asset allocations.

Vector’s defined benefit retirement plan allocations at December 31, 2015 and 2014, by asset category, were as follows:



	Plan Assets at December 31,
	2015		2014
Asset category:
Equity securities	51	%	50	%
Investment grade fixed income securities	30	%	29	%
High yield fixed income securities	11	%	10	%
Alternative investments	3	%	5	%
Short-term investments	5	%	6	%
Total	100	%	100	%

The defined benefit plans’ recurring financial assets subject to fair value measurements and the necessary disclosures are as follows:



	Fair Value Measurements as of December 31, 2015
			Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
Description	Total		(Level 1)		(Level 2)		(Level 3)
Assets:
Insurance contracts	$	1,760	$	—	$	1,760	$	—
Amounts in individually managed investment accounts:
Cash	5,429		5,429		—		—
U.S. equity securities	28,434		28,434		—		—
Common collective trusts	56,327		—		56,327		—
Investment partnership	14,670		—		11,256		3,414
Total	$	106,620	$	33,863	$	69,343	$	3,414



	Fair Value Measurements as of December 31, 2014
			Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
Description	Total		(Level 1)		(Level 2)		(Level 3)
Assets:
Insurance contracts	$	1,762	$	—	$	1,762	$	—
Amounts in individually managed investment accounts:
Cash, mutual funds and common stock	8,319		8,319		—		—
U.S. equity securities	42,046		42,046		—		—
Common collective trusts	61,877		—		61,877		—
Investment partnership	20,013		—		13,189		6,824
Total	$	134,017	$	50,365	$	76,828	$	6,824

The fair value determination disclosed above of assets as Level 3 under the fair value hierarchy was determined based on unobservable inputs and were based on company assumptions, and information obtained from the investments based on the indicated market values of the underlying assets of the investment portfolio. The fair value of investment included in Level 1 are based on quoted market prices from various stock exchanges. The Level 2 investments are based on quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets in markets that are not active.

The changes in the fair value of the Level 3 investments as of December 31, 2015 and 2014 were as follows:



	2015			2014
Balance as of January 1	$	6,824		$	9,031
Transfers	—			(641		)
Distributions	(2,904		)	(1,018		)
Unrealized (loss) gain on long-term investments	(470		)	3,403
Realized loss on long-term investments	(36		)	(3,951		)
Balance as of December 31	$	3,414		$	6,824

For 2015 measurement purposes, annual increases in Medicare Part B trends were assumed to equal rates between 1.29% and 17.92% between 2016 and 2023 and 4.5% thereafter. For 2014 measurement purposes, annual increases in Medicare Part B trends were assumed to equal rates between 1.53% and 6.29% between 2015 and 2023 and 4.5% after 2023.

Assumed health care cost trend rates have a significant effect on the amounts reported for the health care plans. A 1% change in assumed health care cost trend rates would have the following effects:



	1% Increase		1% Decrease
Effect on total of service and interest cost components	$	4	$	(4	)
Effect on benefit obligation	79		(74		)

To comply with ERISA’s minimum funding requirements, the Company does not currently anticipate that it will be required to make any contributions to the pension plan year beginning on January 1, 2016 and ending on December 31, 2016. Any additional funding obligation that the Company may have for subsequent years is contingent on several factors and is not reasonably estimable at this time.

Estimated future pension and postretirement medical benefits payments are as follows:



	Pension		Postretirement Medical
2016	$	9,548	$	595
2017	9,053		618
2018	8,618		607
2019	8,139		609
2020	14,786		606
2021 - 2025	79,462		2,953

Profit Sharing and 401(k) Plans:

The Company maintains 401(k) plans for substantially all U.S. employees which allow eligible employees to invest a percentage of their pre-tax compensation. The Company contributed to the 401(k) plans and expensed $1,467, $1,219 and $1,190 for the years ended December 31, 2015, 2014 and 2013, respectively.

Restructuring

12 Months Ended

Dec. 31, 2015

Restructuring and Related Activities [Abstract]

Restructuring

RESTRUCTURING

In October 2015, the Company's Tobacco segment commenced a restructuring by realigning its sales force and adjusting its business model to more efficiently serve its chain and independent accounts. In connection with the restructuring, the segment's workforce was reduced by 95 employees (or approximately 17% of the Tobacco segment's workforce).

The following table summarizes amounts expensed for the year ended December 31, 2015:



	Amounts expensed through December 31, 2015
Cash Charges:
Employee severance and benefits	$	1,094
Lease termination costs	203
Other restructuring expenses	68
	1,365
Non-Cash:
Employee pension benefits	5,438
Point of sale inventory impairment	454
	5,892

Total restructuring	$	7,257

All amounts expensed through December 31, 2015 are included as Restructuring charges in the Company’s consolidated statements of operations and are all attributable to the Company’s Tobacco segment.

Severance and benefits expensed for the year ended December 31, 2015 relate entirely to a reduction in sales and administrative positions. Non-cash employee pension benefits costs relate to a reduction in manufacturing positions at Liggett’s plant in Mebane, NC.

Employee pension benefits consist of the costs associated with enhanced pension benefits due to employees under the terms of a voluntary termination program initiated in the third quarter of 2015. Pension plan participants electing to accept voluntary termination of employment were offered enhanced pension benefits including an increased payment as well as the option to receive a lump sum benefit instead of an annuity. The cost of the special termination benefit associated with the increased payments was $3,831 and the costs of settlements related to lump sum payments was $1,607.

The following table presents the activity under the Tobacco segment restructuring plan for the year ended December 31, 2015:



	Employee Severance and Benefits			Contract Termination/Exit Costs			Other			Non-Cash Pension Expense			Non-Cash Asset Impairment			Total
Accrual balance as of January 1, 2015	$	—		$	—		$	—		$	—		$	—		$	—
Restructuring charges	1,094			203			68			5,438			454			7,257
Utilized	(672		)	(155		)	(48		)	(5,438		)	(454		)	(6,767		)
Accrual balance as of December 31, 2015	$	422		$	48		$	20		$	—		$	—		$	490

Income Taxes

12 Months Ended

Dec. 31, 2015

Income Tax Disclosure [Abstract]

INCOME TAXES

The Company files a consolidated U.S. income tax return that includes its more than 80%-owned U.S. subsidiaries. The amounts provided for income taxes are as follows:



	Year Ended December 31,
	2015			2014		2013
Current:
U.S. Federal	$	40,542		$	8,809	$	20,808
State	13,886			2,416		3,521
	$	54,428		$	11,225	$	24,329
Deferred:
U.S. Federal	$	(9,943	)	$	16,484	$	(372	)
State	(3,252		)	5,456		(285		)
	(13,195		)	21,940		(657		)
Total	$	41,233		$	33,165	$	23,672

The tax effect of temporary differences which give rise to a significant portion of deferred tax assets and liabilities are as follows:



	December 31, 2015			December 31, 2014
Deferred tax assets:
Employee benefit accruals	$	16,201		$	11,678
Impairment of investments	4,332			—
Impact of timing of settlement payments	39,840			33,485
Various U.S. state tax loss carryforwards	6,713			8,339
Other	—			—
	67,086			53,502
Less: Valuation allowance	(3,900		)	(4,933		)
Net deferred tax assets	$	63,186		$	48,569

Deferred tax liabilities:
Excess of tax basis over book-basis non-consolidated entities	$	(7,292	)	$	(6,190	)
Book/tax differences on fixed and Intangible assets	(52,598		)	(52,972		)
Capitalized interest expense	(4,080		)	—
Book/tax differences on inventory	(16,891		)	(20,062		)
Book/tax differences on long-term investments	(29,701		)	(32,756		)
Impact of accounting on convertible debt	(30,494		)	(31,033		)
Other	(1,559		)	(1,460		)
	$	(142,615	)	$	(144,473	)

Net deferred tax liabilities	$	(79,429	)	$	(95,904	)

Vector Tobacco had tax effected state and local net operating loss carryforwards of $6,713 and $8,339, respectively, at December 31, 2015 and 2014, expiring through tax year 2027. The Company provides a valuation allowance against deferred tax assets if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The valuation allowance of $3,900 and $4,933 at December 31, 2015 and 2014, respectively, consisted primarily of a reserve against Vector Tobacco’s state and local net operating loss carryforwards. The valuation allowance was decreased in 2015 and 2014, respectively, as a result of changes in estimates in Vector Tobacco’s ability to utilize state tax net operating losses in future years because of changes in state tax apportionment and projected taxable income.

The consolidated balance sheets of the Company include deferred income tax assets and liabilities, which represent temporary differences in the application of accounting rules established by generally accepted accounting principles and income tax laws.

Deferred federal income tax expense differs in 2015, 2014 and 2013 due to the nature of the items in current and deferred tax liabilities. The deferred tax expense in 2015 results primarily from the capitalization of interest expense on the Company's equity method real estate investments. The deferred tax expense in 2014 results primarily from the recognition of temporary differences (related to litigation accruals) at the Tobacco segment. The deferred tax expense in 2013 results primarily from the utilitization of state tax net operating losses.

Differences between the amounts provided for income taxes and amounts computed at the federal statutory tax rate are summarized as follows:



	Year Ended December 31,
	2015			2014			2013
Income before income taxes	$	107,705		$	82,279		$	60,720
Federal income tax expense at statutory rate	37,697			28,798			21,252
Increases (decreases) resulting from:
State income taxes, net of federal income tax benefits	6,862			4,804			2,050
Impact of non-controlling interest	(2,516		)	(4,290		)	88
Non-deductible expenses	2,941			2,581			2,698
Impact of domestic production deduction	(3,436		)	(248		)	(1,889		)
Tax credits	(265		)	(275		)	(433		)
Other	152			—			—
Inclusion of tax liabilities from unincorporated entities	831			1,374			—
Changes in valuation allowance, net of equity and tax audit adjustments	(1,033		)	421			(94		)
Income tax expense	$	41,233		$	33,165		$	23,672

The following table summarizes the activity related to the unrecognized tax benefits:



Balance at January 1, 2013	$	6,269
Additions based on tax positions related to prior years	179
Settlements	(250		)
Expirations of the statute of limitations	(3,076		)
Balance at December 31, 2013	3,122
Additions based on tax positions related to prior years	318
Settlements	(442		)
Expirations of the statute of limitations	(1,254		)
Balance at December 31, 2014	1,744
Additions based on tax positions related to prior years	265
Settlements	(132		)
Expirations of the statute of limitations	(354		)
Balance at December 31, 2015	$	1,523

In the event the unrecognized tax benefits of $1,523 and $1,744 at December 31, 2015 and 2014, respectively, were recognized, such recognition would impact the annual effective tax rates. During 2015, the accrual for potential penalties and interest related to these unrecognized tax benefits was decreased by $28, and in total, as of December 31, 2015, a liability for potential penalties and interest of $219 has been recorded. During 2014, the accrual for potential penalties and interest related to these unrecognized tax benefits was decreased by $529, and in total, as of December 31, 2014, a liability for potential penalties and interest of $247 has been recorded.

It is reasonably possible the Company may recognize up to approximately $107 of currently unrecognized tax benefits over the next 12 months, pertaining primarily to expiration of statutes of limitations of positions reported on state and local income tax returns. The Company files U.S. and state and local income tax returns in jurisdictions with varying statutes of limitations.

In 2013, the Internal Revenue Service concluded an audit of the Company’s income tax return for the year ended December 31, 2009. There was no material impact on the Company’s consolidated financial statements as a result of the audit.

Stock Compensation

12 Months Ended

Dec. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK COMPENSATION

The Company granted equity compensation under its Amended and Restated 1999 Long-Term Incentive Plan (the “1999 Plan”) until the 1999 Plan expired on December 31, 2013. On May 16, 2014, the Company's stockholders approved the 2014 Management Incentive Plan (the “2014 Plan”). The 2014 Plan replaced the 1999 Plan. Like the 1999 Plan, the 2014 Plan provides for the Company to grant stock options, stock appreciation rights and restricted stock. The 2014 Plan also provides for awards based on a multi-year performance period and for annual short-term awards based on a twelve-month performance period. Shares available for issuance under the 2014 Plan are 7,888,406 shares. The Company may satisfy its obligations under any award granted under the 2014 plan by issuing new shares. Awards previously granted under the 1999 Plan remain outstanding in accordance with their terms.

Stock Options. The Company accounts for stock compensation by valuing unvested stock options granted prior to January 1, 2006 under the fair value method of accounting and expensing this amount in the statement of operations over the stock options’ remaining vesting period.

The Company recognized compensation expense of $1,675, $1,573 and $2,212 related to stock options in the years ended December 31, 2015, 2014 and 2013, respectively.

All awards have a contractual term of ten years and awards vest over a period of three to seven years depending upon each grant. The fair value of option grants is estimated at the date of grant using the Black-Scholes option pricing model. The Black-Scholes option pricing model was developed for use in estimating the fair value of traded options which have no vesting restrictions and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions including expected stock price characteristics which are significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, the existing models do not necessarily provide a reliable single measure of the fair value of stock-based compensation awards.

The assumptions used under the Black-Scholes option pricing model in computing fair value of options are based on the expected option life considering both the contractual term of the option and expected employee exercise behavior, the interest rate associated with U.S. Treasury issues with a remaining term equal to the expected option life and the expected volatility of the Company’s common stock over the expected term of the option. The assumptions used for grants in the years ended December 31, 2015, 2014 and 2013 were as follows:



	2015		2014		2013
Risk-free interest rate	1.8% -2.0%		1.1% -2.6%		0.6% – 1.8%
Expected volatility	22.18% - 22.25%		18.51% - 22.37%		20.05% – 24.08%
Dividend yield	0.0	%	0.0	%	0.0	%
Expected holding period	7.00 – 10.00 years		4.00 – 10.00 years		4.00 – 10.00 years
Weighted-average grant date fair value (1)	$6.47 - $8.07		$3.28 - $7.32		$2.72 – $5.80

(1) Per share amounts have not been adjusted to give effect to the stock dividends in 2015, 2014 and 2013.

A summary of employee stock option transactions follows:



	Number of Shares		Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value(1)
Outstanding on January 1, 2013	2,645,914		$	11.33	6.6	$	4,371
Granted	868,219		$	13.93
Exercised	(44,293	)	$	12.29
Canceled	(15	)	$	—
Outstanding on December 31, 2013	3,469,825		$	11.98	6.5	$	9,959
Granted	427,219		$	17.82
Exercised	(442,740	)	$	11.41
Canceled	(12	)	$	—
Outstanding on December 31, 2014	3,454,292		$	12.77	6.4	$	25,977
Granted	406,875		$	22.00
Exercised	(115,531	)	$	12.02
Canceled	(5	)	$	—
Outstanding on December 31, 2015	3,745,631		$	13.82	5.9	$	36,612
Options exercisable at:
December 31, 2013	1,959,317
December 31, 2014	1,598,885
December 31, 2015	2,035,345

_____________________________


(1)	The aggregate intrinsic value represents the amount by which the fair value of the underlying common stock ($23.59, $20.30 and $14.85 at December 31, 2015, 2014 and 2013, respectively) exceeds the option exercise price.

Additional information relating to options outstanding at December 31, 2015 follows:



			Options Outstanding				Options Exercisable
Range of Exercise Prices			Outstanding as of	Weighted-Average Remaining Contractual Life (Years)	Weighted-Average Exercise Price		Exercisable as of	Weighted-Average Remaining Contractual Life (Years)	Weighted-Average Exercise Price		Aggregate Intrinsic Value
Range of Exercise Prices			12/31/2015	Weighted-Average Remaining Contractual Life (Years)	Weighted-Average Exercise Price		12/31/2015	Weighted-Average Remaining Contractual Life (Years)	Weighted-Average Exercise Price		Aggregate Intrinsic Value
$0.00	-	$11.00	1,500,905	3.9	$	10.52	1,500,905	3.9	$	10.52	$	—
$11.00	-	$13.20	31,906	5.1	$	12.46	23,928	5.1	$	12.46	—
$13.20	-	$15.40	1,378,728	6.4	$	13.78	510,512	5.0	$	13.52	—
$15.40	-	$17.60	—	—	$	—	—	—	$	—	—
$17.60	-	$19.80	427,217	8.4	$	17.82	—	—	$	—	—
$19.80	-	$22.00	406,875	9.2	$	22.00	—	—	$	—	—
			3,745,631	5.9	$	13.82	2,035,345	4.2	$	11.30	$	25,024

As of December 31, 2015, there was $3,775 of total unrecognized compensation cost related to unvested stock options. The cost is expected to be recognized over a weighted-average period of approximately 1.88 years at December 31, 2015.

The Company reflects the tax savings resulting from tax deductions in excess of expense reflected in its consolidated financial statements as a component of “Cash Flows from Financing Activities.”

Non-qualified options for 406,875 shares of common stock were issued during 2015. The exercise price of the options granted was $22.00 in 2015. The exercise price of the options granted in 2015 were at the fair value on the date of the grants.

Non-qualified options for 427,219 shares of common stock were issued during 2014. The exercise price of the options granted was $17.82 in 2014 . The exercise price of the options granted in 2014 were at the fair value on the date of the grants.

Non-qualified options for 868,219 shares of common stock were issued during 2013. The exercise price of the options granted was $13.93 in 2013. The exercise price of the options granted in 2013 were at the fair value on the date of the grants.

The Company has elected to use the long-form method under which each award grant is tracked on an employee-by-employee basis and grant-by-grant basis to determine if there is a tax benefit or tax deficiency for such award. The Company then compares the fair value expense to the tax deduction received for each grant and aggregates the benefits and deficiencies to establish its hypothetical APIC Pool.

The Company recognizes windfall tax benefits associated with the exercise of stock options directly to stockholders’ deficiency only when realized. A windfall tax benefit occurs when the actual tax benefit realized by the Company upon an employee’s disposition of a share-based award exceeds the deferred tax asset, if any, associated with the award that the Company had recorded.

The total intrinsic value of options exercised during the years ended December 31, 2015, 2014 and 2013 was $1,151, $3,539 and $93, respectively. Tax benefits related to option exercises of $821, $1,178 and $38 were recorded as increases to stockholders’ deficiency for the years ended December 31, 2015, 2014 and 2013, respectively.

Restricted Stock Awards. On November 10, 2015, the Company granted its President and Chief Executive Officer an award of 1,200,000 shares of its common stock subject to service and performance-based vesting. The award shares were issued pursuant to the terms of an agreement that provides that both a performance requirement and a continued employment requirement must be met over a seven-year performance period to earn vested rights with respect to the award shares. The maximum potential amount of the award shares reflects recognition of the CEO’s contributions as CEO since January 1, 2006 and the value of his management and real estate expertise to the Company. The fair market value of the restricted shares on the date of grant was $28,374 and is being amortized over the performance period as a charge to compensation expense. The Company recognized expense of $597 for the year ended December 31, 2015.

On July 23, 2014, the Company granted its President and Chief Executive Officer an award of 1,102,500 shares of its common stock subject to service and performance-based vesting. The award shares were issued pursuant to the terms of an agreement that provides that both a performance requirement and a continued employment requirement must be met over a seven-year performance period to earn vested rights with respect to the award shares. The maximum potential amount of the award shares reflects recognition of the CEO’s contributions as CEO since January 1, 2006 and the value of his management and real estate expertise to the Company. The fair market value of the restricted shares on the date of grant was $20,780 and is being amortized over the performance period as a charge to compensation expense. The Company recognized expense of $2,992 and $1,320 for the years ended December 31, 2015 and 2014, respectively.

In May 2013, the Company granted 11,576 restricted shares of the Company’s common stock (the “May 2013 Grant”) pursuant to the 1999 Plan to each of its five outside directors. The shares vest over three years and the Company will recognize $815 of expense over the vesting period of the May 2013 Grant. The Company recognized expense of $272, $271 and $161 for the years ended December 31, 2015, 2014 and 2013, respectively.

In June 2010, the Company granted 13,401 restricted shares of the Company’s common stock (the “June 2010 Grant”) pursuant to the 1999 Plan to each of its five outside directors. In November 2011, one of the outside directors resigned from the board and 8,509 of the restricted shares granted in June 2010 were forfeited and canceled. The remaining shares vested over three years and the Company recognized $749 of expense over the vesting period of the June 2010 Grant. In November 2011, the Company also granted 8,104 restricted shares of the Company’s stock (the “November 2011 grant”) pursuant to the 1999 Plan to the replacement director. The shares granted to the replacement director vested over approximately 19 months. The Company recognized $120 of expense over the vesting period for the November 2011 Grant. The Company recognized expense of $133 for the year ended December 31, 2013.

In October 2013, the President and Chief Executive Officer of Liggett and Liggett Vector Brands was awarded a restricted stock grant of 30,319 shares of Vector’s common stock pursuant to the 1999 Plan. The shares will vest on the earlier of March 15, 2019, contingent upon performance-based targets being achieved by the Company’s Tobacco segment, or October 31, 2020, if the performance-based targets are not achieved. He will receive dividends on the restricted shares as paid. In the event that his employment with the Company is terminated for any reason other than his death, his disability or a change of control (as defined in this Restricted Share Agreement) of the Company, any remaining balance of the shares not previously vested will be forfeited by him. The fair market value of the restricted shares on the date of grant was $458 and is being amortized over the vesting period as a charge to compensation expense. The Company recognized expense of $86, $86 and $14 for the years ended December 31, 2015, 2014 and 2013, respectively.

As of December 31, 2015, there was $44,632 of total unrecognized compensation costs related to unvested restricted stock awards. The cost is expected to be recognized over a weighted-average period of approximately 3.19 years.

As of December 31, 2014, there was $20,181 of total unrecognized compensation costs related to unvested restricted stock awards.

The Company’s accounting policy is to treat dividends paid on unvested restricted stock as a reduction to additional paid-in capital on the Company’s consolidated balance sheet.

Contingencies

12 Months Ended

Dec. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

CONTINGENCIES

Tobacco-Related Litigation:

Overview. Since 1954, Liggett and other United States cigarette manufacturers have been named as defendants in numerous direct, third-party and purported class actions predicated on the theory that cigarette manufacturers should be liable for damages alleged to have been caused by cigarette smoking or by exposure to secondary smoke from cigarettes. The cases have generally fallen into the following categories: (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs (“Individual Actions”); (ii) lawsuits by individuals requesting the benefit of the Engle ruling (“Engle progeny cases”); (iii) smoking and health cases primarily alleging personal injury or seeking court-supervised programs for ongoing medical monitoring, as well as cases alleging that use of the terms “lights” and/or “ultra lights” constitutes a deceptive and unfair trade practice, common law fraud or violation of federal law, purporting to be brought on behalf of a class of individual plaintiffs (“Class Actions”); and (iv) health care cost recovery actions brought by various foreign and domestic governmental plaintiffs and non-governmental plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits (“Health Care Cost Recovery Actions”). With the commencement of new cases, the defense costs and the risks relating to the unpredictability of litigation increase. The future financial impact of the risks and expenses of litigation are not quantifiable. For the years ended December 31, 2015, 2014 and 2013, Liggett incurred tobacco product liability legal expenses and costs totaling $26,987, $9,944 and $9,321, respectively. The 2013 costs exclude a charge of $86,213 associated with the Engle progeny settlement discussed below. The tobacco product liability legal expenses and costs are included in the operating, selling, administrative and general expenses and litigation settlement and judgment expense line items in the Consolidated Statements of Operations.

Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending cases. Management reviews on a quarterly basis with counsel all pending litigation and evaluates the probability of a loss being incurred and whether an estimate can be made of the possible loss or range of loss that could result from an unfavorable outcome. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation. Damages awarded in tobacco-related litigation can be significant.

Bonds. Although Liggett has been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts are on appeal, there remains a risk that such relief may not be obtainable in all cases. This risk has been reduced given that a majority of states now limit the dollar amount of bonds or require no bond at all. To obtain stays on judgments pending current appeals, Liggett has secured approximately $15,767 in bonds as of February 29, 2016.

In June 2009, Florida amended its existing bond cap statute by adding a $200,000 bond cap that applies to all Engle progeny cases in the aggregate and establishes individual bond caps for individual Engle progeny cases in amounts that vary depending on the number of judgments in effect at a given time. In several cases, plaintiffs challenged the constitutionality of the bond cap statute, but to date the courts have upheld the constitutionality of the statute. It is possible that the Company’s consolidated financial position, results of operations, and cash flows could be materially adversely affected by an unfavorable outcome of such challenges.

Accounting Policy. The Company and its subsidiaries record provisions in their consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except as disclosed in this Note 15: (i) management has concluded that it is not probable that a loss has been incurred in any of the pending tobacco-related cases; or (ii) management is unable to reasonably estimate the possible loss or range of loss that could result from an unfavorable outcome of any of the pending tobacco-related cases and, therefore, management has not provided any amounts in the consolidated financial statements for unfavorable outcomes, if any. Legal defense costs are expensed as incurred.

Cautionary Statement About Engle Progeny Cases. Judgments have been entered against Liggett and other industry defendants in Engle progeny cases. A number of the judgments have been affirmed on appeal and satisfied by the defendants. As of December 31, 2015, 24 Engle progeny cases where Liggett was a defendant at trial resulted in verdicts. Fifteen verdicts were returned in favor of the plaintiffs (although in two of these cases (Irimi and Cohen) the court granted defendants' motion for a new trial and nine in favor of Liggett. In four of the cases, punitive damages were awarded against Liggett. In certain cases, the judgments were entered jointly and severally with other defendants and Liggett may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment. As a result, Liggett under certain circumstances may have to pay more than its proportionate share of any bonding or judgment related amounts. Several of the judgments remain on appeal. Except as discussed in this Note 15 regarding the cases where an adverse verdict was entered against Liggett and that remain on appeal, management is unable to estimate the possible loss or range of loss from the remaining Engle progeny cases as there are currently multiple defendants in each case and, in most cases, discovery has not occurred or is limited. As a result, the Company lacks information about whether plaintiffs are in fact Engle class members (non-class members’ claims are generally time-barred), the relevant smoking history, the nature of the alleged injury and the availability of various defenses, among other things. Further, plaintiffs typically do not specify their demand for damages.

Although Liggett has generally been successful in managing litigation, litigation is subject to uncertainty and significant challenges remain, including with respect to the remaining Engle progeny cases. There can be no assurances that Liggett’s past litigation experience will be representative of future results. Judgments have been entered against Liggett in the past, in Individual Actions and Engle progeny cases, and several of those judgments were affirmed on appeal and satisfied by Liggett. It is possible that the consolidated financial position, results of operations and cash flows of the Company could be materially adversely affected by an unfavorable outcome or settlement of any of the remaining smoking-related litigation. Liggett believes, and has been so advised by counsel, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts. All such cases are, and will continue to be, vigorously defended, however, Liggett has entered into settlement discussions in individual cases or groups of cases, where Liggett has determined it was in its best interest to do so, and it may continue to do so in the future, including the remaining Engle progeny cases. In October 2013, Liggett announced a settlement of the claims of over 4,900 Engle progeny plaintiffs (see Engle Progeny Settlement below). As of December 31, 2015, Liggett (and in certain cases the Company) had, on an individual basis, settled 171 Engle progeny cases for approximately $3,612 in the aggregate. Three of those settlements occurred in the fourth quarter of 2015.

Individual Actions

As of December 31, 2015, there were 40 Individual Actions pending against Liggett and, in certain cases, the Company, where one or more individual plaintiffs allege injury resulting from cigarette smoking, addiction to cigarette smoking or exposure to secondary smoke and seek compensatory and, in some cases, punitive damages. These cases do not include the remaining Engle progeny cases or the individual cases pending in West Virginia state court as part of a consolidated action. The following table lists the number of Individual Actions by state:



State		Number of Cases
Florida		15
Maryland		12
New York		7
Louisiana		2
West Virginia		2
Missouri		1
Ohio		1

The plaintiffs’ allegations of liability in cases in which individuals seek recovery for injuries allegedly caused by cigarette smoking are based on various theories of recovery, including negligence, gross negligence, breach of special duty, strict liability, fraud, concealment, misrepresentation, design defect, failure to warn, breach of express and implied warranties, conspiracy, aiding and abetting, concert of action, unjust enrichment, common law public nuisance, property damage, invasion of privacy, mental anguish, emotional distress, disability, shock, indemnity, violations of deceptive trade practice laws, the federal Racketeer Influenced and Corrupt Organizations Act (“RICO”), state RICO statutes and antitrust statutes. In many of these cases, in addition to compensatory damages, plaintiffs also seek other forms of relief including treble/multiple damages, medical monitoring, disgorgement of profits and punitive damages. Although alleged damages often are not determinable from a complaint, and the law governing the pleading and calculation of damages varies from state to state and jurisdiction to jurisdiction, compensatory and punitive damages have been specifically pleaded in a number of cases, sometimes in amounts ranging into the hundreds of millions and even billions of dollars.

Defenses raised in Individual Actions include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, lack of design defect, statute of limitations, equitable defenses such as “unclean hands” and lack of benefit, failure to state a claim and federal preemption.

Engle Progeny Cases

Engle Case. In May 1994, Engle was filed against Liggett and others in Miami-Dade County, Florida. The class consisted of all Florida residents who, by November 21, 1996, “have suffered, presently suffer or have died from diseases and medical conditions caused by their addiction to cigarette smoking.” In July 1999, after the conclusion of Phase I of the trial, the jury returned a verdict against Liggett and other cigarette manufacturers on certain issues determined by the trial court to be “common” to the causes of action of the plaintiff class. The jury made several findings adverse to the defendants including that defendants’ conduct “rose to a level that would permit a potential award or entitlement to punitive damages.” Phase II of the trial was a causation and damages trial for three of the class plaintiffs and a punitive damages trial on a class-wide basis before the same jury that returned the verdict in Phase I. In April 2000, the jury awarded compensatory damages of $12,704 to the three class plaintiffs, to be reduced in proportion to the respective plaintiff’s fault. In July 2000, the jury awarded approximately $145,000,000 in punitive damages, including $790,000 against Liggett.

In May 2003, Florida’s Third District Court of Appeal reversed the trial court and remanded the case with instructions to decertify the class. The judgment in favor of one of the three class plaintiffs, in the amount of $5,831, was overturned as time barred and the court found that Liggett was not liable to the other two class plaintiffs.

In July 2006, the Florida Supreme Court affirmed the decision vacating the punitive damages award and held that the class should be decertified prospectively, but determined that the following Phase I findings are entitled to res judicata effect in Engle progeny cases: (i) that smoking causes lung cancer, among other diseases; (ii) that nicotine in cigarettes is addictive; (iii) that defendants placed cigarettes on the market that were defective and unreasonably dangerous; (iv) that defendants concealed material information knowing that the information was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v) that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vi) that defendants sold or supplied cigarettes that were defective; and (vii) that defendants were negligent. The Florida Supreme Court decision also allowed former class members to proceed to trial on individual liability issues (using the above findings) and compensatory and punitive damage issues, provided they filed their individual lawsuits by January 2008. In December 2006, the Florida Supreme Court added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations made by defendants. In October 2007, the United States Supreme Court denied defendants’ petition for writ of certiorari.

Pursuant to the Florida Supreme Court’s July 2006 ruling in Engle, which decertified the class on a prospective basis, and affirmed the appellate court’s reversal of the punitive damages award, former class members had until January 2008 in which to file individual lawsuits. As a result, Liggett and the Company, and other cigarette manufacturers, were sued in thousands of Engle progeny cases in both federal and state courts in Florida. Although the Company was not named as a defendant in the Engle case, it was named as a defendant in substantially all of the Engle progeny cases where Liggett was named as a defendant.

Engle Progeny Settlement. In October 2013, the Company entered into a settlement with approximately 4,900 Engle progeny plaintiffs and their counsel. Pursuant to the terms of the settlement, Liggett agreed to pay a total of approximately $110,000, with approximately $61,600 paid in a lump sum and the balance to be paid in installments over 14 years, starting in February 2015. In exchange, the claims of over 4,900 plaintiffs were dismissed with prejudice against the Company and Liggett. Due to the settlement, in 2013 the Company recorded a charge of $86,213, of which $25,213 is related to certain payments discounted to their present value using an 11% annual discount rate. The Company recorded an additional charge of $643 in the first quarter of 2015 for additional cases joining the settlement and the restructuring of certain payments related to several previously settled cases. The installment payments total approximately $48,000 on an undiscounted basis. The Company’s future payments will be approximately $3,400 per annum through 2028, with a cost of living increase beginning in 2021.

Notwithstanding the comprehensive nature of the Engle Progeny Settlement, approximately 260 plaintiffs’ claims remain outstanding. Therefore, the Company and Liggett may still be subject to periodic adverse judgments which could have a material adverse affect on the Company’s consolidated financial position, results of operations and cash flows.

As of December 31, 2015, the following Engle progeny cases have resulted in judgments against Liggett:



Date	Case Name	County	Liggett Compensatory Damages (as adjusted)⁽¹⁾	Liggett Punitive Damages	Status ⁽²⁾
June 2002	Lukacs v. R.J. Reynolds	Miami-Dade	$12,418	$—	Liggett satisfied the judgment and the case is concluded.
August 2009	Campbell v. R.J. Reynolds	Escambia	156	—	Liggett satisfied the judgment and the case is concluded.
March 2010	Douglas v. R.J. Reynolds	Hillsborough	1,350	—	Liggett satisfied the judgment and the case is concluded.
April 2010	Clay v. R.J. Reynolds	Escambia	349	1,000	Liggett satisfied the judgment and the case is concluded.
April 2010	Putney v. R.J. Reynolds	Broward	3,008	—	On June 12, 2013, the Fourth District Court of Appeal reversed and remanded the case for further proceedings regarding the amount of the award. Both sides sought discretionary review from the Florida Supreme Court. In February 2016, the Florida Supreme Court reinstated the jury's verdict. The defendants moved for clarification of that order.
April 2011	Tullo v. R.J. Reynolds	Palm Beach	225	—	Liggett satisfied the judgment and other than an issue with respect to the calculation of interest on the judgment and the amount of costs owed by Liggett, the case is concluded.
January 2012	Ward v. R.J. Reynolds	Escambia	1	—	Liggett satisfied the merits judgment. Subsequently, the trial court entered a final judgment on attorneys' fees and costs for $981 and defendants appealed that judgment.
May 2012	Calloway v. R.J. Reynolds	Broward	1,530	7,600	A joint and several judgment for $16,100 was entered against R.J. Reynolds, Philip Morris, Lorillard and Liggett. On January 6, 2016, the Fourth District Court of Appeal reversed in part, including the $7,600 punitive damages award against Liggett, and remanded the case to the trial court for a new trial on certain issues. Both sides have moved for rehearing.
December 2012	Buchanan v. R.J. Reynolds	Leon	2,750	—	A joint and several judgment for $5,500 was entered against Liggett and Philip Morris. The court refused to reduce the award by decedent's comparative fault. Judgment was affirmed by the First District Court of Appeal, but the court certified an issue of conflict with another case. The defendants sought discretionary review by the Florida Supreme Court, which was declined in February 2016. The defendants are considering their appellate options.
May 2013	Cohen v. R.J. Reynolds	Palm Beach	205	—	Defendants' motion seeking a new trial was granted by the trial court. Plaintiff appealed to the Fourth District Court of Appeal. Defendants cross-appealed.
August 2013	Rizzuto v. R.J. Reynolds	Hernando	3,479	—	Liggett settled its portion of the judgment for $1,500 and the case is concluded as to Liggett.
August 2014	Irimi v. R.J. Reynolds	Broward	31	—	In January 2015, the trial court granted defendants' motion for a new trial. Plaintiff appealed to the Fourth District Court of Appeal.
October 2014	Lambert v. R.J. Reynolds	Pinellas	3,600	9,500	A final judgment was entered against Liggett for $13,100. Liggett was the only defendant at trial. In February 2016, the Second District Court of Appeal affirmed the lower court's decision without opinion. The parties reached an agreement regarding the amount of plaintiff's trial level attorneys' fees and costs in the event plaintiff prevails on appeal.
November 2014	Boatright v. R.J. Reynolds	Polk	—	300	In November 2014, the jury awarded compensatory damages in the amount of $15,000 with 15% fault apportioned to plaintiff and 85% to Philip Morris. The jury further assessed punitive damages against Philip Morris for $19,700 and Liggett for $300. Post trial motions were denied. A joint and several judgment was entered in the amount of $12,750 on the compensatory damages. Judgment was further entered against Liggett for $300 in punitive damages. On appeal to the Second District Court of Appeal.
June 2015	Caprio v. R.J. Reynolds	Broward	—	—	In February 2015, the jury answered certain questions on the verdict form, but were deadlocked as to others. The jury returned a verdict of $559 in economic damages. The court entered a partial judgment and ordered a new trial on the remaining issues, including comparative fault and punitive damages. On appeal to the Fourth District Court of Appeal.
Total Damages Awarded:			29,102	18,400
Amounts paid or compromised:			(17,978)	(1,000)
Damages remaining on Appeal:			$11,124	$17,400
(1) Compensatory damages are adjusted to reflect the jury's allocation of comparative fault and only include Liggett's jury allocated share, regardless of whether a judgment was joint and several. The amounts listed above do not include attorneys' fees or statutory interest.
(2) See Exhibit 99.1 for a more complete description of the cases currently on appeal.

Through December 31, 2015, Liggett paid $20,312, including interest and attorneys' fees, to satisfy the judgments in seven Engle progeny cases (Lukacs, Campbell, Douglas, Clay, Tullo, Ward, and Rizzuto).

The Company’s potential range of loss in the remaining cases on appeal is between $0 and $12,674 in the aggregate, plus interest and attorneys' fees. In determining the range of loss, the Company considers potential settlements as well as future appellate relief. Except as disclosed elsewhere in this Note 15, the Company is unable to determine a range of loss related to the remaining Engle progeny cases. The Company's consolidated balance sheet as of December 31, 2015 contains accruals for the following Engle progeny cases: Buchanan and Lambert. As cases proceed through the appellate process, the Company will consider accruals on a case-by-case basis if an unfavorable outcome becomes probable and the amount can be reasonably estimated.

Appeals of Engle Progeny Judgments. In December 2010, in the Martin case, a state court case against R.J. Reynolds, the First District Court of Appeal held that the trial court correctly construed the Florida Supreme Court’s 2006 decision in Engle in instructing the jury on the preclusive effect of the Phase I Engle findings. In July 2011, the Florida Supreme Court declined to review the First District Court of Appeal’s decision. In March 2012, the United States Supreme Court declined to review the Martin case, along with the Campbell case and two other Engle progeny cases. The Martin decision has led to additional adverse rulings by other state appellate courts.

In Jimmie Lee Brown, a state court case against R.J. Reynolds, the trial court tried the case in two phases. In the first phase, the jury determined that the smoker was addicted to cigarettes that contained nicotine and that his addiction was a legal cause of his death, thereby establishing he was an Engle class member. In the second phase, the jury determined whether the plaintiff established legal cause and damages with regard to each of the underlying claims. The jury found in favor of plaintiff in both phases. In September 2011, the Fourth District Court of Appeal affirmed the judgment entered in plaintiff’s favor and approved the trial court’s procedure of bifurcating the trial. The Fourth District Court of Appeal agreed with Martin that individual post-Engle plaintiffs need not prove conduct elements as part of their burden of proof, but disagreed with Martin to the extent that the First District Court of Appeal only required a finding that the smoker was a class member to establish legal causation as to addiction and the underlying claims. The Fourth District Court of Appeal held that in addition to establishing class membership, Engle progeny plaintiffs must also establish legal causation and damages as to each claim asserted. In so finding, the Fourth District Court of Appeal’s decision in Jimmie Lee Brown is in conflict with Martin.

In Rey, a state court case, the trial court entered final summary judgment on all claims in favor of the Company, Liggett and Lorillard based on what has been referred to in the Engle progeny litigation as the “Liggett Rule.” The Liggett Rule stands for the proposition that a manufacturer cannot have liability to a smoker under any asserted claim if the smoker did not use a product manufactured by that particular defendant. The Liggett Rule is based on the entry of final judgment in favor of Liggett/Brooke Group in Engle on all of the claims asserted against them by class representatives Mary Farnan and Angie Della Vecchia, even though the Florida Supreme Court upheld, as res judicata, the generic finding that Liggett/Brooke Group engaged in a conspiracy to commit fraud by concealment. In September 2011, the Third District Court of Appeal affirmed in part and reversed in part holding that the defendants were entitled to summary judgment on all claims asserted against them other than the claim for civil conspiracy. Defendants’ further appellate efforts were unsuccessful.

In Douglas, a state court case, the Second District Court of Appeal issued a decision affirming the judgment of the trial court in favor of the plaintiff and upholding the use of the Engle jury findings, but certified to the Florida Supreme Court the question of whether granting res judicata effect to the Engle jury findings violates defendants’ federal due process rights. In March 2013, the Florida Supreme Court affirmed the use of Engle jury findings and determined that there is no violation of the defendants’ due process rights. This was the first time the Florida Supreme Court addressed the merits of an Engle progeny case. In October 2013, the United States Supreme Court declined to review the decision and Liggett satisfied the judgment. To date, the United States Supreme Court has declined to review any Engle progeny decisions.

In Hess, a state court case, in April 2015, the Florida Supreme Court held that Engle defendants cannot raise a statute of repose defense to claims for concealment or conspiracy. Defendants' motion for rehearing was denied.

In April 2015, in Graham, a federal case, the Eleventh Circuit held that federal law impliedly preempts use of the res judicata Engle findings to establish claims for strict liability or negligence. In February 2016, the Eleventh Circuit Court of Appeals vacated the panel’s opinion and granted Plaintiff’s motion for rehearing en banc. Defendant's filed a motion requesting that the court enter a briefing order directing the parties to address both implied preemption and whether the application of the Engle findings violates federal due process. That motion is pending.

Maryland Cases

Liggett is currently a defendant in 12 multi-defendant personal injury cases in Maryland that allege claims arising from asbestos and tobacco exposure. Liggett along with other tobacco defendants have moved (or are in the process of moving) to dismiss the cases. In the past, motions to dismiss have generally been successful, typically resulting in the dismissal without prejudice of the tobacco company defendants, including Liggett. Recently, however, a Maryland intermediate appellate court ruled, in Stidham, et al. v. R. J. Reynolds Tobacco Company, et al., that dismissal of tobacco company defendants may not be appropriate where injury is asserted based on both asbestos and tobacco usage. Although Stidham is subject to further appellate review, and the scope of its holding is not yet known, it is possible that Liggett and other tobacco company defendants will not be dismissed from pending synergy exposure cases, and may be named as a defendant in asbestos-related personal injury actions in Maryland going forward, including approximately 20 additional synergy exposure cases currently pending in Maryland state court.

Liggett Only Cases

There are currently three cases pending where Liggett is the only remaining defendant. Each of these cases is an Individual Action. In November 2015, in Hausrath (NY state court), one of the Individual Actions, the court entered a case management order providing discovery deadlines. There has been no further activity in the other two Individual Actions. Cases where Liggett is the only defendant could increase as a result of the remaining Engle progeny cases.

Class Actions

As of December 31, 2015, three actions were pending for which either a class had been certified or plaintiffs were seeking class certification where Liggett is a named defendant. Other cigarette manufacturers are also named in these actions. Liggett is aware of another action seeking class certification recently filed in the Eastern District of Louisiana. Liggett has not been served with that complaint.

Plaintiffs’ allegations of liability in class action cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violation of deceptive trade practice laws and consumer protection statutes and claims under the federal and state anti-racketeering statutes. Plaintiffs in the class actions seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.

Defenses raised in these cases include, among others, lack of proximate cause, individual issues predominate, assumption of the risk, comparative fault and/or contributory negligence, statute of limitations and federal preemption.

In November 1997, in Young v. American Tobacco Co., a purported personal injury class action was commenced on behalf of plaintiff and all similarly situated residents in Louisiana who, though not themselves cigarette smokers, allege they were exposed to secondhand smoke from cigarettes that were manufactured by the defendants, including Liggett, and suffered injury as a result of that exposure. The plaintiffs seek to recover an unspecified amount of compensatory and punitive damages. No class certification hearing has been held. In 2013, plaintiffs’ filed a motion to stay the case and that motion was granted.

In February 1998, in Parsons v. AC & S Inc., a purported class action was commenced on behalf of all West Virginia residents who allegedly have personal injury claims arising from exposure to cigarette smoke and asbestos fibers. The complaint seeks to recover $1,000 in compensatory and punitive damages individually and unspecified compensatory and punitive damages for the class. The case is stayed due to the December 2000 bankruptcy of three of the defendants.

Although not technically a class action, in In Re: Tobacco Litigation (Personal Injury Cases), a West Virginia state court consolidated approximately 750 individual smoker actions that were pending prior to 2001 for trial of certain "common" issues. Liggett was severed from trial of the consolidated action. After two mistrials, in May 2013, the jury rejected all but one of the plaintiffs' claims, finding in favor of plaintiffs on the claim that ventilated filter cigarettes between 1964 and July 1, 1969 should have included instructions on how to use them. The issue of damages was reserved for further proceedings. The court entered judgment in October 2013, dismissing all claims except the ventilated filter claim. The judgment was affirmed on appeal and remanded to the trial court for further proceedings. In April 2015, the plaintiffs filed a petition for writ of certiorari to the United States Supreme Court which subsequently declined review. In July 2015, the trial court ruled on the scope of the ventilated filter claim and determined that only 30 plaintiffs have potentially viable claims against the non-Liggett defendants, which may be pursued in a second phase of the trial. The court intends to try the claims of these plaintiffs in six consolidated trials, each with five plaintiffs. The trial court set the first date for the consolidated trials for January 9, 2017. With respect to Liggett, the trial court requested that Liggett and plaintiffs brief whether any claims against Liggett survive given the outcome of the first phase of the trial. Briefing is complete. If the case proceeds against Liggett, it is estimated that Liggett could be a defendant in less than 25 of the remaining individual cases.

In addition to the cases described above, numerous class actions remain certified against other cigarette manufacturers including cases alleging, among other things, that use of the terms “lights” and “ultra lights” constitutes unfair and deceptive trade practices. Adverse decisions in these cases could have a material adverse affect on Liggett’s sales volume, operating income and cash flows.

Health Care Cost Recovery Actions

As of December 31, 2015, one Health Care Cost Recovery Action was pending against Liggett, Crow Creek Sioux Tribe v. American Tobacco Company, a South Dakota case filed in 1997, where the plaintiff seeks to recover damages based on various theories of recovery as a result of alleged sales of tobacco products to minors. The case is inactive. Other cigarette manufacturers are also named as defendants.

The claims asserted in health care cost recovery actions vary, but can include the equitable claim of indemnity, common law claims of negligence, strict liability, breach of express and implied warranty, breach of special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, claims under state and federal statutes governing consumer fraud, antitrust, deceptive trade practices and false advertising, and claims under RICO. Although no specific damage amounts are typically pleaded, it is possible that requested damages might be in the billions of dollars. In these cases, plaintiffs typically assert equitable claims that the tobacco industry was “unjustly enriched” by their payment of health care costs allegedly attributable to smoking and seek reimbursement of those costs. Relief sought by some, but not all, plaintiffs include punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.

Department of Justice Lawsuit

In September 1999, the United States government commenced litigation against Liggett and other cigarette manufacturers in the United States District Court for the District of Columbia. The action sought to recover an unspecified amount of health care costs paid and to be paid by the federal government for lung cancer, heart disease, emphysema and other smoking-related illnesses allegedly caused by the fraudulent and tortious conduct of defendants, to restrain defendants and co-conspirators from engaging in alleged fraud and other allegedly unlawful conduct in the future, and to compel defendants to disgorge the proceeds of their unlawful conduct. Claims were asserted under RICO.

In August 2006, the trial court entered a Final Judgment against each of the cigarette manufacturing defendants, except Liggett. In May 2009, the United States Court of Appeals for the District of Columbia affirmed most of the district court’s decision. The United States Supreme Court denied review. As a result, the cigarette manufacturing defendants, other than Liggett, are now subject to the trial court’s Final Judgment which ordered the following relief: (i) an injunction against “committing any act of racketeering” relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii) an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii) an injunction against “making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States’ public and that misrepresents or suppresses information concerning cigarettes”; (iv) an injunction against conveying any express or implied health message through use of descriptors on cigarette packaging or in cigarette advertising or promotional material, including “lights,” “ultra lights,” and “low tar,” which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v) the issuance of “corrective statements” in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking “low tar” or “lights” cigarettes, defendants’ manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to environmental tobacco smoke; (vi) the disclosure of defendants’ public document websites and the production of all documents produced to the government or produced in any future court or administrative action concerning smoking and health; (vii) the disclosure of disaggregated marketing data to the government in the same form and on the same schedules as defendants now follow in disclosing such data to the Federal Trade Commission for a period of ten years; (viii) certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette business within the United States; and (ix) payment of the government’s costs in bringing the action. In June 2014, the court approved a consent agreement between the defendants and the Department of Justice regarding the “corrective statements” to be issued by the defendants. In May 2015, the court of appeals issued an opinion on the legality of the "corrective statements," affirming them in part and reversing them in part. The implementation of the “corrective statements” is uncertain as proceedings are ongoing.

It is unclear what impact, if any, the Final Judgment will have on the cigarette industry as a whole. To the extent that the Final Judgment leads to a decline in industry-wide shipments of cigarettes in the United States or otherwise results in restrictions that adversely affect the industry, Liggett’s sales volume, operating income and cash flows could be materially adversely affected.

Upcoming Trials

As of December 31, 2015, there were seven Engle progeny cases scheduled for trial through December 31, 2016, where Liggett (and/or the Company) is a named defendant. Trial dates are, however, subject to change.

MSA and Other State Settlement Agreements

In March 1996, March 1997 and March 1998, Liggett entered into settlements of smoking-related litigation with 45 states and territories. The settlements released Liggett from all smoking-related claims made by those states and territories, including claims for health care cost reimbursement and claims concerning sales of cigarettes to minors.

In November 1998, Philip Morris, Brown & Williamson, R.J. Reynolds and Lorillard (the “Original Participating Manufacturers” or “OPMs”) and Liggett (together with any other tobacco product manufacturer that becomes a signatory, the “Subsequent Participating Manufacturers” or “SPMs”) (the OPMs and SPMs are hereinafter referred to jointly as the “Participating Manufacturers”) entered into the Master Settlement Agreement (the “MSA”) with 46 states, the District of Columbia, Puerto Rico, Guam, the United States Virgin Islands, American Samoa and the Northern Mariana Islands (collectively, the “Settling States”) to settle the asserted and unasserted health care cost recovery and certain other claims of the Settling States. The MSA received final judicial approval in each Settling State.

As a result of the MSA, the Settling States released Liggett from:


•	all claims of the Settling States and their respective political subdivisions and other recipients of state health care funds, relating to: (i) past conduct arising out of the use, sale, distribution, manufacture, development, advertising and marketing of tobacco products; (ii) the health effects of, the exposure to, or research, statements or warnings about, tobacco products; and


•	all monetary claims of the Settling States and their respective subdivisions and other recipients of state health care funds relating to future conduct arising out of the use of, or exposure to, tobacco products that have been manufactured in the ordinary course of business.

The MSA restricts tobacco product advertising and marketing within the Settling States and otherwise restricts the activities of Participating Manufacturers. Among other things, the MSA prohibits the targeting of youth in the advertising, promotion or marketing of tobacco products; bans the use of cartoon characters in all tobacco advertising and promotion; limits each Participating Manufacturer to one tobacco brand name sponsorship during any 12-month period; bans all outdoor advertising, with certain limited exceptions; prohibits payments for tobacco product placement in various media; bans gift offers based on the purchase of tobacco products without sufficient proof that the intended recipient is an adult; prohibits Participating Manufacturers from licensing third parties to advertise tobacco brand names in any manner prohibited under the MSA; and prohibits Participating Manufacturers from using as a tobacco product brand name any nationally recognized non-tobacco brand or trade name or the names of sports teams, entertainment groups or individual celebrities.

The MSA also requires Participating Manufacturers to affirm corporate principles to comply with the MSA and to reduce underage use of tobacco products and imposes restrictions on lobbying activities conducted on behalf of Participating Manufacturers. In addition, the MSA provides for the appointment of an independent auditor to calculate and determine the amounts of payments owed pursuant to the MSA.

Under the payment provisions of the MSA, the Participating Manufacturers are required to make annual payments of $9,000,000 (subject to applicable adjustments, offsets and reductions). These annual payments are allocated based on unit volume of domestic cigarette shipments. The payment obligations under the MSA are the several, and not joint, obligation of each Participating Manufacturer and are not the responsibility of any parent or affiliate of a Participating Manufacturer.

Liggett has no payment obligations under the MSA except to the extent its market share exceeds a market share exemption of approximately 1.65% of total cigarettes sold in the United States. Vector Tobacco has no payment obligations under the MSA except to the extent its market share exceeds a market share exemption of approximately 0.28% of total cigarettes sold in the United States. Liggett and Vector Tobacco’s domestic shipments accounted for 3.3% of the total cigarettes sold in the United States in 2015. If Liggett’s or Vector Tobacco’s market share exceeds their respective market share exemption in a given year, then on April 15 of the following year, Liggett and/or Vector Tobacco, as the case may be, must pay on each excess unit an amount equal (on a per-unit basis) to that due from the OPMs for that year. On December 30, 2015, Liggett and Vector Tobacco pre-paid $100,000 of their approximate $120,700 2015 MSA obligation, the balance of which is due April 2016.

Certain MSA Disputes

NPM Adjustment. In March 2006, an economic consulting firm selected pursuant to the MSA determined that the MSA was a “significant factor contributing to” the Participating Manufacturers' loss of market share to non-participating manufacturers for 2003. Under the MSA, such a “significant factor” determination results in the calculation of a reduction in the payment obligations of the Participating Manufacturers, which is known as the “NPM Adjustment.” Thereafter, similar determinations were made for 2004 - 2006. As a result, the Participating Manufacturers are entitled to potential NPM Adjustments to each of their 2003 - 2006 MSA payments. The Participating Manufacturers are also entitled to potential NPM Adjustments to their 2007 - 2014 payments pursuant to agreements entered into between the OPMs and the Settling States under which the OPMs agreed to make certain payments for the benefit of the Settling States, in exchange for which the Settling States stipulated that the MSA was a “significant factor contributing to” the loss of market share of Participating Manufacturers for each of those years. A Settling State that has diligently enforced its qualifying escrow statute in the year in question may be able to avoid allocation of the NPM Adjustment to the payments made by the Participating Manufacturers for the benefit of that Settling State.

For 2003 - 2014, Liggett and Vector Tobacco, as applicable, disputed that they owed the Settling States the NPM Adjustments as calculated by the independent auditor. As permitted by the MSA, Liggett and Vector Tobacco paid subject to dispute, withheld payment or paid into a disputed payment account, the amounts associated with these NPM Adjustments.

Notwithstanding provisions in the MSA requiring arbitration, litigation was filed in 49 Settling States involving the application of the NPM Adjustment for 2003 and whether it was to be determined through litigation or arbitration. Under the MSA, the independent auditor previously determined the NPM Adjustment for 2003 to be as much as $1,200,000 for all Participating Manufacturers. All but one of the 48 courts that decided the issue ruled that the 2003 NPM Adjustment dispute was arbitrable.

In response to a proposal from the Participating Manufacturers, 45 of the Settling States, representing approximately 90% of the allocable shares of the Settling States, entered into an agreement providing for the nationwide arbitration of the dispute with respect to the NPM Adjustment for 2003, as ordered by the various state courts. In exchange, the Participating Manufacturers agreed to a 20% reduction in amounts recovered for the NPM Adjustment for 2003. In June 2010, the three person arbitration panel was selected. The Participating Manufacturers advised the arbitration panel that they were not contesting diligent enforcement of 16 Settling States for 2003, with a combined allocable share of less than 14%. Substantive hearings commenced in April 2012 and were completed in June 2013. After the partial settlement described below, the Participating Manufacturers continued to contest the diligent enforcement of 15 states.

In December 2012, the Participating Manufacturers entered into a term sheet with 20 Settling States setting out terms for settlement of the NPM Adjustment for 2003 - 2012 and addressing the NPM Adjustment with respect to those states for future years. Certain of the non-settling states objected to the settlement. In March 2013, the arbitration panel entered a Stipulated Partial Settlement and Award which directed the independent auditor to implement certain terms of the term sheet effective with the MSA payments due April 2013. In 2013, two additional states joined the settlement. Several non-settling states filed motions in state courts attempting to vacate the settlement award. Although certain terms of the settlement were implemented by the independent auditor in April 2013, no assurance can be given as to the ultimate outcome of the non-settling states’ challenges. The parties have been working towards converting the term sheet into a final settlement agreement. As a result of the settlement, in the first nine months of 2013, Liggett reduced cost of sales by $6,947. Liggett received credits of $1,733 in April 2014 from these settling states related to the 2013 NPM Adjustment. Liggett received additional credits of $1,940 in April 2015 related to the 2014 NPM Adjustment. Further adjustments could also be due to Liggett and Vector Tobacco pursuant to the settlement for 2013 forward.

In September 2013, the panel issued its decisions with respect to the 15 states that did not enter into the term sheet and as to which the Participating Manufacturers continued to contest diligence. The panel found that six of these states did not diligently enforce their MSA escrow statutes in 2003. As a result of this ruling, Liggett reduced cost of sales by $5,987, in the third quarter of 2013. All six of the states that were found to be non-diligent filed motions in state court seeking to vacate or reduce the amount of the arbitration award. Before the MSA payments for 2013 were due, the Pennsylvania trial court rejected the state’s motion to vacate the award, but granted its motion to reduce the award. As a result, in April 2014, Liggett received a credit in the amount of $6,441 for the 2003 NPM Adjustment (as calculated by the independent auditor). Liggett subsequently reimbursed the six states 20% of that credit pursuant to the agreement discussed above, bringing its net recovery to $5,152, which is approximately $1,315 lower than the amount to which Liggett believes it is entitled. After the April 2014 MSA payment date, a state trial court in Missouri issued a ruling similar to the ruling in Pennsylvania. As such, Liggett’s 2003 NPM Adjustment credit could be reduced by an additional $521. After the April 2014 MSA payment date, a state trial court in Maryland reached a different result from the Pennsylvania and Missouri trial courts, denying the state’s motion to vacate the award and further denying its motion to reduce the amount of the award payable to Liggett. A New Mexico trial court has not yet ruled on New Mexico’s motion. In June 2014, Kentucky and Indiana agreed to settle the dispute and enter into the term sheet described above. As a result, Liggett reduced cost of sales by approximately $1,400 in the second quarter of 2014. The Participating Manufacturers, including Liggett, appealed the Pennsylvania and Missouri decisions, while Maryland appealed the Maryland decision. In April 2015, the Pennsylvania decision was affirmed by the appellate court and, thereafter, the Pennsylvania Supreme Court denied review of that decision. As a result, in the fourth quarter of 2015, Liggett recognized an increase in cost of sales of $834. In September 2015, the portion of the Missouri opinion that reduced the arbitration award was reversed by the appellate court. The Missouri Supreme Court granted a discretionary appeal of that decision. In October 2015, the portion of the Maryland trial court ruling that denied reduction of the arbitration award was reversed by the appellate court. In February 2016, the Maryland Court of Appeals (Maryland’s highest court) denied review of that decision. If Liggett is unsuccessful in its appeals or if other states are successful with respect to any such appeals or motions, the amount of the 2003 NPM Adjustment and any interest or earnings to which Liggett is entitled could be lower than the amounts described above and Liggett might be obligated to pay additional monies.

In October 2015, substantially all of the Participating Manufacturers settled the NPM Adjustment dispute with the state of New York for 2004 - 2014 and agreed to a mechanism for potential future credits against the Participating Manufacturers' MSA payments for 2015 forward. As a result of the settlement, Liggett reduced cost of sales by approximately $5,700 for the year ended December 31, 2015.

In February 2016, Missouri joined the settlement described above, bringing the total number of states that joined the settlement to 26. Missouri’s joinder in the settlement will become effective only if Missouri enacts certain legislation related to the MSA’s escrow statute by June 3, 2016.

The remaining NPM Adjustment accrual of approximately $20,000 at December 31, 2015 relates to the disputed amounts Liggett withheld from the non-settling states for 2004 - 2010, which may be subject to payment, with interest, if Liggett loses the disputes for those years. Following release of previously disputed amounts to the state of New York as part of the October 2015 settlement, it is anticipated there will be approximately $23,000 remaining in the disputed payments accounts relating to Liggett's 2011- 2014 NPM Adjustment disputes with the non-settling states.

Disputes over the NPM Adjustments for 2004-2014 remain to be arbitrated with the states that have not joined the settlement. Liggett is currently involved in litigation with the non-settling states over the scope and form of the arbitration for 2004.

“Gross” v. “Net” Calculations. In October 2004, the independent auditor notified all Participating Manufacturers that their payment obligations under the MSA, dating from the agreement’s execution in late 1998, had been recalculated using “net” units, rather than “gross” units (which had been used since 1999). Liggett objected to this retroactive change and disputed the change in methodology.

In December 2012, the parties arbitrated the dispute. In February 2013, the arbitrators ruled that the independent auditor was precluded from recalculating Liggett’s grandfathered market share (“GFMS”) exemption. The arbitrators further ruled that, for purposes of calculating Liggett’s payment obligations, Liggett’s market share, calculated on a net basis, should be increased by a factor of 1.25%. Liggett filed a motion seeking correction of the part of the arbitrators’ decision that would require the 1.25% increase in Liggett’s market share. The states opposed Liggett’s motion.

In October 2014, the panel issued a Corrected Final Award that eliminated the 1.25% adjustment increase. The panel further determined that the independent auditor shall compute Liggett’s market share for all years after 2000 on a “net” basis, but adjust that computation to approximate “gross” market share by using actual returned product data for each year. In July 2015, the independent auditor issued calculations, purportedly based on the Corrected Final Award, which indicated that Liggett owed approximately $16,000 for years 2001 - 2013. The independent auditor subsequently issued preliminary revised calculations indicating that Liggett owes $6,200 for years 2001-2013. Based on these preliminary revised calculations, Liggett is fully accrued for this matter.

Other State Settlements. The MSA replaced Liggett’s prior settlements with all states and territories except for Florida, Mississippi, Texas and Minnesota. Each of these four states, prior to the effective date of the MSA, negotiated and executed settlement agreements with each of the other major tobacco companies, separate from those settlements reached previously with Liggett. Except as described below, Liggett’s agreements with these states remain in full force and effect. These states’ settlement agreements with Liggett contained most favored nation provisions which could reduce Liggett’s payment obligations based on subsequent settlements or resolutions by those states with certain other tobacco companies. Beginning in 1999, Liggett determined that, based on each of these four states’ settlements with United States Tobacco Company, Liggett’s payment obligations to those states were eliminated. With respect to all non-economic obligations under the previous settlements, Liggett believes it is entitled to the most favorable provisions as between the MSA and each state’s respective settlement with the other major tobacco companies. Therefore, Liggett’s non-economic obligations to all states and territories are now defined by the MSA.

In 2003, as a result of a dispute with Minnesota regarding its settlement agreement, Liggett agreed to pay $100 a year in any year cigarettes manufactured by Liggett are sold in that state. The Attorneys General for Florida, Mississippi and Texas previously advised Liggett that they believed that Liggett had failed to make payments under the respective settlement agreements with those states. In 2010, Liggett settled with Florida and agreed to pay $1,200 and to make further annual payments of $250 for a period of 21 years, starting in March 2011, with the payments from year 12 forward being subject to an inflation adjustment. These payments are in lieu of any other payments allegedly due to Florida. In January 2016, Mississippi commenced litigation against Liggett regarding this dispute. There can be no assurance that Liggett will be able to resolve the matters with Texas and Mississippi or that Liggett will not be required to make additional payments which could adversely affect the Company’s consolidated financial position, results of operations and cash flows.

Cautionary Statement

Management is not able to reasonably predict the outcome of the litigation pending or threatened against Liggett or the Company. Litigation is subject to many uncertainties. Liggett has been found liable in multiple Engle progeny cases and Individual Actions, several of which were affirmed on appeal and satisfied by Liggett. It is possible that other cases could be decided unfavorably against Liggett and that Liggett will be unsuccessful on appeal. Liggett may attempt to settle particular cases if it believes it is in its best interest to do so.

Management cannot predict the cash requirements related to any future defense costs, settlements or judgments, including cash required to bond any appeals, and there is a risk that those requirements will not be able to be met. An unfavorable outcome of a pending smoking-related case could encourage the commencement of additional litigation. Except as discussed in this Note 15, management is unable to estimate the loss or range of loss that could result from an unfavorable outcome of the cases pending against Liggett or the costs of defending such cases and as a result has not provided any amounts in its consolidated financial statements for unfavorable outcomes.

The tobacco industry is subject to a wide range of laws and regulations regarding the marketing, sale, taxation and use of tobacco products imposed by local, state and federal governments. There have been a number of restrictive regulatory actions, adverse legislative and political decisions and other unfavorable developments concerning cigarette smoking and the tobacco industry. These developments may negatively affect the perception of potential triers of fact with respect to the tobacco industry, possibly to the detriment of certain pending litigation, and may prompt the commencement of additional litigation or legislation.

It is possible that the Company’s consolidated financial position, results of operations and cash flows could be materially adversely affected by an unfavorable outcome in any of the smoking-related litigation.

The activity in the Company’s accruals for the MSA and tobacco litigation for the three years ended December 31, 2015 were as follows:



	Current Liabilities									Non-Current Liabilities
	Payments due under Master Settlement Agreement			Litigation Accruals			Total			Payments due under Master Settlement Agreement			Litigation Accruals			Total

Balance at January 1, 2013	$	32,970		$	1,470		$	34,440		$	52,639		$	1,862		$	54,501
Expenses	117,085			63,292			180,377			—			25,218			25,218
NPM Settlement adjustment	(3,928		)	—			(3,928		)	(18,138		)	—			(18,138		)
Change in MSA obligations capitalized as inventory	1,611			—			1,611			—			—			—
Payments	(129,320		)	(6,070		)	(135,390		)	—			—			—
Reclassification from non-current liabilities	6,930			223			7,153			(6,930		)	(223		)	(7,153		)
Interest on withholding	—			395			395			—			201			201
Balance as of December 31, 2013	25,348			59,310			84,658			27,571			27,058			54,629
Expenses	118,069			2,849			120,918			—			—			—
NPM Settlement adjustment	—			—			—			(1,419		)	—			(1,419		)
Change in MSA obligations capitalized as inventory	(1,095		)	—			(1,095		)	—			—			—
Payments	(116,343		)	(62,878		)	(179,221		)	—			—			—
Reclassification from non-current liabilities	343			3,575			3,918			(343		)	(3,575		)	(3,918		)
Interest on withholding	—			293			293			—			2,217			2,217
Balance as of December 31, 2014	26,322			3,149			29,471			25,809			25,700			51,509
Expenses	118,284			20,644			138,928			—			(195		)	(195		)
NPM Settlement adjustment	1,351			—			1,351			(5,715		)	—			(5,715		)
Change in MSA obligations capitalized as inventory	1,426			—			1,426			—			—			—
Payments	(118,142		)	(5,869		)	(124,011		)	—			—			—
Reclassification from non-current liabilities	—			3,305			3,305			—			(3,305		)	(3,305		)
Interest on withholding	—			1,675			1,675			—			2,518			2,518
Balance as of December 31, 2015	$	29,241		$	22,904		$	52,145		$	20,094		$	24,718		$	44,812

Other Matters:

Liggett’s and Vector Tobacco’s management are unaware of any material environmental conditions affecting their existing facilities. Liggett’s and Vector Tobacco’s management believe that current operations are conducted in material compliance with all environmental laws and regulations and other laws and regulations governing cigarette manufacturers. Compliance with federal, state and local provisions regulating the discharge of materials into the environment, or otherwise relating to the protection of the environment, has not had a material affect on the capital expenditures, results of operations or competitive position of Liggett or Vector Tobacco.

Liggett Vector Brands entered into an agreement with a subsidiary of the Convenience Distribution Association to support a program to permit certain tobacco distributors to secure, on reasonable terms, tax stamp bonds required by state and local governments for the distribution of cigarettes. Under the agreement, Liggett Vector Brands has agreed to pay a portion of losses incurred by the surety under the bond program, with a maximum loss exposure of $500. In 2013, Liggett paid $83 for obligations under this program. The Company believes the fair value of Liggett Vector Brands’ remaining obligation under the agreement was immaterial at December 31, 2015.

Management is of the opinion that the liabilities, if any, resulting from other proceedings, lawsuits and claims pending against the Company and certain of its consolidated subsidiaries unrelated to tobacco product liability should not materially affect the Company’s financial position, results of operations or cash flows.

Supplemental Cash Flow Information

12 Months Ended

Dec. 31, 2015

Supplemental Cash Flow Elements [Abstract]

SUPPLEMENTAL CASH FLOW INFORMATION



	Year Ended December 31,
	2015		2014		2013
Cash paid during the period for:
Interest	$	96,958	$	98,754	$	114,301
Income taxes	52,040		16,610		17,585
Non-cash investing and financing activities:
Issuance of stock dividend	584		520		450
Acquisitions	—		—		84,859
Non-controlling interest	—		2,733		87,657
Debt retired in conversion to stock	25,000		132,530		43,222
Embedded derivative, net retired in conversion to stock	889		6,680		17,377

Related Party Transactions	12 Months Ended
Related Party Transactions	Dec. 31, 2015
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS Ladenburg Thalmann Financial Services Inc. As of December 31, 2015, the Company owned 14,191,200 common shares of Ladenburg Thalmann Financial Services Inc. (“LTS”), a publicly traded diversified financial services company engaged in independent brokerage and advisory services, investment banking, equity research, institutional sales and trading, asset management services, wholesale life insurance brokerage and trust services. The Company, through its various investments in LTS, beneficially owned approximately 7.84% and accounts for its investment in LTS under the equity method of accounting. In September 2006, the Company entered into an agreement with LTS pursuant to which the Company agreed to make available to LTS the services of the Company’s Executive Vice President (the “EVP”) to serve as the President and Chief Executive Officer of LTS and to provide certain other financial, accounting and tax services, including assistance with complying with Section 404 of the Sarbanes-Oxley Act of 2002 and assistance in the preparation of income tax returns. LTS paid the Company $850 for 2015 and 2014 and $750 for 2013 under the agreement and pays the Company at a rate of $850 per year in 2016. These amounts are recorded as equity income. LTS paid compensation to the President and Chief Executive Officer of the Company, who serves as Vice Chairman of LTS, of $1,300, $1,375 and $1,250 for 2015, 2014 and 2013, respectively, and director fees of $38, $39 and $36 for 2015, 2014 and 2013, respectively. LTS paid compensation to the Company EVP, who serves as President and CEO of LTS, of $1,450, $1,375 and $1,250 for 2015, 2014 and 2013, respectively. On November 4, 2011, Vector was part of a consortium, which included Dr. Phillip Frost, who is a beneficial owner of approximately 15.3% of the Company’s common stock and the EVP that agreed to provide a five-year loan to LTS. Vector’s portion of the loan was $15,000. Interest on the loan, which is due on November 4, 2016, is payable quarterly at 11% per annum and commenced on December 31, 2011. The Company recorded equity income of $280, $574 and $1,810 in 2015, 2014 and 2013, respectively. At December 31, 2015, $1,680 principal amount of the loan remained outstanding and was recorded as part of the ending carrying value of the Company's equity method investment in LTS. In addition, LTS paid a one-time funding fee to the consortium of lenders and issued warrants (“LTS Warrants”) to purchase shares of LTS common stock. Vector received $75 as its portion of the funding fee and 1,000,000 of the LTS Warrants. The LTS Warrants are exercisable at any time prior to their expiration on November 4, 2016 at $1.68 per share, which was the closing price of the LTS common stock on November 4, 2011. The LTS Warrants may be exercised in cash, by net exercise or pursuant to the Company’s surrender of all or a portion of the principal amount of its note. The LTS Warrants were included in the ending carrying value of the Company's equity method investment in LTS. On May 22, 2013, the Company purchased in a public offering 240,000 shares of LTS’s 8% Series A Cumulative Redeemable Preferred Stock (Liquidation Preference $25.00 Per Share) (“LTS Preferred”) for $6,000. LTS will pay a monthly cumulative dividend of 8% per annum on the LTS Preferred. LTS, at its option, may redeem any or all of the LTS Preferred at $25.00 per share plus any accumulated and unpaid dividends on or after May 24, 2018. The Company recorded dividend income from the investment of $133 in 2015 and $480 in 2014. Castle Brands Inc. As of December 31, 2015, the Company owned 12,671,159 common shares of Castle (NYSE MKT: ROX), a publicly traded developer and importer of premium branded spirits. The Company accounts for its investment in Castle under the equity method. In October 2008, the Company entered into an agreement with Castle where the Company agreed to make available to Castle the services of the EVP to serve as the President and Chief Executive Officer of Castle and to provide other financial, accounting and tax services. The Company recognized management fees at a rate of $100 in each of 2015, 2014 and 2013, under the agreement and Castle has agreed to pay it at a rate of $100 per year in 2016. These amounts are recorded as equity income. In December 2010, the Company participated in a consortium that lent Castle $1,000. The consortium included Dr. Frost and the EVP. The Company lent $200 of this amount and received a note bearing interest at 11% per annum. On October 14, 2011, $217 of principal and outstanding interest associated with this note was exchanged for shares of Castle’s convertible preferred stock. As part of the debt exchange, Castle also issued 357,796 warrants (the “Castle Warrants”). The Castle Warrants entitled Vector to purchase 357,796 shares of Castle common stock. The Castle Warrants were exercisable at any time prior to their expiration on October 14, 2016 at $0.38 per share and were exercised in February 2014. In February 2014, Castle forced a conversion of its convertible preferred stock and the Company received 884,787 additional common shares of Castle stock and the Company’s shares of Castle’s convertible preferred stock were canceled. In 2013, the Company purchased in a private placement $200 of Castle’s convertible debt, which bears interest at 5% per annum, is convertible into 222,222 shares of Castle common stock and is due on December 15, 2018. The Castle convertible debt was included in the ending carrying value of the Company's equity method investment in Castle. Morgans Hotel Group Co. As of December 31, 2015, the Company owned 2,459,788 common shares of Morgans Hotel Group Co. (NASDAQ: MHGC), a publicly traded company that acquires, owns, develops and redevelops boutique hotels, primarily in gateway cities and select resort markets in the United States, Europe and other international locations. The Company's President and Chief Executive Officer serves as MHGC's Chairman of the Board of Directors. The Company beneficially owned approximately 7.09% and accounts for its investment in MHFC as investment securities available for sale. Insurance. The Company’s Chief Executive Officer, a firm in which he is a shareholder, and affiliates of that firm received insurance commissions aggregating approximately $217, $261 and $245 in 2015, 2014 and 2013, respectively, on various insurance policies issued for the Company and its subsidiaries. Other. In addition to its investment in LTS and Castle, the Company has made investments in entities where Dr. Frost has a relationship. These include the following: (i) three investments in 2006, 2008, 2009, 2011, and 2015 totaling approximately $12,788 in common stock of OPKO Inc. (NYSE MKT: OPK) and its predecessor eXegenics Inc. and in January 2013, the Company purchased $5,000 of Opko’s 3.00% convertible senior notes due 2033 which were converted into 726,036 shares of common stock in May 2015 ; (ii) a $500 investment in 2008 in Cardo Medical Inc.; and (iii) a $250 investment in 2008 in Cocrystal Pharma, Inc. (f/ka/ Cocrystal Discovery Inc.). Dr. Frost is a director, executive officer and/or more than 10% shareholder in these entities as well as LTS. Additional investments in entities where Dr. Frost has a relationship may be made in the future. In May 2009, the Company issued in a private placement the 6.75% Note in the principal amount of $50,000. The purchase price was paid in cash ($38,225) and by tendering $11,005 principal amount of the 5% Notes, valued at 107% of principal amount. The purchaser of the 6.75% Note was an entity affiliated with Dr. Frost. In March 2014, the holder of the 6.75% Note elected to convert $25,000 of the principal balance of the Note into 2,338,930 shares of the Company's common stock. On November 14, 2014, the Note was amended to extend the stated maturity date of the Note from November 15, 2014 to February 15, 2015. On February 3, 2015, the remaining $25,000 of principal of the Note was converted into 2,338,930 shares of the Company's common stock. Vector made cash interest payments of $1,094 and $5,415 associated with the Note in 2015 and 2014, respectively. In September 2012, the Company entered into an office lease (the “Lease”) with Frost Real Estate Holdings, LLC (“FREH”), an entity affiliated with Dr. Frost. The Lease is for 12,390 square feet of space in an office building in Miami, Florida. The initial term of the Lease is five years, subject to two optional five-year term extensions. Payments under the lease commenced in May 2013. The Lease provides for payments of $31 per month in the first year increasing to $35 per month in the fifth year, plus applicable sales tax. The rent is inclusive of operating expenses, property taxes and parking. A $220 tenant improvement allowance will be credited to the rent pro-rata over the initial five-year term. In connection with the execution of the Lease, the Company received the advice and opinion of a commercial real estate firm that the Lease terms were fair and that the Company received terms favorable in the market. The Company recorded rental expense of $380 and $336 as of December 31, 2015 and 2014, respectively, associated with the lease. A son of the Company's President and Chief Executive Officer is an associate broker with Douglas Elliman Realty, LLC and he received commissions and other payments of $453 in accordance with brokerage activities in 2015. The Company's President and Chief Executive Officer has reserved a unit in a real estate venture for a purchase price of $5,200 in 2015 and he may reserve or purchase units in other real estate ventures in the future.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References + Details

Investments and Fair Value Measurements

12 Months Ended

Dec. 31, 2015

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]

INVESTMENTS AND FAIR VALUE MEASUREMENTS

The Company’s recurring financial assets and liabilities subject to fair value measurements are as follows:



	Fair Value Measurements as of December 31, 2015
Description	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Gains (Losses)
Assets:
Money market funds	$	93,915	$	93,915	$	—	$	—

Certificates of deposit	3,469		—		3,469		—

Bonds	12,767		12,767		—		—

Investment securities available for sale
Equity securities	67,273		67,273		—		—
Mutual funds invested in fixed income securities	20,111		20,111		—		—
Fixed income securities
U.S. government securities	28,132		—		28,132		—
Corporate securities	41,561		—		41,561		—
U.S. government and federal agency	5,790		—		5,790		—
Commercial mortgage-backed securities	8,728		—		8,728		—
U.S. asset-backed securities	8,276		—		8,276		—
Index-linked U.S. bonds	2,105		—		2,105		—
Total fixed income securities	94,592		—		94,592		—

Total investment securities available for sale	181,976		87,384		94,592		—

Total	$	292,127	$	194,066	$	98,061	$	—

Liabilities:
Fair value of derivatives embedded within convertible debt	$	144,042	$	—	$	—	$	144,042


Nonrecurring fair value measurements
Long-term investments (1)	$	11,189					$	11,189	$	(811	)
Real estate held for sale (2)	3,780						3,780		(230		)
	$	14,969					$	14,969	$	(1,041	)


(1)	Long-term investments with a carrying amount of $12,000 were written down to their fair value of $11,189, resulting in an impairment charge of $811, which was included in earnings.


(2)	Real estate with a carrying value of $4,010 was written down to its fair value of $3,780, resulting in an impairment charge of $230, which was included in earnings.



	Fair Value Measurements as of December 31, 2014
Description	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Money market funds	$	205,180	$	205,180	$	—	$	—

Certificates of deposit	3,462		—		3,462		—

Bonds	4,868		4,868		—		—

Investment securities available for sale
Equity securities	77,609		77,083		526		—
Mutual funds invested in fixed income securities	59,826		59,826		—		—
Fixed income securities
U.S. government securities	35,446		—		35,446		—
Corporate securities	55,888		7,397		48,491		—
U.S. government and agency	4,770		—		4,770		—
Commercial mortgage-backed securities	16,508		—		16,508		—
U.S. asset-backed securities	16,955		—		16,955		—
Index-linked U.S. bonds	2,098		—		2,098		—
Total fixed income securities	131,665		7,397		124,268		—

Total investment securities available for sale	269,100		144,306		124,794		—

Total	$	482,610	$	354,354	$	128,256	$	—

Liabilities:
Fair value of derivatives embedded within convertible debt	$	169,386	$	—	$	—	$	169,386

The fair value of the Level 2 certificates of deposit are based on prices posted by the financial institutions. The fair value of investment securities available for sale included in Level 1 are based on quoted market prices from various stock exchanges. The Level 2 investment securities available for sale are based on quoted market prices of securities that are thinly traded.

The fair value of derivatives embedded within convertible debt was derived using a valuation model. These derivatives have been classified as Level 3. The valuation model assumes future dividend payments by the Company and utilizes interest rates and credit spreads based upon the implied credit spread of the 5.50% Convertible Notes due 2020 to determine the fair value of the derivatives embedded within the convertible debt. The changes in fair value of derivatives embedded within convertible debt are presented on the consolidated statements of operations.

The value of the embedded derivatives is contingent on changes in implied interest rates of the convertible debt, the Company's stock price, stock volatility as well as projections of future cash and stock dividends over the term of the debt. The interest rate component of the value of the embedded derivative is computed by calculating an equivalent non-convertible, unsecured and subordinated borrowing cost. This rate is determined by calculating the implied rate on the Company's 2020 Convertible Notes when removing the embedded option value within the convertible security. This rate is based upon market observable inputs and influenced by the Company's stock price, convertible bond trading price, risk free interest rates and stock volatility.

The unobservable inputs related to the valuations of the Level 3 assets and liabilities are as follows at December 31, 2015:



	Quantitative Information about Level 3 Fair Value Measurements
	Fair Value at
	December 31, 2015		Valuation Technique	Unobservable Input	Range (Actual)

Fair value of derivatives embedded within convertible debt	$	144,042	Discounted cash flow	Assumed annual stock dividend	5		%
				Assumed annual cash dividend	$	1.60
				Stock price	$	23.59
				Convertible trading price (of par)	114.31		%
				Volatility	18.30		%
				Risk-free rate	Term structure of US Treasury Securities
				Implied credit spread	5.0% - 5.5% (5.25%)

The unobservable inputs related to the valuations of the Level 3 assets and liabilities are as follows at December 31, 2014:



	Quantitative Information about Level 3 Fair Value Measurements
	Fair Value at
	December 31, 2014		Valuation Technique	Unobservable Input	Range (Actual)

Fair value of derivatives embedded within convertible debt	$	169,386	Discounted cash flow	Assumed annual stock dividend	5		%
				Assumed annual cash dividend	$	1.60
				Stock price	$	21.31
				Convertible trading price (of par)	106.8		%
				Volatility	16.00		%
				Implied credit spread	6.25% - 7.25% (6.75%)

In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company is required to record assets and liabilities at fair value on a nonrecurring basis. Generally, assets and liabilities are recorded at fair value on a nonrecurring basis as a result of impairment charges. The Company had no nonrecurring nonfinancial assets subject to fair value measurements as of December 31, 2014.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Segment Information

12 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

SEGMENT INFORMATION

The Company’s significant business segments were Tobacco, E-Cigarettes and Real Estate. The Tobacco segment consists of the manufacture and sale of cigarettes. The E-Cigarettes segment includes the operations of the Company's e-cigarette business. The Real Estate segment includes the Company’s investment in New Valley, which includes Douglas Elliman, Escena, our previous investment in Indian Creek, Sagaponack and investments in real estate ventures. The accounting policies of the segments are the same as those described in the summary of significant accounting policies.

Financial information for the Company’s operations before taxes and non-controlling interests for the years ended December 31, 2015, 2014 and 2013 follows:



							Real			Corporate
	Tobacco			E-Cigarettes			Estate			and Other					Total

2015
Revenues	$	1,017,761		$	(1,970	)	$	641,406		$	—				$	1,657,197
Operating income (loss)	209,393		(1)	(13,037		)	24,087			(20,523		)			199,920
Equity in earnings from real estate ventures	—			—			2,001			—					2,001
Identifiable assets	344,033			985			585,098		(4)	380,640			(5)	(6)	1,310,756
Depreciation and amortization	11,323			—			12,589			1,742					25,654
Capital expenditures	3,730			—			7,247			—					10,977

2014
Revenues	$	1,021,259		$	8,589		$	561,467		$	—				$	1,591,315
Operating income (loss)	199,119		(2)	(13,124		)	42,354			(15,911		)			212,438
Equity in earnings from real estate ventures	—			—			4,103			—					4,103
Identifiable assets	325,870			8,139			498,058		(4)	591,187			(5)	(6)	1,423,254
Depreciation and amortization	10,885			—			12,204			1,410					24,499
Capital expenditures	9,256			—			6,923			7,225					23,404

2013
Revenues	$	1,014,341		$	—		$	65,580		$	—				$	1,079,921
Operating income (loss)	113,039		(3)	(1,018		)	15,805			(16,640		)			111,186
Equity in earnings from real estate ventures	—			—			22,925			—					22,925
Identifiable assets	328,084			8,950			421,240		(4)	357,519			(5)	(6)	1,115,793
Depreciation and amortization	9,509			—			2,421			701					12,631
Capital expenditures	9,784			—			1,194			2,297					13,275

_____________________________


⁽¹⁾	Operating income includes $4,364 of income from MSA Settlement, $20,072 of litigation judgment expense, $7,257 of restructuring expense, and $1,607 of pension settlement expense.


⁽²⁾	Operating income includes $1,419 of income from NPM Settlement and $2,475 of litigation settlement charges and judgment expense.


⁽³⁾	Operating income includes $11,823 of income from MSA Settlements, $86,213 of Engle progeny settlement charge, and $1,893 of litigation judgment expense for the year ended and December 31, 2014.


⁽⁴⁾	Includes real estate investments accounted for under the equity method of accounting of $217,168, $163,460 and $128,202 as of December 31, 2015, 2014 and 2013, respectively.

⁽⁵⁾

Corporate and Other identifiable assets primarily includes cash of $112,130, investment securities of $181,976, and long-term investments of $62,225 as of December 31, 2015. Corporate and other identifiable assets primarily includes cash of $213,227, investment securities of $269,100, and long-term investments of $52,025 as of December 31, 2014. Corporate and other identifiable assets primarily includes cash of $152,189, investment securities of $119,430, and long-term investments of $42,452 as of December 31, 2013.


⁽⁶⁾	Includes long-term investments accounted for under the equity method of accounting of $21,495, $20,484 and $22,411 as of December 31, 2015, 2014 and 2013, respectively.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

+ Details

Quarterly Financial Results (Unaudited)

12 Months Ended

Dec. 31, 2015

Quarterly Financial Information Disclosure [Abstract]

QUARTERLY FINANCIAL RESULTS (UNAUDITED)

Unaudited quarterly data for the years ended December 31, 2015 and 2014 are as follows:



	December 31,		September 30,		June 30,		March 31,
	2015		2015		2015		2015
Revenues	$	430,330	$	449,934	$	416,173	$	360,760
Gross Profit	137,742		154,017		136,969		118,742
Operating income (1)	31,032		69,367		55,803		43,718
Net income applicable to common shares attributed to Vector Group Ltd. (2)	$	7,904	$	12,466	$	17,607	$	21,221
Per basic common share (3):
Net income applicable to common shares attributed to Vector Group Ltd.	$	0.06	$	0.10	$	0.14	$	0.18
Per diluted common share (3):
Net income applicable to common shares attributed to Vector Group Ltd.	$	0.06	$	0.10	$	0.14	$	0.18

_____________________________


(1)	Operating income has been decreased by $238, $237, and $237 from the Company's previously filed Form 10-Qs for the periods ending September 30, 2015, June 30, 2015 and March 31, 2015, respectively, as a result of the application of the equity method of accounting for the Company's investments in LTS and ROX.

(2)

Net income applicable to common shares attributed to Vector Group Ltd. has been increased by $261, $265 from the Company's previously filed Form 10-Qs for the periods ending September 30, 2015 and March 31, 2015, respectively, and decreased by $261 from the Company's previously filed Form 10-Q for the period ending June 30, 2015 as a result of the application of the equity method of accounting for the Company's investments in LTS and ROX.

(3)

Per share computations include the impact of a 5% stock dividend paid on September 29, 2015 and the impact of the application of the equity method of accounting for the Company's investments in LTS and ROX. Quarterly basic and diluted net income per common share were computed independently for each quarter and do not necessarily total to the year to date basic and diluted net income per common share.



	December 31,		September 30,		June 30,		March 31,
	2014		2014		2014		2014
Revenues	$	417,590	$	419,876	$	406,613	$	347,236
Gross Profit	126,085		132,640		127,331		108,199
Operating income (1)	47,136		62,746		60,071		42,485
Net income applicable to common shares attributed to Vector Group Ltd. (2)	$	12,215	$	14,190	$	7,917	$	2,534
Per basic common share (3):
Net income applicable to common shares attributed to Vector Group Ltd.	$	0.11	$	0.13	$	0.07	$	0.02
Per diluted common share (3):
Net income applicable to common shares attributed to Vector Group Ltd.	$	0.11	$	0.13	$	0.07	$	0.02

_____________________________


(1)	Operating income has been decreased by $238, $237, and $237 from the Company's previously filed Form 10-Qs for the periods ending September 30, 2014, June 30, 2014 and March 31, 2014, respectively, as a result of the application of the equity method of accounting for the Company's investments in LTS and ROX.


(2)	Net income applicable to common shares attributed to Vector Group Ltd. has been decreased by $689, $8, and $46 from the Company's previously filed Form 10-Qs for the periods ending September 30, 2014, June 30, 2014 and March 31, 2014, respectively, as a result of the application of the equity method of accounting for the Company's investments in LTS and ROX.

(3)

Per share computations include the impact of a 5% stock dividend paid on September 26, 2014 and the impact of the application of the equity method of accounting for the Company's investments in LTS and ROX.. Quarterly basic and diluted net income per common share were computed independently for each quarter and do not necessarily total to the year to date basic and diluted net income per common share.

Condensed Consolidating Financial Information

12 Months Ended

Dec. 31, 2015

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

CONDENSED CONSOLIDATING FINANCIAL INFORMATION

The accompanying condensed consolidating financial information has been prepared and presented pursuant to Securities and Exchange Commission (“SEC”) Regulation S-X, Rule 3-10, “Financial Statements of Guarantors and Affiliates Whose Securities Collateralize an Issue Registered or Being Registered.” Each of the subsidiary guarantors is 100% owned, directly or indirectly, by the Company, and all guarantees are full and unconditional and joint and several.

The Company’s investments in its consolidated subsidiaries are presented under the equity method of accounting.

The Company has outstanding $600,000 principal amount of its 7.75% Senior Secured Notes due 2021 that are guaranteed subject to certain customary automatic release provisions described above on a joint and several basis by all of the 100% owned domestic subsidiaries of the Company that are engaged in the conduct of its cigarette businesses. (See Note 9.) The notes are not guaranteed by any of the Company’s subsidiaries engaged in the real estate businesses conducted through its subsidiary New Valley.

Presented herein are Condensed Consolidating Balance Sheets as of December 31, 2015 and 2014 and the related Condensed Consolidating Statements of Operations and Cash Flows for the years ended December 31, 2015, 2014 and 2013 of Vector Group. (Parent/Issuer), the guarantor subsidiaries (Subsidiary Guarantors) and the subsidiaries that are not guarantors (Subsidiary Non-Guarantors).

The indenture contains covenants that restrict the payment of dividends by the Company if the Company’s consolidated earnings before interest, taxes, depreciation and amortization (“Consolidated EBITDA”), as defined in the indenture, for the most recently ended four full quarters is less than $75,000. The indenture also restricts the incurrence of debt if the Company’s Leverage Ratio and its Secured Leverage Ratio, as defined in the indenture, exceed 3.0 and 1.5, respectively. The Company’s Leverage Ratio is defined in the indenture as the ratio of the Company’s and the guaranteeing subsidiaries’ total debt less the fair market value of the Company’s cash, investments in marketable securities and long-term investments to Consolidated EBITDA, as defined in the indenture. The Company’s Secured Leverage Ratio is defined in the indenture in the same manner as the Leverage Ratio, except that secured indebtedness is substituted for indebtedness.

CONDENSED CONSOLIDATING BALANCE SHEETS



				December 31, 2015
						Subsidiary					Consolidated
	Parent/			Subsidiary		Non-		Consolidating			Vector Group
	Issuer			Guarantors		Guarantors		Adjustments			Ltd.
ASSETS:
Current assets:
Cash and cash equivalents	$	111,470		$	12,375	$	116,523	$	—		$	240,368
Investment securities available for sale	131,810			50,166		—		—			181,976
Accounts receivable - trade, net	—			15,913		7,976		—			23,889
Intercompany receivables	11,293			—		—		(11,293		)	—
Inventories	—			86,516		—		—			86,516
Income taxes receivable, net	8,213			—		—		(5,372		)	2,841
Restricted assets	—			7,781		1,414		—			9,195
Other current assets	575			3,747		34,632		—			38,954
Total current assets	263,361			176,498		160,545		(16,665		)	583,739
Property, plant and equipment, net	1,711			54,097		19,824		—			75,632
Real estate held for sale, net	—			—		23,318		—			23,318
Long-term investments	61,747			478		501		—			62,726
Investments in real estate ventures	—			—		217,168		—			217,168
Investments in consolidated subsidiaries	532,501			—		—		(532,501		)	—
Restricted assets	1,713			10,590		—		—			12,303
Goodwill and other intangible assets, net	—			107,511		156,448		—			263,959
Prepaid pension costs	—			20,650		—		—			20,650
Other assets	37,723			11,769		1,769		—			51,261
Total assets	$	898,756		$	381,593	$	579,573	$	(549,166	)	$	1,310,756
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY:
Current liabilities:
Current portion of notes payable and long-term debt	$	—		$	8,733	$	186	$	—		$	8,919
Current portion of employee benefits	—			915		—		—			915
Intercompany payables	—			586		10,707		(11,293		)	—
Income taxes payable, net	—			5,464		4		(5,372		)	96
Litigation accruals and current payments due under the Master Settlement Agreement	—			52,145		—		—			52,145
Other current liabilities	38,140			74,083		41,994		—			154,217
Total current liabilities	38,140			141,926		52,891		(16,665		)	216,292
Notes payable, long-term debt and other obligations, less current portion	878,509			7,519		221		—			886,249
Fair value of derivatives embedded within convertible debt	144,042			—		—		—			144,042
Non-current employee benefits	39,244			15,811		—		—			55,055
Deferred income taxes, net	2,675			33,791		42,963		—			79,429
Other liabilities, primarily litigation accruals and payments due under the Master Settlement Agreement	2,193			44,982		4,675		—			51,850
Total liabilities	1,104,803			244,029		100,750		(16,665		)	1,432,917
Commitments and contingencies
Stockholders’ (deficiency) equity attributed to Vector Group Ltd.	(206,047		)	137,564		394,937		(532,501		)	(206,047		)
Non-controlling interest	—			—		83,886		—			83,886
Total stockholders’ (deficiency) equity	(206,047		)	137,564		478,823		(532,501		)	(122,161		)
Total liabilities and stockholders’ deficiency	$	898,756		$	381,593	$	579,573	$	(549,166	)	$	1,310,756

CONDENSED CONSOLIDATING BALANCE SHEETS



				December 31, 2014
						Subsidiary					Consolidated
	Parent/			Subsidiary		Non-		Consolidating			Vector Group
	Issuer			Guarantors		Guarantors		Adjustments			Ltd.
ASSETS:
Current assets:
Cash and cash equivalents	$	211,751		$	9,724	$	104,890	$	—		$	326,365
Investment securities available for sale	202,252			66,848		—		—			269,100
Accounts receivable - trade, net	—			18,024		5,304		—			23,328
Intercompany receivables	795			267		—		(1,062		)	—
Inventories	—			90,323		—		—			90,323
Income taxes receivable, net	1,055			463		21		1,743			3,282
Restricted assets	—			1,181		1,414		—			2,595
Other current assets	585			9,133		26,686		—			36,404
Total current assets	416,438			195,963		138,315		681			751,397
Property, plant and equipment, net	2,648			61,149		20,315		—			84,112
Real estate held for sale, net	—			—		10,643		—			10,643
Long-term investments	51,506			519		698		—			52,723
Investments in real estate ventures	—			—		163,460		—			163,460
Investments in consolidated subsidiaries	518,567			—		—		(518,567		)	—
Restricted assets	1,707			10,306		—		—			12,013
Goodwill and other intangible assets,net	—			107,511		162,461		—			269,972
Prepaid pension costs	—			25,032		—		—			25,032
Other assets	40,913			10,743		2,246		—			53,902
Total assets	$	1,031,779		$	411,223	$	498,138	$	(517,886	)	$	1,423,254
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY:
Current liabilities:
Current portion of notes payable and long-term debt	$	25,000		$	27,248	$	392	$	—		$	52,640
Current portion of fair value of derivatives embedded within convertible debt	884			—		—		—			884
Current portion of employee benefits	—			931		—		—			931
Intercompany payables	—			—		1,062		(1,062		)	—
Income taxes payable, net	—			—		—		1,743			1,743
Litigation accruals and current payments due under the Master Settlement Agreement	—			29,471		—		—			29,471
Other current liabilities	36,653			58,677		31,425		—			126,755
Total current liabilities	62,537			116,327		32,879		681			212,424
Notes payable, long-term debt and other obligations, less current portion	852,560			8,120		31		—			860,711
Fair value of derivatives embedded within convertible debt	168,502			—		—		—			168,502
Non-current employee benefits	32,842			16,472		—		—			49,314
Deferred income taxes, net	14,176			43,058		38,670		—			95,904
Other liabilities, primarily litigation accruals and payments due under the Master Settlement Agreement	921			51,775		4,383		—			57,079
Total liabilities	1,131,538			235,752		75,963		681			1,443,934
Commitments and contingencies
Stockholders’ (deficiency) equity attributed to Vector Group Ltd.	(99,759		)	175,471		343,096		(518,567		)	(99,759		)
Non-controlling interest	—			—		79,079		—			79,079
Total stockholders’ (deficiency) equity	(99,759		)	175,471		422,175		(518,567		)	(20,680		)
Total liabilities and stockholders’ deficiency	$	1,031,779		$	411,223	$	498,138	$	(517,886	)	$	1,423,254

CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS



				Year Ended December 31, 2015
							Subsidiary						Consolidated
	Parent/			Subsidiary			Non-			Consolidating			Vector Group
	Issuer			Guarantors			Guarantors			Adjustments			Ltd.
Revenues	$	—		$	1,016,279		$	641,406		$	(488	)	$	1,657,197
Expenses:
Cost of sales	—			699,440			410,287			—			1,109,727
Operating, selling, administrative and general expenses	29,237			84,437			207,035			(488		)	320,221
Litigation, settlement and judgment expense	—			20,072			—			—			20,072
Management fee expense	—			10,250			—			(10,250		)	—
Restructuring charges	—			7,257			—			—			7,257
Operating (loss) income	(29,237		)	194,823			24,084			10,250			199,920
Other income (expenses):
Interest expense	(115,731		)	(4,953		)	(7		)	—			(120,691		)
Change in fair value of derivatives embedded within convertible debt	24,455			—			—			—			24,455
Equity in earnings from real estate ventures	—			—			2,001			—			2,001
Equity in losses from investments	(2,640		)	(41		)	—			—			(2,681		)
(Loss) gain on sale of investment securities available for sale	(2,037		)	13,175			—			—			11,138
Impairment of investment securities available for sale	(4,859		)	(7,987		)	—			—			(12,846		)
Equity in earnings in consolidated subsidiaries	125,042			—			—			(125,042		)	—
Management fee income	10,250			—			—			(10,250		)	—
Other, net	4,016			639			1,754			—			6,409
Income before provision for income taxes	9,259			195,656			27,832			(125,042		)	107,705
Income tax benefit (expense)	49,939			(82,282		)	(8,890		)	—			(41,233		)
Net income	59,198			113,374			18,942			(125,042		)	66,472
Net income attributed to non-controlling interest	—			—			(7,274		)	—			(7,274		)
Net income attributed to Vector Group Ltd.	$	59,198		$	113,374		$	11,668		$	(125,042	)	$	59,198
Comprehensive income attributed to non-controlling interest	$	—		$	—		$	(7,274	)	$	—		$	(7,274	)
Comprehensive income attributed to Vector Group Ltd.	$	52,228		$	105,456		$	11,668		$	(117,124	)	$	52,228

CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS



				Year Ended December 31, 2014
							Subsidiary						Consolidated
	Parent/			Subsidiary			Non-			Consolidating			Vector Group
	Issuer			Guarantors			Guarantors			Adjustments			Ltd.
Revenues	$	—		$	1,030,157		$	561,467		$	(309	)	$	1,591,315
Expenses:
Cost of sales	—			743,032			354,028			—			1,097,060
Operating, selling, administrative and general expenses	24,262			90,208			165,181			(309		)	279,342
Litigation, settlement and judgment expense	—			2,475			—			—			2,475
Management fee expense	—			9,870			—			(9,870		)	—
Operating (loss) income	(24,262		)	184,572			42,258			9,870			212,438
Other income (expenses):
Interest expense	(157,321		)	(4,241		)	(41		)	612			(160,991		)
Change in fair value of derivatives embedded within convertible debt	19,409			—			—			—			19,409
Acceleration of interest expense related to debt conversion	(5,205		)	—			—			—			(5,205		)
Equity in earnings from real estate ventures	—			—			4,103			—			4,103
Equity in earnings from investments	3,122			18			—			—			3,140
Loss on sale of investment securities available for sale	(11		)	—			—			—			(11		)
Equity in earnings in consolidated subsidiaries	124,001			—			—			(124,001		)	—
Management fee income	9,870			—			—			(9,870		)	—
Other, net	4,178			1,044			4,786			(612		)	9,396
(Loss) income before provision for income taxes	(26,219		)	181,393			51,106			(124,001		)	82,279
Income tax benefit (expense)	63,064			(78,801		)	(17,428		)	—			(33,165		)
Net income	36,845			102,592			33,678			(124,001		)	49,114
Net income attributed to non-controlling interest	—			—			(12,258		)	—			(12,258		)
Net income attributed to Vector Group Ltd.	$	36,845		$	102,592		$	21,420		$	(124,001	)	$	36,856
Comprehensive income attributed to non-controlling interest	$	—		$	—		$	(12,258	)	$	—		$	(12,258	)
Comprehensive income attributed to Vector Group Ltd.	$	34,922		$	102,536		$	21,420		$	(123,956	)	$	34,922

CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS



	Year Ended December 31, 2013
	Parent/ Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Consolidating Adjustments			Consolidated Vector Group Ltd.
Revenues	$	—		$	1,014,341		$	65,580		$	—		$	1,079,921
Expenses:
Cost of sales	—			729,393			37,638			—			767,031
Operating, selling, administrative and general expenses	23,685			77,780			12,133			—			113,598
Litigation judgment expense	—			88,106			—			—			88,106
Management fee expense	—			9,508			—			(9,508		)	—
Operating (loss) income	(23,685		)	109,554			15,809			9,508			111,186
Other income (expenses):
Interest expense	(130,417		)	(1,716		)	(14		)	—			(132,147		)
Changes in fair value of derivatives embedded within convertible debt	18,935			—			—			—			18,935
Acceleration of interest expense related to debt conversion	(12,414		)	—			—			—			(12,414		)
Loss on extinguishment of debt	(21,458		)	—			—			—			(21,458		)
Equity in earnings from real estate ventures	—			—			22,925			—			22,925
(Loss) gain on sale of investment securities available for sale	(272		)	5,424			—			—			5,152
Gain on acquisition of Douglas Elliman	—			—			60,842			—			60,842
Equity in earnings from investments	3,126			—			—			—			3,126
Equity in earnings in consolidated subsidiaries	144,689			—			—			(144,689		)	—
Management fee income	9,508			—			—			(9,508		)	—
Other, net	1,462			2,763			348			—			4,573
(Loss) income before provision for income taxes	(10,526		)	116,025			99,910			(144,689		)	60,720
Income tax benefit (expense)	47,826			(30,758		)	(40,740		)	—			(23,672		)
Net income	37,300			85,267			59,170			(144,689		)	37,048
Net loss attributed to non-controlling interest	—			—			252			—			252
Net income attributed to Vector Group Ltd.	$	37,300		$	85,267		$	59,422		$	(144,689	)	$	37,300
Comprehensive loss attributed to non-controlling interest	$	—		$	—		$	252		$	—		$	252
Comprehensive income attributed to Vector Group Ltd.	$	52,894		$	102,344		$	59,422		$	(161,766	)	$	52,894

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS



				Year Ended December 31, 2015
							Subsidiary						Consolidated
	Parent/			Subsidiary			Non-			Consolidating			Vector Group
	Issuer			Guarantors			Guarantors			Adjustments			Ltd.
Net cash provided by operating activities	$	136,370		$	172,065		$	45,715		$	(209,671	)	$	144,479
Cash flows from investing activities:
Sale of investment securities	256,161			14,415			—			—			270,576
Maturities of investment securities	5,491			—			—			—			5,491
Purchase of investment securities	(207,822		)	(6,324		)	—			—			(214,146		)
Proceeds from sale or liquidation of long-term investments	1,106			—			197			—			1,303
Purchase of long-term investments	(10,000		)	—			—			—			(10,000		)
Investments in real estate ventures	—			—			(70,272		)	—			(70,272		)
Distributions from investments in real estate ventures	—			—			17,563			—			17,563
Increase in cash surrender value of life insurance policies	(1,257		)	(485		)	—			—			(1,742		)
Increase in restricted assets	(6		)	(6,883		)	—			—			(6,889		)
Issuance of notes receivable	—			—			(4,410		)	—			(4,410		)
Investments in subsidiaries	(103,174		)	—			—			103,174			—
Proceeds from sale of fixed assets	—			4			—			—			4
Repayment of notes receivable	—			—			4,000			—			4,000
Capital expenditures	—			(3,730		)	(7,247		)	—			(10,977		)
Proceeds from sale of preferred securities	—			—			1,000			—			1,000
Investments in real estate held for sale	—			—			(12,603		)	—			(12,603		)
Pay down of investment securities	8,739			—			—			—			8,739
Net cash used in investing activities	(50,762		)	(3,003		)	(71,772		)	103,174			(22,363		)
Cash flows from financing activities:
Proceeds from issuance of debt	—			1,799			306			—			2,105
Deferred financing costs	—			(624		)	—			—			(624		)
Repayments of debt	—			(6,362		)	(322		)	—			(6,684		)
Borrowings under revolver	—			153,361			—			—			153,361
Repayments on revolver	—			(167,915		)	—			—			(167,915		)
Capital contributions received	—			33,658			69,516			(103,174		)	—
Intercompany dividends paid	—			(181,825		)	(29,343		)	211,168			—
Dividends and distributions on common stock	(188,151		)	—			—			—			(188,151		)
Distributions to non-controlling interest	—			—			(3,280		)	—			(3,280		)
Contributions from non-controlling interest	—			—			813			—			813
Proceeds from exercise of Vector options	1,441			—			—			—			1,441
Tax benefit of options exercised	821			1,497			—			(1,497		)	821
Net cash (used in) provided by financing activities	(185,889		)	(166,411		)	37,690			106,497			(208,113		)
Net (decrease) increase in cash and cash equivalents	(100,281		)	2,651			11,633			—			(85,997		)
Cash and cash equivalents, beginning of year	211,751			9,724			104,890			—			326,365
Cash and cash equivalents, end of year	$	111,470		$	12,375		$	116,523		$	—		$	240,368

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS



				Year Ended December 31, 2014
							Subsidiary						Consolidated
	Parent/			Subsidiary			Non-			Consolidating			Vector Group
	Issuer			Guarantors			Guarantors			Adjustments			Ltd.
Net cash provided by operating activities	$	61,779		$	83,671		$	62,656		$	(100,730	)	$	107,376
Cash flows from investing activities:
Sale of investment securities	154,615			—			—			—			154,615
Maturities of investment securities	930			—			—			—			930
Purchase of investment securities	(299,417		)	(6,314		)	—			—			(305,731		)
Proceeds from sale of or liquidation of long-term investments	2,367			—			49			—			2,416
Purchase of long-term investments	(12,000		)	—			—			—			(12,000		)
Investments in real estate ventures	—			—			(40,916		)	—			(40,916		)
Distributions from investments in real estate ventures	—			—			7,309			—			7,309
Increase in cash surrender value of life insurance policies	—			(484		)	—			—			(484		)
Decrease (increase) in restricted assets	188			(371		)	(689		)	—			(872		)
Issuance of notes receivable	(35,000		)	—			(8,250		)	35,000			(8,250		)
Investments in subsidiaries	(85,278		)	—			—			85,278			—
Proceeds from sale of fixed assets	—			4			—			—			4
Purchase of subsidiaries	—			—			(750		)	—			(750		)
Repayment of notes receivable	35,000			—			4,850			(35,000		)	4,850
Purchase of preferred securities	—			—			(1,000		)	—			(1,000		)
Capital expenditures	(15		)	(16,466		)	(6,923		)	—			(23,404		)
Pay down of investment securities	1,849			—			—			—			1,849
Net cash used in investing activities	(236,761		)	(23,631		)	(46,320		)	85,278			(221,434		)
Cash flows from financing activities:
Proceeds from issuance of debt	408,750			40,164			—			(35,000		)	413,914
Deferred financing costs	(12,360		)	—			—			—			(12,360		)
Repayments of debt	—			(43,724		)	(3,877		)	35,000			(12,601		)
Borrowings under revolver	—			886,130			—			—			886,130
Repayments on revolver	—			(898,788		)	—			—			(898,788		)
Capital contributions received	—			15,270			70,008			(85,278		)	—
Intercompany dividends paid	—			(61,180		)	(39,550		)	100,730			—
Dividends and distributions on common stock	(167,328		)	—			—			—			(167,328		)
Distributions to non-controlling interest	—			—			(9,339		)	—			(9,339		)
Proceeds from exercise of Vector options	5,151			—			—			—			5,151
Tax benefit of options exercised	1,178			—			—			—			1,178
Net cash provided by (used in) financing activities	235,391			(62,128		)	17,242			15,452			205,957
Net increase (decrease) in cash and cash equivalents	60,409			(2,088		)	33,578			—			91,899
Cash and cash equivalents, beginning of year	151,342			11,812			71,312			—			234,466
Cash and cash equivalents, end of year	$	211,751		$	9,724		$	104,890		$	—		$	326,365

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS



	Year Ended December 31, 2013
	Parent/ Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Consolidating Adjustments			Consolidated Vector Group Ltd.
Net cash provided by (used in) operating activities	$	71,730		$	115,829		$	(16,239	)	$	(119,294	)	$	52,026
Cash flows from investing activities:
Sale of investment securities	110,419			6,602			—			—			117,021
Maturities of investment securities	27			—			—			—			27
Purchase of investment securities	(159,463		)	(11,000		)	—			—			(170,463		)
Proceeds from sale or liquidation of long-term investments	10,847			—			80			—			10,927
Purchase of long-term investments	(5,000		)	(501		)	—			—			(5,501		)
Investments in real estate ventures	—			—			(75,731		)	—			(75,731		)
Distributions from investments in real estate ventures	—			—			3,142			—			3,142
Increase in cash surrender value of life insurance policies	(144		)	(484		)	—			—			(628		)
Decrease in restricted assets	3			1,078			—			—			1,081
Issuance of notes receivable	—			—			(8,600		)	—			(8,600		)
Proceeds from sale of fixed assets	35			13			—			—			48
Cash acquired in Douglas Elliman consolidation	—			—			116,935			—			116,935
Purchase of subsidiaries	—			—			(67,616		)	—			(67,616		)
Investments in subsidiaries	(155,961		)	—			—			155,961			—
Capital expenditures	(2,297		)	(9,784		)	(1,194		)	—			(13,275		)
Pay down of investment securities	681			—			—			—			681
Net cash used in investing activities	(200,853		)	(14,076		)	(32,984		)	155,961			(91,952		)
Cash flows from financing activities:
Proceeds from issuance of debt	450,000			4,687			3,080			—			457,767
Repayments of debt	(415,000		)	(7,466		)	(115		)	—			(422,581		)
Deferred financing charges	(11,750		)	—			—			—			(11,750		)
Borrowings under revolver	—			978,788			—			—			978,788
Repayments on revolver	—			(977,794		)	—			—			(977,794		)
Capital contributions received	—			13,950			142,011			(155,961		)	—
Intercompany dividends paid	—			(105,882		)	(13,412		)	119,294			—
Dividends and distributions on common stock	(144,711		)	—			—			—			(144,711		)
Distributions to non-controlling interest	—			—			(11,764		)	—			(11,764		)
Proceeds from exercise of Vector options	544			—			—			—			544
Tax benefit of options exercised	38			—			—			—			38
Net cash (used in) provided by financing activities	(120,879		)	(93,717		)	119,800			(36,667		)	(131,463		)
Net (decrease) increase in cash and cash equivalents	(250,002		)	8,036			70,577			—			(171,389		)
Cash and cash equivalents, beginning of year	401,344			3,776			735			—			405,855
Cash and cash equivalents, end of year	$	151,342		$	11,812		$	71,312		$	—		$	234,466

Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2015

Valuation and Qualifying Accounts [Abstract]

SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS

VECTOR GROUP LTD.

SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS

(Dollars in Thousands)



Description	Balance at Beginning of Period		Additions Charged to Costs and Expenses		Deductions		Balance at End of Period
Year Ended December 31, 2015
Allowances for:
Doubtful accounts	$	37	$	75	$	—	$	112
Cash discounts	415		25,616		25,664		367
Deferred tax valuation allowance	4,933		—		1,033		3,900
Sales returns	7,720		8,516		8,414		7,822
Total	$	13,105	$	34,207	$	35,111	$	12,201
Year Ended December 31, 2014
Allowances for:
Doubtful accounts	$	192	$	31	$	186	$	37
Cash discounts	241		25,801		25,627		415
Deferred tax valuation allowance	6,014		—		1,081		4,933
Sales returns	4,420		6,886		3,586		7,720
Total	$	10,867	$	32,718	$	30,480	$	13,105
Year Ended December 31, 2013
Allowances for:
Doubtful accounts	$	318	$	198	$	324	$	192
Cash discounts	259		25,207		25,225		241
Deferred tax valuation allowance	6,310		—		296		6,014
Sales returns	4,067		4,019		3,666		4,420
Total	$	10,954	$	29,424	$	29,511	$	10,867

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2015
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation: The consolidated financial statements of Vector Group Ltd. (the “Company” or “Vector”) include the accounts of VGR Holding LLC (“VGR Holding”), Liggett Group LLC (“Liggett”), Vector Tobacco Inc. (“Vector Tobacco”), Liggett Vector Brands LLC (“Liggett Vector Brands”), Zoom E-Cigs LLC (“Zoom”), New Valley LLC (“New Valley”) and other less significant subsidiaries. New Valley includes the accounts of Douglas Elliman Realty, LLC (“Douglas Elliman”) and other less significant subsidiaries. All significant intercompany balances and transactions have been eliminated. Liggett and Vector Tobacco are engaged in the manufacture and sale of cigarettes in the United States. Zoom is engaged in the sale of electronic cigarettes in the United States. New Valley is engaged in the real estate business.
Reclassifications	Revisions to December 31, 2014 Consolidated Balance Sheet. The Company has revised its December 31, 2014 Consolidated Balance Sheet, which originally presented deferred income tax assets and liabilities (current and noncurrent) on a gross basis, rather than a net basis by jurisdiction. The revisions conform to ASC 740-10-45-6 which states all current deferred tax liabilities and assets within the same tax jurisdiction shall be offset and presented as a single amount and all noncurrent deferred tax liabilities and assets shall be offset and presented as a single amount. The Company assessed the materiality of this error on previously issued consolidated financial statements and concluded that the error was immaterial. In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes” (“ASU 2015-17”), which requires deferred tax liabilities and assets to be classified as noncurrent in a classified statement of financial position. The guidance is effective for financial statements issued for annual periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018. Earlier application is permitted for all entities as of the beginning of an interim or annual reporting period. This amendment may be applied either prospectively or retrospectively to all periods presented. The Company adopted the provisions of this ASU retrospectively in the fourth quarter of 2015, and adjusted all prior periods accordingly. The adoption of this ASU will simplify the presentation of deferred income taxes and reduce complexity without decreasing the usefulness of information provided to users of financial statements. The adoption of ASU 2015-17 did not have a significant impact on the Company's financial position, results of operations and cash flows.”
Estimates and Assumptions	Estimates and Assumptions: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Significant estimates subject to material changes in the near term include valuation of intangible assets, inventory valuation, promotional accruals, sales returns and allowances, actuarial assumptions of pension plans, the estimated fair value of embedded derivative liabilities, settlement accruals, valuation of investments, including other-than-temporary impairments to such investments, and litigation and defense costs. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents: Cash includes cash on hand, cash on deposit in banks, money market accounts and cash equivalents, comprised of short-term investments which have an original maturity of 90 days or less. Interest on short-term investments is recognized when earned. The Company places its cash and cash equivalents with large commercial banks. The Federal Deposit Insurance Corporation (“FDIC”) and Securities Investor Protection Corporation (“SIPC”) insure these balances, up to $250 and $500, respectively. Substantially all of the Company’s cash balances at December 31, 2015 are uninsured.
Financial Instruments	Financial Instruments: The carrying value of cash and cash equivalents, restricted assets and short-term loans approximate their fair value. The fair value of the senior secured notes and the variable interest senior convertible debentures for the years ended December 31, 2015 and 2014 was estimated based on current market quotations. As required by authoritative guidance, derivatives embedded within the Company’s convertible debt are recognized on the Company’s balance sheet and are stated at estimated fair value at each reporting period. Changes in the fair value of the embedded derivatives are reflected quarterly as “Changes in fair value of derivatives embedded within convertible debt.” The estimated fair values for financial instruments presented herein are not necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair values.
Investment Securities	Investment Securities: The Company classifies investments in debt and marketable equity securities as available for sale. Investments classified as available for sale are carried at fair value, with net unrealized gains and losses included as a separate component of stockholders’ deficiency. The cost of securities sold is determined based on average cost. Investments in marketable equity securities represent less than a 20 percent interest in the investees and the Company does not exercise significant influence over such entities. Gains are recognized when realized in the Company’s consolidated statements of operations. Losses are recognized as realized or upon the determination of the occurrence of an other-than-temporary decline in fair value. The Company’s policy is to review its securities on a periodic basis to evaluate whether any security has experienced an other-than-temporary decline in fair value. If it is determined that an other-than-temporary decline exists in one of the Company’s marketable securities, it is the Company’s policy to record an impairment charge with respect to such investment in the Company’s consolidated statements of operations.
Significant Concentrations of Credit Risk	Significant Concentrations of Credit Risk: Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and trade receivables. The Company places its temporary cash in money market securities (investment grade or better) with what management believes are high credit quality financial institutions. Liggett’s customers are primarily candy and tobacco distributors and large grocery, drug and convenience store chains. Two customers, accounted for 19% and 10% of Liggett's revenues in 2015 and 18% and 10% in 2013. One customer accounted for 19% of Liggett's revenues in 2014. Concentrations of credit risk with respect to trade receivables are generally limited due to the large number of customers, located primarily throughout the United States, comprising Liggett’s customer base. Liggett’s two largest customers represented approximately 4% and 1%, respectively, of net accounts receivable at December 31, 2015 and 5% and 1%, respectively, at December 31, 2013. Liggett’s largest customer represented approximately 11% of net accounts receivable at December 31, 2014. Ongoing credit evaluations of customers’ financial condition are performed and, generally, no collateral is required. Liggett maintains reserves for potential credit losses and such losses, in the aggregate, have not exceeded management’s expectations.
Accounts Receivable	Accounts Receivable: Accounts receivable-trade are recorded at their net realizable value. The allowance for doubtful accounts and cash discounts was $479 and $452 at December 31, 2015 and 2014, respectively. Uncollectible accounts are written off when the likelihood of collection is remote and when collection efforts have been abandoned.
Inventories	Inventories: Tobacco inventories are stated at the lower of cost or market and are determined primarily by the last-in, first-out (LIFO) method at Liggett and Vector Tobacco. Although portions of leaf tobacco inventories may not be used or sold within one year because of the time required for aging, they are included in current assets, which is common practice in the industry. It is not practicable to determine the amount that will not be used or sold within one year.
Restricted Assets	Restricted Assets: Current restricted assets of $9,195 and $2,595 at December 31, 2015 and 2014, respectively, consist primarily of certificates of deposits and supersedeas bonds. Long-term restricted assets of $12,303 and $12,013 at December 31, 2015 and 2014, respectively, consist primarily of certificates of deposit which collateralize letters of credit, supersedeas bonds and deposits on long-term debt. The certificates of deposit mature at various dates from February 2016 to August 2020.
Property, Plant and Equipment	Property, Plant and Equipment: Property, plant and equipment are stated at cost. Property, plant and equipment are depreciated using the straight-line method over the estimated useful lives of the respective assets, which are 20 to 30 years for buildings and 3 to 10 years for machinery and equipment. Repairs and maintenance costs are charged to expense as incurred. The costs of major renewals and betterments are capitalized. The cost and related accumulated depreciation of property, plant and equipment are removed from the accounts upon retirement or other disposition and any resulting gain or loss is reflected in operations. The cost of leasehold improvements is amortized over the lesser of the related leases or the estimated useful lives of the improvements. Costs of major additions and betterments are capitalized, while expenditures for routine maintenance and repairs are charged to expense as incurred.
Investment in Real Estate Ventures	Investments in Real Estate Ventures: In accounting for its Investments in real estate ventures, the Company identified its participation in Variable Interest Entities (“VIE”), which are defined as entities in which the equity investors have not provided enough equity to finance its activities or the equity investors (1) cannot directly or indirectly make decisions about the entity’s activities through their voting rights or similar rights; (2) do not have the obligation to absorb the expected losses of the entity; (3) do not have the right to receive the expected residual returns of the entity; or (4) have voting rights that are not proportionate to their economic interests and the entity’s activities involve or are conducted on behalf of an investor with a disproportionately small voting interest. The Company's interest in VIEs is primarily in the form of equity ownership. The Company examines specific criteria and uses judgment when determining if the Company is the primary beneficiary of a VIE. Factors considered include risk and reward sharing, experience and financial condition of other partner(s), voting rights, involvement in day-to-day capital and operating decisions, representation on a VIE's executive committee, existence of unilateral kick-out rights exclusive of protective rights or voting rights and level of economic disproportionality between the Company and its other partner(s). Accounting guidance requires the consolidation of VIEs in which the Company is the primary beneficiary. The guidance requires consolidation of VIEs that an enterprise has a controlling financial interest. A controlling financial interest will have both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. The Company's maximum exposure to loss in its investments in unconsolidated VIEs is limited to its investment in the unconsolidated VIEs which is the carrying value. The Company's maximum exposure to loss in its investment in its consolidated VIEs is limited to its investment which is the carrying value of the investment net of the non-controlling interest. Creditors of the consolidated VIEs have no recourse to the general credit of the primary beneficiary.
Intangible Assets	Goodwill and Other Intangible Assets: Goodwill from acquisitions represents the excess of the purchase price over the fair value of the underlying acquired net tangible and intangible assets. Factors that contribute to the recognition of goodwill in the Company’s acquisitions include (i) expected growth rates and profitability of the acquired companies, (ii) securing buyer-specific synergies that increase revenue and profits and are not otherwise available to market participants, (iii) significant cost savings opportunities, (iv) experienced workforce and (v) the Company’s strategies for growth in sales, income and cash flows. Goodwill is tested for impairment at least annually as of October 1and monitored for interim triggering events on an on-going basis. Other intangible assets with indefinite useful lives are not amortized, but rather, are tested for impairment at least annually. In evaluating goodwill for impairment, the Company has the option to first assess qualitative factors to determine whether further impairment testing is necessary. Among other relevant events and circumstances that affect the fair value of reporting units, the Company considers individual factors such as macroeconomic conditions, changes in the industry and the markets in which the Company operates as well as the historical and expected future financial performance. If we conclude that it is more likely than not that fair value is less than its carrying value, recoverability of goodwill is evaluated using a two-step process. The first step involves a comparison of the fair value of the reporting unit to the Company’s carrying amount. Fair value is determined based on an income approach and a market approach that are equally weighted. If the carrying amount of the reporting unit, including the goodwill, exceeds the fair value of the reporting unit, the second step is performed. The second step involves a comparison of the implied fair value and carrying value of the goodwill of the reporting unit. To the extent that the carrying amount exceeds the implied fair value of the goodwill, an impairment loss is recognized. To determine the implied fair value of the Company’s indefinite-lived intangible asset, trademark, it utilizes the relief from royalty method, pursuant to which the asset is valued by reference to the amount of royalty income it would generate if licensed in an arm’s length transaction. Under the relief from royalty method, similar to the discounted cash flow method, estimated net revenues expected to be generated by the asset during its life are multiplied by a benchmark royalty rate and then discounted by the estimated weighted average cost of capital associated with the asset. The resulting capitalized royalty stream is an indication of the value of owning the asset. To the extent that the carrying amount exceeds the implied fair value of the intangible asset, an impairment loss is recognized. The fair value of the intangible asset associated with the benefit under the Master Settlement Agreement (“MSA”) is calculated using discounted cash flows. This approach involves two steps: (i) estimating future cash savings due to the payment exemption under the MSA and (ii) discounting the resulting cash flow savings to determine fair value. This fair value is then compared with the carrying value of the intangible asset associated with the benefit under the MSA. To the extent that the carrying amount exceeds the implied fair value of the intangible asset, an impairment loss is recognized. Intangible assets with finite lives are amortized over their respective estimated useful lives. Identifiable intangible assets that are subject to amortization are evaluated for impairment using a process similar to that used to evaluate long-lived assets described below.
Impairment Long-Lived Assets	Impairment of Long-Lived Assets: The Company reviews long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. The Company performs a test for recoverability, comparing projected undiscounted cash flows to the carrying value of the asset group to determine if impairment exists. If impairment is determined to exist, any related impairment loss is calculated based on fair value of the asset on the basis of discounted cash flow. Impairment losses on assets to be disposed of, if any, are based on the estimated proceeds to be received, less costs of disposal.
Pension, Postretirement and Postemployment Benefit Plans	Pension, Postretirement and Postemployment Benefits Plans: The cost of providing retiree pension benefits, health care and life insurance benefits is actuarially determined and accrued over the service period of the active employee group. The Company recognizes the funded status of each defined benefit pension plan, retiree health care and other postretirement benefit plans and postemployment benefit plans on the balance sheet.
Stock Options	Stock Options: The Company accounts for employee stock compensation plans by measuring compensation cost for share-based payments at fair value. The fair value is recognized as compensation expense over the vesting period on a straight-line basis. The terms of certain stock options awarded under the 2014 Management Incentive Plan in February 2014 and under the 1999 Plan in November 2013, February 2013, December 2009 and January 2001 provide for common stock dividend equivalents (paid in cash at the same rate as paid on the common stock) with respect to the shares underlying the unexercised portion of the options. The Company recognizes payments of the dividend equivalent rights on these options on the Company consolidated balance sheet as reductions in additional paid-in capital until fully utilized and then accumulated deficit ($5,566, $4,612 and $4,007 net of income taxes, for the years ended December 31, 2015, 2014 and 2013, respectively), which are included as “Distributions and dividends on common stock” in the Company’s consolidated statement of changes in stockholders’ equity.
Income Taxes	Income Taxes: The Company accounts for income taxes under the liability method and records deferred taxes for the impact of temporary differences between the amounts of assets and liabilities recognized for financial reporting purposes and the amounts recognized for tax purposes as well as tax credit carryforwards and loss carryforwards. These deferred taxes are measured by applying currently enacted tax rates. A valuation allowance reduces deferred tax assets when it is deemed more likely than not that some portion or all of the deferred tax assets will not be realized. A current tax provision is recorded for income taxes currently payable. The Company accounts for uncertainty in income taxes by recognizing the financial statement impact of a tax position when it is more likely than not that the position will be sustained upon examination. If the tax position meets the more-likely-than-not recognition threshold, the tax effect is recognized at the largest amount of the benefit that is greater than 50% likely of being realized upon ultimate settlement. The guidance requires that a liability created for unrecognized deferred tax benefits shall be presented as a liability and not combined with deferred tax liabilities or assets.
Distributions and Dividends on Common Stock	Distributions and Dividends on Common Stock: The Company records distributions on its common stock as dividends in its consolidated statement of stockholders’ deficiency to the extent of retained earnings. Any amounts exceeding retained earnings are recorded as a reduction to additional paid-in-capital to the extent paid-in-capital is available. The Company’s stock dividends are recorded as stock splits and given retroactive effect to earnings per share for all years presented.
Revenue Recognition	Revenue Recognition: Tobacco and E-Cigarettes sales: Revenues from sales are recognized upon the shipment of finished goods when title and risk of loss have passed to the customer, there is persuasive evidence of an arrangement, the sale price is fixed or determinable and collectibility is reasonably assured. The Company provides an allowance for expected sales returns, net of any related inventory cost recoveries (e.g. federal excise taxes). Certain sales incentives, including promotional price discounts, are classified as reductions of net sales. The Company includes federal excise taxes on tobacco sales in revenues and cost of goods sold. Since the Company’s primary line of business is tobacco, the Company’s financial position and its results of operations and cash flows have been and could continue to be materially adversely affected by significant unit sales volume declines at the Company and industry levels, regulation, litigation and defense costs, increased tobacco costs or reductions in the selling price of cigarettes in the near term. Tobacco Shipping and Handling Fees and Costs: Shipping and handling fees related to sales transactions are neither billed to customers nor recorded as revenue. Shipping and handling costs, which were $5,488 in 2015, $5,585 in 2014 and $5,559 in 2013 are recorded as operating, selling, administrative and general expenses. Real estate sales: Revenue is recognized only when persuasive evidence of an arrangement exists, the price is fixed or determinable, the transaction has been completed and collectibility of the resulting receivable is reasonably assured. Real estate commissions earned by the Company’s real estate brokerage businesses are recorded as revenue on a gross basis upon the closing of a real estate transaction as evidenced when the escrow or similar account is closed, the transaction documents have been recorded and funds are distributed to all appropriate parties. Commissions expenses are recognized concurrently with related revenues. Property management fees and rental commissions earned are recorded as revenue when the related services are performed.
Shipping and Handling Fees and Costs	Tobacco Shipping and Handling Fees and Costs: Shipping and handling fees related to sales transactions are neither billed to customers nor recorded as revenue. Shipping and handling costs, which were $5,488 in 2015, $5,585 in 2014 and $5,559 in 2013 are recorded as operating, selling, administrative and general expenses.
Advertising Costs	Advertising: Tobacco and E-Cigarettes advertising costs, which are expensed as incurred and included within operating, selling, administration and general expenses, were $5,097, $9,493 and $4,839 for the years ended December 31, 2015, 2014 and 2013, respectively. Real estate advertising costs, which are expensed as incurred and included within operating, selling, administration and general expenses, were $25,657, $14,952 and $1,298 for the years ended December 31, 2015 and 2014 and 2013, respectively.
Comprehensive Income	Comprehensive Income: The Company presents net income and other comprehensive income in two separate, but consecutive, statements. The items are presented before related tax effects with detailed amounts shown for the income tax expense or benefit related to each component of other comprehensive income.
Fair Value of Derivatives Embedded within Convertible Debt	Fair Value of Derivatives Embedded within Convertible Debt: The Company has estimated the fair market value of the embedded derivatives based principally on the results of a valuation model. The estimated fair value of the derivatives embedded within the convertible debt is based principally on the present value of future dividend payments expected to be received by the convertible debt holders over the term of the debt. The discount rate applied to the future cash flows is estimated based on a spread in the yield of the Company’s debt when compared to risk-free securities with the same duration; thus, a readily determinable fair market value of the embedded derivatives is not available. The valuation model assumes future dividend payments by the Company and utilizes interest rates and credit spreads for secured to unsecured debt, unsecured to subordinated debt and subordinated debt to preferred stock to determine the fair value of the derivatives embedded within the convertible debt. The valuation also considers other items, including current and future dividends and the volatility of Vector’s stock price. At December 31, 2015, the range of estimated fair market values of the Company’s embedded derivatives was between $143,422 and $144,660. The Company recorded the fair market value of its embedded derivatives at the midpoint of the inputs at $144,042 as of December 31, 2015. At December 31, 2014, the range of estimated fair market values of the Company’s embedded derivatives was between $167,593 and $171,215. The Company recorded the fair market value of its embedded derivatives at the midpoint of the inputs at $169,386 as of December 31, 2014. The estimated fair market value of the Company’s embedded derivatives could change significantly based on future market conditions. (See Note 9.)
Capital and Credit Markets	Capital and Credit Markets: The Company has performed additional assessments to determine the impact, if any, of market developments, on the Company’s consolidated financial statements. The Company’s additional assessments have included a review of access to liquidity in the capital and credit markets, counterparty creditworthiness, value of the Company’s investments (including long-term investments, mortgage receivable and employee benefit plans) and macroeconomic conditions. The volatility in capital and credit markets may create additional risks in the upcoming months and possibly years and the Company will continue to perform additional assessments to determine the impact, if any, on the Company’s consolidated financial statements. Thus, future impairment charges may occur. On a quarterly basis, the Company evaluates its investments to determine whether an impairment has occurred. If so, the Company also makes a determination of whether such impairment is considered temporary or other than temporary. The Company believes that the assessment of temporary or other-than-temporary impairment is facts-and-circumstances driven. However, among the matters that are considered in making such a determination are the period of time the investment has remained below its cost or carrying value, the likelihood of recovery given the reason for the decrease in market value and the Company’s original expected holding period of the investment.
Contingencies	Contingencies: The Company records Liggett’s product liability legal expenses as operating, selling, administrative and general expenses as those costs are incurred. As discussed in Note 15, legal proceedings covering a wide range of matters are pending or threatened in various jurisdictions against Liggett and the Company. The Company and its subsidiaries record provisions in their consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except as disclosed in Note 15: (i) management has concluded that it is not probable that a loss has been incurred in any of the pending tobacco-related cases; or (ii) management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome of any of the pending tobacco-related cases and, therefore, management has not provided any amounts in the consolidated financial statements for unfavorable outcomes, if any. Legal defense costs are expensed as incurred. Adverse verdicts have been entered against Liggett in 15 state court Engle progeny cases and several of these verdicts have been affirmed on appeal and satisfied by Liggett. In certain cases, the judgments entered have been joint and several with other defendants. In four of these cases, punitive damages were awarded against Liggett. The Company's potential range of loss in the remaining cases on appeal is between $0 and $12,674 in the aggregate, plus accrued interest and attorneys’ fees. In determining the range of loss, we consider potential settlements as well as future appellate relief. Except as discussed in Note 15, management is unable to estimate the possible loss or range of loss from remaining Engle progeny cases as there are currently multiple defendants in each case and discovery has not occurred or is limited. As a result, the Company lacks information about whether plaintiffs are, in fact, Engle class members (non-class members’ claims are generally time-barred), the relevant smoking history, the nature of the alleged injury and the availability of various defenses, among other things. Further, plaintiffs typically do not specify their demand for damages. Litigation is subject to many uncertainties, and it is possible that the Company’s consolidated financial position, results of operations or cash flows could be materially adversely affected by an unfavorable outcome in any such tobacco-related litigation.
New Accounting Pronouncements	New Accounting Pronouncements: In February 2016, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-17, Leases. The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The new standard is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the effect that this guidance will have on its consolidated financial statements. In January 2016, the FASB issued ASU 2016-01, Financial Instruments--Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, which amends the guidance in U.S. GAAP on the classification and measurement of financial instruments. Changes to the current guidance primarily affects the accounting for equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. In addition, the ASU clarifies guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017, and upon adoption, an entity should apply the amendments by means of a cumulative-effect adjustment to the balance sheet at the beginning of the first reporting period in which the guidance is effective. Early adoption is not permitted except for the provision to record fair value changes for financial liabilities under the fair value option resulting from instrument-specific credit risk in other comprehensive income. The Company is evaluating the effect that this guidance will have on its consolidated financial statements. In September 2015, the FASB issued ASU 2015-16, Business Combination (Topic 805): Simplifying the Accounting for Measurement Period Adjustments (“ASU 2015-16”), which requires adjustments to provisional amounts initially recorded in a business combination that are identified during the measurement period to be recognized in the reporting period in which the adjustment amounts are determined. This includes any effect on earnings of changes in depreciation, amortization, or other income effects as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date. ASU 2015-15 also requires the disclosure of the nature and amount of measurement-period adjustments recognized in the current period, including separately the amounts in current-period income statement line items that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. The guidance is effective for the Company beginning January 1, 2016. The Company will apply the guidance prospectively for all business combinations that occur subsequent to the adoption date. In August 2015, FASB issued ASU 2015-15, Interest - Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measure of Debt Issuance Costs Associated with Line-of-Credit Arrangements (Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting), which codifies an Securities and Exchange Commission staff announcement that entities are permitted to defer and present debt issuance costs related to line-of-credit arrangement as assets. Given the absence of authoritative guidance within ASU 2015-03 for debt issuance costs related to line-of-credit arrangements, ASU 2015-15 clarifies that the Securities and Exchange Commission staff would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. This guidance is effective immediately and will be applied prospectively to any line-of-credit arrangements entered into subsequent to the effective date. In April 2015, FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”), which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected. Upon adoption, the Company will apply the new guidance on a retrospective basis and adjust the balance sheet of each individual period presented to reflect the period-specific effects of applying the new guidance. This guidance is effective for the Company beginning January 1, 2016. The Company is evaluating the effect that this guidance will have on its consolidated financial statements. In February 2015, FASB issued ASU 2015-02, Consolidation: Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 amends the consolidation requirements and significantly changes the consolidation analysis required. ASU 2015-02 requires management to reevaluate all legal entities under a revised consolidation model specifically (1) modify the evaluation of whether limited partnership and similar legal entities are VIEs, (2) eliminate the presumption that a general partner should consolidate a limited partnership, (3) affect the consolidation analysis of reporting entities that are involved with VIEs particularly those that have fee arrangements and related party relationships, and (4) provide a scope exception from consolidation guidance for reporting entities with interests in legal entities that are required to comply with or operate in accordance with requirements that are similar to those in Rule 2a-7 of the Investment Act of 1940 for registered money market funds. The guidance is effective for the Company beginning January 1, 2016. The Company is evaluating the effect that this guidance will have on its consolidated financial statements. In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40)-Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). ASU 2014-15 provides guidance to U.S. GAAP about management’s responsibility to evaluate whether there is a substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. Specifically, ASU 2014-15 (1) defines the term substantial doubt, (2) requires an evaluation of every reporting period including interim periods, (3) provides principles for considering the mitigating effect of management’s plan, (4) requires certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) requires an express statement and other disclosures when substantial doubt is not alleviated, and (6) requires an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this update are effective for annual periods beginning after December 15, 2016 and interim periods within those reporting periods. Earlier adoption is permitted. In May 2014, FASB issued ASU 2014-9, Revenue from Contracts with Customers (Topic 606), (“ASU 2014-9”). ASU 2014-9 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The new standard is effective for annual reporting periods beginning after December 15, 2018, with early adoption permitted for annual reporting periods beginning subsequent to December 15, 2016. The new standard is required to be applied retrospectively to each prior reporting period presented or with the cumulative effect of initially applying it recognized at the date of initial application. The Company has not yet selected a transition method and it has not determined the impact of the new standard on its consolidated financial statements.
Earnings Per Share	Basic EPS is computed by dividing net income available to common stockholders attributed to Vector Group Ltd. by the weighted-average number of shares outstanding, which includes vested restricted stock. Diluted EPS includes the dilutive effect of non-vested restricted stock grants, stock options and convertible securities. Diluted EPS is computed by dividing net income available to common stockholders by the diluted weighted-average number of shares outstanding, which includes dilutive non-vested restricted stock grants, stock options and convertible securities.

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

Schedule of revision of prior period gross revenues and costs of consolidated real estate investments

The cumulative impact of the revisions and application of the new ASU are presented in the table below:



	December 31, 2014
	As Previously Reported		Revision			ASU Adoption			As Revised

Deferred income taxes	$	29,192	$	(29,192	)	$	—		$	—
Total current assets	857,846		(29,192		)	—			828,654

Deferred income taxes	51,129		(51,129		)	—			—
Total assets	$	1,573,392	$	(80,321	)	$	—		$	1,493,071

Deferred income taxes, net	$	57,671	$	(29,192	)	$	(28,479	)	$	—
Total current liabilities	270,095		(29,192		)	(28,479		)	212,424

Deferred income taxes, net	145,639		(51,129		)	28,479			122,989
Total liabilities	1,551,340		(80,321		)	—			1,471,019
Total stockholders' equity	22,052					—			22,052
Total liabilities and stockholders' equity	$	1,573,392	$	(80,321	)	$	—		$	1,493,071

The cumulative impact of the revisions and application of the equity method of accounting for the two investments are presented in the tables below:



	December 31, 2014
	As Previously Reported			(1)	Revision			As Revised

Investment securities available for sale	$	346,043			$	(76,943	)	$	269,100
Other current assets	36,718				(314		)	36,404
Total current assets	828,654				(77,257		)	751,397

Long-term investments	40,292				12,431			52,723
Other assets	58,893				(4,991		)	53,902
Total assets	$	1,493,071			$	(69,817	)	$	1,423,254


Deferred income taxes, net	$	122,989			$	(27,085	)	$	95,904
Total liabilities	1,471,019				(27,085		)	1,443,934
Accumulated deficit	(90,160		)		(6,849		)	(97,009		)
Accumulated other comprehensive income	34,540				(35,883		)	(1,343		)
Total Vector Group Ltd. stockholders' deficiency	(57,027		)		(42,732		)	(99,759		)
Total stockholders' equity (deficiency)	22,052				(42,732		)	(20,680		)
Total liabilities and stockholders' equity (deficiency)	$	1,493,071			$	(69,817	)	$	1,423,254

(1) The amounts shown in the “As Previously Reported” column reflect the impact of the deferred tax adjustments presented in the preceding table.



	Year ended								Year ended
	December 31, 2014								December 31, 2013
	As Previously Reported		Revision			As Revised			As Previously Reported		Revision			As Revised

Operating, selling, administrative and general expenses	$	278,392	$	950		$	279,342		$	112,748	$	850		$	113,598
Operating income	213,388		(950		)	212,438			112,036		(850		)	111,186

Equity in earnings from investments	1,242		1,898			3,140			2,066		1,060			3,126
Other, net	10,552		(1,156		)	9,396			7,550		(2,977		)	4,573
Income before provision for income taxes	82,487		(208		)	82,279			63,487		(2,767		)	60,720
Income tax expense	33,251		(86		)	33,165			24,795		(1,123		)	23,672
Net income	49,236		(122		)	49,114			38,692		(1,644		)	37,048

Net income attributed to Vector Group Ltd.	36,978		(122		)	36,856			38,944		(1,644		)	37,300

Other comprehensive income (loss), net of tax	11,680		(13,614		)	(1,934		)	33,128		(17,534		)	15,594

Comprehensive income	60,916		(13,736		)	47,180			71,820		(19,178		)	52,642

Comprehensive income attributed to Vector Group Ltd.	$	48,658	$	(13,736	)	$	34,922		$	72,072	$	(19,178	)	$	52,894

Schedule of accumulated other comprehensive income (loss), net of income taxes

The components of accumulated other comprehensive (loss) income, net of income taxes, were as follows:



	December 31, 2015			December 31, 2014			December 31, 2013
Net unrealized gains on investment securities available for sale, net of income taxes of $7,758, $12,706 and $11,528, respectively	$	12,048		$	18,102		$	16,867
Net unrealized losses on long-term investment accounted for under the equity method, net of income tax benefits of $0, $1,156, and $418, respectively	—			(1,658		)	(612		)
Forward contracts adjustment, net of income taxes of $11, $36, and $63, respectively	(19		)	(55		)	(92		)
Pension-related amounts, net of income taxes of $13,977, $12,167, and $10,644, respectively	(20,342		)	(17,732		)	(15,572		)
Accumulated other comprehensive (loss) income	$	(8,313	)	$	(1,343	)	$	591

Schedule of other Income, net

Other income, net consists of:



	Year Ended
	December 31,
	2015			2014		2013
Interest and dividend income	$	7,038		$	5,803	$	4,381
Out-of-period adjustment	—			1,231		—
Acceleration of closing fee related to termination of Douglas Elliman joint venture	—			2,335		—
Impairment of real estate held for sale	(230		)	—		—
Loss on sale of assets	(78		)	—		—
Gain on long-term investment	390			—		189
Impairment of long-term investments	(811		)	—		—
Other income	100			27		3
Other income, net	$	6,409		$	9,396	$	4,573

Schedule of other current liabilities

Other current liabilities consists of:



	December 31, 2015		December 31, 2014
Accounts payable	$	19,639	$	10,856
Accrued promotional expenses	24,816		20,191
Accrued excise and payroll taxes payable, net	26,556		23,172
Accrued interest	28,147		28,321
Commissions payable	11,008		9,523
Accrued salaries and benefits	20,134		16,009
Other current liabilities	23,917		18,683
Total other current liabilities	$	154,217	$	126,755

Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2015

Earnings Per Share [Abstract]

Net income for purpose of determining basic EPS

As a result, in its calculation of basic EPS for the years ended December 31, 2015, 2014 and 2013, respectively, the Company has adjusted its net income for the effect of these participating securities as follows:



	2015			2014			2013
Net income attributed to Vector Group Ltd.	$	59,198		$	36,856		$	37,300
Income attributable to participating securities	(1,752		)	(1,024		)	(1,023		)
Net income available to common stockholders attributed to Vector Group Ltd.	$	57,446		$	35,832		$	36,277

Basic and diluted EPS calculation shares

Basic and diluted EPS were calculated using the following shares for the years ended December 31, 2015, 2014 and 2013:



	2015	2014	2013
Weighted-average shares for basic EPS	117,760,538	108,075,400	100,886,113
Plus incremental shares related to stock options and non-vested restricted stock	32,030	66,732	261,837
Weighted-average shares for diluted EPS	117,792,568	108,142,132	101,147,950

Outstanding shares not included in the computation of diluted EPS



	Year Ended December 31,
	2015		2014		2013
Weighted-average shares of non-vested restricted stock	N/A		N/A		30,319
Weighted-average expense per share	N/A		N/A		$	15.10
Weighted-average number of shares issuable upon conversion of debt	25,113,350		32,216,245		30,862,794
Weighted-average conversion price	$	19.55	$	16.83	$	13.81

Investment Securities Available for Sale (Tables)

12 Months Ended

Dec. 31, 2015

Available-for-sale Securities [Abstract]

Available-for-sale Securities

The components of investment securities available for sale at December 31, 2015 were as follows:



	Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Marketable equity securities	$	47,502	$	19,833	$	(62	)	$	67,273
Mutual funds invested in fixed income securities	20,126		—		(15		)	20,111
Marketable debt securities	94,540		52		—			94,592
Total investment securities available for sale	$	162,168	$	19,885	$	(77	)	$	181,976

The components of investment securities available for sale at December 31, 2014 were as follows:



	Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Marketable equity securities	$	46,695	$	32,018	$	(1,104	)	$	77,609
Mutual funds invested in fixed income securities	61,485		—		(1,659		)	59,826
Marketable debt securities	130,111		2,470		(916		)	131,665
Total investment securities available for sale	$	238,291	$	34,488	$	(3,679	)	$	269,100

Schedule of Maturity Dates of Fixed Income Securities

The table below summarizes the maturity dates of marketable debt securities at December 31, 2015.



Investment Type:	Fair Value		Under 1 Year		1 Year up to 5 Years		More than 5 Years
U.S. Government securities	$	28,132	$	—	$	28,132	$	—
Corporate securities	41,561		2,154		39,347		60
U.S. mortgage-backed securities	5,790		636		5,003		151
Commercial mortgage-backed securities	8,728		5,739		715		2,274
U.S. asset-backed securities	8,276		2,342		5,934		—
Index-linked U.S. bonds	2,105		—		2,105		—
Total marketable debt securities by maturity dates	$	94,592	$	10,871	$	81,236	$	2,485

Schedule of Unrealized Loss on Investments

The available-for-sale investment securities with continuous unrealized losses for less than 12 months and 12 months or greater and their related fair values were as follows:



	In loss position for
	Less than 12 months					12 months or more
	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses			Total Fair Value		Total Unrealized Losses
December 31, 2015
Marketable equity securities	$	5,938	$	(62	)	$	—	$	—		$	5,938	$	(62	)
Mutual funds invested in fixed income securities	10,053		(15		)						10,053		(15		)
	$	15,991	$	(77	)	$	—	$	—		$	15,991	$	(77	)

December 31, 2014
Marketable equity securities	$	6,599	$	(138	)	$	3,534	$	(966	)	$	10,133	$	(1,104	)
Mutual funds invested in fixed income securities	59,826		(1,659		)	—		—			59,826		(1,659		)
Marketable debt securities
U.S. Government securities	22,375		(18		)	—		—			22,375		(18		)
Corporate securities	30,896		(204		)	7,224		(131		)	38,120		(335		)
U.S. mortgage-backed securities	3,370		(26		)	—		—			3,370		(26		)
Commercial mortgage-backed securities	11,332		(46		)	5,176		(432		)	16,508		(478		)
U.S. asset-backed securities	15,228		(29		)	—		—			15,228		(29		)
Index-linked U.S. bonds	2,098		(30		)	—		—			2,098		(30		)
	$	151,724	$	(2,150	)	$	15,934	$	(1,529	)	$	167,658	$	(3,679	)

Schedule of Realized Gains (Losses)

Gross realized gains and losses on available-for-sale investment securities were as follows:



	Year Ended December 31,
	2015			2014			2013
Gross realized gains on sales	$	13,727		$	275		$	5,538
Gross realized losses on sales	(2,589		)	(286		)	(386		)
Gains (losses) on sale of investment securities available for sale	$	11,138		$	(11	)	$	5,152

Gross realized losses on other-than-temporary impairments	$	(12,846	)	$	—		$	—

- Definition

Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.

+ References + Details

Inventories (Tables)

12 Months Ended

Dec. 31, 2015

Inventory, Net [Abstract]

Schedule of inventories

Inventories consist of:



	December 31, 2015			December 31, 2014
Leaf tobacco	$	49,856		$	49,948
Other raw materials	3,578			3,532
Work-in-process	789			879
Finished goods	61,493			62,876
E-Cigarettes	80			3,079
Inventories at current cost	115,796			120,314
LIFO adjustments	(29,280		)	(29,991		)
	$	86,516		$	90,323

Property, Plant and Equipment (Tables)

12 Months Ended

Dec. 31, 2015

Property, Plant and Equipment [Abstract]

Schedule of property, plant and equipment

Property, plant and equipment consist of:



	December 31, 2015			December 31, 2014
Land and improvements	$	1,442		$	1,442
Buildings	15,908			15,418
Machinery and equipment	178,131			167,090
Leasehold improvements	21,142			17,212
	216,623			201,162
Less accumulated depreciation and amortization	(140,991		)	(117,050		)
	$	75,632		$	84,112

Long Term Investments (Tables)

12 Months Ended

Dec. 31, 2015

Long-term Investments [Abstract]

Long-term investments

Long-term investments consist of the following:



	December 31, 2015		December 31, 2014
Investments accounted at cost	$	41,231	$	32,239
Investments accounted under the equity method	21,495		20,484
	$	62,726	$	52,723

Schedule of cost method investments

Long-term investments consist of the following investments accounted for at cost:



	December 31, 2015				December 31, 2014
	Carrying Value		Fair Value		Carrying Value		Fair Value
Investment partnerships	$	40,730	$	44,217	$	31,541	$	38,039
Real estate partnership	501		552		698		1,108
	$	41,231	$	44,769	$	32,239	$	39,147

Schedule of Equity Method Investments [Line Items]

Schedule of equity method investments

Long-term investments consist of the following investments accounted for under the equity method:



	December 31, 2015		December 31, 2014
Indian Creek Investors LP	$	4,989	$	8,053
Boyar Value Fund	7,302		—
Ladenburg Thalmann Financial Services Inc.	9,204		12,173
Castle Brands, Inc.	—		258
	$	21,495	$	20,484

Castle Brands [Member]

Schedule of Equity Method Investments [Line Items]

Schedule of equity method investments

Pursuant to Rule 4-08(g) is the following summarized financial data for Castle. The Company has elected a three-month lag reporting period for Castle.



	September 30, 2015		September 30, 2014
Current assets	$	36,922	$	31,121
Non-current assets	9,845		9,834
Total assets	$	46,767	$	40,955

Current liabilities	$	9,947	$	8,703
Non-current liabilities	13,696		12,028
Total liabilities	23,643		20,731
Total controlling shareholders' equity	19,978		17,490
Non-controlling interest	3,146		2,734
Total shareholders' equity	23,124		20,224
Total liabilities and shareholders' equity	$	46,767	$	40,955



	Twelve Months Ended September 30,
	2015			2014			2013
Revenues	$	67,143		$	51,426		$	43,484
Expenses	(41,317		)	(32,495		)	(28,117		)
Gross profit	25,826			18,931			15,367
Other expenses	(25,920		)	(20,399		)	(19,176		)
Loss from continuing operations	(94		)	(1,468		)	(3,809		)
Net loss	$	(2,946	)	$	(4,845	)	$	(8,604	)

Indian Creek and Boyar Value Fund [Member]

Schedule of Equity Method Investments [Line Items]

Schedule of equity method investments

Pursuant to Rule 4-08(g), the following summarized financial data for unconsolidated subsidiaries includes information for Indian Creek and Boyar Value Fund.



	December 31, 2015		December 31, 2014
Investment securities	$	40,676	$	71,331
Cash and cash equivalents	101		309
Other assets	8,664		32
Total assets	$	49,441	$	71,672

Other liabilities	$	408	$	6,571
Total liabilities	408		6,571
Partners' capital	49,033		65,101
Total liabilities and partners' capital	$	49,441	$	71,672



	Year Ended December 31,
	2015			2014			2013
Investment income	$	565		$	3,314		$	565
Expenses	(868		)	(1,298		)	(839		)
Net investment (loss) income	(303		)	2,016			(274		)
Total net realized (loss) gain and net change in unrealized depreciation from investments	(14,809		)	(168		)	16,496
Net (decrease) increase in partners' capital resulting from operations	$	(15,112	)	$	1,848		$	16,222

Ladenburg Thalmann Financial Services [Member]

Schedule of Equity Method Investments [Line Items]

Schedule of equity method investments

Pursuant to Rule 4-08(g) is the following summarized financial data for LTS. The Company has elected a three-month lag reporting period for LTS.



	September 30, 2015			September 30, 2014
Cash and cash equivalents	$	114,548		$	94,952
Receivables from clearing brokers, note receivable and other receivable, net	115,334			123,947
Goodwill and intangible assets, net	269,774			211,862
Other assets	63,634			62,571
Total assets	$	563,290		$	493,332

Accrued compensation, commissions and fees payable	$	72,936		$	61,205
Accounts payable and accrued liabilities	24,615			22,328
Notes payable, net of $1,655 and $951 unamortized discount in 2015 and 2014, respectively	59,184			62,131
Other liabilities	21,487			32,802
Total liabilities	178,222			178,466
Preferred stock	1			1
Common stock	19			18
Additional paid-in capital	517,988			452,263
Accumulated deficit	(132,952		)	(137,406		)
Total controlling shareholders' equity	385,056			314,876
Non-controlling interest	12			(10		)
Total shareholders' equity	385,068			314,866
Total liabilities and shareholders' equity	$	563,290		$	493,332

(1) The table above presents the nature and amounts of the major components of assets and liabilities, along with information regarding redeemable stock and non-controlling interest.



	Twelve Months Ended September 30,
	2015			2014			2013
Revenues	$	1,122,735		$	867,756		$	753,840
Expenses	(1,132,010		)	(856,072		)	(756,988		)
Gross (loss) profit	(9,275		)	11,684			(3,148		)
Change in fair value of contingent consideration	31			12			(121		)
(Loss) income from continuing operations	(9,244		)	11,696			(3,269		)
Net income (loss)	$	4,396		$	22,482		$	(5,389	)

New Valley LLC (Tables)

12 Months Ended

Dec. 31, 2015

Schedule of Investments [Abstract]

Preliminary fair values of the assets acquired, liabilities assumed and the non-controlling interest recorded for Douglas Elliman

In 2014, the Company reassessed its initial purchase accounting allocations. The following table reconciles initial allocation to final allocation of acquired assets and liabilities:



	Preliminary December 13, 2013		Measurement Period Adjustments			Final December 13, 2013
	Preliminary December 13, 2013		Measurement Period Adjustments			Final December 13, 2013
Cash and cash equivalents	$	116,935	$	—		$	116,935
Other current assets	12,647		—			12,647
Property, plant and equipment, net	20,275		—			20,275
Goodwill	72,135		(1,729		)	70,406
Trademarks	80,000		—			80,000
Other intangible assets, net	12,928		5,856			18,784
Other non-current assets	3,384		—			3,384
Total assets acquired	$	318,304	$	4,127		$	322,431

Notes payable - current	$	201	$	—		$	201
Other current liabilities	26,247		105			26,352
Notes payable - long term	420		—			420
Other long-term liabilities	—		4,022			4,022
Total liabilities assumed	$	26,868	$	4,127		$	30,995

Net assets acquired	$	291,436	$	—		$	291,436

Non-controlling interest	$	85,703	$	—		$	85,703

Schedule of Equity Method Investments [Line Items]

Schedule of equity method investments

Long-term investments consist of the following investments accounted for under the equity method:



	December 31, 2015		December 31, 2014
Indian Creek Investors LP	$	4,989	$	8,053
Boyar Value Fund	7,302		—
Ladenburg Thalmann Financial Services Inc.	9,204		12,173
Castle Brands, Inc.	—		258
	$	21,495	$	20,484

Investments In non-consolidated real estate businesses

The components of “Investments in real estate ventures” were as follows:



	December 31, 2015		December 31, 2014

Land Development - Milanosesto Holdings (Sesto Holdings)	$	—	$	5,037

10 Madison Square Park (1107 Broadway)	11,391		6,383
The Marquand (11 East 68th Street)	13,900		12,000
11 Beach Street	13,209		12,328
20 Times Square (701 Seventh Avenue)	14,985		12,481
111 Murray Street	25,567		27,319
160 Leroy Street	3,952		1,467
215 Chrystie Street	5,592		3,300
The Dutch (25-19 43rd Avenue)	1,077		733
Queens Plaza (23-10 Queens Plaza South)	16,177		11,082
87 Park (8701 Collins Avenue)	8,658		6,144
125 Greenwich Street	9,750		9,308
West Hollywood Edition (9040 Sunset Boulevard)	10,510		5,604
76 Eleventh Avenue	17,967		—
Monad Terrace	6,608		—
Takanasee	4,680		—
Condominium and Mixed Use Development	164,023		108,149

Maryland Portfolio	—		3,234
ST Portfolio	15,754		15,283
Apartment Buildings	15,754		18,517

Park Lane Hotel	19,697		19,341
Hotel Taiwana	7,069		7,629
Coral Beach and Tennis Club	3,159		2,816
Hotels	29,925		29,786

The Plaza at Harmon Meadow	5,449		—
Commercial	5,449		—

Other	2,017		1,971

Investments in real estate ventures	$	217,168	$	163,460

Investment in Consolidated Real Estate

The components of “Real Estate Held for Sale, net” were as follows:



	December 31, 2015		December 31, 2014
Escena, net	$	10,716	$	10,643
Sagaponack	12,602		—
Investment in consolidated real estate businesses, net	$	23,318	$	10,643

The assets have been classified as an “Real estate held for sale, net” on the Company’s consolidated balance sheet and the components are as follows:



	December 31, 2015			December 31, 2014
Land and land improvements	$	8,907		$	8,953
Building and building improvements	1,875			1,865
Other	1,923			1,568
	12,705			12,386
Less accumulated depreciation	(1,989		)	(1,743		)
	$	10,716		$	10,643

Land Development [Member]

Schedule of Equity Method Investments [Line Items]

Schedule of equity method investments

Land Development:



	December 31, 2015		December 31, 2014
Balance Sheets
Investment in real estate	$	—	$	759,038
Total assets	—		789,107
Total debt	—		520,760
Total liabilities	$	—	$	609,066

Condominium and Mixed Use Development [Member]

Schedule of Equity Method Investments [Line Items]

Schedule of equity method investments

Condominium and Mixed Use Development:



	Year Ended December 31,
	2015		2014		2013
Income Statement
Revenue	$	141,884	$	182,635	$	39,120
Cost of Goods Sold	92,837		96,993		11,938
Other Expenses	10,672		6,798		22,375
Income from continuing operations	$	38,375	$	78,844	$	4,807



	December 31, 2015		December 31, 2014
Balance Sheets
Investment in real estate	$	2,921,611	$	1,617,397
Total assets	3,237,835		1,894,670
Total debt	2,014,682		1,121,099
Total liabilities	2,195,940		1,301,223
Non controlling interest	535,573		364,560

Douglas Elliman Realty LLC [Member]

Schedule of Equity Method Investments [Line Items]

Schedule of equity method investments



	January 1 through December 13,
	2013
Revenues	$	416,453
Costs and expenses	369,852
Depreciation expense	3,790
Amortization expense	213
Other income (expense)	(22		)
Interest expense, net	23
Income tax expense	996
Net income	$	41,557

Apartment and Office Buildings [Member]

Schedule of Equity Method Investments [Line Items]

Schedule of equity method investments

Apartment & Office Buildings:



	Year Ended December 31,
	2015		2014			2013
Income Statement
Revenue	$	83,871	$	85,704		$	59,917
Other Expenses	75,384		86,153			64,643
Income from continuing operations	$	8,487	$	(449	)	$	(4,726	)



	December 31, 2015			December 31, 2014
Balance Sheets
Investment in real estate	$	590,331		$	632,753
Total assets	626,513			669,368
Total debt	512,479			498,330
Total liabilities	529,692			511,027
Non controlling interest	(4,463		)	49,170

Hotels [Member]

Schedule of Equity Method Investments [Line Items]

Schedule of equity method investments

Hotels:



	Year Ended December 31,
	2015			2014			2013
Income Statement
Revenue	$	83,324		$	82,899		$	22,090
Cost of Goods Sold	3,837			3,064			3,691
Other Expenses	112,069			133,258			35,164
Loss from continuing operations	$	(32,582	)	$	(53,423	)	$	(16,765	)



	December 31, 2015		December 31, 2014
Balance Sheets
Investment in real estate	$	824,753	$	777,157
Total assets	894,447		903,677
Total debt	511,029		506,655
Total liabilities	538,426		540,706
Non controlling interest	294,470		295,051

Commercial [Member]

Schedule of Equity Method Investments [Line Items]

Schedule of equity method investments

Commercial:



	Year Ended December 31,
	2015			2014		2013
Income Statement
Revenue	$	5,638		$	—	$	—
Other Expenses	5,642			—		—
Loss from continuing operations	$	(4	)	$	—	$	—



	December 31, 2015		December 31, 2014
Balance Sheets
Investment in real estate	$	65,398	$	—
Total assets	67,343		—
Total debt	55,624		—
Total liabilities	56,415		—

Other [Member]

Schedule of Equity Method Investments [Line Items]

Schedule of equity method investments

Other:



	Year Ended December 31,
	2015		2014		2013
Income Statement
Revenue	$	3,030	$	2,714	$	2,558
Other Expenses	1,049		1,019		927
Income from continuing operations	$	1,981	$	1,695	$	1,631



	December 31, 2015		December 31, 2014
Balance Sheets
Total assets	$	5,157	$	4,786
Total liabilities	$	1,022	$	766

Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule Intangible Assets

The components of Goodwill and other intangible assets, net were as follows:



	December 31, 2015		December 31, 2014
Goodwill	$	70,791	$	70,791

Indefinite life intangibles:
Intangible asset associated with benefit under the MSA	107,511		107,511
Trademark - Douglas Elliman	80,000		80,000

Intangibles with a finite life, net	5,657		11,670

Total goodwill and other intangible assets, net	$	263,959	$	269,972

Other intangible assets and contract liabilities assumed were as follows:



	Useful Lives in Years	December 31, 2015			December 31, 2014
Intangible asset associated with benefit under the MSA	Indefinite	$	107,511		$	107,511

Trademark - Douglas Elliman	Indefinite	80,000			80,000

Favorable leases	1 - 10	13,444			13,444
Other intangibles	1 - 5	5,691			5,690
		19,135			19,134
Less: Accumulated amortization on amortizable intangibles		(13,478		)	(7,464		)
Other intangibles, net		$	5,657		$	11,670

Contract liabilities assumed:

Unfavorable leases	1 - 10	$	4,022		$	4,022
Less: Accumulated amortization on amortizable intangibles		(1,591		)	(808		)
Unfavorable leases, net		$	2,431		$	3,214

Notes Payable, Long Term Debt and Other Obligations (Tables)

12 Months Ended

Dec. 31, 2015

Debt Disclosure [Abstract]

Notes payable, long-term debt and other obligations

Notes payable, long-term debt and other obligations consist of:



	December 31, 2015			December 31, 2014
Vector:
7.75% Senior Secured Notes due 2021, including premium of $8,014 and $9,275	$	608,014		$	609,275
6.75% Variable Interest Senior Convertible Note due 2015 (as amended), net of unamortized discount of $0 and $0*	—			25,000
5.5% Variable Interest Senior Convertible Debentures due 2020, net of unamortized discount of $86,136 and $98,831*	172,614			159,919
7.5% Variable Interest Senior Convertible Notes due 2019, net of unamortized discount of $132,119 and $146,634*	97,881			83,366
Liggett:
Revolving credit facility	3,213			17,767
Term loan under credit facility	3,269			3,589
Equipment loans	9,716			13,966
Other	461			469
Total notes payable, long-term debt and other obligations	895,168			913,351
Less:
Current maturities	(8,919		)	(52,640		)
Amount due after one year	$	886,249		$	860,711

_____________________________

Schedule of Amortization Of Debt Discount Created By Embedded Derivative



	Year Ended December 31,
	2015		2014		2013
6.75% note	$	—	$	6,097	$	5,914
6.75% exchange notes	—		13,570		11,799
3.875% convertible debentures	—		—		155
7.5% convertible notes	8,777		5,553		3,614
5.5% convertible notes	9,752		6,851		—
Interest expense associated with embedded derivatives	$	18,529	$	32,071	$	21,482

A summary of non-cash changes in fair value of derivatives embedded within convertible debt is as follows:



	Year Ended December 31,
	2015			2014		2013
6.75% note	$	(5	)	$	3,212	$	5,075
6.75% exchange notes	—			8,990		9,625
3.875% convertible debentures	—			—		(1,417		)
7.5% convertible notes	15,555			5,296		5,652
5.5% convertible notes	8,905			1,911		—
Gain on changes in fair value of derivatives embedded within convertible debt	$	24,455		$	19,409	$	18,935

Schedule Of Changes In Fair Value Of Derivatives

A summary of non-cash changes in fair value of derivatives embedded within convertible debt is as follows:



	Year Ended December 31,
	2015			2014		2013
6.75% note	$	(5	)	$	3,212	$	5,075
6.75% exchange notes	—			8,990		9,625
3.875% convertible debentures	—			—		(1,417		)
7.5% convertible notes	15,555			5,296		5,652
5.5% convertible notes	8,905			1,911		—
Gain on changes in fair value of derivatives embedded within convertible debt	$	24,455		$	19,409	$	18,935

The following table reconciles the fair value of derivatives embedded within convertible debt:



	6.75% Note			6.75% Exchange Notes			3.875% Convertible Debentures			7.5% Convertible Notes			5.5% Convertible Notes			Total
Balance at January 1, 2013	$	11,682		$	22,146		$	39,714		$	98,586		$	—		$	172,128
Conversion of $43,222 of 3.875% Variable Interest Senior Convertible Debentures due June 15, 2016	—			—			(41,131		)	—			—			(41,131		)
(Gain) loss from changes in fair value of embedded derivatives	(5,075		)	(9,625		)	1,417			(5,652		)	—			(18,935		)
Balance at December 31, 2013	6,607			12,521			—			92,934			—			112,062
Issuance of 5.5% Note	—			—			—			—			82,775			82,775
Conversion of $25,000 of 6.75% Variable Interest Senior Convertible Note due February 15, 2015	(2,511		)	—			—			—			—			(2,511		)
Conversion of $107,530 of 6.75% Variable Interest Senior Convertible Exchange Notes due November 15, 2014	—			(3,531		)	—			—			—			(3,531		)
Gain from changes in fair value of embedded derivatives	(3,212		)	(8,990		)	—			(5,296		)	(1,911		)	(19,409		)
Balance at December 31, 2014	884			—			—			87,638			80,864			169,386
Conversion of $25,000 of 6.75% Variable Interest Senior Convertible Note due February 15, 2015	(889		)	—			—			—			—			(889		)
Loss (gain) from changes in fair value of embedded derivatives	5			—			—			(15,555		)	(8,905		)	(24,455		)
Balance at December 31, 2015	$	—		$	—		$	—		$	72,083		$	71,959		$	144,042

Components of non-cash interest expense



	Year Ended December 31,
	2015		2014		2013
Amortization of beneficial conversion feature:
6.75% note	$	—	$	5,317	$	5,157
6.75% exchange notes	—		8,386		7,294
3.875% convertible debentures	—		—		82
7.5% convertible notes	5,738		3,631		2,363
5.5% convertible notes	2,943		2,067		—
Interest expense associated with beneficial conversion feature	$	8,681	$	19,401	$	14,896

Schedule of Unamortized Debt Discount

The following table reconciles unamortized debt discount within convertible debt:



	6.75% Note			6.75% Exchange Notes			3.875% Convertible Debentures			7.5% Convertible Notes			5.5% Convertible Notes			Total
Balance at January 1, 2013	$	30,383		$	45,038		$	36,107		$	161,795		$	—		$	273,323
Conversion of $43,222 of 3.875% Variable Interest Senior Convertible Debentures due June 15, 2016	—			—			(35,870		)	—			—			(35,870		)
Amortization of embedded derivatives	(5,914		)	(11,799		)	(155		)	(3,614		)	—			(21,482		)
Amortization of beneficial conversion feature	(5,157		)	(7,294		)	(82		)	(2,363		)	—			(14,896		)
Balance at December 31, 2013	19,312			25,945			—			155,818			—			201,075
Conversion of $107,530 of 6.75% Variable Interest Senior Convertible Exchange Notes due November 15, 2014	—			(3,989		)	—			—			—			(3,989		)
Conversion of $25,000 of 6.75% Variable Interest Senior Convertible Note due February 15, 2015	(7,898		)	—			—			—			—			(7,898		)
Issuance of convertible notes - embedded derivative	—			—			—			—			82,775			82,775
Issuance of convertible notes - beneficial conversion feature	—			—			—			—			24,974			24,974
Amortization of embedded derivatives	(6,097		)	(13,570		)	—			(5,553		)	(6,851		)	(32,071		)
Amortization of beneficial conversion feature	(5,317		)	(8,386		)	—			(3,631		)	(2,067		)	(19,401		)
Balance at December 31, 2014	—			—			—			146,634			98,831			245,465
Amortization of embedded derivatives	—			—			—			(8,777		)	(9,752		)	(18,529		)
Amortization of beneficial conversion feature	—			—			—			(5,738		)	(2,943		)	(8,681		)
Balance at December 31, 2015	$	—		$	—		$	—		$	132,119		$	86,136		$	218,255

Fair Value of Notes Payable and Long-term Debt

The estimated fair value of the Company’s notes payable and long-term debt are as follows:



	December 31, 2015				December 31, 2014
	Carrying Value		Fair Value		Carrying Value		Fair Value
Notes payable and long-term debt	$	895,168	$	1,297,875	$	913,351	$	1,313,711

Schedule of Maturities of Long-term Debt

Scheduled maturities of long-term debt are as follows:



	Principal		Unamortized Discount/ (Premium)			Net
Year Ending December 31:
2016	$	8,919	$	—		$	8,919
2017	2,254		—			2,254
2018	2,001		—			2,001
2019	231,160		132,119			99,041
2020	261,075		86,136			174,939
Thereafter	600,000		(8,014		)	608,014
Total	$	1,105,409	$	210,241		$	895,168

Commitments (Tables)

12 Months Ended

Dec. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Schedule of aggregate minimum rentals under operating leases with non-cancelable terms

The aggregate minimum rentals under operating leases with non-cancelable terms of one year or more as of December 31, 2015 are as follows:



	Lease Commitments
Year Ending December 31:
2016	$	25,463
2017	21,064
2018	18,928
2019	14,912
2020	11,835
Thereafter	72,888
Total	$	165,090

Employee Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2015

Compensation and Retirement Disclosure [Abstract]

Schedule of Defined Benefit Plans Disclosures

The following table provides a reconciliation of benefit obligations, plan assets and the funded status of the pension plans and other postretirement benefits:



	Pension Benefits						Other Postretirement Benefits
	2015			2014			2015			2014
Change in benefit obligation:
Benefit obligation at January 1	$	(150,199	)	$	(150,911	)	$	(9,031	)	$	(8,899	)
Service cost	(532		)	(523		)	(8		)	(9		)
Interest cost	(4,992		)	(6,196		)	(371		)	(430		)
Plan settlement	17,047			—			—			—
Special termination benefits	(3,831		)	—			—			—
Benefits paid	9,879			10,207			522			552
Expenses paid	490			322			—			—
Actuarial (gain) loss	(1,368		)	(3,098		)	454			(245		)
Benefit obligation at December 31	$	(133,506	)	$	(150,199	)	$	(8,434	)	$	(9,031	)
Change in plan assets:
Fair value of plan assets at January 1	$	134,017		$	137,036		$	—		$	—
Actual return on plan assets	(327		)	7,162			—			—
Plan settlement	(17,047		)	—			—			—
Expenses paid	(490		)	(322		)	—			—
Contributions	346			348			522			552
Benefits paid	(9,879		)	(10,207		)	(522		)	(552		)
Fair value of plan assets at December 31	$	106,620		$	134,017		$	—		$	—
Unfunded status at December 31	$	(26,886	)	$	(16,182	)	$	(8,434	)	$	(9,031	)
Amounts recognized in the consolidated balance sheets:
Prepaid pension costs	$	20,650		$	25,032		$	—		$	—
Other accrued liabilities	(320		)	(324		)	(595		)	(607		)
Non-current employee benefit liabilities	(47,216		)	(40,890		)	(7,839		)	(8,424		)
Net amounts recognized	$	(26,886	)	$	(16,182	)	$	(8,434	)	$	(9,031	)

Schedule of Net Benefit Costs



	Pension Benefits									Other Postretirement Benefits
	2015			2014			2013			2015			2014			2013
Service cost — benefits earned during the period	$	532		$	523		$	1,170		$	8		$	9		$	16
Interest cost on projected benefit obligation	4,992			6,196			5,518			371			430			418
Expected return on assets	(7,378		)	(8,518		)	(7,915		)	—			—			—
Settlement loss	3,214			—			244			—			—			—
Special termination benefit recognized	3,831			—			—			—			—			—
Amortization of net loss (gain)	1,083			1,075			1,918			(97		)	(60		)	(64		)
Net expense (income)	$	6,274		$	(724	)	$	935		$	282		$	379		$	370

Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year

The following table summarizes amounts in accumulated other comprehensive loss that are expected to be recognized as components of net periodic benefit cost for the year ending 2016.



	Defined Benefit Pension Plans		Post- Retirement Plans			Total
Actuarial loss (gain)	$	1,855	$	(75	)	$	1,780

Schedule of Amounts Recognized in Other Comprehensive Income (Loss)

As of December 31, 2015, accumulated other comprehensive (loss) income, before income taxes, consists of the following:



	Defined Benefit Pension Plans			Post- Retirement Plans			Total
Accumulated other comprehensive (loss) income as of January 1, 2015	$	(30,481	)	$	582		$	(29,899	)
Amortization of gain (loss)	4,297			(97		)	4,200
Net (loss) gain arising during the year	(9,074		)	454			(8,620		)
Accumulated other comprehensive (loss) income as of December 31, 2015	$	(35,258	)	$	939		$	(34,319	)

As of December 31, 2014, accumulated other comprehensive (loss) income, before income taxes, consisted of the following:



	Defined Benefit Pension Plans			Post- Retirement Plans			Total
Accumulated other comprehensive (loss) income as of January 1, 2014	$	(27,102	)	$	886		$	(26,216	)
Amortization of gain (loss)	1,075			(60		)	1,015
Net loss arising during the year	(4,454		)	(244		)	(4,698		)
Accumulated other comprehensive (loss) income as of December 31, 2014	$	(30,481	)	$	582		$	(29,899	)

Schedule of Assumptions Used



	Pension Benefits			Other Postretirement Benefits
	2015	2014	2013	2015	2014	2013
Weighted average assumptions:
Discount rates — benefit obligation	3.75% - 4.50%	2.75% - 4.00%	3.00% - 4.75%	4.75%	4.25%	5.00%
Discount rates — service cost	2.75% - 4.25%	3.00% - 4.75%	2.25% - 4.00%	4.25%	5.00%	4.25%
Assumed rates of return on invested assets	6.00%	6.50%	6.50%	—%	—%	—%
Salary increase assumptions	N/A	N/A	N/A	3.00%	3.00%	3.00%

Schedule of Allocation of Plan Assets

Vector’s defined benefit retirement plan allocations at December 31, 2015 and 2014, by asset category, were as follows:



	Plan Assets at December 31,
	2015		2014
Asset category:
Equity securities	51	%	50	%
Investment grade fixed income securities	30	%	29	%
High yield fixed income securities	11	%	10	%
Alternative investments	3	%	5	%
Short-term investments	5	%	6	%
Total	100	%	100	%

The defined benefit plans’ recurring financial assets subject to fair value measurements and the necessary disclosures are as follows:



	Fair Value Measurements as of December 31, 2015
			Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
Description	Total		(Level 1)		(Level 2)		(Level 3)
Assets:
Insurance contracts	$	1,760	$	—	$	1,760	$	—
Amounts in individually managed investment accounts:
Cash	5,429		5,429		—		—
U.S. equity securities	28,434		28,434		—		—
Common collective trusts	56,327		—		56,327		—
Investment partnership	14,670		—		11,256		3,414
Total	$	106,620	$	33,863	$	69,343	$	3,414



	Fair Value Measurements as of December 31, 2014
			Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
Description	Total		(Level 1)		(Level 2)		(Level 3)
Assets:
Insurance contracts	$	1,762	$	—	$	1,762	$	—
Amounts in individually managed investment accounts:
Cash, mutual funds and common stock	8,319		8,319		—		—
U.S. equity securities	42,046		42,046		—		—
Common collective trusts	61,877		—		61,877		—
Investment partnership	20,013		—		13,189		6,824
Total	$	134,017	$	50,365	$	76,828	$	6,824

Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets

The changes in the fair value of the Level 3 investments as of December 31, 2015 and 2014 were as follows:



	2015			2014
Balance as of January 1	$	6,824		$	9,031
Transfers	—			(641		)
Distributions	(2,904		)	(1,018		)
Unrealized (loss) gain on long-term investments	(470		)	3,403
Realized loss on long-term investments	(36		)	(3,951		)
Balance as of December 31	$	3,414		$	6,824

Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates

A 1% change in assumed health care cost trend rates would have the following effects:



	1% Increase		1% Decrease
Effect on total of service and interest cost components	$	4	$	(4	)
Effect on benefit obligation	79		(74		)

Schedule of Expected Benefit Payments

Estimated future pension and postretirement medical benefits payments are as follows:



	Pension		Postretirement Medical
2016	$	9,548	$	595
2017	9,053		618
2018	8,618		607
2019	8,139		609
2020	14,786		606
2021 - 2025	79,462		2,953

Restructuring (Tables)

12 Months Ended

Dec. 31, 2015

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Costs

The following table summarizes amounts expensed for the year ended December 31, 2015:



	Amounts expensed through December 31, 2015
Cash Charges:
Employee severance and benefits	$	1,094
Lease termination costs	203
Other restructuring expenses	68
	1,365
Non-Cash:
Employee pension benefits	5,438
Point of sale inventory impairment	454
	5,892

Total restructuring	$	7,257

Schedule of Restructuring Reserve

The following table presents the activity under the Tobacco segment restructuring plan for the year ended December 31, 2015:



	Employee Severance and Benefits			Contract Termination/Exit Costs			Other			Non-Cash Pension Expense			Non-Cash Asset Impairment			Total
Accrual balance as of January 1, 2015	$	—		$	—		$	—		$	—		$	—		$	—
Restructuring charges	1,094			203			68			5,438			454			7,257
Utilized	(672		)	(155		)	(48		)	(5,438		)	(454		)	(6,767		)
Accrual balance as of December 31, 2015	$	422		$	48		$	20		$	—		$	—		$	490

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2015

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit)

The amounts provided for income taxes are as follows:



	Year Ended December 31,
	2015			2014		2013
Current:
U.S. Federal	$	40,542		$	8,809	$	20,808
State	13,886			2,416		3,521
	$	54,428		$	11,225	$	24,329
Deferred:
U.S. Federal	$	(9,943	)	$	16,484	$	(372	)
State	(3,252		)	5,456		(285		)
	(13,195		)	21,940		(657		)
Total	$	41,233		$	33,165	$	23,672

Schedule of Deferred Tax Assets and Liabilities

The tax effect of temporary differences which give rise to a significant portion of deferred tax assets and liabilities are as follows:



	December 31, 2015			December 31, 2014
Deferred tax assets:
Employee benefit accruals	$	16,201		$	11,678
Impairment of investments	4,332			—
Impact of timing of settlement payments	39,840			33,485
Various U.S. state tax loss carryforwards	6,713			8,339
Other	—			—
	67,086			53,502
Less: Valuation allowance	(3,900		)	(4,933		)
Net deferred tax assets	$	63,186		$	48,569

Deferred tax liabilities:
Excess of tax basis over book-basis non-consolidated entities	$	(7,292	)	$	(6,190	)
Book/tax differences on fixed and Intangible assets	(52,598		)	(52,972		)
Capitalized interest expense	(4,080		)	—
Book/tax differences on inventory	(16,891		)	(20,062		)
Book/tax differences on long-term investments	(29,701		)	(32,756		)
Impact of accounting on convertible debt	(30,494		)	(31,033		)
Other	(1,559		)	(1,460		)
	$	(142,615	)	$	(144,473	)

Net deferred tax liabilities	$	(79,429	)	$	(95,904	)

Schedule of Effective Income Tax Rate Reconciliation

Differences between the amounts provided for income taxes and amounts computed at the federal statutory tax rate are summarized as follows:



	Year Ended December 31,
	2015			2014			2013
Income before income taxes	$	107,705		$	82,279		$	60,720
Federal income tax expense at statutory rate	37,697			28,798			21,252
Increases (decreases) resulting from:
State income taxes, net of federal income tax benefits	6,862			4,804			2,050
Impact of non-controlling interest	(2,516		)	(4,290		)	88
Non-deductible expenses	2,941			2,581			2,698
Impact of domestic production deduction	(3,436		)	(248		)	(1,889		)
Tax credits	(265		)	(275		)	(433		)
Other	152			—			—
Inclusion of tax liabilities from unincorporated entities	831			1,374			—
Changes in valuation allowance, net of equity and tax audit adjustments	(1,033		)	421			(94		)
Income tax expense	$	41,233		$	33,165		$	23,672

Summary of Income Tax Contingencies

The following table summarizes the activity related to the unrecognized tax benefits:



Balance at January 1, 2013	$	6,269
Additions based on tax positions related to prior years	179
Settlements	(250		)
Expirations of the statute of limitations	(3,076		)
Balance at December 31, 2013	3,122
Additions based on tax positions related to prior years	318
Settlements	(442		)
Expirations of the statute of limitations	(1,254		)
Balance at December 31, 2014	1,744
Additions based on tax positions related to prior years	265
Settlements	(132		)
Expirations of the statute of limitations	(354		)
Balance at December 31, 2015	$	1,523

Stock Compensation (Tables)

12 Months Ended

Dec. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The assumptions used for grants in the years ended December 31, 2015, 2014 and 2013 were as follows:



	2015		2014		2013
Risk-free interest rate	1.8% -2.0%		1.1% -2.6%		0.6% – 1.8%
Expected volatility	22.18% - 22.25%		18.51% - 22.37%		20.05% – 24.08%
Dividend yield	0.0	%	0.0	%	0.0	%
Expected holding period	7.00 – 10.00 years		4.00 – 10.00 years		4.00 – 10.00 years
Weighted-average grant date fair value (1)	$6.47 - $8.07		$3.28 - $7.32		$2.72 – $5.80

Schedule of Share-based Compensation, Stock Options, Activity

A summary of employee stock option transactions follows:



	Number of Shares		Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value(1)
Outstanding on January 1, 2013	2,645,914		$	11.33	6.6	$	4,371
Granted	868,219		$	13.93
Exercised	(44,293	)	$	12.29
Canceled	(15	)	$	—
Outstanding on December 31, 2013	3,469,825		$	11.98	6.5	$	9,959
Granted	427,219		$	17.82
Exercised	(442,740	)	$	11.41
Canceled	(12	)	$	—
Outstanding on December 31, 2014	3,454,292		$	12.77	6.4	$	25,977
Granted	406,875		$	22.00
Exercised	(115,531	)	$	12.02
Canceled	(5	)	$	—
Outstanding on December 31, 2015	3,745,631		$	13.82	5.9	$	36,612
Options exercisable at:
December 31, 2013	1,959,317
December 31, 2014	1,598,885
December 31, 2015	2,035,345

_____________________________


(1)	The aggregate intrinsic value represents the amount by which the fair value of the underlying common stock ($23.59, $20.30 and $14.85 at December 31, 2015, 2014 and 2013, respectively) exceeds the option exercise price.

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range

Additional information relating to options outstanding at December 31, 2015 follows:



			Options Outstanding				Options Exercisable
Range of Exercise Prices			Outstanding as of	Weighted-Average Remaining Contractual Life (Years)	Weighted-Average Exercise Price		Exercisable as of	Weighted-Average Remaining Contractual Life (Years)	Weighted-Average Exercise Price		Aggregate Intrinsic Value
Range of Exercise Prices			12/31/2015	Weighted-Average Remaining Contractual Life (Years)	Weighted-Average Exercise Price		12/31/2015	Weighted-Average Remaining Contractual Life (Years)	Weighted-Average Exercise Price		Aggregate Intrinsic Value
$0.00	-	$11.00	1,500,905	3.9	$	10.52	1,500,905	3.9	$	10.52	$	—
$11.00	-	$13.20	31,906	5.1	$	12.46	23,928	5.1	$	12.46	—
$13.20	-	$15.40	1,378,728	6.4	$	13.78	510,512	5.0	$	13.52	—
$15.40	-	$17.60	—	—	$	—	—	—	$	—	—
$17.60	-	$19.80	427,217	8.4	$	17.82	—	—	$	—	—
$19.80	-	$22.00	406,875	9.2	$	22.00	—	—	$	—	—
			3,745,631	5.9	$	13.82	2,035,345	4.2	$	11.30	$	25,024

Contingencies (Tables)

12 Months Ended

Dec. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Cases Pending by State

These cases do not include the remaining Engle progeny cases or the individual cases pending in West Virginia state court as part of a consolidated action. The following table lists the number of Individual Actions by state:



State		Number of Cases
Florida		15
Maryland		12
New York		7
Louisiana		2
West Virginia		2
Missouri		1
Ohio		1

Schedule of Judgments Entered

As of December 31, 2015, the following Engle progeny cases have resulted in judgments against Liggett:



Date	Case Name	County	Liggett Compensatory Damages (as adjusted)⁽¹⁾	Liggett Punitive Damages	Status ⁽²⁾
June 2002	Lukacs v. R.J. Reynolds	Miami-Dade	$12,418	$—	Liggett satisfied the judgment and the case is concluded.
August 2009	Campbell v. R.J. Reynolds	Escambia	156	—	Liggett satisfied the judgment and the case is concluded.
March 2010	Douglas v. R.J. Reynolds	Hillsborough	1,350	—	Liggett satisfied the judgment and the case is concluded.
April 2010	Clay v. R.J. Reynolds	Escambia	349	1,000	Liggett satisfied the judgment and the case is concluded.
April 2010	Putney v. R.J. Reynolds	Broward	3,008	—	On June 12, 2013, the Fourth District Court of Appeal reversed and remanded the case for further proceedings regarding the amount of the award. Both sides sought discretionary review from the Florida Supreme Court. In February 2016, the Florida Supreme Court reinstated the jury's verdict. The defendants moved for clarification of that order.
April 2011	Tullo v. R.J. Reynolds	Palm Beach	225	—	Liggett satisfied the judgment and other than an issue with respect to the calculation of interest on the judgment and the amount of costs owed by Liggett, the case is concluded.
January 2012	Ward v. R.J. Reynolds	Escambia	1	—	Liggett satisfied the merits judgment. Subsequently, the trial court entered a final judgment on attorneys' fees and costs for $981 and defendants appealed that judgment.
May 2012	Calloway v. R.J. Reynolds	Broward	1,530	7,600	A joint and several judgment for $16,100 was entered against R.J. Reynolds, Philip Morris, Lorillard and Liggett. On January 6, 2016, the Fourth District Court of Appeal reversed in part, including the $7,600 punitive damages award against Liggett, and remanded the case to the trial court for a new trial on certain issues. Both sides have moved for rehearing.
December 2012	Buchanan v. R.J. Reynolds	Leon	2,750	—	A joint and several judgment for $5,500 was entered against Liggett and Philip Morris. The court refused to reduce the award by decedent's comparative fault. Judgment was affirmed by the First District Court of Appeal, but the court certified an issue of conflict with another case. The defendants sought discretionary review by the Florida Supreme Court, which was declined in February 2016. The defendants are considering their appellate options.
May 2013	Cohen v. R.J. Reynolds	Palm Beach	205	—	Defendants' motion seeking a new trial was granted by the trial court. Plaintiff appealed to the Fourth District Court of Appeal. Defendants cross-appealed.
August 2013	Rizzuto v. R.J. Reynolds	Hernando	3,479	—	Liggett settled its portion of the judgment for $1,500 and the case is concluded as to Liggett.
August 2014	Irimi v. R.J. Reynolds	Broward	31	—	In January 2015, the trial court granted defendants' motion for a new trial. Plaintiff appealed to the Fourth District Court of Appeal.
October 2014	Lambert v. R.J. Reynolds	Pinellas	3,600	9,500	A final judgment was entered against Liggett for $13,100. Liggett was the only defendant at trial. In February 2016, the Second District Court of Appeal affirmed the lower court's decision without opinion. The parties reached an agreement regarding the amount of plaintiff's trial level attorneys' fees and costs in the event plaintiff prevails on appeal.
November 2014	Boatright v. R.J. Reynolds	Polk	—	300	In November 2014, the jury awarded compensatory damages in the amount of $15,000 with 15% fault apportioned to plaintiff and 85% to Philip Morris. The jury further assessed punitive damages against Philip Morris for $19,700 and Liggett for $300. Post trial motions were denied. A joint and several judgment was entered in the amount of $12,750 on the compensatory damages. Judgment was further entered against Liggett for $300 in punitive damages. On appeal to the Second District Court of Appeal.
June 2015	Caprio v. R.J. Reynolds	Broward	—	—	In February 2015, the jury answered certain questions on the verdict form, but were deadlocked as to others. The jury returned a verdict of $559 in economic damages. The court entered a partial judgment and ordered a new trial on the remaining issues, including comparative fault and punitive damages. On appeal to the Fourth District Court of Appeal.
Total Damages Awarded:			29,102	18,400
Amounts paid or compromised:			(17,978)	(1,000)
Damages remaining on Appeal:			$11,124	$17,400
(1) Compensatory damages are adjusted to reflect the jury's allocation of comparative fault and only include Liggett's jury allocated share, regardless of whether a judgment was joint and several. The amounts listed above do not include attorneys' fees or statutory interest.
(2) See Exhibit 99.1 for a more complete description of the cases currently on appeal.

Schedule of Loss Contingencies

The activity in the Company’s accruals for the MSA and tobacco litigation for the three years ended December 31, 2015 were as follows:



	Current Liabilities									Non-Current Liabilities
	Payments due under Master Settlement Agreement			Litigation Accruals			Total			Payments due under Master Settlement Agreement			Litigation Accruals			Total

Balance at January 1, 2013	$	32,970		$	1,470		$	34,440		$	52,639		$	1,862		$	54,501
Expenses	117,085			63,292			180,377			—			25,218			25,218
NPM Settlement adjustment	(3,928		)	—			(3,928		)	(18,138		)	—			(18,138		)
Change in MSA obligations capitalized as inventory	1,611			—			1,611			—			—			—
Payments	(129,320		)	(6,070		)	(135,390		)	—			—			—
Reclassification from non-current liabilities	6,930			223			7,153			(6,930		)	(223		)	(7,153		)
Interest on withholding	—			395			395			—			201			201
Balance as of December 31, 2013	25,348			59,310			84,658			27,571			27,058			54,629
Expenses	118,069			2,849			120,918			—			—			—
NPM Settlement adjustment	—			—			—			(1,419		)	—			(1,419		)
Change in MSA obligations capitalized as inventory	(1,095		)	—			(1,095		)	—			—			—
Payments	(116,343		)	(62,878		)	(179,221		)	—			—			—
Reclassification from non-current liabilities	343			3,575			3,918			(343		)	(3,575		)	(3,918		)
Interest on withholding	—			293			293			—			2,217			2,217
Balance as of December 31, 2014	26,322			3,149			29,471			25,809			25,700			51,509
Expenses	118,284			20,644			138,928			—			(195		)	(195		)
NPM Settlement adjustment	1,351			—			1,351			(5,715		)	—			(5,715		)
Change in MSA obligations capitalized as inventory	1,426			—			1,426			—			—			—
Payments	(118,142		)	(5,869		)	(124,011		)	—			—			—
Reclassification from non-current liabilities	—			3,305			3,305			—			(3,305		)	(3,305		)
Interest on withholding	—			1,675			1,675			—			2,518			2,518
Balance as of December 31, 2015	$	29,241		$	22,904		$	52,145		$	20,094		$	24,718		$	44,812

- Definition

Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14472-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12021-110248

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14453-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12053-110248

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14394-108349

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14615-108349

+ Details

Supplemental Cash Flow Information (Tables)

12 Months Ended

Dec. 31, 2015

Supplemental Cash Flow Elements [Abstract]

Schedule of Supplemental Cash Flow Information



	Year Ended December 31,
	2015		2014		2013
Cash paid during the period for:
Interest	$	96,958	$	98,754	$	114,301
Income taxes	52,040		16,610		17,585
Non-cash investing and financing activities:
Issuance of stock dividend	584		520		450
Acquisitions	—		—		84,859
Non-controlling interest	—		2,733		87,657
Debt retired in conversion to stock	25,000		132,530		43,222
Embedded derivative, net retired in conversion to stock	889		6,680		17,377

Investments and Fair Value Measurements (Tables)

12 Months Ended

Dec. 31, 2015

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]

Company's recurring financial assets and liabilities subject to fair value measurements

The Company’s recurring financial assets and liabilities subject to fair value measurements are as follows:



	Fair Value Measurements as of December 31, 2015
Description	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Gains (Losses)
Assets:
Money market funds	$	93,915	$	93,915	$	—	$	—

Certificates of deposit	3,469		—		3,469		—

Bonds	12,767		12,767		—		—

Investment securities available for sale
Equity securities	67,273		67,273		—		—
Mutual funds invested in fixed income securities	20,111		20,111		—		—
Fixed income securities
U.S. government securities	28,132		—		28,132		—
Corporate securities	41,561		—		41,561		—
U.S. government and federal agency	5,790		—		5,790		—
Commercial mortgage-backed securities	8,728		—		8,728		—
U.S. asset-backed securities	8,276		—		8,276		—
Index-linked U.S. bonds	2,105		—		2,105		—
Total fixed income securities	94,592		—		94,592		—

Total investment securities available for sale	181,976		87,384		94,592		—

Total	$	292,127	$	194,066	$	98,061	$	—

Liabilities:
Fair value of derivatives embedded within convertible debt	$	144,042	$	—	$	—	$	144,042


Nonrecurring fair value measurements
Long-term investments (1)	$	11,189					$	11,189	$	(811	)
Real estate held for sale (2)	3,780						3,780		(230		)
	$	14,969					$	14,969	$	(1,041	)


(1)	Long-term investments with a carrying amount of $12,000 were written down to their fair value of $11,189, resulting in an impairment charge of $811, which was included in earnings.


(2)	Real estate with a carrying value of $4,010 was written down to its fair value of $3,780, resulting in an impairment charge of $230, which was included in earnings.



	Fair Value Measurements as of December 31, 2014
Description	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Money market funds	$	205,180	$	205,180	$	—	$	—

Certificates of deposit	3,462		—		3,462		—

Bonds	4,868		4,868		—		—

Investment securities available for sale
Equity securities	77,609		77,083		526		—
Mutual funds invested in fixed income securities	59,826		59,826		—		—
Fixed income securities
U.S. government securities	35,446		—		35,446		—
Corporate securities	55,888		7,397		48,491		—
U.S. government and agency	4,770		—		4,770		—
Commercial mortgage-backed securities	16,508		—		16,508		—
U.S. asset-backed securities	16,955		—		16,955		—
Index-linked U.S. bonds	2,098		—		2,098		—
Total fixed income securities	131,665		7,397		124,268		—

Total investment securities available for sale	269,100		144,306		124,794		—

Total	$	482,610	$	354,354	$	128,256	$	—

Liabilities:
Fair value of derivatives embedded within convertible debt	$	169,386	$	—	$	—	$	169,386

Fair value inputs, assets and liabilities, quantitative information

The unobservable inputs related to the valuations of the Level 3 assets and liabilities are as follows at December 31, 2015:



	Quantitative Information about Level 3 Fair Value Measurements
	Fair Value at
	December 31, 2015		Valuation Technique	Unobservable Input	Range (Actual)

Fair value of derivatives embedded within convertible debt	$	144,042	Discounted cash flow	Assumed annual stock dividend	5		%
				Assumed annual cash dividend	$	1.60
				Stock price	$	23.59
				Convertible trading price (of par)	114.31		%
				Volatility	18.30		%
				Risk-free rate	Term structure of US Treasury Securities
				Implied credit spread	5.0% - 5.5% (5.25%)

The unobservable inputs related to the valuations of the Level 3 assets and liabilities are as follows at December 31, 2014:



	Quantitative Information about Level 3 Fair Value Measurements
	Fair Value at
	December 31, 2014		Valuation Technique	Unobservable Input	Range (Actual)

Fair value of derivatives embedded within convertible debt	$	169,386	Discounted cash flow	Assumed annual stock dividend	5		%
				Assumed annual cash dividend	$	1.60
				Stock price	$	21.31
				Convertible trading price (of par)	106.8		%
				Volatility	16.00		%
				Implied credit spread	6.25% - 7.25% (6.75%)

Segment Information (Tables)

12 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

Financial information for the company's operations before taxes and minority interests

Financial information for the Company’s operations before taxes and non-controlling interests for the years ended December 31, 2015, 2014 and 2013 follows:



							Real			Corporate
	Tobacco			E-Cigarettes			Estate			and Other					Total

2015
Revenues	$	1,017,761		$	(1,970	)	$	641,406		$	—				$	1,657,197
Operating income (loss)	209,393		(1)	(13,037		)	24,087			(20,523		)			199,920
Equity in earnings from real estate ventures	—			—			2,001			—					2,001
Identifiable assets	344,033			985			585,098		(4)	380,640			(5)	(6)	1,310,756
Depreciation and amortization	11,323			—			12,589			1,742					25,654
Capital expenditures	3,730			—			7,247			—					10,977

2014
Revenues	$	1,021,259		$	8,589		$	561,467		$	—				$	1,591,315
Operating income (loss)	199,119		(2)	(13,124		)	42,354			(15,911		)			212,438
Equity in earnings from real estate ventures	—			—			4,103			—					4,103
Identifiable assets	325,870			8,139			498,058		(4)	591,187			(5)	(6)	1,423,254
Depreciation and amortization	10,885			—			12,204			1,410					24,499
Capital expenditures	9,256			—			6,923			7,225					23,404

2013
Revenues	$	1,014,341		$	—		$	65,580		$	—				$	1,079,921
Operating income (loss)	113,039		(3)	(1,018		)	15,805			(16,640		)			111,186
Equity in earnings from real estate ventures	—			—			22,925			—					22,925
Identifiable assets	328,084			8,950			421,240		(4)	357,519			(5)	(6)	1,115,793
Depreciation and amortization	9,509			—			2,421			701					12,631
Capital expenditures	9,784			—			1,194			2,297					13,275

_____________________________


⁽¹⁾	Operating income includes $4,364 of income from MSA Settlement, $20,072 of litigation judgment expense, $7,257 of restructuring expense, and $1,607 of pension settlement expense.


⁽²⁾	Operating income includes $1,419 of income from NPM Settlement and $2,475 of litigation settlement charges and judgment expense.


⁽³⁾	Operating income includes $11,823 of income from MSA Settlements, $86,213 of Engle progeny settlement charge, and $1,893 of litigation judgment expense for the year ended and December 31, 2014.


⁽⁴⁾	Includes real estate investments accounted for under the equity method of accounting of $217,168, $163,460 and $128,202 as of December 31, 2015, 2014 and 2013, respectively.

⁽⁵⁾


⁽⁶⁾	Includes long-term investments accounted for under the equity method of accounting of $21,495, $20,484 and $22,411 as of December 31, 2015, 2014 and 2013, respectively.

Quarterly Financial Results (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2015

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information

Unaudited quarterly data for the years ended December 31, 2015 and 2014 are as follows:



	December 31,		September 30,		June 30,		March 31,
	2015		2015		2015		2015
Revenues	$	430,330	$	449,934	$	416,173	$	360,760
Gross Profit	137,742		154,017		136,969		118,742
Operating income (1)	31,032		69,367		55,803		43,718
Net income applicable to common shares attributed to Vector Group Ltd. (2)	$	7,904	$	12,466	$	17,607	$	21,221
Per basic common share (3):
Net income applicable to common shares attributed to Vector Group Ltd.	$	0.06	$	0.10	$	0.14	$	0.18
Per diluted common share (3):
Net income applicable to common shares attributed to Vector Group Ltd.	$	0.06	$	0.10	$	0.14	$	0.18

_____________________________


(1)	Operating income has been decreased by $238, $237, and $237 from the Company's previously filed Form 10-Qs for the periods ending September 30, 2015, June 30, 2015 and March 31, 2015, respectively, as a result of the application of the equity method of accounting for the Company's investments in LTS and ROX.

(2)

(3)



	December 31,		September 30,		June 30,		March 31,
	2014		2014		2014		2014
Revenues	$	417,590	$	419,876	$	406,613	$	347,236
Gross Profit	126,085		132,640		127,331		108,199
Operating income (1)	47,136		62,746		60,071		42,485
Net income applicable to common shares attributed to Vector Group Ltd. (2)	$	12,215	$	14,190	$	7,917	$	2,534
Per basic common share (3):
Net income applicable to common shares attributed to Vector Group Ltd.	$	0.11	$	0.13	$	0.07	$	0.02
Per diluted common share (3):
Net income applicable to common shares attributed to Vector Group Ltd.	$	0.11	$	0.13	$	0.07	$	0.02

_____________________________


(1)	Operating income has been decreased by $238, $237, and $237 from the Company's previously filed Form 10-Qs for the periods ending September 30, 2014, June 30, 2014 and March 31, 2014, respectively, as a result of the application of the equity method of accounting for the Company's investments in LTS and ROX.


(2)	Net income applicable to common shares attributed to Vector Group Ltd. has been decreased by $689, $8, and $46 from the Company's previously filed Form 10-Qs for the periods ending September 30, 2014, June 30, 2014 and March 31, 2014, respectively, as a result of the application of the equity method of accounting for the Company's investments in LTS and ROX.

(3)

Condensed Consolidating Financial Information (Tables)

12 Months Ended

Dec. 31, 2015

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Schedule of Condensed Consolidated Balance Sheet

CONDENSED CONSOLIDATING BALANCE SHEETS



				December 31, 2015
						Subsidiary					Consolidated
	Parent/			Subsidiary		Non-		Consolidating			Vector Group
	Issuer			Guarantors		Guarantors		Adjustments			Ltd.
ASSETS:
Current assets:
Cash and cash equivalents	$	111,470		$	12,375	$	116,523	$	—		$	240,368
Investment securities available for sale	131,810			50,166		—		—			181,976
Accounts receivable - trade, net	—			15,913		7,976		—			23,889
Intercompany receivables	11,293			—		—		(11,293		)	—
Inventories	—			86,516		—		—			86,516
Income taxes receivable, net	8,213			—		—		(5,372		)	2,841
Restricted assets	—			7,781		1,414		—			9,195
Other current assets	575			3,747		34,632		—			38,954
Total current assets	263,361			176,498		160,545		(16,665		)	583,739
Property, plant and equipment, net	1,711			54,097		19,824		—			75,632
Real estate held for sale, net	—			—		23,318		—			23,318
Long-term investments	61,747			478		501		—			62,726
Investments in real estate ventures	—			—		217,168		—			217,168
Investments in consolidated subsidiaries	532,501			—		—		(532,501		)	—
Restricted assets	1,713			10,590		—		—			12,303
Goodwill and other intangible assets, net	—			107,511		156,448		—			263,959
Prepaid pension costs	—			20,650		—		—			20,650
Other assets	37,723			11,769		1,769		—			51,261
Total assets	$	898,756		$	381,593	$	579,573	$	(549,166	)	$	1,310,756
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY:
Current liabilities:
Current portion of notes payable and long-term debt	$	—		$	8,733	$	186	$	—		$	8,919
Current portion of employee benefits	—			915		—		—			915
Intercompany payables	—			586		10,707		(11,293		)	—
Income taxes payable, net	—			5,464		4		(5,372		)	96
Litigation accruals and current payments due under the Master Settlement Agreement	—			52,145		—		—			52,145
Other current liabilities	38,140			74,083		41,994		—			154,217
Total current liabilities	38,140			141,926		52,891		(16,665		)	216,292
Notes payable, long-term debt and other obligations, less current portion	878,509			7,519		221		—			886,249
Fair value of derivatives embedded within convertible debt	144,042			—		—		—			144,042
Non-current employee benefits	39,244			15,811		—		—			55,055
Deferred income taxes, net	2,675			33,791		42,963		—			79,429
Other liabilities, primarily litigation accruals and payments due under the Master Settlement Agreement	2,193			44,982		4,675		—			51,850
Total liabilities	1,104,803			244,029		100,750		(16,665		)	1,432,917
Commitments and contingencies
Stockholders’ (deficiency) equity attributed to Vector Group Ltd.	(206,047		)	137,564		394,937		(532,501		)	(206,047		)
Non-controlling interest	—			—		83,886		—			83,886
Total stockholders’ (deficiency) equity	(206,047		)	137,564		478,823		(532,501		)	(122,161		)
Total liabilities and stockholders’ deficiency	$	898,756		$	381,593	$	579,573	$	(549,166	)	$	1,310,756

CONDENSED CONSOLIDATING BALANCE SHEETS



				December 31, 2014
						Subsidiary					Consolidated
	Parent/			Subsidiary		Non-		Consolidating			Vector Group
	Issuer			Guarantors		Guarantors		Adjustments			Ltd.
ASSETS:
Current assets:
Cash and cash equivalents	$	211,751		$	9,724	$	104,890	$	—		$	326,365
Investment securities available for sale	202,252			66,848		—		—			269,100
Accounts receivable - trade, net	—			18,024		5,304		—			23,328
Intercompany receivables	795			267		—		(1,062		)	—
Inventories	—			90,323		—		—			90,323
Income taxes receivable, net	1,055			463		21		1,743			3,282
Restricted assets	—			1,181		1,414		—			2,595
Other current assets	585			9,133		26,686		—			36,404
Total current assets	416,438			195,963		138,315		681			751,397
Property, plant and equipment, net	2,648			61,149		20,315		—			84,112
Real estate held for sale, net	—			—		10,643		—			10,643
Long-term investments	51,506			519		698		—			52,723
Investments in real estate ventures	—			—		163,460		—			163,460
Investments in consolidated subsidiaries	518,567			—		—		(518,567		)	—
Restricted assets	1,707			10,306		—		—			12,013
Goodwill and other intangible assets,net	—			107,511		162,461		—			269,972
Prepaid pension costs	—			25,032		—		—			25,032
Other assets	40,913			10,743		2,246		—			53,902
Total assets	$	1,031,779		$	411,223	$	498,138	$	(517,886	)	$	1,423,254
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY:
Current liabilities:
Current portion of notes payable and long-term debt	$	25,000		$	27,248	$	392	$	—		$	52,640
Current portion of fair value of derivatives embedded within convertible debt	884			—		—		—			884
Current portion of employee benefits	—			931		—		—			931
Intercompany payables	—			—		1,062		(1,062		)	—
Income taxes payable, net	—			—		—		1,743			1,743
Litigation accruals and current payments due under the Master Settlement Agreement	—			29,471		—		—			29,471
Other current liabilities	36,653			58,677		31,425		—			126,755
Total current liabilities	62,537			116,327		32,879		681			212,424
Notes payable, long-term debt and other obligations, less current portion	852,560			8,120		31		—			860,711
Fair value of derivatives embedded within convertible debt	168,502			—		—		—			168,502
Non-current employee benefits	32,842			16,472		—		—			49,314
Deferred income taxes, net	14,176			43,058		38,670		—			95,904
Other liabilities, primarily litigation accruals and payments due under the Master Settlement Agreement	921			51,775		4,383		—			57,079
Total liabilities	1,131,538			235,752		75,963		681			1,443,934
Commitments and contingencies
Stockholders’ (deficiency) equity attributed to Vector Group Ltd.	(99,759		)	175,471		343,096		(518,567		)	(99,759		)
Non-controlling interest	—			—		79,079		—			79,079
Total stockholders’ (deficiency) equity	(99,759		)	175,471		422,175		(518,567		)	(20,680		)
Total liabilities and stockholders’ deficiency	$	1,031,779		$	411,223	$	498,138	$	(517,886	)	$	1,423,254

Schedule of Condensed Consolidating Statemetns of Operations

CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS



				Year Ended December 31, 2015
							Subsidiary						Consolidated
	Parent/			Subsidiary			Non-			Consolidating			Vector Group
	Issuer			Guarantors			Guarantors			Adjustments			Ltd.
Revenues	$	—		$	1,016,279		$	641,406		$	(488	)	$	1,657,197
Expenses:
Cost of sales	—			699,440			410,287			—			1,109,727
Operating, selling, administrative and general expenses	29,237			84,437			207,035			(488		)	320,221
Litigation, settlement and judgment expense	—			20,072			—			—			20,072
Management fee expense	—			10,250			—			(10,250		)	—
Restructuring charges	—			7,257			—			—			7,257
Operating (loss) income	(29,237		)	194,823			24,084			10,250			199,920
Other income (expenses):
Interest expense	(115,731		)	(4,953		)	(7		)	—			(120,691		)
Change in fair value of derivatives embedded within convertible debt	24,455			—			—			—			24,455
Equity in earnings from real estate ventures	—			—			2,001			—			2,001
Equity in losses from investments	(2,640		)	(41		)	—			—			(2,681		)
(Loss) gain on sale of investment securities available for sale	(2,037		)	13,175			—			—			11,138
Impairment of investment securities available for sale	(4,859		)	(7,987		)	—			—			(12,846		)
Equity in earnings in consolidated subsidiaries	125,042			—			—			(125,042		)	—
Management fee income	10,250			—			—			(10,250		)	—
Other, net	4,016			639			1,754			—			6,409
Income before provision for income taxes	9,259			195,656			27,832			(125,042		)	107,705
Income tax benefit (expense)	49,939			(82,282		)	(8,890		)	—			(41,233		)
Net income	59,198			113,374			18,942			(125,042		)	66,472
Net income attributed to non-controlling interest	—			—			(7,274		)	—			(7,274		)
Net income attributed to Vector Group Ltd.	$	59,198		$	113,374		$	11,668		$	(125,042	)	$	59,198
Comprehensive income attributed to non-controlling interest	$	—		$	—		$	(7,274	)	$	—		$	(7,274	)
Comprehensive income attributed to Vector Group Ltd.	$	52,228		$	105,456		$	11,668		$	(117,124	)	$	52,228

CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS



				Year Ended December 31, 2014
							Subsidiary						Consolidated
	Parent/			Subsidiary			Non-			Consolidating			Vector Group
	Issuer			Guarantors			Guarantors			Adjustments			Ltd.
Revenues	$	—		$	1,030,157		$	561,467		$	(309	)	$	1,591,315
Expenses:
Cost of sales	—			743,032			354,028			—			1,097,060
Operating, selling, administrative and general expenses	24,262			90,208			165,181			(309		)	279,342
Litigation, settlement and judgment expense	—			2,475			—			—			2,475
Management fee expense	—			9,870			—			(9,870		)	—
Operating (loss) income	(24,262		)	184,572			42,258			9,870			212,438
Other income (expenses):
Interest expense	(157,321		)	(4,241		)	(41		)	612			(160,991		)
Change in fair value of derivatives embedded within convertible debt	19,409			—			—			—			19,409
Acceleration of interest expense related to debt conversion	(5,205		)	—			—			—			(5,205		)
Equity in earnings from real estate ventures	—			—			4,103			—			4,103
Equity in earnings from investments	3,122			18			—			—			3,140
Loss on sale of investment securities available for sale	(11		)	—			—			—			(11		)
Equity in earnings in consolidated subsidiaries	124,001			—			—			(124,001		)	—
Management fee income	9,870			—			—			(9,870		)	—
Other, net	4,178			1,044			4,786			(612		)	9,396
(Loss) income before provision for income taxes	(26,219		)	181,393			51,106			(124,001		)	82,279
Income tax benefit (expense)	63,064			(78,801		)	(17,428		)	—			(33,165		)
Net income	36,845			102,592			33,678			(124,001		)	49,114
Net income attributed to non-controlling interest	—			—			(12,258		)	—			(12,258		)
Net income attributed to Vector Group Ltd.	$	36,845		$	102,592		$	21,420		$	(124,001	)	$	36,856
Comprehensive income attributed to non-controlling interest	$	—		$	—		$	(12,258	)	$	—		$	(12,258	)
Comprehensive income attributed to Vector Group Ltd.	$	34,922		$	102,536		$	21,420		$	(123,956	)	$	34,922

CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS



	Year Ended December 31, 2013
	Parent/ Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Consolidating Adjustments			Consolidated Vector Group Ltd.
Revenues	$	—		$	1,014,341		$	65,580		$	—		$	1,079,921
Expenses:
Cost of sales	—			729,393			37,638			—			767,031
Operating, selling, administrative and general expenses	23,685			77,780			12,133			—			113,598
Litigation judgment expense	—			88,106			—			—			88,106
Management fee expense	—			9,508			—			(9,508		)	—
Operating (loss) income	(23,685		)	109,554			15,809			9,508			111,186
Other income (expenses):
Interest expense	(130,417		)	(1,716		)	(14		)	—			(132,147		)
Changes in fair value of derivatives embedded within convertible debt	18,935			—			—			—			18,935
Acceleration of interest expense related to debt conversion	(12,414		)	—			—			—			(12,414		)
Loss on extinguishment of debt	(21,458		)	—			—			—			(21,458		)
Equity in earnings from real estate ventures	—			—			22,925			—			22,925
(Loss) gain on sale of investment securities available for sale	(272		)	5,424			—			—			5,152
Gain on acquisition of Douglas Elliman	—			—			60,842			—			60,842
Equity in earnings from investments	3,126			—			—			—			3,126
Equity in earnings in consolidated subsidiaries	144,689			—			—			(144,689		)	—
Management fee income	9,508			—			—			(9,508		)	—
Other, net	1,462			2,763			348			—			4,573
(Loss) income before provision for income taxes	(10,526		)	116,025			99,910			(144,689		)	60,720
Income tax benefit (expense)	47,826			(30,758		)	(40,740		)	—			(23,672		)
Net income	37,300			85,267			59,170			(144,689		)	37,048
Net loss attributed to non-controlling interest	—			—			252			—			252
Net income attributed to Vector Group Ltd.	$	37,300		$	85,267		$	59,422		$	(144,689	)	$	37,300
Comprehensive loss attributed to non-controlling interest	$	—		$	—		$	252		$	—		$	252
Comprehensive income attributed to Vector Group Ltd.	$	52,894		$	102,344		$	59,422		$	(161,766	)	$	52,894

Schedule of Condensed Consolidating Cash Flow Statement

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS



				Year Ended December 31, 2015
							Subsidiary						Consolidated
	Parent/			Subsidiary			Non-			Consolidating			Vector Group
	Issuer			Guarantors			Guarantors			Adjustments			Ltd.
Net cash provided by operating activities	$	136,370		$	172,065		$	45,715		$	(209,671	)	$	144,479
Cash flows from investing activities:
Sale of investment securities	256,161			14,415			—			—			270,576
Maturities of investment securities	5,491			—			—			—			5,491
Purchase of investment securities	(207,822		)	(6,324		)	—			—			(214,146		)
Proceeds from sale or liquidation of long-term investments	1,106			—			197			—			1,303
Purchase of long-term investments	(10,000		)	—			—			—			(10,000		)
Investments in real estate ventures	—			—			(70,272		)	—			(70,272		)
Distributions from investments in real estate ventures	—			—			17,563			—			17,563
Increase in cash surrender value of life insurance policies	(1,257		)	(485		)	—			—			(1,742		)
Increase in restricted assets	(6		)	(6,883		)	—			—			(6,889		)
Issuance of notes receivable	—			—			(4,410		)	—			(4,410		)
Investments in subsidiaries	(103,174		)	—			—			103,174			—
Proceeds from sale of fixed assets	—			4			—			—			4
Repayment of notes receivable	—			—			4,000			—			4,000
Capital expenditures	—			(3,730		)	(7,247		)	—			(10,977		)
Proceeds from sale of preferred securities	—			—			1,000			—			1,000
Investments in real estate held for sale	—			—			(12,603		)	—			(12,603		)
Pay down of investment securities	8,739			—			—			—			8,739
Net cash used in investing activities	(50,762		)	(3,003		)	(71,772		)	103,174			(22,363		)
Cash flows from financing activities:
Proceeds from issuance of debt	—			1,799			306			—			2,105
Deferred financing costs	—			(624		)	—			—			(624		)
Repayments of debt	—			(6,362		)	(322		)	—			(6,684		)
Borrowings under revolver	—			153,361			—			—			153,361
Repayments on revolver	—			(167,915		)	—			—			(167,915		)
Capital contributions received	—			33,658			69,516			(103,174		)	—
Intercompany dividends paid	—			(181,825		)	(29,343		)	211,168			—
Dividends and distributions on common stock	(188,151		)	—			—			—			(188,151		)
Distributions to non-controlling interest	—			—			(3,280		)	—			(3,280		)
Contributions from non-controlling interest	—			—			813			—			813
Proceeds from exercise of Vector options	1,441			—			—			—			1,441
Tax benefit of options exercised	821			1,497			—			(1,497		)	821
Net cash (used in) provided by financing activities	(185,889		)	(166,411		)	37,690			106,497			(208,113		)
Net (decrease) increase in cash and cash equivalents	(100,281		)	2,651			11,633			—			(85,997		)
Cash and cash equivalents, beginning of year	211,751			9,724			104,890			—			326,365
Cash and cash equivalents, end of year	$	111,470		$	12,375		$	116,523		$	—		$	240,368

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS



				Year Ended December 31, 2014
							Subsidiary						Consolidated
	Parent/			Subsidiary			Non-			Consolidating			Vector Group
	Issuer			Guarantors			Guarantors			Adjustments			Ltd.
Net cash provided by operating activities	$	61,779		$	83,671		$	62,656		$	(100,730	)	$	107,376
Cash flows from investing activities:
Sale of investment securities	154,615			—			—			—			154,615
Maturities of investment securities	930			—			—			—			930
Purchase of investment securities	(299,417		)	(6,314		)	—			—			(305,731		)
Proceeds from sale of or liquidation of long-term investments	2,367			—			49			—			2,416
Purchase of long-term investments	(12,000		)	—			—			—			(12,000		)
Investments in real estate ventures	—			—			(40,916		)	—			(40,916		)
Distributions from investments in real estate ventures	—			—			7,309			—			7,309
Increase in cash surrender value of life insurance policies	—			(484		)	—			—			(484		)
Decrease (increase) in restricted assets	188			(371		)	(689		)	—			(872		)
Issuance of notes receivable	(35,000		)	—			(8,250		)	35,000			(8,250		)
Investments in subsidiaries	(85,278		)	—			—			85,278			—
Proceeds from sale of fixed assets	—			4			—			—			4
Purchase of subsidiaries	—			—			(750		)	—			(750		)
Repayment of notes receivable	35,000			—			4,850			(35,000		)	4,850
Purchase of preferred securities	—			—			(1,000		)	—			(1,000		)
Capital expenditures	(15		)	(16,466		)	(6,923		)	—			(23,404		)
Pay down of investment securities	1,849			—			—			—			1,849
Net cash used in investing activities	(236,761		)	(23,631		)	(46,320		)	85,278			(221,434		)
Cash flows from financing activities:
Proceeds from issuance of debt	408,750			40,164			—			(35,000		)	413,914
Deferred financing costs	(12,360		)	—			—			—			(12,360		)
Repayments of debt	—			(43,724		)	(3,877		)	35,000			(12,601		)
Borrowings under revolver	—			886,130			—			—			886,130
Repayments on revolver	—			(898,788		)	—			—			(898,788		)
Capital contributions received	—			15,270			70,008			(85,278		)	—
Intercompany dividends paid	—			(61,180		)	(39,550		)	100,730			—
Dividends and distributions on common stock	(167,328		)	—			—			—			(167,328		)
Distributions to non-controlling interest	—			—			(9,339		)	—			(9,339		)
Proceeds from exercise of Vector options	5,151			—			—			—			5,151
Tax benefit of options exercised	1,178			—			—			—			1,178
Net cash provided by (used in) financing activities	235,391			(62,128		)	17,242			15,452			205,957
Net increase (decrease) in cash and cash equivalents	60,409			(2,088		)	33,578			—			91,899
Cash and cash equivalents, beginning of year	151,342			11,812			71,312			—			234,466
Cash and cash equivalents, end of year	$	211,751		$	9,724		$	104,890		$	—		$	326,365

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS



	Year Ended December 31, 2013
	Parent/ Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Consolidating Adjustments			Consolidated Vector Group Ltd.
Net cash provided by (used in) operating activities	$	71,730		$	115,829		$	(16,239	)	$	(119,294	)	$	52,026
Cash flows from investing activities:
Sale of investment securities	110,419			6,602			—			—			117,021
Maturities of investment securities	27			—			—			—			27
Purchase of investment securities	(159,463		)	(11,000		)	—			—			(170,463		)
Proceeds from sale or liquidation of long-term investments	10,847			—			80			—			10,927
Purchase of long-term investments	(5,000		)	(501		)	—			—			(5,501		)
Investments in real estate ventures	—			—			(75,731		)	—			(75,731		)
Distributions from investments in real estate ventures	—			—			3,142			—			3,142
Increase in cash surrender value of life insurance policies	(144		)	(484		)	—			—			(628		)
Decrease in restricted assets	3			1,078			—			—			1,081
Issuance of notes receivable	—			—			(8,600		)	—			(8,600		)
Proceeds from sale of fixed assets	35			13			—			—			48
Cash acquired in Douglas Elliman consolidation	—			—			116,935			—			116,935
Purchase of subsidiaries	—			—			(67,616		)	—			(67,616		)
Investments in subsidiaries	(155,961		)	—			—			155,961			—
Capital expenditures	(2,297		)	(9,784		)	(1,194		)	—			(13,275		)
Pay down of investment securities	681			—			—			—			681
Net cash used in investing activities	(200,853		)	(14,076		)	(32,984		)	155,961			(91,952		)
Cash flows from financing activities:
Proceeds from issuance of debt	450,000			4,687			3,080			—			457,767
Repayments of debt	(415,000		)	(7,466		)	(115		)	—			(422,581		)
Deferred financing charges	(11,750		)	—			—			—			(11,750		)
Borrowings under revolver	—			978,788			—			—			978,788
Repayments on revolver	—			(977,794		)	—			—			(977,794		)
Capital contributions received	—			13,950			142,011			(155,961		)	—
Intercompany dividends paid	—			(105,882		)	(13,412		)	119,294			—
Dividends and distributions on common stock	(144,711		)	—			—			—			(144,711		)
Distributions to non-controlling interest	—			—			(11,764		)	—			(11,764		)
Proceeds from exercise of Vector options	544			—			—			—			544
Tax benefit of options exercised	38			—			—			—			38
Net cash (used in) provided by financing activities	(120,879		)	(93,717		)	119,800			(36,667		)	(131,463		)
Net (decrease) increase in cash and cash equivalents	(250,002		)	8,036			70,577			—			(171,389		)
Cash and cash equivalents, beginning of year	401,344			3,776			735			—			405,855
Cash and cash equivalents, end of year	$	151,342		$	11,812		$	71,312		$	—		$	234,466

Summary of Significant Accounting Policies (Schedule of Revisions) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Investment securities available for sale	$ 181,976				$ 269,100				$ 181,976	$ 269,100
Other current assets	38,954				36,404				38,954	36,404
Total current assets	583,739				751,397				583,739	751,397
Long-term investments	62,726				52,723				62,726	52,723
Other assets	51,261				53,902				51,261	53,902
Total assets	1,310,756				1,423,254	$ 1,423,254			1,310,756	1,423,254	$ 1,115,793
Total current liabilities	216,292				212,424				216,292	212,424
Deferred income taxes, net	79,429				95,904				79,429	95,904
Total liabilities	1,432,917				1,443,934				1,432,917	1,443,934
Accumulated deficit	(210,113)				(97,009)				(210,113)	(97,009)
Accumulated other comprehensive loss	(8,313)				(1,343)				(8,313)	(1,343)	591
Stockholders' deficiency	(206,047)				(99,759)				(206,047)	(99,759)
Total stockholders’ equity (deficiency)	(122,161)				(20,680)				(122,161)	(20,680)	(50,605)	$ (89,070)
Total liabilities and stockholders' deficiency	1,310,756				1,423,254				1,310,756	1,423,254
Operating, selling, administrative and general expenses									320,221	279,342	113,598
Operating income	31,032	$ 69,367	$ 55,803	$ 43,718	47,136	62,746	$ 60,071	$ 42,485	199,920	212,438	111,186
Equity in (losses) earnings from investments									(2,681)	3,140	3,126
Other, net									6,409	9,396	4,573
Income before provision for income taxes									107,705	82,279	60,720
Income tax expense									41,233	33,165	23,672
Net income									66,472	49,114	37,048
Net income (loss) attributed to Vector Group Ltd.	$ 7,904	12,466	17,607	21,221	12,215	14,190	7,917	2,534	59,198	36,856	37,300
Other comprehensive (loss) income									(12,547)	(3,297)	26,252
Comprehensive income									59,502	47,180	52,642
Comprehensive income attributed to Vector Group Ltd.									$ 52,228	34,922	52,894
ASU Adoption
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Deferred income taxes					0					0
Total current assets					828,654					828,654
Deferred income taxes					0					0
Total assets					1,493,071					1,493,071
Deferred income taxes, net					0					0
Total current liabilities					212,424					212,424
Deferred income taxes, net					122,989					122,989
Total liabilities					1,471,019					1,471,019
Total stockholders’ equity (deficiency)					22,052					22,052
Total liabilities and stockholders' deficiency					1,493,071					1,493,071
ASU Adoption \| As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Deferred income taxes					29,192					29,192
Total current assets					857,846					857,846
Deferred income taxes					51,129					51,129
Total assets					1,573,392					1,573,392
Deferred income taxes, net					57,671					57,671
Total current liabilities					270,095					270,095
Deferred income taxes, net					145,639					145,639
Total liabilities					1,551,340					1,551,340
Total stockholders’ equity (deficiency)					22,052					22,052
Total liabilities and stockholders' deficiency					1,573,392					1,573,392
ASU Adoption \| Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Deferred income taxes					(29,192)					(29,192)
Total current assets					(29,192)					(29,192)
Deferred income taxes					(51,129)					(51,129)
Total assets					(80,321)					(80,321)
Deferred income taxes, net					(29,192)					(29,192)
Total current liabilities					(29,192)					(29,192)
Deferred income taxes, net					(51,129)					(51,129)
Total liabilities					(80,321)					(80,321)
Total liabilities and stockholders' deficiency					(80,321)					(80,321)
Accounting Standards Update 2015-17 [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Deferred income taxes					0					0
Total current assets					0					0
Deferred income taxes					0					0
Total assets					0					0
Deferred income taxes, net					(28,479)					(28,479)
Total current liabilities					(28,479)					(28,479)
Deferred income taxes, net					28,479					28,479
Total liabilities					0					0
Total stockholders’ equity (deficiency)					0					0
Total liabilities and stockholders' deficiency					0					0
Adoption of Equity Method [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Investment securities available for sale					269,100					269,100
Other current assets					36,404					36,404
Total current assets					751,397					751,397
Long-term investments					52,723					52,723
Other assets					53,902					53,902
Total assets					1,423,254					1,423,254
Deferred income taxes, net					95,904					95,904
Total liabilities					1,443,934					1,443,934
Accumulated deficit					(97,009)					(97,009)
Accumulated other comprehensive loss					(1,343)					(1,343)
Stockholders' deficiency					(99,759)					(99,759)
Total stockholders’ equity (deficiency)					(20,680)					(20,680)
Total liabilities and stockholders' deficiency					1,423,254					1,423,254
Operating, selling, administrative and general expenses										279,342	113,598
Operating income		(238)	(237)	(237)		(238)	(237)	(237)		212,438	111,186
Equity in (losses) earnings from investments										3,140	3,126
Other, net										9,396	4,573
Income before provision for income taxes										82,279	60,720
Income tax expense										33,165	23,672
Net income										49,114	37,048
Net income (loss) attributed to Vector Group Ltd.		$ 261	$ (261)	$ 265		$ (689)	$ (8)	$ (46)		36,856	37,300
Other comprehensive (loss) income										(1,934)	15,594
Comprehensive income										47,180	52,642
Comprehensive income attributed to Vector Group Ltd.										34,922	52,894
Adoption of Equity Method [Member] \| As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Investment securities available for sale					346,043					346,043
Other current assets					36,718					36,718
Total current assets					828,654					828,654
Long-term investments					40,292					40,292
Other assets					58,893					58,893
Total assets					1,493,071					1,493,071
Deferred income taxes, net					122,989					122,989
Total liabilities					1,471,019					1,471,019
Accumulated deficit					(90,160)					(90,160)
Accumulated other comprehensive loss					34,540					34,540
Stockholders' deficiency					(57,027)					(57,027)
Total stockholders’ equity (deficiency)					22,052					22,052
Total liabilities and stockholders' deficiency					1,493,071					1,493,071
Operating, selling, administrative and general expenses										278,392	112,748
Operating income										213,388	112,036
Equity in (losses) earnings from investments										1,242	2,066
Other, net										10,552	7,550
Income before provision for income taxes										82,487	63,487
Income tax expense										33,251	24,795
Net income										49,236	38,692
Net income (loss) attributed to Vector Group Ltd.										36,978	38,944
Other comprehensive (loss) income										11,680	33,128
Comprehensive income										60,916	71,820
Comprehensive income attributed to Vector Group Ltd.										48,658	72,072
Adoption of Equity Method [Member] \| Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Investment securities available for sale					(76,943)					(76,943)
Other current assets					(314)					(314)
Total current assets					(77,257)					(77,257)
Long-term investments					12,431					12,431
Other assets					(4,991)					(4,991)
Total assets					(69,817)					(69,817)
Deferred income taxes, net					(27,085)					(27,085)
Total liabilities					(27,085)					(27,085)
Accumulated deficit					(6,849)					(6,849)
Accumulated other comprehensive loss					(35,883)					(35,883)
Stockholders' deficiency					(42,732)					(42,732)
Total stockholders’ equity (deficiency)					(42,732)					(42,732)
Total liabilities and stockholders' deficiency					$ (69,817)					(69,817)
Operating, selling, administrative and general expenses										950	850
Operating income										(950)	(850)
Equity in (losses) earnings from investments										1,898	1,060
Other, net										(1,156)	(2,977)
Income before provision for income taxes										(208)	(2,767)
Income tax expense										(86)	(1,123)
Net income										(122)	(1,644)
Net income (loss) attributed to Vector Group Ltd.										(122)	(1,644)
Other comprehensive (loss) income										(13,614)	(17,534)
Comprehensive income										(13,736)	(19,178)
Comprehensive income attributed to Vector Group Ltd.										$ (13,736)	$ (19,178)

Summary of Significant Accounting Policies (Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Component of Accumulated Other Comprehensive Income (Loss) [Line Items]
Net unrealized gains on investment securities available for sale, net of income taxes of $7,758, $12,706 and $11,528, respectively	$ 12,048	$ 18,102	$ 16,867
Net unrealized losses on long-term investment accounted for under the equity method, net of income tax benefits of $0, $1,156, and $418, respectively	0	(1,658)	(612)
Forward contracts adjustment, net of income taxes of $11, $36, and $63, respectively	(19)	(55)	(92)
Pension-related amounts, net of income taxes of $13,977, $12,167, and $10,644, respectively	(20,342)	(17,732)	(15,572)
Accumulated other comprehensive (loss) income	(8,313)	(1,343)	591
Accumulated Net Unrealized Investment Gain (Loss) [Member]
Component of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive (loss) income, tax effect	7,758	12,706	11,528
Accumulated Net Unrealized Long-Term Equity Method Investment Gain (Loss) [Member]
Component of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive (loss) income, tax effect	0	1,156	418
Accumulated Translation Adjustment [Member]
Component of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive (loss) income, tax effect	11	36	63
Accumulated Defined Benefit Plans Adjustment [Member]
Component of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive (loss) income, tax effect	$ 13,977	$ 12,167	$ 10,644

Summary of Significant Accounting Policies (Other Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accounting Policies [Line Items]
Allowance for doubtful accounts and cash discounts	$ 479	$ 452
Current restricted assets	9,195	2,595
Long-term restricted assets	12,303	12,013
Tax on payments of dividend equivalent rights	5,566	4,612	$ 4,007
Shipping and handling fees and costs	5,488	5,585	5,559
Fair market value of embedded derivatives at the midpoint of the inputs	144,042	169,386
Tobacco and E-Cigarettes [Member] \| Selling, General and Administrative Expenses [Member]
Accounting Policies [Line Items]
Advertising costs	5,097	9,493	4,839
Real Estate [Member] \| Selling, General and Administrative Expenses [Member]
Accounting Policies [Line Items]
Advertising costs	$ 25,657	14,952	$ 1,298
Minimum [Member]
Accounting Policies [Line Items]
Inventory classification of current asset, range	1 year
Unrecognized tax benefits, recognition of tax positions, likelihood of being realized upon settlement	50.00%
Fair market value of embedded derivatives at the midpoint of the inputs	$ 143,422	167,593
Maximum [Member]
Accounting Policies [Line Items]
Cash equivalent, maturity period	90 days
Marketable securities, ownership interest	20.00%
Fair market value of embedded derivatives at the midpoint of the inputs	$ 144,660	$ 171,215

Summary of Significant Accounting Policies (Concentration of Credit Risk Narrative) (Details) - Customer Concentration Risk [Member] - customers	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Sales Revenue [Member]
Concentration Risk [Line Items]
Concentration risk, number of customers	2	1
Sales Revenue [Member] \| First Largest Customer [Member]
Concentration Risk [Line Items]
Concentration risk, percent	19.00%	19.00%	18.00%
Sales Revenue [Member] \| Second Largest Customer [Member]
Concentration Risk [Line Items]
Concentration risk, percent	10.00%		10.00%
Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration risk, number of customers	2
Accounts Receivable [Member] \| First Largest Customer [Member]
Concentration Risk [Line Items]
Concentration risk, number of customers		0.11
Concentration risk, percent	4.00%		5.00%
Accounts Receivable [Member] \| Second Largest Customer [Member]
Concentration Risk [Line Items]
Concentration risk, percent	1.00%		1.00%

Summary of Significant Accounting Policies (Property, Plant and Equipment Narrative) (Details)	12 Months Ended
	Dec. 31, 2015
Buildings \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	20 years
Buildings \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	30 years
Machinery and equipment \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Machinery and equipment \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	10 years

Summary of Significant Accounting Policies (Contingencies Narrative) (Details) - Liggett [Member] $ in Thousands	12 Months Ended
	Dec. 31, 2015 USD ($) case
Loss Contingencies [Line Items]
Damages awarded \| $	$ 29,102
State Cases [Member]
Loss Contingencies [Line Items]
Cases pending (in cases)	260
Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Plaintiffs' verdicts (in cases)	15
Engle Progency Cases Excluding Lukacs [Member]
Loss Contingencies [Line Items]
Cases including punitive damages (in cases)	4
Engle Progency Cases Excluding Lukacs [Member] \| Minimum [Member]
Loss Contingencies [Line Items]
Cases including punitive damages (in cases)	4

Summary of Significant Accounting Policies (Other Income) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accounting Policies [Abstract]
Interest and dividend income	$ 7,038	$ 5,803	$ 4,381
Out-of-period adjustment	0	1,231	0
Acceleration of closing fee related to termination of Douglas Elliman joint venture	0	2,335	0
Impairment of real estate held for sale	(230)	0	0
Loss on sale of assets	(78)	0	0
Gain on long-term investment	390	0	189
Impairment of Long Term Investments	(811)	0	0
Other income	100	27	3
Other income, net	$ 6,409	$ 9,396	$ 4,573

Summary of Significant Accounting Policies (Schedule of other accrued liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Other Liabilities Disclosure [Abstract]
Accounts payable	$ 19,639	$ 10,856
Accrued promotional expenses	24,816	20,191
Accrued excise and payroll taxes payable, net	26,556	23,172
Accrued interest	28,147	28,321
Commissions payable	11,008	9,523
Accrued salaries and benefits	20,134	16,009
Other current liabilities	23,917	18,683
Total other current liabilities	$ 154,217	$ 126,755

Earnings Per Share Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Sep. 29, 2015	Sep. 26, 2014	Sep. 27, 2013
Class of Stock [Line Items]
Effect of stock dividend	$ 0	$ 0	$ 0
Dividend equivalent rights	5,566	4,612	4,007
Tax on payments of dividend equivalent rights	211	306	91
Common Stock
Class of Stock [Line Items]
Stock dividend paid to company stockholders				5.00%	5.00%	5.00%
Effect of stock dividend	$ 584	$ 520	$ 450
Increase in number of shares subject to outstanding stock options	5.00%	5.00%	5.00%

Earnings Per Share Basic Earnings Per Share (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Earnings Per Share [Abstract]
Net income (loss) attributed to Vector Group Ltd.	$ 7,904	$ 12,466	$ 17,607	$ 21,221	$ 12,215	$ 14,190	$ 7,917	$ 2,534	$ 59,198	$ 36,856	$ 37,300
Income attributable to participating securities									(1,752)	(1,024)	(1,023)
Net income available to common stockholders attributed to Vector Group Ltd.									$ 57,446	$ 35,832	$ 36,277

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Earnings Per Share (Schedule of Basic and diluted EPS) (Details) - shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Earnings Per Share [Abstract]
Weighted-average shares for basic EPS (in shares)	117,760,538	108,075,400	100,886,113
Plus incremental shares related to stock options and non-vested restricted stock (in shares)	32,030	66,732	261,837
Weighted-average shares for diluted EPS (in shares)	117,792,568	108,142,132	101,147,950

Earnings Per Share Antidilutive Securities Excluded from Earnings Per Share (Details) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Weighted-average shares of non-vested restricted stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of EPS (in shares)			30,319
Weighted-average expense per share (in dollars per share)			$ 15.10
Weighted-average number of shares issuable upon conversion of debt
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of EPS (in shares)	25,113,350	32,216,245	30,862,794
Weighted-average conversion price (in dollars per share)	$ 19.55	$ 16.83	$ 13.81

Investment Securities Available for Sale (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Cost	$ 162,168	$ 238,291
Gross Unrealized Gains	19,885	34,488
Gross Unrealized Losses	(77)	(3,679)
Fair Value	181,976	269,100
Marketable equity securities
Schedule of Available-for-sale Securities [Line Items]
Cost	47,502	46,695
Gross Unrealized Gains	19,833	32,018
Gross Unrealized Losses	(62)	(1,104)
Fair Value	67,273	77,609
Mutual funds invested in fixed income securities
Schedule of Available-for-sale Securities [Line Items]
Cost	20,126	61,485
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(15)	(1,659)
Fair Value	20,111	59,826
Marketable debt securities
Schedule of Available-for-sale Securities [Line Items]
Cost	94,540	130,111
Gross Unrealized Gains	52	2,470
Gross Unrealized Losses	0	(916)
Fair Value	$ 94,592	$ 131,665

Investment Securities Available for Sale (Details 2) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Schedule of Available-for-sale Securities [Line Items]
Market Value	$ 181,976	$ 269,100
In loss position for Less than 12 months, Fair Value	15,991	151,724
In loss position for Less than 12 months, Unrealized Losses	(77)	(2,150)
In loss position for 12 months or more, Fair Value	0	15,934
In loss position for 12 months or more, Unrealized Losses	0	(1,529)
Total Fair Value	15,991	167,658
Total Unrealized Losses	(77)	(3,679)
Gross realized gains on sales	13,727	275	$ 5,538
Gross realized losses on sales	(2,589)	(286)	(386)
Gains (losses) on sale of investment securities available for sale	11,138	(11)	5,152
Gross realized losses on other-than-temporary impairments	(12,846)	0	0
Proceeds from investment securities sales	270,576	154,615	117,021
Proceeds from early redemptions by issuers	14,230	2,779	$ 708
Chief Executive Officer [Member]
Schedule of Available-for-sale Securities [Line Items]
Gross realized losses on other-than-temporary impairments	(6,895)
Marketable equity securities
Schedule of Available-for-sale Securities [Line Items]
Market Value	67,273	77,609
In loss position for Less than 12 months, Fair Value	5,938	6,599
In loss position for Less than 12 months, Unrealized Losses	(62)	(138)
In loss position for 12 months or more, Fair Value	0	3,534
In loss position for 12 months or more, Unrealized Losses	0	(966)
Total Fair Value	5,938	10,133
Total Unrealized Losses	(62)	(1,104)
Mutual funds invested in fixed income securities
Schedule of Available-for-sale Securities [Line Items]
Market Value	20,111	59,826
In loss position for Less than 12 months, Fair Value	10,053	59,826
In loss position for Less than 12 months, Unrealized Losses	(15)	(1,659)
In loss position for 12 months or more, Fair Value		0
In loss position for 12 months or more, Unrealized Losses		0
Total Fair Value	10,053	59,826
Total Unrealized Losses	(15)	(1,659)
U.S. Government securities
Schedule of Available-for-sale Securities [Line Items]
Under 1 Year	0
1 Year up to 5 Years	28,132
More than 5 Years	0
Market Value	28,132
In loss position for Less than 12 months, Fair Value		22,375
In loss position for Less than 12 months, Unrealized Losses		(18)
In loss position for 12 months or more, Fair Value		0
In loss position for 12 months or more, Unrealized Losses		0
Total Fair Value		22,375
Total Unrealized Losses		(18)
Corporate securities
Schedule of Available-for-sale Securities [Line Items]
Under 1 Year	2,154
1 Year up to 5 Years	39,347
More than 5 Years	60
Market Value	41,561
In loss position for Less than 12 months, Fair Value		30,896
In loss position for Less than 12 months, Unrealized Losses		(204)
In loss position for 12 months or more, Fair Value		7,224
In loss position for 12 months or more, Unrealized Losses		(131)
Total Fair Value		38,120
Total Unrealized Losses		(335)
U.S. mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Under 1 Year	636
1 Year up to 5 Years	5,003
More than 5 Years	151
Market Value	5,790
In loss position for Less than 12 months, Fair Value		3,370
In loss position for Less than 12 months, Unrealized Losses		(26)
In loss position for 12 months or more, Fair Value		0
In loss position for 12 months or more, Unrealized Losses		0
Total Fair Value		3,370
Total Unrealized Losses		(26)
Commercial mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Under 1 Year	5,739
1 Year up to 5 Years	715
More than 5 Years	2,274
Market Value	8,728
In loss position for Less than 12 months, Fair Value		11,332
In loss position for Less than 12 months, Unrealized Losses		(46)
In loss position for 12 months or more, Fair Value		5,176
In loss position for 12 months or more, Unrealized Losses		(432)
Total Fair Value		16,508
Total Unrealized Losses		(478)
U.S. asset backed securities
Schedule of Available-for-sale Securities [Line Items]
Under 1 Year	2,342
1 Year up to 5 Years	5,934
More than 5 Years	0
Market Value	8,276
In loss position for Less than 12 months, Fair Value		15,228
In loss position for Less than 12 months, Unrealized Losses		(29)
In loss position for 12 months or more, Fair Value		0
In loss position for 12 months or more, Unrealized Losses		0
Total Fair Value		15,228
Total Unrealized Losses		(29)
Index-linked U.S. bonds
Schedule of Available-for-sale Securities [Line Items]
Under 1 Year	0
1 Year up to 5 Years	2,105
More than 5 Years	0
Market Value	2,105
In loss position for Less than 12 months, Fair Value		2,098
In loss position for Less than 12 months, Unrealized Losses		(30)
In loss position for 12 months or more, Fair Value		0
In loss position for 12 months or more, Unrealized Losses		0
Total Fair Value		2,098
Total Unrealized Losses		$ (30)
Marketable debt securities
Schedule of Available-for-sale Securities [Line Items]
Under 1 Year	10,871
1 Year up to 5 Years	81,236
More than 5 Years	2,485
Market Value	$ 94,592

Inventories (Details) - USD ($) $ in Thousands	12 Months Ended
Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Schedule of Inventory [Line Items]
Leaf tobacco	$ 49,856	$ 49,948
Other raw materials	3,578	3,532
Work-in-process	789	879
Finished goods	61,493	62,876
E-Cigarettes	80	3,079
Inventories at current cost	115,796	120,314
LIFO adjustments	(29,280)	(29,991)
Inventories, net	86,516	90,323
Purchase commitments	832	3,266
LIFO inventory liquidation reduction of cost of goods sold	1,703
Capitalized MSA cost in finished goods inventory	15,796	14,369
Federal excise tax in inventory	23,455	22,642
Liggett [Member] \| Leaf tobacco [Member]
Schedule of Inventory [Line Items]
Purchase commitments	15,466
Raw Materials [Member]
Schedule of Inventory [Line Items]
LIFO adjustments	(643)	(861)
Leaf tobacco [Member]
Schedule of Inventory [Line Items]
LIFO adjustments	(19,863)	(19,941)
Work-in-Process [Member]
Schedule of Inventory [Line Items]
LIFO adjustments	(33)	(39)
E-Cigarettes [Member]
Schedule of Inventory [Line Items]
LIFO adjustments	(5)	(96)
Finished Goods [Member]
Schedule of Inventory [Line Items]
LIFO adjustments	$ (8,736)	$ (9,054)

Property, Plant and Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 216,623	$ 201,162
Less accumulated depreciation and amortization	(140,991)	(117,050)
Property, plant and equipment, net	75,632	84,112
Depreciation and amortization	20,423	17,843	$ 11,063
Future machinery and equipment purchase commitments	832	3,266
Land and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	1,442	1,442
Buildings
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	15,908	15,418
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	178,131	167,090
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 21,142	$ 17,212

Long Term Investments (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Value	$ 62,726	$ 52,723
Equity method investments	21,495	20,484
Long-term investments	62,726	52,723
Carrying Value [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Value	41,231	32,239
Fair Value [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	44,769	39,147
Real Estate Investment [Member] \| Carrying Value [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Value	501	698
Real Estate Investment [Member] \| Fair Value [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	552	1,108
Investment partnerships [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Value	41,231	32,239
Investment partnerships [Member] \| Carrying Value [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Value	40,730	31,541
Investment partnerships [Member] \| Fair Value [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 44,217	$ 38,039

Long Term Investments (Narrative) (Details) $ in Thousands	12 Months Ended
Long Term Investments (Narrative) (Details) $ in Thousands	Dec. 31, 2015 USD ($) partnerships	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
Schedule of Equity Method Investments [Line Items]
Ownership percentage in equity method investment	7.84%
Equity method investments	$ 21,495	$ 20,484
Equity (loss) income on long-term investments accounted for under the equity method	$ 2,001	4,103	$ 22,925
Partnerships accounted for on equity method \| partnerships	3
Equity Method Investments [Member]
Schedule of Equity Method Investments [Line Items]
Cash distributions from equity method investments	$ 2,364	3,283	12,358
Equity (loss) income on long-term investments accounted for under the equity method	(2,681)	3,140	3,126
Investment Partnerships [Member]
Schedule of Equity Method Investments [Line Items]
Contributions	5,000
Reinsurance Company [Member]
Schedule of Equity Method Investments [Line Items]
Contributions	5,000
Limited Partnership [Member]
Schedule of Equity Method Investments [Line Items]
Proceeds from limited partnership investments	$ 587	549	$ 769
Indian Creek Investors LP [Member]
Schedule of Equity Method Investments [Line Items]
Ownership percentage in equity method investment	19.93%
Equity method investments	$ 4,989	8,053
Boyar Value Fund [Member]
Schedule of Equity Method Investments [Line Items]
Ownership percentage in equity method investment	29.92%
Equity method investments	$ 7,302	0
Ladenburg Thalmann Financial Services [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investments	9,204	12,173
Quoted market value	39,167
Difference between carrying amount and underlying equity	$ 21,463
Castle Brands [Member]
Schedule of Equity Method Investments [Line Items]
Ownership percentage in equity method investment	7.99%
Equity method investments	$ 0	$ 258
Quoted market value	15,585
Difference between carrying amount and underlying equity	$ 1,848

Long Term Investments Equity Method Investments (Details) - USD ($) $ in Thousands	9 Months Ended			12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]
Equity method investments				$ 21,495	$ 20,484
Indian Creek and Boyar Value Fund [Member]
Balance Sheets
Investment securities				40,676	71,331
Cash and cash equivalents				101	309
Other assets				8,664	32
Total assets				49,441	71,672
Other liabilities				408	6,571
Total liabilities				408	6,571
Total shareholders' equity				49,033	65,101
Total liabilities and shareholders' equity				49,441	71,672
Income Statement
Revenues				565	3,314	$ 565
Expenses				(868)	(1,298)	(839)
Gross profit (loss)				(303)	2,016	(274)
Total net realized (loss) gain and net change in unrealized depreciation from investments				(14,809)	(168)	16,496
Income (loss) from continuing operations				(15,112)	1,848	16,222
Indian Creek Investors LP [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investments				4,989	8,053
Boyar Value Fund [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investments				7,302	0
Ladenburg Thalmann Financial Services [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investments				9,204	12,173
Balance Sheets
Cash and cash equivalents	$ 114,548	$ 94,952
Receivables from clearing brokers, note receivable and other receivable, net	115,334	123,947
Goodwill and intangible assets, net	269,774	211,862
Other assets	63,634	62,571
Total assets	563,290	493,332
Accrued compensation and commissions and fees payable	72,936	61,205
Accounts payable and accrued liabilities	24,615	22,328
Unamortized discount	1,655	951
Notes payable, net of unamortized discount	59,184	62,131
Other liabilities	21,487	32,802
Total liabilities	178,222	178,466
Preferred stock	1	1
Common stock	19	18
Additional paid-in capital	517,988	452,263
Accumulated deficit	(132,952)	(137,406)
Total controlling shareholders' equity	385,056	314,876
Non-controlling interest	12	(10)
Total shareholders' equity	385,068	314,866
Total liabilities and shareholders' equity	563,290	493,332
Income Statement
Revenues				1,122,735	867,756	753,840
Expenses				(1,132,010)	(856,072)	(756,988)
Gross profit (loss)				(9,275)	11,684	(3,148)
Change in fair value of contingent consideration				31	12	(121)
Income (loss) from continuing operations				(9,244)	11,696	(3,269)
Net income (loss)				4,396	22,482	$ (5,389)
Castle Brands [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investments				$ 0	$ 258
Balance Sheets
Current assets	36,922	31,121
Non-current assets	9,845	9,834
Total assets	46,767	40,955
Current liabilities	9,947	8,703
Non-current liabilities	13,696	12,028
Total liabilities	23,643	20,731
Total controlling shareholders' equity	19,978	17,490
Non-controlling interest	3,146	2,734
Total shareholders' equity	23,124	20,224
Total liabilities and shareholders' equity	46,767	40,955
Income Statement
Revenues	67,143	51,426	$ 43,484
Expenses	(41,317)	(32,495)	(28,117)
Gross profit (loss)	25,826	18,931	15,367
Other expenses	(25,920)	(20,399)	(19,176)
Income (loss) from continuing operations	(94)	(1,468)	(3,809)
Net income (loss)	$ (2,946)	$ (4,845)	$ (8,604)

New Valley LLC (Narrative) (Details) $ in Thousands			1 Months Ended						3 Months Ended								12 Months Ended
New Valley LLC (Narrative) (Details) $ in Thousands	May 12, 2014 USD ($)	Dec. 13, 2013 USD ($)	Dec. 31, 2013 USD ($)	Dec. 31, 2013 USD ($)	Nov. 30, 2013 USD ($) story spft residential_unit room	Oct. 31, 2013 USD ($)	Jul. 31, 2012 USD ($) units	Oct. 31, 2010 USD ($) a	Dec. 31, 2015 USD ($) a residential_unit units	Sep. 30, 2015 USD ($)	Jun. 30, 2015 USD ($)	Mar. 31, 2015 USD ($)	Dec. 31, 2014 USD ($) spft residential_unit	Sep. 30, 2014 USD ($) units	Jun. 30, 2014 USD ($)	Mar. 31, 2014 USD ($)	Dec. 31, 2015 USD ($) a residential_unit units	Dec. 31, 2014 USD ($) spft residential_unit	Dec. 31, 2013 USD ($)	May 31, 2015 USD ($)	Apr. 30, 2015 USD ($)	Oct. 31, 2014 USD ($)	Aug. 31, 2014 USD ($)	May 31, 2014 USD ($) spft	Oct. 30, 2013 a residential_unit hole room	Aug. 31, 2013 USD ($)	May 31, 2013 story spft residential_unit	Mar. 31, 2013 USD ($)	Dec. 31, 2012 USD ($) story	Oct. 31, 2012 USD ($)	Sep. 30, 2012 USD ($)	Sep. 10, 2012 sqft	Jun. 30, 2012 USD ($)	Dec. 31, 2011 USD ($) story spft	Oct. 31, 2011 USD ($) pool units	Feb. 28, 2011 USD ($) residential_unit	Mar. 31, 2008 a
Investment Holdings [Line Items]
Real estate held for sale, net									$ 23,318				$ 10,643				$ 23,318	$ 10,643
Payments to acquire additional interest																	$ 0	0	$ 0
Ownership percentage in equity method investment									7.84%								7.84%
Investments in real estate ventures																	$ 70,272	40,916	75,731
Equity method investments									$ 21,495				20,484				21,495	20,484
Investments in real estate ventures									217,168				163,460				217,168	163,460
Equity (loss) income on long-term investments accounted for under the equity method																	2,001	4,103	22,925
Management fee income																	0	0	0
Distributions from investments in real estate ventures																	(17,563)	(7,309)	(3,142)
Gain on equity method investment																	(2,681)	3,140	3,126
Square footage of real estate \| sqft																																12,390
Operating income									31,032	$ 69,367	$ 55,803	$ 43,718	47,136	$ 62,746	$ 60,071	$ 42,485	199,920	212,438	111,186
Total assets			$ 1,115,793	$ 1,115,793					1,310,756				1,423,254	$ 1,423,254			1,310,756	1,423,254	1,115,793
Consolidated Variable Interest Entities [Member]
Investment Holdings [Line Items]
Total assets									13,702				10,775				13,702	10,775
11 Beach Street [Member]
Investment Holdings [Line Items]
Investments in real estate ventures			1,519	1,519															1,519
Escena [Member]
Investment Holdings [Line Items]
Area of land \| a																									7
Number of units in real estate property \| room																									450
Number of residential lots \| residential_unit																									867
Number of holes in golf course \| hole																									18
Asset impairment charges																	230
Operating income																	(789)	(760)	(1,184)
Number of residential lots sold \| residential_unit																									200
Proceeds from sale of equity method investments						$ 22,700
Number of residential lots remaining \| residential_unit																									667
New Valley LLC [Member]
Investment Holdings [Line Items]
Investments in real estate ventures									217,168				163,460				217,168	163,460
Interest costs capitalized																	9,928
Investment in consolidated real estate businesses, net									23,318				10,643				23,318	10,643
New Valley LLC [Member] \| Douglas Elliman Realty LLC [Member]
Investment Holdings [Line Items]
Payments to acquire additional interest		$ 60,000
Additional interest acquired		20.59%
Ownership percentage in equity method investment		70.59%																											50.00%
Investments in real estate ventures																													$ 84,859
Revenues of acquired operations			20,482
Net income of acquired operations			$ 732
Equity (loss) income on long-term investments accounted for under the equity method				22,974
Management fee income				$ 2,204
Gain on equity method investment		$ 60,842
New Valley LLC [Member] \| Sesto Holdings S.r.l. [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment								7.20%
Investments in real estate ventures								$ 5,000
Maximum exposure to loss as a result of this investment									0								0
New Valley LLC [Member] \| Broadway 1107 [Member]
Investment Holdings [Line Items]
Equity (loss) income on long-term investments accounted for under the equity method																		552	$ 525
Distributions from investments in real estate ventures																		(1,717)
New Valley LLC [Member] \| 10 Madison Square Park West (f/k/a 1107 Broadway) [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																																		5.00%
Investments in real estate ventures																	3,217
Investments in real estate ventures									11,391				6,383				11,391	6,383																$ 5,489
Equity (loss) income on long-term investments accounted for under the equity method																	1,010	2,254
Distributions from investments in real estate ventures																		(2,449)
Maximum exposure to loss as a result of this investment									10,610								10,610
Square footage of real estate \| spft																																		260,000
New Valley LLC [Member] \| The Whitman [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																																				12.00%
Investments in real estate ventures																																				$ 900
Number of units in real estate property \| residential_unit																																				4
Units sold \| residential_unit																																				3
New Valley LLC [Member] \| The Marquand (11 East 68th Street) [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																																		18.00%
Investments in real estate ventures									13,900				$ 12,000				13,900	12,000																$ 7,000
Equity (loss) income on long-term investments accounted for under the equity method																	1,900	$ 5,000
Maximum exposure to loss as a result of this investment									$ 13,900								$ 13,900
Number of units in real estate property \| residential_unit									29								29
Square footage of real estate \| spft																																		105,000
Units sold \| residential_unit									5				8				5	8
Number of stories in real estate property \| story																																		12
New Valley LLC [Member] \| 11 Beach Street [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment			49.50%	49.50%															49.50%
Equity method investments													$ 2,178					$ 2,178
Investments in real estate ventures									$ 13,209				12,328				$ 13,209	12,328															$ 9,642
Equity (loss) income on long-term investments accounted for under the equity method																	(521)
Distributions from investments in real estate ventures																	(1,010)
Maximum exposure to loss as a result of this investment									11,807								11,807
New Valley LLC [Member] \| 701 Seventh Avenue [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																															11.50%
Equity method investments									1,035				2,421				1,035	2,421												$ 1,507
Investments in real estate ventures									14,000								14,000														$ 7,800
Equity (loss) income on long-term investments accounted for under the equity method																	(9)
Distributions from investments in real estate ventures																		(1,088)
Maximum exposure to loss as a result of this investment									$ 13,507								$ 13,507
New Valley LLC [Member] \| 111 Murray Street [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment									9.50%								9.50%										25.00%
Equity method investments									$ 9,617								$ 9,617
Investments in real estate ventures									25,567				$ 27,319				25,567	$ 27,319
Equity (loss) income on long-term investments accounted for under the equity method																	(165)
Distributions from investments in real estate ventures																	(11,204)
Gain on equity method investment																	344
Maximum exposure to loss as a result of this investment									25,567								25,567
Interest Rate													12.00%					12.00%
Number of units in real estate property \| residential_unit																											157
Square footage of real estate \| spft																											31,000
Number of stories in real estate property \| story																											15
New Valley LLC [Member] \| NV Leroy LLC [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																												50.00%
New Valley LLC [Member] \| 160 Leroy Street [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																												5.00%
Equity method investments																												$ 1,150
Investments in real estate ventures									3,952				$ 1,467				3,952	$ 1,467
Maximum exposure to loss as a result of this investment									1,925								1,925
New Valley LLC [Member] \| Chrystie Street [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																													49.00%
Investments in real estate ventures																	1,997	1,252
Investments in real estate ventures																													$ 1,973
Equity (loss) income on long-term investments accounted for under the equity method																	(194)
Maximum exposure to loss as a result of this investment									5,103								5,103
New Valley LLC [Member] \| 25-19 43rd Avenue [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																								9.90%
Equity method investments									247								247
Investments in real estate ventures									1,077				733				1,077	733						$ 733
Maximum exposure to loss as a result of this investment									980								980
Number of units in real estate property \| units														86
Square footage of real estate \| spft																								87,000
New Valley LLC [Member] \| 23-10 Queens Plaza South [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																										45.40%
Equity method investments									3,630				4,532				3,630	4,532
Investments in real estate ventures													$ (1,508)					$ (1,508)								$ 7,350
Equity (loss) income on long-term investments accounted for under the equity method																	(2)
Maximum exposure to loss as a result of this investment									14,710								14,710
New Valley LLC [Member] \| 23-10 Queens Plaza South [Member] \| Residential Real Estate [Member]
Investment Holdings [Line Items]
Square footage of real estate \| spft													472,574					472,574
New Valley LLC [Member] \| 8701 Collins Avenue [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment			15.00%	15.00%															15.00%
Equity method investments			$ 3,750	$ 3,750					2,275				$ 2,250				2,275	$ 2,250	$ 3,750
Equity (loss) income on long-term investments accounted for under the equity method																	(584)	100
Maximum exposure to loss as a result of this investment									7,835								7,835
New Valley LLC [Member] \| 125 Greenwich Street [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																							78.50%
Equity method investments																							$ 1,916
Investments in real estate ventures									9,750				9,308				9,750	9,308					7,308
New Valley LLC [Member] \| West Hollywood Edition (9040 Sunset Boulevard) [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																						48.50%
Equity method investments									4,123								4,123
Investments in real estate ventures									10,510				5,604				10,510	5,604				$ 5,604
Equity (loss) income on long-term investments accounted for under the equity method																	(89)
Maximum exposure to loss as a result of this investment									9,638								9,638
Construction loan									50,000								50,000
New Valley LLC [Member] \| 76 Eleventh Avenue [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																				5.10%
Equity method investments																				$ 17,000
Investments in real estate ventures									17,967				0				17,967	0
Maximum exposure to loss as a result of this investment									17,000								17,000
New Valley LLC [Member] \| Maryland Portfolio [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment							30.00%
Investments in real estate ventures							$ 5,000		0				3,234				0	3,234
Equity (loss) income on long-term investments accounted for under the equity method																	(1,175)	349	(542)
Distributions from investments in real estate ventures																	(2,059)	(613)
Maximum exposure to loss as a result of this investment									0								0
Number of units in real estate property \| units							5,500
Joint venture, percentage of ownership in real estate							25.00%
New Valley LLC [Member] \| ST Portfolio [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment					16.40%
Investments in real estate ventures					$ 16,365				15,754				15,283				15,754	15,283
Equity (loss) income on long-term investments accounted for under the equity method																	1,702	(8)	(381)
Distributions from investments in real estate ventures																	(1,231)	(693)
Maximum exposure to loss as a result of this investment									15,754								15,754
Number of units in real estate property \| residential_unit					488
Square footage of real estate \| spft					20,000
New Valley LLC [Member] \| Park Lane Hotel [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment					5.00%
Equity method investments									1,895								1,895
Investments in real estate ventures									19,697				19,341				19,697	19,341
Equity (loss) income on long-term investments accounted for under the equity method																	(1,539)	(2,643)	183
Maximum exposure to loss as a result of this investment									19,697								19,697
Number of units in real estate property \| room					605
Number of stories in real estate property \| story					47
Term of development					30 months
New Valley LLC [Member] \| Hill Street Partners LLP [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																																			17.00%
Equity method investments													514					514
Investments in real estate ventures																																			$ 2,658
New Valley LLC [Member] \| Hotel Taiwana [Member]
Investment Holdings [Line Items]
Investments in real estate ventures									7,069				7,629				7,069	7,629
Equity (loss) income on long-term investments accounted for under the equity method																	(560)	(313)	0
Maximum exposure to loss as a result of this investment									$ 7,069								$ 7,069
New Valley LLC [Member] \| Coral Beach [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment									49.00%								49.00%
Equity method investments									$ 1,377								$ 1,377
Investments in real estate ventures									3,030								3,030
Equity (loss) income on long-term investments accounted for under the equity method																	(1,034)	(1,299)	$ (66)
Maximum exposure to loss as a result of this investment									$ 3,159								$ 3,159
New Valley LLC [Member] \| Coral Beach [Member] \| Hotel One [Member]
Investment Holdings [Line Items]
Area of land \| a									52								52
Number of units in real estate property \| units									39								39
New Valley LLC [Member] \| Coral Beach [Member] \| Hotel Two [Member]
Investment Holdings [Line Items]
Number of units in real estate property \| units									62								62
New Valley LLC [Member] \| Harmon Meadow [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment									49.00%								49.00%
Investments in real estate ventures									$ 5,931								$ 5,931
Equity (loss) income on long-term investments accounted for under the equity method																	(2)
Distributions from investments in real estate ventures																	(480)
Maximum exposure to loss as a result of this investment									5,449								5,449
New Valley LLC [Member] \| Monad Terrace [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																				31.30%
Equity method investments																				$ 6,200
Investments in real estate ventures									6,608				0				6,608	0
Equity (loss) income on long-term investments accounted for under the equity method																	(196)
Maximum exposure to loss as a result of this investment									$ 6,242								$ 6,242
New Valley LLC [Member] \| Takanasee [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment									22.80%								22.80%
Equity method investments									$ 4,428								$ 4,428
Investments in real estate ventures									4,680				0				4,680	0
Maximum exposure to loss as a result of this investment									4,428								4,428
New Valley LLC [Member] \| Escena [Member]
Investment Holdings [Line Items]
Real estate held for sale, net									10,716				10,643				10,716	10,643
Area of real estate property \| a																																					450
New Valley LLC [Member] \| Indian Creek [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																												80.00%
Investments in real estate ventures																												$ 7,616
Distributions from investments in real estate ventures	$ (7,100)
Operating income																		2,400
Proceeds from sale of equity method investments	$ 14,400
New Valley LLC [Member] \| Sagaponack [Member]
Investment Holdings [Line Items]
Real estate held for sale, net									$ 12,602				0				12,602	0
Investment in consolidated real estate businesses, net																					$ 12,502
Douglas Elliman Realty LLC [Member]
Investment Holdings [Line Items]
Gross commissions																	$ 3,077
Sesto Holdings S.r.l. [Member] \| Land Development [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment								42.00%
Area of land \| a								322
Hill Street Partners LLP [Member] \| Hotel Taiwana [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																																			37.00%
Number of units in real estate property \| units																																			30
Number of pools (in pools) \| pool																																			6
Chrystie Street [Member] \| Chrystie Venture LLC [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment																													37.50%
Number of stories in real estate property \| story																													29
NV Greenwich LLC [Member] \| 125 Greenwich Street [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment									13.30%								13.30%
Equity method investments									$ 6,359								$ 6,359						$ 9,750
Equity (loss) income on long-term investments accounted for under the equity method																	600
Distributions from investments in real estate ventures																	(7,348)
Maximum exposure to loss as a result of this investment									$ 7,003								$ 7,003
NV Leroy LLC [Member] \| 160 Leroy Street [Member]
Investment Holdings [Line Items]
Ownership percentage in equity method investment									3.10%								3.10%
Equity method investments									$ 702				$ 317				$ 702	$ 317										$ 1,924
Gain on equity method investment																	$ 1,680

(Investment in Non-Consolidated Real Estate Businesses Schedules) (Details) - USD ($) $ in Thousands	11 Months Ended	12 Months Ended
	Dec. 13, 2013	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Oct. 31, 2014	Aug. 31, 2014	May 31, 2014	Nov. 30, 2013	Dec. 31, 2012	Jul. 31, 2012	Jun. 30, 2012	Dec. 31, 2011
Schedule of Investments [Line Items]
Investments in real estate ventures		$ 217,168	$ 163,460
Land Development [Member]
Balance Sheets
Investment in real estate		0	759,038
Total assets		0	789,107
Total debt		0	520,760
Total liabilities		0	609,066
Condominium and Mixed Use Development [Member]
Income Statement
Revenues		141,884	182,635	$ 39,120
Costs and expenses		92,837	96,993	11,938
Other expenses		(10,672)	(6,798)	(22,375)
Income (loss) from continuing operations		38,375	78,844	4,807
Balance Sheets
Investment in real estate		2,921,611	1,617,397
Total assets		3,237,835	1,894,670
Total debt		2,014,682	1,121,099
Total liabilities		2,195,940	1,301,223
Non-controlling interest		535,573	364,560
11 Beach Street [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures				1,519
Apartment and Office Buildings [Member]
Income Statement
Revenues		83,871	85,704	59,917
Other expenses		(75,384)	(86,153)	(64,643)
Income (loss) from continuing operations		8,487	(449)	(4,726)
Balance Sheets
Investment in real estate		590,331	632,753
Total assets		626,513	669,368
Total debt		512,479	498,330
Total liabilities		529,692	511,027
Non-controlling interest		(4,463)	49,170
Hotels [Member]
Income Statement
Revenues		83,324	82,899	22,090
Costs and expenses		3,837	3,064	3,691
Other expenses		(112,069)	(133,258)	(35,164)
Income (loss) from continuing operations		(32,582)	(53,423)	(16,765)
Balance Sheets
Investment in real estate		824,753	777,157
Total assets		894,447	903,677
Total debt		511,029	506,655
Total liabilities		538,426	540,706
Non-controlling interest		294,470	295,051
Commercial [Member]
Income Statement
Revenues		5,638	0	0
Other expenses		(5,642)	0	0
Income (loss) from continuing operations		(4)	0	0
Balance Sheets
Investment in real estate		65,398	0
Total assets		67,343	0
Total debt		55,624	0
Total liabilities		56,415	0
Other [Member]
Income Statement
Revenues		3,030	2,714	2,558
Other expenses		(1,049)	(1,019)	(927)
Income (loss) from continuing operations		1,981	1,695	$ 1,631
Balance Sheets
Total assets		5,157	4,786
Total liabilities		1,022	766
New Valley LLC [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		217,168	163,460
New Valley LLC [Member] \| Douglas Elliman Realty LLC [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures									$ 84,859
Income Statement
Revenues	$ 416,453
Costs and expenses	369,852
Depreciation	3,790
Amortization expense	213
Other income (expense)	(22)
Interest expense, net	23
Income tax expense	996
Net income (loss)	$ 41,557
New Valley LLC [Member] \| Land Development - Milanosesto Holdings (Sesto Holdings) [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		0	5,037
New Valley LLC [Member] \| Condominium and Mixed Use Development [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		164,023	108,149
New Valley LLC [Member] \| 10 Madison Square Park West (f/k/a 1107 Broadway) [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		11,391	6,383									$ 5,489
New Valley LLC [Member] \| The Marquand (11 East 68th Street) [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		13,900	12,000									$ 7,000
New Valley LLC [Member] \| 11 Beach Street [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		13,209	12,328								$ 9,642
New Valley LLC [Member] \| 20 Times Square (f/k/a 701 Seventh Avenue) [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		14,985	12,481
New Valley LLC [Member] \| 111 Murray Street [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		25,567	27,319
New Valley LLC [Member] \| 160 Leroy Street [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		3,952	1,467
New Valley LLC [Member] \| 215 Chrystie Street [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		5,592	3,300
New Valley LLC [Member] \| 25-19 43rd Avenue [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		1,077	733				$ 733
New Valley LLC [Member] \| Queens Plaza (23-10 Queens Plaza South) [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		16,177	11,082
New Valley LLC [Member] \| 87 Park (8701 Collins Avenue) [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		8,658	6,144
New Valley LLC [Member] \| 125 Greenwich Street [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		9,750	9,308			$ 7,308
New Valley LLC [Member] \| West Hollywood Edition (9040 Sunset Boulevard) [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		10,510	5,604		$ 5,604
New Valley LLC [Member] \| 76 Eleventh Avenue [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		17,967	0
New Valley LLC [Member] \| Monad Terrace [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		6,608	0
New Valley LLC [Member] \| Takanasee [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		4,680	0
New Valley LLC [Member] \| Apartment Buildings [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		15,754	18,517
New Valley LLC [Member] \| Maryland Portfolio [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		0	3,234							$ 5,000
New Valley LLC [Member] \| ST Portfolio [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		15,754	15,283					$ 16,365
New Valley LLC [Member] \| Hotels [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		29,925	29,786
New Valley LLC [Member] \| Park Lane Hotel [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		19,697	19,341
New Valley LLC [Member] \| Hotel Taiwana [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		7,069	7,629
New Valley LLC [Member] \| Coral Beach and Tennis Club [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		3,159	2,816
New Valley LLC [Member] \| Commercial [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		5,449	0
New Valley LLC [Member] \| The Plaza at Harmon Meadow [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		5,449	0
New Valley LLC [Member] \| Other [Member]
Schedule of Investments [Line Items]
Investments in real estate ventures		$ 2,017	$ 1,971

New Valley LLC (Other Schedules) (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Apr. 30, 2015	Dec. 31, 2014	Dec. 13, 2013
Preliminary fair values of the assets acquired, liabilities assumed and the non-controlling interest recorded for Douglas Elliman
Goodwill	$ 70,791		$ 70,791
Other Investments
Real estate held for sale, net	23,318		10,643
New Valley LLC [Member]
Other Investments
Investment in consolidated real estate businesses, net	23,318		10,643
Land and land improvements	8,907		8,953
Building and building improvements	1,875		1,865
Other	1,923		1,568
Real estate investment, at cost	12,705		12,386
Less accumulated depreciation	(1,989)		(1,743)
Real estate investment, net	10,716		10,643
New Valley LLC [Member] \| Escena [Member]
Other Investments
Real estate held for sale, net	10,716		10,643
New Valley LLC [Member] \| Sagaponack [Member]
Other Investments
Real estate held for sale, net	$ 12,602		$ 0
Investment in consolidated real estate businesses, net		$ 12,502
New Valley LLC [Member] \| Douglas Elliman Realty LLC [Member]
Preliminary fair values of the assets acquired, liabilities assumed and the non-controlling interest recorded for Douglas Elliman
Cash and cash equivalents				$ 116,935
Other current assets				12,647
Property, plant and equipment, net				20,275
Trademarks				80,000
Goodwill				70,406
Other intangible assets, net				18,784
Other non-current assets				3,384
Total assets acquired				322,431
Notes payable - current				201
Other current liabilities				26,352
Notes payable - long term				420
Other long-term liabilities				4,022
Total liabilities assumed				30,995
Net assets acquired				291,436
Non-controlling interest				85,703
New Valley LLC [Member] \| Douglas Elliman Realty LLC [Member] \| Preliminary [Member]
Preliminary fair values of the assets acquired, liabilities assumed and the non-controlling interest recorded for Douglas Elliman
Cash and cash equivalents				116,935
Other current assets				12,647
Property, plant and equipment, net				20,275
Trademarks				80,000
Goodwill				72,135
Other intangible assets, net				12,928
Other non-current assets				3,384
Total assets acquired				318,304
Notes payable - current				201
Other current liabilities				26,247
Notes payable - long term				420
Other long-term liabilities				0
Total liabilities assumed				26,868
Net assets acquired				291,436
Non-controlling interest				85,703
New Valley LLC [Member] \| Douglas Elliman Realty LLC [Member] \| Measurement Period Adjustments [Member]
Preliminary fair values of the assets acquired, liabilities assumed and the non-controlling interest recorded for Douglas Elliman
Cash and cash equivalents				0
Other current assets				0
Property, plant and equipment, net				0
Trademarks				0
Goodwill				(1,729)
Other intangible assets, net				5,856
Other non-current assets				0
Total assets acquired				4,127
Notes payable - current				0
Other current liabilities				105
Notes payable - long term				0
Other long-term liabilities				4,022
Total liabilities assumed				4,127
Net assets acquired				0
Non-controlling interest				$ 0

Goodwill and Other Intangible Assets (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Goodwill	$ 70,791,000	$ 70,791,000
Goodwill and other intangible assets, net	263,959,000	269,972,000
Finite-lived intangible assets, gross	19,135,000	19,134,000
Less: accumulated amortization on amortizable intangibles	(13,478,000)	(7,464,000)
Finite-lived intangible assets, net	5,657,000	11,670,000
Amortization expense	5,080,000	5,088,000
Amortization expense, 2016	1,573,000
Amortization expense, 2017	932,000
Amortization expense, 2018	833,000
Amortization income, 2019	(166,000)
Amortization income, 2020	(22,000)
Amortization expense, thereafter	75,000
Favorable leases
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	13,444,000	13,444,000
Amortization expense	$ 3,730,000	4,034,000
Favorable leases \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Lives	1 year
Favorable leases \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Lives	10 years
Other intangibles
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	$ 5,691,000	5,690,000
Amortization expense	$ 208,000	69,000
Other intangibles \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Lives	1 year
Other intangibles \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Lives	5 years
Unfavorable leases
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	$ 4,022,000	4,022,000
Less: accumulated amortization on amortizable intangibles	(1,591,000)	(808,000)
Finite-lived intangible assets, net	2,431,000	3,214,000
Amortization expense	$ 783,000	783,000
Unfavorable leases \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Lives	1 year
Unfavorable leases \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Lives	10 years
Backlog intangible asset
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 1,925,000	1,768,000
Intangible asset associated with benefit under the MSA
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, net	107,511,000	107,511,000
Trademark - Douglas Elliman
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, net	80,000,000	$ 80,000,000
Impairment of intangibles	$ 0

Notes Payable, Long Term Debt and Other Obligations (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Mar. 14, 2014	Dec. 31, 2013	Dec. 31, 2012
Debt Instrument [Line Items]
Total notes payable, long - term debt and other obligations	$ 895,168	$ 913,351
Less: Current maturities	(8,919)	(52,640)
Amount due after one year	886,249	860,711
Unamortized discount	210,241
Secured Debt [Member] \| 7.75% Senior Secured Notes Due 2021 [Member]
Debt Instrument [Line Items]
Total notes payable, long - term debt and other obligations	608,014	609,275
Unamortized discount	8,014	9,275
Secured Debt [Member] \| 6.75% Variable Interest Senior Convertible Note Due 2014 [Member]
Debt Instrument [Line Items]
Unamortized discount	0	0
Convertible Debt [Member]
Debt Instrument [Line Items]
Unamortized discount	218,255	245,465		$ 201,075	$ 273,323
Convertible Debt [Member] \| 6.75% Variable Interest Senior Convertible Note Due 2014 [Member]
Debt Instrument [Line Items]
Total notes payable, long - term debt and other obligations	0	25,000	$ 0
Convertible Debt [Member] \| 5.5% Variable Interest Senior Convertible Debentures due 2020 [Member]
Debt Instrument [Line Items]
Total notes payable, long - term debt and other obligations	172,614	159,919
Unamortized discount	86,136	98,831
Convertible Debt [Member] \| 7.5% Variable Interest Senior Convertible Notes due 2019 [Member]
Debt Instrument [Line Items]
Total notes payable, long - term debt and other obligations	97,881	83,366
Unamortized discount	132,119	146,634
Line of Credit [Member] \| Revolving Credit Facility [Member] \| Liggett [Member]
Debt Instrument [Line Items]
Total notes payable, long - term debt and other obligations	3,213	17,767
Line of Credit [Member] \| Term Loan Under Credit Facility [Member] \| Liggett [Member]
Debt Instrument [Line Items]
Total notes payable, long - term debt and other obligations	3,269	3,589
Loans Payable [Member] \| Liggett [Member]
Debt Instrument [Line Items]
Total notes payable, long - term debt and other obligations	9,716	13,966
Other [Member]
Debt Instrument [Line Items]
Total notes payable, long - term debt and other obligations	$ 461	$ 469

Notes Payable, Long Term Debt and Other Obligations - Textuals (Details)							1 Months Ended			12 Months Ended
	Feb. 03, 2015 USD ($) shares	Apr. 15, 2014 USD ($)	Mar. 24, 2014 USD ($) $ / shares shares	Mar. 14, 2014 USD ($) shares	Jan. 29, 2013 USD ($)	May 11, 2009 USD ($)	Feb. 28, 2013 USD ($)	Nov. 30, 2012 USD ($) $ / shares shares	Jul. 31, 2006 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($) shares	Dec. 31, 2013 USD ($)	Dec. 31, 2012 USD ($)	Dec. 31, 2011 USD ($)	Nov. 30, 2013 USD ($) shares	Mar. 14, 2013 USD ($)	Jan. 31, 2013 USD ($)	Nov. 04, 2011	Nov. 30, 2009
Debt Instrument [Line Items]
Fair value of derivatives embedded within convertible debt										$ 144,042,000	$ 168,502,000
Subsidiary Guarantors, Percentage Ownership										100.00%
Proceeds from issuance of debt										$ 2,105,000	413,914,000	$ 457,767,000
Loss on extinguishment of debt										0	0	21,458,000
Acceleration of interest expense related to debt conversion										0	5,205,000	12,414,000
Acceleration of interest expense related to debt conversion										0	5,205,000	12,414,000
Long-term Debt, Gross										1,105,409,000
Long-term Debt										895,168,000	913,351,000
Non-cash interest expense (income)										(6,504,000)	(35,584,000)	(22,995,000)
Interest expense associated with embedded derivatives										18,529,000	32,071,000	21,482,000
6.75% Variable Interest Senior Convertible Note Due 2014 [Member]
Debt Instrument [Line Items]
Fair value of derivatives embedded within convertible debt										0	884,000
5.5% Variable Interest Senior Convertible Debentures due 2020 [Member]
Debt Instrument [Line Items]
Fair value of derivatives embedded within convertible debt										71,959,000	80,864,000
7.5% Variable Interest Senior Convertible Notes due 2019 [Member]
Debt Instrument [Line Items]
Fair value of derivatives embedded within convertible debt										72,083,000	87,638,000
Executive Vice President [Member]
Debt Instrument [Line Items]
Stock Ownership In Company Percentage																		15.30%
Jefferies & Company Inc. [Member]
Debt Instrument [Line Items]
Own-share Lending Arrangement, Shares, Issued \| shares								7,077,720
Own-share Lending Arrangement, Nominal Lending Fee Per Share \| $ / shares								$ 0.10
Own-share Lending Arrangement, Shares, Outstanding, Value								$ 3,204,000
Own-share Lending Arrangement, Shares Returned \| shares								3,538,860
Own-share Lending Arrangement, Shares, Outstanding \| shares								3,538,859
Own-share Lending Arrangement, Amount Amortized								$ 286,000
Secured Debt [Member] \| 11% Senior Secured Notes Due 2015 [Member]
Debt Instrument [Line Items]
Interest rate effective percentage					11.00%
Interest Rate																	7.75%
Face amount					$ 415,000,000											$ 78,685,000	$ 600,000,000
Repayments of Long-term Debt					$ 336,315,000
Debt Instrument, Redemption Price, Percentage				103.667%	104.292%
Loss on extinguishment of debt										21,458,000
Redemption Premium										17,820,000
Non-cash interest expense (income)										3,638,000
Secured Debt [Member] \| 7.75% Senior Secured Notes Due 2021 [Member]
Debt Instrument [Line Items]
Interest rate effective percentage							7.75%
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed		106.75%
Face amount		$ 150,000,000					$ 450,000,000
Subsidiary Guarantors, Percentage Ownership							100.00%
Proceeds from issuance of debt		$ 158,670,000					$ 438,250,000
Debt Redemption Price as a Percentage of Principal Amount							107.75%
Mandatory Redemption Percent In Event Of Change In Control							101.00%
Maximum Term to Consummate Registered Exchange Offer							360 days
Indenture Threshold for Earnings for Payment of Dividends							$ 75,000,000
Debt Instrument, Percent of Principal							35.00%
Long-term Debt										$ 608,014,000	609,275,000
Leverage Ratio Requirement							3.0
Secured Leverage Ratio Requirement							1.5
Convertible Debt [Member]
Debt Instrument [Line Items]
Term Before Record Date to Determine Additional Interest										3 years
Convertible Debt [Member] \| 5% Variable Interest Senior Convertible Notes due November 15, 2011 [Member]
Debt Instrument [Line Items]
Interest Rate										5.00%
Principal Amount Of Debt Sold						$ 11,005,000
Debt instrument, premium percentage																			107.00%
Convertible Debt [Member] \| 6.75% Variable Interest Senior Convertible Note Due 2014 [Member]
Debt Instrument [Line Items]
Interest rate effective percentage				6.75%						6.75%
Proceeds from private placement debt offering						$ 38,225,000
Debt Conversion, Original Debt, Interest Rate of Debt						3.75%
Period for Prior Cash Dividend Paid										3 months
Note conversion, net of income taxes (in shares) \| shares	2,338,930			2,338,930
Debt Conversion, Original Debt, Amount	$ 50,000,000
Debt Conversion, Converted Instrument, Amount				$ 25,000,000
Acceleration of interest expense related to debt conversion										$ 3,679,000
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt										25,000,000
Long-term Debt				$ 0						$ 0	25,000,000
Convertible Debt [Member] \| 3.875% Senior Convertible Debentures [Member]
Debt Instrument [Line Items]
Interest rate effective percentage										3.875%
Face amount															$ 43,222,000
Convertible Preferred Stock, Shares Issued upon Conversion \| shares															3,274,610
Principal Amount Of Debt Sold									$ 110,000,000
Debt Conversion, Original Debt, Amount													$ 55,778,000	$ 11,000,000
Acceleration of interest expense related to debt conversion										$ 12,414,000
Debt Reclassified from Debt to Equity										43,222,000
Interest expense associated with embedded derivatives										$ 0	0	$ 155,000
Convertible Debt [Member] \| 6.75% Variable Interest Senior Convertible Exchange Notes due 2014 [Member]
Debt Instrument [Line Items]
Interest rate effective percentage										6.75%
Debt Conversion, Original Debt, Interest Rate of Debt										5.75%		3.75%
Debt Conversion, Original Debt, Amount											$ 107,530,000
Debt Conversion, Converted Instrument, Shares Issued \| shares											8,867,443
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt											$ 107,530,000
Acceleration of interest expense related to debt conversion											1,526,000
Interest expense associated with embedded derivatives										$ 0	13,570,000	$ 11,799,000
Convertible Debt [Member] \| 7.5% Senior Convertible Debentures [Member]
Debt Instrument [Line Items]
Interest rate effective percentage								7.50%
Principal Amount Of Debt Sold								$ 230,000,000
Proceeds from issuance of debt								$ 218,900,000
Debt Conversion, Original Debt, Interest Rate of Debt								2.50%
Debt Instrument, Convertible, Conversion Price \| $ / shares								$ 15.98
Note conversion, net of income taxes (in shares) \| shares								62.5743
Debt Instrument, Convertible, Conversion Basis Amount										1,000,000
Debt Instrument, Percent of Principal			100.00%
Interest expense associated with embedded derivatives										$ 8,777,000	5,553,000	3,614,000
Convertible Debt [Member] \| 5.5% Variable Interest Senior Convertible Debentures due 2020 [Member]
Debt Instrument [Line Items]
Interest rate effective percentage			5.50%							5.50%
Interest Rate			1.75%
Face amount			$ 258,750,000
Proceeds from issuance of debt			$ 250,300,000
Debt Instrument, Convertible, Conversion Price \| $ / shares			$ 24.64
Debt Instrument, Convertible, Conversion Basis Amount			$ 1,000
Debt Instrument, Percent of Principal			100.00%
Long-term Debt										$ 172,614,000	159,919,000
Debt Instrument, Convertible, Conversion Basis Shares \| shares			40.5891
Interest expense associated with embedded derivatives										$ 9,752,000	6,851,000	$ 0
Convertible Debt [Member] \| 7.5% Variable Interest Senior Convertible Notes due 2019 [Member]
Debt Instrument [Line Items]
Interest rate effective percentage										7.50%
Long-term Debt										$ 97,881,000	$ 83,366,000
Convertible Debt [Member] \| Executive Vice President [Member] \| 6.75% Variable Interest Senior Convertible Note Due 2014 [Member]
Debt Instrument [Line Items]
Stock Ownership In Company Percentage						11.70%

Notes Payable, Long Term Debt and Other Obligations - Other Schedules (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Interest expense associated with embedded derivatives	$ 18,529	$ 32,071	$ 21,482
Unamortized Debt Discount [Roll Forward]
Amortization of beneficial conversion feature	(8,681)	(19,401)	(14,896)
Ending balance of unamortized discount	210,241
Convertible Debt [Member]
Unamortized Debt Discount [Roll Forward]
Beginning balance of unamortized discount	245,465	201,075	273,323
Decrease in unamortized discount due to conversion			(35,870)
Issuance of convertible notes - embedded derivative		82,775
Increase of convertible notes - beneficial conversion feature		24,974
Amortization of embedded derivatives	(18,529)	(32,071)	(21,482)
Amortization of beneficial conversion feature	(8,681)	(19,401)	(14,896)
Ending balance of unamortized discount	218,255	245,465	201,075
Convertible Debt [Member] \| 6.75% Senior Convertible Debentures [Member]
Debt Instrument [Line Items]
Interest expense associated with embedded derivatives	0	6,097	5,914
Convertible Debt [Member] \| 6.75% Variable Interest Senior Convertible Exchange Notes due 2014 [Member]
Debt Instrument [Line Items]
Interest expense associated with embedded derivatives	0	13,570	11,799
Convertible Debt [Member] \| 3.875% Senior Convertible Debentures [Member]
Debt Instrument [Line Items]
Interest expense associated with embedded derivatives	0	0	155
Convertible Debt [Member] \| 7.5% Senior Convertible Debentures [Member]
Debt Instrument [Line Items]
Interest expense associated with embedded derivatives	8,777	5,553	3,614
Convertible Debt [Member] \| 5.5% Variable Interest Senior Convertible Debentures due 2020 [Member]
Debt Instrument [Line Items]
Interest expense associated with embedded derivatives	9,752	6,851	0
Unamortized Debt Discount [Roll Forward]
Beginning balance of unamortized discount	98,831
Ending balance of unamortized discount	86,136	98,831
Interest Rate Risk [Member]
Debt Instrument [Line Items]
Gain on changes in fair value of derivatives embedded within convertible debt	24,455	19,409	18,935
Interest Rate Risk [Member] \| Convertible Debt [Member]
Fair Value Of Derivatives [Roll Forward]
Beginning balance of derivative liability fair value	169,386	112,062	172,128
Decrease in derivative due to conversion	(889)		(41,131)
Increase from issuance		82,775
(Gain) loss from changes in fair value of embedded derivatives	(24,455)	(19,409)	(18,935)
Ending balance of derivative liability fair value	144,042	169,386	112,062
Interest Rate Risk [Member] \| Convertible Debt [Member] \| 6.75% Senior Convertible Debentures [Member]
Debt Instrument [Line Items]
Gain on changes in fair value of derivatives embedded within convertible debt	(5)	3,212	5,075
Fair Value Of Derivatives [Roll Forward]
Beginning balance of derivative liability fair value	884	6,607	11,682
Decrease in derivative due to conversion	(889)	(2,511)
(Gain) loss from changes in fair value of embedded derivatives	5	(3,212)	(5,075)
Ending balance of derivative liability fair value	0	884	6,607
Unamortized Debt Discount [Roll Forward]
Beginning balance of unamortized discount	0	19,312	30,383
Decrease in unamortized discount due to conversion		(7,898)
Issuance of convertible notes - embedded derivative		0
Increase of convertible notes - beneficial conversion feature		0
Amortization of embedded derivatives	0	(6,097)	(5,914)
Amortization of beneficial conversion feature	0	(5,317)	(5,157)
Ending balance of unamortized discount	0	0	19,312
Interest Rate Risk [Member] \| Convertible Debt [Member] \| 6.75% Variable Interest Senior Convertible Exchange Notes due 2014 [Member]
Debt Instrument [Line Items]
Gain on changes in fair value of derivatives embedded within convertible debt	0	8,990	9,625
Fair Value Of Derivatives [Roll Forward]
Beginning balance of derivative liability fair value	0	12,521	22,146
Decrease in derivative due to conversion		(3,531)
(Gain) loss from changes in fair value of embedded derivatives	0	(8,990)	(9,625)
Ending balance of derivative liability fair value	0	0	12,521
Unamortized Debt Discount [Roll Forward]
Beginning balance of unamortized discount	0	25,945	45,038
Decrease in unamortized discount due to conversion		(3,989)
Issuance of convertible notes - embedded derivative		0
Increase of convertible notes - beneficial conversion feature		0
Amortization of embedded derivatives	0	(13,570)	(11,799)
Amortization of beneficial conversion feature	0	(8,386)	(7,294)
Ending balance of unamortized discount	0	0	25,945
Interest Rate Risk [Member] \| Convertible Debt [Member] \| 3.875% Senior Convertible Debentures [Member]
Debt Instrument [Line Items]
Gain on changes in fair value of derivatives embedded within convertible debt	0	0	(1,417)
Fair Value Of Derivatives [Roll Forward]
Beginning balance of derivative liability fair value	0	0	39,714
Decrease in derivative due to conversion			(41,131)
(Gain) loss from changes in fair value of embedded derivatives	0	0	1,417
Ending balance of derivative liability fair value	0	0	0
Unamortized Debt Discount [Roll Forward]
Beginning balance of unamortized discount	0	0	36,107
Decrease in unamortized discount due to conversion			(35,870)
Issuance of convertible notes - embedded derivative		0
Increase of convertible notes - beneficial conversion feature		0
Amortization of embedded derivatives	0	0	(155)
Amortization of beneficial conversion feature	0	0	(82)
Ending balance of unamortized discount	0	0	0
Interest Rate Risk [Member] \| Convertible Debt [Member] \| 7.5% Senior Convertible Debentures [Member]
Debt Instrument [Line Items]
Gain on changes in fair value of derivatives embedded within convertible debt	15,555	5,296	5,652
Fair Value Of Derivatives [Roll Forward]
Beginning balance of derivative liability fair value	87,638	92,934	98,586
(Gain) loss from changes in fair value of embedded derivatives	(15,555)	(5,296)	(5,652)
Ending balance of derivative liability fair value	72,083	87,638	92,934
Unamortized Debt Discount [Roll Forward]
Beginning balance of unamortized discount	146,634	155,818	161,795
Issuance of convertible notes - embedded derivative		0
Increase of convertible notes - beneficial conversion feature		0
Amortization of embedded derivatives	(8,777)	(5,553)	(3,614)
Amortization of beneficial conversion feature	(5,738)	(3,631)	(2,363)
Ending balance of unamortized discount	132,119	146,634	155,818
Interest Rate Risk [Member] \| Convertible Debt [Member] \| 5.5% Variable Interest Senior Convertible Debentures due 2020 [Member]
Debt Instrument [Line Items]
Gain on changes in fair value of derivatives embedded within convertible debt	8,905	1,911	0
Fair Value Of Derivatives [Roll Forward]
Beginning balance of derivative liability fair value	80,864	0	0
Increase from issuance		82,775
(Gain) loss from changes in fair value of embedded derivatives	(8,905)	(1,911)	0
Ending balance of derivative liability fair value	71,959	80,864	0
Unamortized Debt Discount [Roll Forward]
Beginning balance of unamortized discount	98,831	0	0
Issuance of convertible notes - embedded derivative		82,775
Increase of convertible notes - beneficial conversion feature		24,974
Amortization of embedded derivatives	(9,752)	(6,851)	0
Amortization of beneficial conversion feature	(2,943)	(2,067)	0
Ending balance of unamortized discount	$ 86,136	$ 98,831	$ 0

Notes Payable, Long Term Debt and Other Obligations - Liggett Debt and Commitments (Details)		12 Months Ended
	Jan. 14, 2015 USD ($)	Dec. 31, 2015 USD ($) financingagreements	Dec. 31, 2014 USD ($) financingagreements	Dec. 31, 2013 USD ($) financingagreements
Debt Instrument [Line Items]
Long-term Debt		$ 895,168,000	$ 913,351,000
Liggett [Member]
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity		$ 50,000,000
Line of Credit, covenant term restriction prior to payment of dividend		30 days
Required minimum borrowing availability 30 days prior to payment of dividend		$ 5,000,000
Line of Credit [Member] \| Liggett [Member]
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity	$ 60,000,000
Debt Covenant, Borrowing Base, Account Receivable	85.00%
Debt Covenant, Borrowing Base, Account Receivable Plus Amount	$ 10,000,000
Debt Covenant, Borrowing Base, Inventory	80.00%
Debt Covenant, Borrowing Base, Inventory, Cost Multiplier	60.00%
Debt Covenant, Borrowing Base, Inventory, Liquidation Value	85.00%
Credit Facility, Covenant measurement trailing period	12 months
Minimum Ebitda Ratio On Trailing Twelve Month Basis If Excess Availability Is Less Than 20000 Thousand	$ 100,000,000
Covenant, excess availability in credit facility threshold	20,000,000
Covenant, capital expenditure requirement, maximum carryover amount	10,000,000
Maximum Capital Expenditures Allowed Before Maximum Carryover Amount of 2500 Thousand	$ 20,000,000
Interest rate at end of period		2.70%
Covenant, Excess Property Value		$ 5,000,000
Line of Credit [Member] \| Liggett [Member] \| Federal Funds Rate [Member]
Debt Instrument [Line Items]
Basis spread on variable rate	0.50%
Line of Credit [Member] \| Liggett [Member] \| Prime Rate [Member]
Debt Instrument [Line Items]
Basis spread on variable rate	1.00%
Line of Credit [Member] \| Liggett [Member] \| LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate	2.25%
Line of Credit [Member] \| Revolving Credit Facility [Member] \| Liggett [Member]
Debt Instrument [Line Items]
Long-term Debt		3,213,000	17,767,000
Line of Credit [Member] \| Revolving Credit and Term Loan Facility [Member] \| Liggett [Member]
Debt Instrument [Line Items]
Long-term Line of Credit		6,482,000
Availability as determined under the facility		51,452,000
Line of Credit [Member] \| Term Loan Under Credit Facility [Member] \| Liggett [Member]
Debt Instrument [Line Items]
Face amount	$ 3,600,000
Periodic Payment	$ 25,000
Outstanding Principal After Total Future Periodic Payments		2,000,000
Long-term Debt		$ 3,269,000	$ 3,589,000
Financing Agreements [Member] \| Three Financing Arrangements [Member] \| Liggett [Member]
Debt Instrument [Line Items]
Financing Agreements Entered Into \| financingagreements			3
Long-term Debt, Weighted Average Interest Rate			5.02%
Long-term Debt			$ 5,115,000
Monthly Installment Amount			$ 95,000
Financing Agreements [Member] \| Three Financing Arrangements [Member] \| Liggett [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Interest Rate			4.98%
Financing Agreements [Member] \| Three Financing Arrangements [Member] \| Liggett [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Interest Rate			5.04%
Financing Agreements [Member] \| Two Financing Agreements [Member] \| Liggett [Member]
Debt Instrument [Line Items]
Financing Agreements Entered Into \| financingagreements		2		2
Long-term Debt, Weighted Average Interest Rate		4.79%		4.49%
Interest Rate				3.28%
Long-term Debt		$ 1,765,000		$ 6,580,000
Monthly repayments of long term debt				$ 181,000
Monthly Installment Amount		$ 33,000
Financing Agreements [Member] \| Two Financing Agreements [Member] \| Liggett [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Interest Rate		4.49%		4.93%
Financing Agreements [Member] \| Two Financing Agreements [Member] \| Liggett [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Interest Rate		4.85%
Refinanced Financing Agreements [Member] \| Three Financing Arrangements [Member] \| Liggett [Member]
Debt Instrument [Line Items]
Interest Rate			4.99%
Term of Loan			36 months
Refinanced Financing Agreements [Member] \| Financing Arrangement 5 Point 63 Percent [Member] \| Liggett [Member]
Debt Instrument [Line Items]
Interest Rate			5.63%
Long-term Debt			$ 2,843,000
Term of Loan			21 months

Notes Payable, Long Term Debt and Other Obligations - Fair Value of Notes Payable and Long Term Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value of long-term debt		$ 1,313,711
Carrying Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value of long-term debt	$ 895,168	$ 913,351
Significant Other Observable Inputs (Level 2) \| Fair Value, Measurements, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value of long-term debt	$ 1,297,875

Notes Payable, Long Term Debt and Other Obligations - Schedule of Maturities (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Debt Disclosure [Abstract]
2015 Principal	$ 8,919
2015 Unamortized Discount	0
2015 Net	8,919
2016 Principal	2,254
2016 Unamortized Discount	0
2016 Net	2,254
2017 Principal	2,001
2017 Unamortized Discount	0
2017 Net	2,001
2018 Principal	231,160
2018 Unamortized Discount	132,119
2018 Net	99,041
2019 Principal	261,075
2019 Unamortized Discount	86,136
2019 Net	174,939
Thereafter Principal	600,000
Thereafter Unamortized Discount	(8,014)
Thereafter Net	608,014
Long-term Debt, Gross	1,105,409
Unamortized Discount/ (Premium)	210,241
Total notes payable, long - term debt and other obligations	$ 895,168	$ 913,351

Commitments (Details) - USD ($) $ in Thousands	12 Months Ended
Commitments (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]
Operating lease term (more than one year)	1 year
Lease Commitments, 2016	$ 25,463
Lease Commitments, 2017	21,064
Lease Commitments, 2018	18,928
Lease Commitments, 2019	14,912
Lease Commitments, 2020	11,835
Lease Commitments, Thereafter	72,888
Lease Commitments, Total	165,090
Rental expense	$ 24,446	$ 22,516	$ 6,523

Employee Benefit Plans (Narrative) (Details) $ in Thousands	12 Months Ended
Employee Benefit Plans (Narrative) (Details) $ in Thousands	Dec. 31, 2015 USD ($) employees plans yr	Dec. 31, 2014 USD ($) plans	Dec. 31, 2013 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Number of defined benefit plans \| plans	4	4
Accumulated other comprehensive income (loss)	$ 34,319	$ 29,899	$ 26,216
Accumulated benefit obligations in excess of aggregate projected benefit obligation	47,535	41,214
Accumulated benefit obligations in excess of aggregate accumulated benefit obligation	47,535	41,214
Accumulated benefit obligations in excess of aggregate fair value of plan assets	0	0
Defined Benefit Plan, Estimated Future Benefit Payments [Abstract]
Defined Contribution Plan, Cost Recognized	$ 1,467	1,219	1,190
Qualified Defined Benefit Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Number of defined benefit plans \| plans	2
Non-qualified Defined Benefit Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Number of defined benefit plans \| plans	1
Supplemental Employee Retirement Plans [Member]
Defined Benefit Plan, Estimated Future Benefit Payments [Abstract]
2016	$ 0
2017	0
2018	0
2019	0
2020	7,111
2021 - 2025	$ 47,586
Postretirement Medical [Member]
Defined Benefit Plan Disclosure [Line Items]
Number Of Participating Employees \| employees	219
Employee Contribution Percentage	100.00%
Defined Benefit Plan, Estimated Future Benefit Payments [Abstract]
2016	$ 595
2017	618
2018	607
2019	609
2020	606
2021 - 2025	$ 2,953
Life Insurance Benefit [Member]
Defined Benefit Plan Disclosure [Line Items]
Number Of Participating Employees \| employees	164
Postretirement Life Insurance [Member]
Defined Benefit Plan Disclosure [Line Items]
Number Of Participating Employees \| employees	402
Pension Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Number of defined benefit plans \| plans	3
Accumulated other comprehensive income (loss)	$ 35,258	30,481	27,102
Defined Benefit Plan, Estimated Future Benefit Payments [Abstract]
2016	9,548
2017	9,053
2018	8,618
2019	8,139
2020	14,786
2021 - 2025	79,462
Other Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Accumulated other comprehensive income (loss)	$ (939)	$ (582)	$ (886)
Houly Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Period For Amortization of Benefit Plan Gains and Losses (in years)	16 years 1 month 28 days
Salaried Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Period For Amortization of Benefit Plan Gains and Losses (in years)	15 years 11 months 26 days
Minimum [Member]
Defined Benefit Plan Disclosure [Line Items]
Percentage of Excess in Projected Benefit Obligation and Fair Value Assets To Be Amortized	10.00%
Minimum [Member] \| Supplemental Employee Retirement Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Age Requirement For Plant Participation \| yr	60
Required employment period	8 years
Ten Year Rate of Return [Member] \| Pension Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Actual Rate of Return Period (in years)	10 years
Actual Rate of Return On Plan Assets	6.00%	6.60%	7.20%
Five Year Rate of Return [Member] \| Pension Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Actual Rate of Return Period (in years)	5 years
Actual Rate of Return On Plan Assets	6.30%	9.80%	13.60%
President and Chief Executive Officer [Member] \| Supplemental Employee Retirement Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Additional SERP Benefit			$ 736
Service Period Credit Upon Termination			36 months

Employee Benefit Plans Schedule of Defined Benefit Plan Activity (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Amounts recognized in the consolidated balance sheets:
Prepaid pension costs	$ 20,650	$ 25,032
Non-current employee benefit liabilities	(55,055)	(49,314)
Pension Plans [Member]
Change in benefit obligation:
Benefit obligation at January 1	(150,199)	(150,911)
Service cost	(532)	(523)	$ (1,170)
Interest cost	(4,992)	(6,196)	(5,518)
Plan settlement	17,047	0
Special termination benefits	(3,831)	0	0
Benefits paid	9,879	10,207
Expenses paid	490	322
Actuarial (gain) loss	(1,368)	(3,098)
Benefit obligation at December 31	(133,506)	(150,199)	(150,911)
Change in plan assets:
Balance as of January 1	134,017	137,036
Actual return on plan assets	(327)	7,162
Plan settlement	(17,047)	0
Expenses paid	(490)	(322)
Contributions	346	348
Benefits paid	(9,879)	(10,207)
Balance as of December 31	106,620	134,017	137,036
Unfunded status at December 31	(26,886)	(16,182)
Amounts recognized in the consolidated balance sheets:
Prepaid pension costs	20,650	25,032
Other accrued liabilities	(320)	(324)
Non-current employee benefit liabilities	(47,216)	(40,890)
Net amounts recognized	(26,886)	(16,182)
Other Postretirement Benefits [Member]
Change in benefit obligation:
Benefit obligation at January 1	(9,031)	(8,899)
Service cost	(8)	(9)	(16)
Interest cost	(371)	(430)	(418)
Plan settlement	0	0
Special termination benefits	0	0	0
Benefits paid	522	552
Expenses paid	0	0
Actuarial (gain) loss	454	(245)
Benefit obligation at December 31	(8,434)	(9,031)	(8,899)
Change in plan assets:
Balance as of January 1	0	0
Actual return on plan assets	0	0
Plan settlement	0	0
Expenses paid	0	0
Contributions	522	552
Benefits paid	(522)	(552)
Balance as of December 31	0	0	$ 0
Unfunded status at December 31	(8,434)	(9,031)
Amounts recognized in the consolidated balance sheets:
Prepaid pension costs	0	0
Other accrued liabilities	(595)	(607)
Non-current employee benefit liabilities	(7,839)	(8,424)
Net amounts recognized	$ (8,434)	$ (9,031)

Employee Benefit Plans Net Periodic Cost (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Pension Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost — benefits earned during the period	$ 532	$ 523	$ 1,170
Interest cost on projected benefit obligation	4,992	6,196	5,518
Expected return on assets	(7,378)	(8,518)	(7,915)
Settlement loss	3,214	0	244
Special termination benefit recognized	3,831	0	0
Amortization of net loss (gain)	1,083	1,075	1,918
Net expense (income)	6,274	(724)	935
Other Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost — benefits earned during the period	8	9	16
Interest cost on projected benefit obligation	371	430	418
Expected return on assets	0	0	0
Settlement loss	0	0	0
Special termination benefit recognized	0	0	0
Amortization of net loss (gain)	(97)	(60)	(64)
Net expense (income)	$ 282	$ 379	$ 370

Employee Benefit Plans Accumulated Other Comprehensive Income Next Fixal Year (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2015 USD ($)
Defined Benefit Plan, Amount to be Amortized from Accumulated Other Comprehensive Income (Loss) Next Fiscal Year [Abstract]
Actuarial loss (gain)	$ 1,780
Pension Plans [Member]
Defined Benefit Plan, Amount to be Amortized from Accumulated Other Comprehensive Income (Loss) Next Fiscal Year [Abstract]
Actuarial loss (gain)	1,855
Postretirement Benefits [Member]
Defined Benefit Plan, Amount to be Amortized from Accumulated Other Comprehensive Income (Loss) Next Fiscal Year [Abstract]
Actuarial loss (gain)	$ (75)

Employee Benefit Plans Amounts Recognized Accumlated Other Comprehensive Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Plan Disclosure [Line Items]
Accumulated other comprehensive (loss) income as of January 1, 2015	$ (29,899)	$ (26,216)
Amortization of gain (loss)	4,200	1,015
Net (loss) gain arising during the year	(8,620)	(4,698)	$ 9,513
Accumulated other comprehensive (loss) income as of December 31, 2015	(34,319)	(29,899)	(26,216)
Defined Benefit Pension Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Accumulated other comprehensive (loss) income as of January 1, 2015	(30,481)	(27,102)
Amortization of gain (loss)	4,297	1,075
Net (loss) gain arising during the year	(9,074)	(4,454)
Accumulated other comprehensive (loss) income as of December 31, 2015	(35,258)	(30,481)	(27,102)
Other Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Accumulated other comprehensive (loss) income as of January 1, 2015	582	886
Amortization of gain (loss)	(97)	(60)
Net (loss) gain arising during the year	454	(244)
Accumulated other comprehensive (loss) income as of December 31, 2015	$ 939	$ 582	$ 886

Employee Benefit Plans Defined Benefit Plan Assumptions Used (Details)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Pension Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Assumed rates of return on invested assets	6.00%	6.50%	6.50%
Pension Plans [Member] \| Minimum [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rates — benefit obligation	3.75%	2.75%	3.00%
Discount rates — service cost	2.75%	3.00%	2.25%
Pension Plans [Member] \| Maximum [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rates — benefit obligation	4.50%	4.00%	4.75%
Discount rates — service cost	4.25%	4.75%	4.00%
Other Postretirement Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount rates — benefit obligation	4.75%	4.25%	5.00%
Discount rates — service cost	4.25%	5.00%	4.25%
Assumed rates of return on invested assets	0.00%	0.00%	0.00%
Salary increase assumptions	3.00%	3.00%	3.00%

Employee Benefit Plans Plan Asset Allocation (Details)	Nov. 29, 2012	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target Allocation Percentage of Assets, Rebalancing Allocation	5.00%
Actual Allocation		100.00%	100.00%
Marketable equity securities
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target Allocation Percentage of Assets	50.00%
Actual Allocation		51.00%	50.00%
Investment Grade Fixed Income Investments [Member]
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target Allocation Percentage of Assets	30.00%
Actual Allocation		30.00%	29.00%
High Yield Fixed Income Investments [Member]
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target Allocation Percentage of Assets	10.00%
Actual Allocation		11.00%	10.00%
Alternative Investments [Member]
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target Allocation Percentage of Assets	5.00%
Actual Allocation		3.00%	5.00%
Short-term Investments [Member]
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target Allocation Percentage of Assets	5.00%
Actual Allocation		5.00%	6.00%

Employee Benefit Plans Pension Plan Assets Fair Value Measurement Reconciliation of Unobservable Inputs (Details) - Significant Unobservable Inputs (Level 3) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Change in plan assets:
Balance as of January 1	$ 6,824	$ 9,031
Transfers	0	(641)
Distributions	(2,904)	(1,018)
Unrealized (loss) gain on long-term investments	(470)	3,403
Realized loss on long-term investments	(36)	(3,951)
Balance as of December 31	$ 3,414	$ 6,824

Employee Benefit Plans Assumed Health Care Cost Trend Rates (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Plan, Effect of One-Percentage Point Change in Assumed Health Care Cost Trend Rates [Abstract]
Effect on total of service and interest cost components, 1% Increase	$ 4
Effect on total of service and interest cost components, 1% Decrease	(4)
Effect on benefit obligation, 1% Increase	79
Effect on benefit obligation, 1% Decrease	$ (74)
Health Trend Rates For the Subsequent Tenth Year [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year	4.50%	4.50%
Minimum [Member] \| Health Trend Rates For the Subsequent Nine Years [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year	1.29%	1.53%
Maximum [Member] \| Health Trend Rates For the Subsequent Nine Years [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year	17.92%	6.29%

Employee Benefit Plans Future Benefit Payments (Details) $ in Thousands	Dec. 31, 2015 USD ($)
Pension Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
2016	$ 9,548
2017	9,053
2018	8,618
2019	8,139
2020	14,786
2021 - 2025	79,462
Postretirement Medical [Member]
Defined Benefit Plan Disclosure [Line Items]
2016	595
2017	618
2018	607
2019	609
2020	606
2021 - 2025	$ 2,953

Restructuring - Schedule of Restructuring and Related Costs (Details) $ in Thousands	1 Months Ended	12 Months Ended
	Oct. 30, 2015 employee	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
Restructuring Reserve [Roll Forward]
Restructuring charges		$ 7,257	$ 0	$ 0
Tobacco [Member]
Restructuring Cost and Reserve [Line Items]
Number of positions eliminated \| employee	95
Percent of positions eliminated	17.00%
Restructuring Expense, Non Cash Charges		5,892
Restructuring Expense, Cash Charges		1,365
Restructuring Reserve [Roll Forward]
Accrual balance as of January 1, 2015		0
Restructuring charges		7,257
Utilized		(6,767)
December 31, 2015		490	0
Tobacco [Member] \| Employee severance and benefits
Restructuring Cost and Reserve [Line Items]
Restructuring Expense, Cash Charges		1,094
Restructuring Reserve [Roll Forward]
Accrual balance as of January 1, 2015		0
Restructuring charges		1,094
Utilized		(672)
December 31, 2015		422	0
Tobacco [Member] \| Lease termination costs
Restructuring Cost and Reserve [Line Items]
Restructuring Expense, Cash Charges		203
Restructuring Reserve [Roll Forward]
Accrual balance as of January 1, 2015		0
Restructuring charges		203
Utilized		(155)
December 31, 2015		48	0
Tobacco [Member] \| Employee pension benefits
Restructuring Cost and Reserve [Line Items]
Restructuring Expense, Non Cash Charges		5,438
Tobacco [Member] \| Other restructuring expenses
Restructuring Cost and Reserve [Line Items]
Restructuring Expense, Cash Charges		68
Restructuring Reserve [Roll Forward]
Accrual balance as of January 1, 2015		0
Restructuring charges		68
Utilized		(48)
December 31, 2015		20	0
Tobacco [Member] \| Point of Sale inventory impairment
Restructuring Cost and Reserve [Line Items]
Restructuring Expense, Non Cash Charges		454
Tobacco [Member] \| Non-Cash Pension Expense
Restructuring Reserve [Roll Forward]
Accrual balance as of January 1, 2015		0
Restructuring charges		5,438
Utilized		(5,438)
December 31, 2015		0	0
Tobacco [Member] \| Non-Cash Asset Impairment
Restructuring Reserve [Roll Forward]
Accrual balance as of January 1, 2015		0
Restructuring charges		454
Utilized		(454)
December 31, 2015		0	$ 0
Tobacco [Member] \| Special Termination Benefits
Restructuring Reserve [Roll Forward]
Restructuring charges		3,831
Utilized		$ (1,607)

Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Ownership percentage of subsidiaries included in tax return (more than 80%)	80.00%
Various U.S. state tax loss carryforwards	$ 6,713	$ 8,339
Valuation allowance	3,900	4,933
Unrecognized tax benefits	1,523	1,744	$ 3,122	$ 6,269
Unrecognized tax benefits, penalties and interest expense	(28)	(529)
Unrecognized tax benefits, penalties and interest accrued	219	$ 247
Reasonably possible amount recognized over next 12 months	$ 107

Income Taxes (Components of Income Taxes) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Current:
U.S. Federal	$ 40,542	$ 8,809	$ 20,808
State	13,886	2,416	3,521
Current Total	54,428	11,225	24,329
Deferred:
U.S. Federal	(9,943)	16,484	(372)
State	(3,252)	5,456	(285)
Deferred Total	(13,195)	21,940	(657)
Income tax expense	$ 41,233	$ 33,165	$ 23,672

Income Taxes (Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Deferred tax assets:
Employee benefit accruals	$ 16,201	$ 11,678
Impairment of investments	4,332	0
Impact of timing of settlement payments	39,840	33,485
Various U.S. state tax loss carryforwards	6,713	8,339
Other	0	0
Deferred tax assets	67,086	53,502
Less: Valuation allowance	(3,900)	(4,933)
Net deferred tax assets	63,186	48,569
Deferred tax liabilities:
Excess of tax basis over book-basis non-consolidated entities	(7,292)	(6,190)
Book/tax differences on fixed and Intangible assets	(52,598)	(52,972)
Deferred Tax Liabilities, Deferred Expense, Capitalized Interest	(4,080)	0
Book/tax differences on inventory	(16,891)	(20,062)
Book/tax differences on long-term investments	(29,701)	(32,756)
Impact of accounting on convertible debt	(30,494)	(31,033)
Other	(1,559)	(1,460)
Deferred tax liabilities	(142,615)	(144,473)
Net deferred tax liabilities	$ (79,429)	$ (95,904)

Income Taxes (Income Tax Reconciliation) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Income before provision for income taxes	$ 107,705	$ 82,279	$ 60,720
Federal income tax expense at statutory rate	37,697	28,798	21,252
Increases (decreases) resulting from:
State income taxes, net of federal income tax benefits	6,862	4,804	2,050
Impact of non-controlling interest	(2,516)	(4,290)	88
Non-deductible expenses	2,941	2,581	2,698
Impact of domestic production deduction	(3,436)	(248)	(1,889)
Tax credits	(265)	(275)	(433)
Other	152	0	0
Inclusion of tax liabilities from unincorporated entities	831	1,374	0
Changes in valuation allowance, net of equity and tax audit adjustments	(1,033)	421	(94)
Income tax expense	$ 41,233	$ 33,165	$ 23,672

Income Taxes (Unrecognized Tax Benefits) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance	$ 1,744	$ 3,122	$ 6,269
Additions based on tax positions related to prior years	265	318	179
Expirations of the statute of limitations	(354)	(1,254)	(3,076)
Settlements	(132)	(442)	(250)
Balance	$ 1,523	$ 1,744	$ 3,122

Stock Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
	May 16, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price of options (in dollars per share)			$ 17.82	$ 13.93
Option exercises in period, intrinsic value		$ 1,151	$ 3,539	$ 93
Tax benefit of options exercised		821	1,178	38
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense		$ 1,675	1,573	2,212
Contractual term		10 years
Total compensation cost not yet recognized		$ 3,775
Total compensation cost not yet recognized, period for recognition		1 year 10 months 18 days
Tax benefit of options exercised		$ 821	$ 1,178	$ 38
Stock Options [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		3 years
Stock Options [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		7 years
Non-Qualfied Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued (in shares)		406,875	427,219	868,219
Exercise price of options (in dollars per share)		$ 22.00	$ 17.82	$ 13.93
2014 Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual short-term cash incentives performance period	12 months
Shares authorized		7,888,406

Stock Compensation Fair Value Assumptions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate, Minimum	1.80%	1.10%	0.60%
Risk-free interest rate, Maximum	2.00%	2.60%	1.80%
Expected volatility, Minimum	22.18%	18.51%	20.05%
Expected volatility, Maximum	22.25%	22.37%	24.08%
Dividend yield	0.00%	0.00%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected holding period	7 years	4 years	4 years
Weighted-average grant date fair value	$ 6.47	$ 3.28	$ 2.72
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected holding period	10 years	10 years	10 years
Weighted-average grant date fair value	$ 8.07	$ 7.32	$ 5.80

Stock Compensation Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2011	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding (in shares)	3,454,292.000	3,469,825.000	2,645,914
Granted (in shares)	406,875		868,219
Exercised (in shares)	(115,531)	(442,740)	(44,293)
Canceled (in shares)	(5)	(12)	(15)
Outstanding (in shares)	3,745,631	3,454,292.000	3,469,825.000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 12.77	$ 11.98	$ 11.33
Granted, Weighted Average Exercise Price (in dollars per share)		17.82	13.93
Exercised, Weighted Average Exercise Price (in dollars per share)	12.02	11.41	12.29
Cancelled, Weighted Average Exercise Price (in dollars per share)	0.00	0.00	0.00
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 13.82	$ 12.77	$ 11.98
Outstanding, Weighted Average Remaining Contractual Term	5 years 10 months 24 days	6 years 4 months 24 days	6 years 6 months 18 days	6 years 7 months 6 days
Outstanding, Aggregate Intrinsic Value	$ 36,612	$ 25,977	$ 9,959		$ 4,371
Options exercisable (in shares)	2,035,345	1,598,885	1,959,317
Common stock fair value	$ 23.59	$ 20.3	$ 14.85

Stock Compensation Shares Authorized under Stock Option Plans by Exercise Price Range (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2011	Dec. 31, 2012
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding (in shares)	3,745,631	3,454,292.000	3,469,825.000		2,645,914
Outstanding, Weighted Average Remaining Contractual Term	5 years 10 months 24 days	6 years 4 months 24 days	6 years 6 months 18 days	6 years 7 months 6 days
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 13.82	$ 12.77	$ 11.98		$ 11.33
Options exercisable (in shares)	2,035,345	1,598,885	1,959,317
Exercisable, Weighted-Average Remaining Contractual Life (Years)	4 years 2 months 12 days
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 11.30
Options Exercisable, Weighted Aggregate Intrinsic Value	$ 25,024
Exercise Price Range One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Minimum (in dollars per share)	$ 0.00
Range of Exercise Prices, Maximum (in dollars per share)	$ 11.00
Options Outstanding (in shares)	1,500,905
Outstanding, Weighted Average Remaining Contractual Term	3 years 10 months 24 days
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 10.52
Options exercisable (in shares)	1,500,905
Exercisable, Weighted-Average Remaining Contractual Life (Years)	3 years 10 months 24 days
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 10.52
Options Exercisable, Weighted Aggregate Intrinsic Value	$ 0
Exercise Price Range Two [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Minimum (in dollars per share)	$ 11.00
Range of Exercise Prices, Maximum (in dollars per share)	$ 13.20
Options Outstanding (in shares)	31,906
Outstanding, Weighted Average Remaining Contractual Term	5 years 1 month 6 days
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 12.46
Options exercisable (in shares)	23,928
Exercisable, Weighted-Average Remaining Contractual Life (Years)	5 years 1 month 6 days
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 12.46
Options Exercisable, Weighted Aggregate Intrinsic Value	$ 0
Exercise Price Range Three [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Minimum (in dollars per share)	$ 13.20
Range of Exercise Prices, Maximum (in dollars per share)	$ 15.40
Options Outstanding (in shares)	1,378,728
Outstanding, Weighted Average Remaining Contractual Term	6 years 4 months 24 days
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 13.78
Options exercisable (in shares)	510,512
Exercisable, Weighted-Average Remaining Contractual Life (Years)	5 years
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 13.52
Options Exercisable, Weighted Aggregate Intrinsic Value	$ 0
Exercise Price Range Four [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Minimum (in dollars per share)	$ 15.40
Range of Exercise Prices, Maximum (in dollars per share)	$ 17.60
Options Outstanding (in shares)	0
Outstanding, Weighted Average Remaining Contractual Term	0 years
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 0.00
Options exercisable (in shares)	0
Exercisable, Weighted-Average Remaining Contractual Life (Years)	0 years
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 0.00
Options Exercisable, Weighted Aggregate Intrinsic Value	$ 0
Exercise Price Range Five [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Minimum (in dollars per share)	$ 17.60
Range of Exercise Prices, Maximum (in dollars per share)	$ 19.80
Options Outstanding (in shares)	427,217
Outstanding, Weighted Average Remaining Contractual Term	8 years 4 months 24 days
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 17.82
Options exercisable (in shares)	0
Exercisable, Weighted-Average Remaining Contractual Life (Years)	0 years
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 0.00
Options Exercisable, Weighted Aggregate Intrinsic Value	$ 0
Exercise Price Range Six [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Minimum (in dollars per share)	$ 19.80
Range of Exercise Prices, Maximum (in dollars per share)	$ 22.00
Options Outstanding (in shares)	406,875
Outstanding, Weighted Average Remaining Contractual Term	9 years 2 months 12 days
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 22.00
Options exercisable (in shares)	0
Exercisable, Weighted-Average Remaining Contractual Life (Years)	0 years
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 0.00
Options Exercisable, Weighted Aggregate Intrinsic Value	$ 0

Stock Compensation Restricted Stock Activity (Details) - Restricted Stock [Member] $ in Thousands			1 Months Ended				12 Months Ended
	Oct. 10, 2015 USD ($) shares	Jul. 23, 2014 USD ($) shares	Oct. 31, 2013 USD ($) shares	May 31, 2013 USD ($) directors shares	Nov. 30, 2011 USD ($) directors shares	Jun. 30, 2010 USD ($) shares	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total compensation cost not yet recognized							$ 44,632	$ 20,181
Total compensation cost not yet recognized, period for recognition							3 years 2 months 9 days
Restricted Stock Granted During May 2013 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Other than options, grants in period (shares) \| shares				11,576
Share-based compensation expense							$ 272	271	$ 161
Number of directors (in directors) \| directors				5
Share-based compensation over vesting period				$ 815
Award vesting period				3 years
Restricted Stock Granted During June 2010 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Other than options, grants in period (shares) \| shares						13,401
Share-based compensation over vesting period						$ 749
Number of directors resigned (in directors) \| directors					1
Forfeited in the period (shares) \| shares					8,509
Award vesting period					3 years
Restricted Stock Granted During November 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Other than options, grants in period (shares) \| shares					8,104
Share-based compensation expense								133
Share-based compensation over vesting period					$ 120
Award vesting period					19 months
Chief Executive Officer [Member] \| Restricted Stock Granted During November 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Other than options, grants in period (shares) \| shares	1,200,000
Performance period	7 years
Other than options, granted, fair value	$ 28,374
Share-based compensation expense							597
Chief Executive Officer [Member] \| Restricted Stock Granted During July 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Other than options, grants in period (shares) \| shares		1,102,500
Other than options, granted, fair value		$ 20,780
Share-based compensation expense							2,992	1,320
Chief Executive Officer [Member] \| Restricted Stock Granted During October 2013 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Other than options, grants in period (shares) \| shares			30,319
Share-based compensation expense							$ 86	$ 86	$ 14
Share-based compensation over vesting period			$ 458

Contingencies (Details)		1 Months Ended											3 Months Ended		12 Months Ended					25 Months Ended	78 Months Ended
Contingencies (Details)	May 15, 2013 case	Dec. 31, 2013 USD ($)	Oct. 31, 2013 USD ($) case	May 31, 2013 state	Dec. 31, 2012 state	Mar. 31, 2012 case	Jun. 30, 2010 person	May 31, 2009	May 31, 2003 USD ($) plaintiff	Jul. 31, 2000 USD ($)	Apr. 30, 2000 USD ($) plaintiff	Nov. 30, 1998 state	Dec. 31, 2015 USD ($) case	Mar. 31, 2015 USD ($)	Dec. 31, 2015 USD ($) case defendant sponsorship	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)	Dec. 31, 2010 USD ($) yr	Dec. 31, 2003 USD ($) state	Mar. 31, 1998 state	Sep. 30, 2012 state	Jul. 30, 2015 USD ($)	Jul. 13, 2015 case plaintiff claims	Apr. 30, 2015 USD ($)	Jun. 30, 2014 USD ($)	Apr. 30, 2014 USD ($)	Sep. 30, 2013 USD ($) state	Nov. 30, 2011 state	Jun. 30, 2009 USD ($)	Dec. 31, 2001 case
Loss Contingencies [Line Items]
Litigation, settlement and judgment expense															$ 20,072,000	$ 2,475,000	$ 88,106,000
Liggett Only Cases [Member]
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													3		3
Master Settlement Agreement [Member]
Loss Contingencies [Line Items]
Brand Name Sponsorship Period															12 months
Master Settlement Agreement [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Number of brand name sponsorships allowed \| sponsorship															1
Damages From Cigarette Smoking MSA and Other State Settlement Agreements [Member]
Loss Contingencies [Line Items]
Annual payment requirement															$ 9,000,000,000
MSA 2015 Obligation [Member]
Loss Contingencies [Line Items]
Previously accrued expense													$ 120,700,000		$ 120,700,000
NPM Adjustment [Member]
Loss Contingencies [Line Items]
Amounts not expensed by the Company																			$ 1,200,000,000
Loss Contingency, Aggregate Number of Settling States \| state																					49
Courts that decided the issue \| state																			48
Courts That Did Not Rule \| state																			1
Settling States \| state				2	20														45
Allocable Share of Settling States																			90.00%
Percentage of Reduction of any Potential 2003 NPM Adjustment																			20.00%
Number of People on Arbitration Panel \| person							3
Loss Contingency, Number of Settling States With Diligent Enforcement Not Contested \| state																												16
Combined Allocable Share, Diligent Enforcement not Contested							14.00%
Loss Contingency, Number of Non-Settling States \| state																											15
Loss Contingency, Number of Non-Settling States that Did not Diligently Enforce Escrow Statutes \| state																											6
Additional Synergy Exposure Cases [Member] \| Maryland
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													20		20
Department of Justice Lawsuit [Member]
Loss Contingencies [Line Items]
Required Reporting Period								10 years
Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Loss Contingency, Number of Cases Declined for Review by Supreme Court \| case						2
Engle Case Class Action [Member]
Loss Contingencies [Line Items]
Damages awarded										$ 145,000,000,000
Parsons v. AC & S Inc. [Member]
Loss Contingencies [Line Items]
Loss Contingency, Number of Defendants \| defendant															3
Loss Contingency, Damages Sought, Value															$ 1,000,000
Tobacco Litigation Personal Injury Cases [Member]
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													25		25								30							750
Loss Contingency, Claims Scheduled For Trial \| claims																							6
Number of Plaintiffs in Each Trial \| plaintiff																							5
Tobacco Litigation Personal Injury Cases [Member] \| Cases Ending in Mistrial [Member]
Loss Contingencies [Line Items]
Loss Contingency, Claims Dismissed, Number \| case	2
Loss Contingency, Claims Settled, Number \| case	1
Liggett [Member]
Loss Contingencies [Line Items]
Bonds													$ 15,767,000		$ 15,767,000
Damages awarded															29,102,000
Punitive Damages Awarded															18,400,000
Plaintiff legal fees															26,987,000	$ 9,944,000	9,321,000
Litigation Award Paid															(17,978,000)
Punitive Damages Paid															$ (1,000,000)
Liggett [Member] \| Florida
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													15		15
Liggett [Member] \| New York
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													7		7
Liggett [Member] \| Maryland
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													12		12
Liggett [Member] \| Louisiana
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													2		2
Liggett [Member] \| West Virginia
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													2		2
Liggett [Member] \| Missouri
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													1		1
Liggett [Member] \| Ohio
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													1		1
Liggett [Member] \| Individual Actions [Member]
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													40		40
Liggett [Member] \| Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Plaintiffs' verdicts (in cases) \| case													15		15
Liggett [Member] \| State Cases [Member]
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													260		260
Liggett [Member] \| Engle Progency Cases Excluding Lukacs [Member]
Loss Contingencies [Line Items]
Cases including punitive damages (in cases) \| case															4
Liggett [Member] \| Class Actions [Member]
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													3		3
Liggett [Member] \| Master Settlement Agreement [Member]
Loss Contingencies [Line Items]
Loss Contingency, Number of States Not Included in Settlement Agreement \| state												4
Liggett [Member] \| Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													1		1
Liggett [Member] \| Damages From Cigarette Smoking MSA and Other State Settlement Agreements [Member]
Loss Contingencies [Line Items]
MSA Payment Obligations													$ 0		$ 0
Payment obligations													1.65%		1.65%
Number of States \| state												46								45
Liggett [Member] \| NPM Adjustment [Member]
Loss Contingencies [Line Items]
Loss Contingency, Settlement Adjustment Credit													$ 834,000		$ 834,000										$ 1,400,000	$ 6,441,000	$ 5,987,000
Loss Contingency, Settlement Adjustment Credit, Disputed Entitled Amount																										1,315,000
Loss Contingency Possible Loss Additional Amount, Adjusted																										521,000
Loss Contingency, Net Recovery																										5,152,000
Liggett [Member] \| Gross Versus Net Dispute [Member]
Loss Contingencies [Line Items]
Previously accrued expense													$ 6,200,000		$ 6,200,000							$ 16,000,000
Payment obligations													1.25%		1.25%
Liggett [Member] \| Minnesota Settlement [Member]
Loss Contingencies [Line Items]
Annual payment requirement																			$ 100,000
Liggett [Member] \| Florida Settlement [Member]
Loss Contingencies [Line Items]
Damages awarded																		$ 1,200,000
Annual payment requirement																		$ 250,000
Years Annual Payments Required \| yr																		21
Liggett [Member] \| Florida Settlement [Member] \| Minimum [Member]
Loss Contingencies [Line Items]
Years Annual Payments Required That Are Subject To Inflation Adjustment \| yr																		12
Liggett [Member] \| Irimi and Cohen [Member]
Loss Contingencies [Line Items]
Plaintiffs' verdicts (in cases) \| case													2		2
Liggett [Member] \| Lukacs, Campbell, Douglas, Clay, Ward and Rizzuto [Member]
Loss Contingencies [Line Items]
Payments for Legal Settlements															$ 20,312,000
Settlements / dismissal of litigation \| case															7
Liggett [Member] \| Irimi v. R.J. Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															$ 31,000
Punitive Damages Awarded															0
Liggett [Member] \| Rizzuto v. R.J. Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															3,479,000
Punitive Damages Awarded															0
Liggett [Member] \| Cohen v. R.J. Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															205,000
Punitive Damages Awarded															0
Liggett [Member] \| Buchanan v. R.J. Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															2,750,000
Punitive Damages Awarded															0
Liggett [Member] \| Buchanan v. R.J. Reynolds [Member] \| Joint and Several Judgment [Member]
Loss Contingencies [Line Items]
Damages awarded															5,500,000
Liggett [Member] \| Calloway v RJ Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															1,530,000
Punitive Damages Awarded															7,600,000
Liggett [Member] \| Calloway v RJ Reynolds [Member] \| Joint and Several Judgment [Member]
Loss Contingencies [Line Items]
Damages awarded															16,100,000
Liggett [Member] \| Ward v R J Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															1,000
Punitive Damages Awarded															0
Liggett [Member] \| Tullo v R J Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															225,000
Punitive Damages Awarded															0
Liggett [Member] \| Putney v R J Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															3,008,000
Punitive Damages Awarded															0
Liggett [Member] \| Clay v R J Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															349,000
Punitive Damages Awarded															1,000,000
Liggett [Member] \| Douglas v R J Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															1,350,000
Punitive Damages Awarded															0
Liggett [Member] \| Campbell v R J Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															156,000
Punitive Damages Awarded															$ 0
Liggett [Member] \| Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Bond cap																													$ 200,000,000
Damages awarded			$ 110,000,000
Settlements / dismissal of litigation \| case			4,900												24
Plaintiffs' verdicts (in cases) \| case													15		15
Defense verdicts (in cases) \| case													9		9
Loss Contingency, Claims Scheduled For Trial \| case													7		7
Loss Contingency, Settlement Agreement, Consideration Paid Lump Sum			$ 61,600,000
Loss Contingency, Settlement Agreement, Consideration Installment Payments Term			14 years
Litigation Settlement Expense Amount Discounted			$ 25,213,000
Discount rate			11.00%
Litigation, settlement and judgment expense			$ 86,213,000											$ 643,000
Loss Contingency, Settlement Agreement, Consideration, Paid in Equal Installments over Term			48,000,000
Loss Contingency, Settlement Agreement, Consideration Expected Yearly Next Five Years			$ 3,400,000
Liggett [Member] \| Engle Progeny Cases [Member] \| Cases Settled without Litigation [Member]
Loss Contingencies [Line Items]
Damages awarded															$ 3,612,000
Settlements / dismissal of litigation \| case			4,900										3		171
Litigation, settlement and judgment expense																	86,213,000
Liggett [Member] \| Engle Progency Cases Excluding Lukacs [Member] \| Minimum [Member]
Loss Contingencies [Line Items]
Cases including punitive damages (in cases) \| case															4
Liggett [Member] \| Lukacs case [Member]
Loss Contingencies [Line Items]
Damages awarded															$ 12,418,000
Punitive Damages Awarded															0
Liggett [Member] \| Lambert v. R.J. Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															3,600,000
Punitive Damages Awarded															9,500,000
Liggett [Member] \| Engle Case Class Action [Member]
Loss Contingencies [Line Items]
Loss Contingency Over Turned Judgment									$ 5,831,000
Number of plaintiffs (in plaintiffs) \| plaintiff											3
Damages awarded										$ 790,000,000	$ 12,704,000
Plaintiffs' verdicts (in cases) \| plaintiff									1
Defense verdicts (in cases) \| plaintiff									2
Liggett [Member] \| Boatright v. R.J. Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															0
Punitive Damages Awarded															300,000
Liggett [Member] \| Putney, Calloway, Cohen, Irimi, Lambert, Boatright and Caprio [Member]
Loss Contingencies [Line Items]
Minimum loss exposure													$ 0		0
Maximum loss exposure													$ 12,674,000		12,674,000
Liggett [Member] \| Caprio v. R.J. Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															0
Punitive Damages Awarded															0
Phillip Morris [Member] \| Boatright v. R.J. Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															15,000,000
Punitive Damages Awarded															19,700,000
Phillip Morris [Member] \| Boatright v. R.J. Reynolds [Member] \| Joint and Several Judgment [Member]
Loss Contingencies [Line Items]
Damages awarded															12,750,000
Phillip Morris [Member] \| Caprio v. R.J. Reynolds [Member] \| Economic Damages [Member]
Loss Contingencies [Line Items]
Damages awarded															$ 559,000
Liggett Only Cases [Member] \| Other Individual Actions [Member]
Loss Contingencies [Line Items]
Cases pending (in cases) \| case													2		2
Liggett Only Cases [Member] \| Rizzuto v. R.J. Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															$ 1,500,000
Liggett Vector Brands [Member]
Loss Contingencies [Line Items]
Maximum loss exposure													$ 500,000		500,000
Litigation, settlement and judgment expense																	$ 83,000
Vector Tobacco [Member] \| Damages From Cigarette Smoking MSA and Other State Settlement Agreements [Member]
Loss Contingencies [Line Items]
MSA Payment Obligations													$ 0		$ 0
Payment obligations													0.28%		0.28%
Liggett and Vector Tobacco [Member]
Loss Contingencies [Line Items]
Total cigarettes sold													3.30%		3.30%
Liggett and Vector Tobacco [Member] \| Damages From Cigarette Smoking MSA and Other State Settlement Agreements [Member]
Loss Contingencies [Line Items]
Damages awarded		$ 100,000,000
Liggett and Vector Tobacco [Member] \| NPM Adjustment [Member]
Loss Contingencies [Line Items]
Previously accrued expense													$ 20,000,000		$ 20,000,000
Gain (loss) related to litigation settlement															5,700,000
Loss Contingency, Settlement Adjustment Credit													6,947,000		6,947,000									$ 1,940,000		$ 1,733,000
Amount Remaining in Disputed Payment Accounts													$ 23,000,000		23,000,000
Pending Litigation [Member] \| Liggett [Member]
Loss Contingencies [Line Items]
Damages awarded															11,124,000
Punitive Damages Awarded															17,400,000
Pending Litigation [Member] \| Liggett [Member] \| Lambert v. R.J. Reynolds [Member]
Loss Contingencies [Line Items]
Damages awarded															$ 13,100,000

Contingencies Contingencies Litigation Accrual Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Loss Contingency Accrual [Roll Forward]
Payments due under Master Settlement Agreement, Current	$ 26,322
Payments due under Master Settlement Agreement, Non-Current	25,809
Litigation Accruals, Non-Current	25,700
Payments due under Master Settlement Agreement, Current	29,241	$ 26,322
Payments due under Master Settlement Agreement, Non-Current	20,094	25,809
Litigation Accruals, Non-Current	24,718	25,700
Current Liabilities [Member]
Loss Contingency Accrual [Roll Forward]
Total, Current	29,471	84,658	$ 34,440
Expenses	138,928	120,918	180,377
NPM Settlement adjustment	1,351	0	(3,928)
Change in MSA obligations capitalized as inventory	1,426	(1,095)	1,611
Payments	(124,011)	(179,221)	(135,390)
Reclassification to non-current liabilities	3,305	3,918	7,153
Interest on withholding	1,675	293	395
Total, Current	52,145	29,471	84,658
Current Liabilities [Member] \| Pending Litigation [Member]
Loss Contingency Accrual [Roll Forward]
Litigation Accruals, Current	3,149	59,310	1,470
Expenses	20,644	2,849	63,292
NPM Settlement adjustment	0	0	0
Change in MSA obligations capitalized as inventory	0	0	0
Payments	(5,869)	(62,878)	(6,070)
Reclassification to non-current liabilities	3,305	3,575	223
Interest on withholding	1,675	293	395
Litigation Accruals, Current	22,904	3,149	59,310
Current Liabilities [Member] \| Master Settlement Agreement [Member]
Loss Contingency Accrual [Roll Forward]
Payments due under Master Settlement Agreement, Current	26,322	25,348	32,970
Expenses	118,284	118,069	117,085
NPM Settlement adjustment	1,351	0	(3,928)
Change in MSA obligations capitalized as inventory	1,426	(1,095)	1,611
Payments	(118,142)	(116,343)	(129,320)
Reclassification to non-current liabilities	0	343	6,930
Interest on withholding	0	0	0
Payments due under Master Settlement Agreement, Current	29,241	26,322	25,348
Non-Current Liabilities [Member]
Loss Contingency Accrual [Roll Forward]
Total, Non-Current	51,509	54,629	54,501
Expenses	(195)	0	25,218
NPM Settlement adjustment	(5,715)	(1,419)	(18,138)
Change in MSA obligations capitalized as inventory	0	0	0
Payments	0	0	0
Reclassification to non-current liabilities	(3,305)	(3,918)	(7,153)
Interest on withholding	2,518	2,217	201
Total, Non-Current	44,812	51,509	54,629
Non-Current Liabilities [Member] \| Pending Litigation [Member]
Loss Contingency Accrual [Roll Forward]
Litigation Accruals, Non-Current	25,700	27,058	1,862
Expenses	(195)	0	25,218
NPM Settlement adjustment	0	0	0
Change in MSA obligations capitalized as inventory	0	0	0
Payments	0	0	0
Reclassification to non-current liabilities	(3,305)	(3,575)	(223)
Interest on withholding	2,518	2,217	201
Litigation Accruals, Non-Current	24,718	25,700	27,058
Non-Current Liabilities [Member] \| Master Settlement Agreement [Member]
Loss Contingency Accrual [Roll Forward]
Payments due under Master Settlement Agreement, Non-Current	25,809	27,571	52,639
Expenses	0	0	0
NPM Settlement adjustment	(5,715)	(1,419)	(18,138)
Change in MSA obligations capitalized as inventory	0	0	0
Payments	0	0	0
Reclassification to non-current liabilities	0	(343)	(6,930)
Interest on withholding	0	0	0
Payments due under Master Settlement Agreement, Non-Current	$ 20,094	$ 25,809	$ 27,571

Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash paid during the period for:
Interest	$ 96,958	$ 98,754	$ 114,301
Income taxes	52,040	16,610	17,585
Non-cash investing and financing activities:
Issuance of stock dividend	584	520	450
Acquisitions	0	0	84,859
Non-controlling interest	0	2,733	87,657
Debt retired in conversion to stock	25,000	132,530	43,222
Embedded derivative, net retired in conversion to stock	$ 889	$ 6,680	$ 17,377

Related Party Transactions (Details)						1 Months Ended			12 Months Ended				48 Months Ended
Related Party Transactions (Details)	Feb. 03, 2015 shares	Mar. 14, 2014 USD ($) shares	May 22, 2013 USD ($) $ / shares shares	Nov. 04, 2011 USD ($) $ / shares shares	May 11, 2009 USD ($)	May 31, 2015 shares	Jan. 31, 2013 USD ($)	Sep. 30, 2012	Dec. 31, 2015 USD ($) shares	Dec. 31, 2014 USD ($) shares	Dec. 31, 2013 USD ($)	Dec. 31, 2008 USD ($)	Dec. 31, 2009 USD ($)	Feb. 28, 2014 $ / shares shares	Dec. 31, 2012 investments	Sep. 10, 2012 USD ($) sqft extension	Oct. 14, 2011 USD ($) shares	Dec. 30, 2010 USD ($)
Related Party Transaction [Line Items]
Ownership percentage in equity method investment									7.84%
Interest Expense									$ 120,691,000	$ 160,991,000	$ 132,147,000
Square footage of real estate \| sqft																12,390
Initial Term of Lease								5 years
Number of Lease Extensions \| extension																2
Term of Lease Extensions								5 years
Related Party Transactions, Lease Payments Per Month in Year One																$ 31,000
Related Party Transactions, Lease Payments Per Month in Year Five																35,000
Related Party Transaction, Tenant Improvement Allowance																$ 220,000
Ladenburg Thalmann Financial Services [Member]
Related Party Transaction [Line Items]
Investment in equity securities, shares held \| shares			240,000
Related Party Transaction, Warrant Exercisable Price \| $ / shares				$ 1.68
Related Party Transaction, Management Loan Agreement Portion Attributable to Company				$ 15,000,000
Related Party Transaction, Debt Interest Rate			8.00%						11.00%
Preferred Stock, Liquidation Preference Per Share \| $ / shares			$ 25.00
Investment Income, Dividend									$ 133,000	480,000
Payments to acquire investments			$ 6,000,000
Related Party Transaction, Interest Income From Management Loan									280,000	574,000	1,810,000
Related Party Transaction, Amounts of Transaction									1,680,000
Ladenburg Thalmann Financial Services [Member] \| Vice Chairman [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Other Revenues from Transactions with Related Party, President Compensation									1,300,000	1,375,000	1,250,000
Ladenburg Thalmann Financial Services [Member] \| Director [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Other Revenues from Transactions with Related Party, President Compensation									38,000	39,000	36,000
Ladenburg Thalmann Financial Services [Member] \| President and Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Other Revenues from Transactions with Related Party, President Compensation									$ 1,450,000	$ 1,375,000	1,250,000
Executive Vice President [Member]
Related Party Transaction [Line Items]
Stock Ownership In Company Percentage				15.30%
Related Party Transactions, Principal Premium Percentage					107.00%
Percent of ownership by management (more than 10%)													10.00%
Castle Brands [Member]
Related Party Transaction [Line Items]
Investment in equity securities, shares held \| shares									12,671,159
Related Party Transaction, Warrant Issued \| shares																	357,796
Related Party Transaction, Warrants Convertible to Common Stock \| shares										222,222				884,787			357,796
Related Party Transaction, Warrant Exercisable Price \| $ / shares														$ 0.38
Related Party Transaction, Management Loan Agreement																		$ 1,000,000
Related Party Transaction, Principal and Interest Exchanged For Preferred Stock																	$ 217,000
Related Party Transaction, Management Loan Agreement Portion Attributable to Company																		$ 200,000
Related Party Transaction, Debt Interest Rate										5.00%			11.00%
Face amount										$ 200,000
Frost Real Estate Holdings, LLC [Member]
Related Party Transaction [Line Items]
Interest Expense									$ 380,000	336,000
Management Fees [Member] \| Ladenburg Thalmann Financial Services [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Other Revenues from Transactions with Related Party									850,000	850,000	750,000
Management Fees [Member] \| Castle Brands [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Other Revenues from Transactions with Related Party									100,000	100,000	100,000
Management Fee Increase [Member] \| Ladenburg Thalmann Financial Services [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Other Revenues from Transactions with Related Party									850,000
Management Fee Increase [Member] \| Castle Brands [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Other Revenues from Transactions with Related Party									100,000
Aggregate Funding Fee [Member] \| Ladenburg Thalmann Financial Services [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Other Revenues from Transactions with Related Party				$ 75,000
Insurance Commissions [Member] \| President [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Other Revenues from Transactions with Related Party									$ 217,000	261,000	$ 245,000
Investment [Member] \| Ladenburg Thalmann Financial Services [Member]
Related Party Transaction [Line Items]
Investment in equity securities, shares held \| shares									14,191,200
Investment [Member] \| OPKO Inc. [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Number of investments \| investments															3
Related Party Transaction, Debt Interest Rate							3.00%
Related Party Transaction, Amounts of Transaction							$ 5,000,000						$ 12,788,000
Debt Conversion, Converted Instrument, Shares Issued \| shares						726,036
Investment [Member] \| Cardo Medical Inc. [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Amounts of Transaction												$ 500,000
Investment [Member] \| Cocrystal Discovery Inc. [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Amounts of Transaction												$ 250,000
Investment [Member] \| Morgans Hotel Group Co. [Member]
Related Party Transaction [Line Items]
Investment in equity securities, shares held \| shares									2,459,788
Ownership percentage in equity method investment									7.09%
Brokerage Activities [Member] \| Douglas Elliman Realty LLC [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Amounts of Transaction									$ 453,000
Purchase of Unit in Real Estate Venture [Member] \| Douglas Elliman Realty LLC [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Amounts of Transaction									5,200,000
6.75% Variable Interest Senior Convertible Note Due 2014 [Member] \| Executive Vice President [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Management Loan Agreement					$ 50,000,000
Related Party Transaction, Debt Interest Rate					6.75%
Interest Expense									$ 1,094,000	$ 5,415,000
6.75% Variable Interest Senior Convertible Note Due 2014 [Member] \| Private Placement Purchase Price [Member] \| Executive Vice President [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Amounts of Transaction					$ 38,225,000
5% Variable Interest Senior Convertible Notes due November 15, 2011 [Member] \| Executive Vice President [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Debt Interest Rate					5.00%
5% Variable Interest Senior Convertible Notes due November 15, 2011 [Member] \| Private Placement Tender Offer [Member] \| Executive Vice President [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Amounts of Transaction					$ 11,005,000
Warrant [Member] \| New Valley LLC [Member] \| Ladenburg Thalmann Financial Services [Member]
Related Party Transaction [Line Items]
Investment in equity securities, shares held \| shares				1,000,000
Convertible Debt [Member] \| 6.75% Variable Interest Senior Convertible Note Due 2014 [Member]
Related Party Transaction [Line Items]
Debt Conversion, Converted Instrument, Amount		$ 25,000,000
Note conversion, net of income taxes (in shares) \| shares	2,338,930	2,338,930
Convertible Debt [Member] \| 6.75% Variable Interest Senior Convertible Note Due 2014 [Member] \| Executive Vice President [Member]
Related Party Transaction [Line Items]
Stock Ownership In Company Percentage					11.70%

Investments and Fair Value Measurements (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Assets:
Investment securities available for sale	$ 181,976,000	$ 269,100,000
Liabilities:
Long-term investments	62,726,000	52,723,000
Real estate held for sale, net	$ 23,318,000	10,643,000
Nonrecurring fair value measurements		0
Convertible Debt [Member] \| 7.5% Variable Interest Senior Convertible Notes due 2019 [Member]
Liabilities:
Interest rate effective percentage	7.50%
Marketable equity securities
Assets:
Investment securities available for sale	$ 67,273,000	77,609,000
Mutual funds invested in fixed income securities
Assets:
Investment securities available for sale	20,111,000	59,826,000
U.S. Government securities
Assets:
Investment securities available for sale	28,132,000
Corporate securities
Assets:
Investment securities available for sale	41,561,000
U.S. mortgage-backed securities
Assets:
Investment securities available for sale	5,790,000
Commercial mortgage-backed securities
Assets:
Investment securities available for sale	8,728,000
U.S. asset backed securities
Assets:
Investment securities available for sale	8,276,000
Fixed Income Securities [Member]
Assets:
Investment securities available for sale	94,592,000
Fair Value, Measurements, Recurring [Member]
Assets:
Money market funds	93,915,000	205,180,000
Certificates of deposit	3,469,000	3,462,000
Bonds	12,767,000	4,868,000
Investment securities available for sale	181,976,000	269,100,000
Total	292,127,000	482,610,000
Liabilities:
Fair value of derivatives embedded within convertible debt	144,042,000	169,386,000
Fair Value, Measurements, Recurring [Member] \| Marketable equity securities
Assets:
Investment securities available for sale	67,273,000	77,609,000
Fair Value, Measurements, Recurring [Member] \| Mutual funds invested in fixed income securities
Assets:
Investment securities available for sale	20,111,000	59,826,000
Fair Value, Measurements, Recurring [Member] \| U.S. Government securities
Assets:
Investment securities available for sale	28,132,000	35,446,000
Fair Value, Measurements, Recurring [Member] \| Corporate securities
Assets:
Investment securities available for sale	41,561,000	55,888,000
Fair Value, Measurements, Recurring [Member] \| U.S. mortgage-backed securities
Assets:
Investment securities available for sale	5,790,000	4,770,000
Fair Value, Measurements, Recurring [Member] \| Commercial mortgage-backed securities
Assets:
Investment securities available for sale	8,728,000	16,508,000
Fair Value, Measurements, Recurring [Member] \| U.S. asset backed securities
Assets:
Investment securities available for sale	8,276,000	16,955,000
Fair Value, Measurements, Recurring [Member] \| Commodity Index Linked Notes [Member]
Assets:
Investment securities available for sale	2,105,000	2,098,000
Fair Value, Measurements, Recurring [Member] \| Fixed Income Securities [Member]
Assets:
Investment securities available for sale	94,592,000	131,665,000
Fair Value, Measurements, Recurring [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Assets:
Money market funds	93,915,000	205,180,000
Certificates of deposit	0	0
Bonds	12,767,000	4,868,000
Investment securities available for sale	87,384,000	144,306,000
Total	194,066,000	354,354,000
Liabilities:
Fair value of derivatives embedded within convertible debt	0	0
Fair Value, Measurements, Recurring [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1) \| Marketable equity securities
Assets:
Investment securities available for sale	67,273,000	77,083,000
Fair Value, Measurements, Recurring [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1) \| Mutual funds invested in fixed income securities
Assets:
Investment securities available for sale	20,111,000	59,826,000
Fair Value, Measurements, Recurring [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1) \| U.S. Government securities
Assets:
Investment securities available for sale	0	0
Fair Value, Measurements, Recurring [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1) \| Corporate securities
Assets:
Investment securities available for sale	0	7,397,000
Fair Value, Measurements, Recurring [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1) \| U.S. mortgage-backed securities
Assets:
Investment securities available for sale	0	0
Fair Value, Measurements, Recurring [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1) \| Commercial mortgage-backed securities
Assets:
Investment securities available for sale	0	0
Fair Value, Measurements, Recurring [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1) \| U.S. asset backed securities
Assets:
Investment securities available for sale	0	0
Fair Value, Measurements, Recurring [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1) \| Commodity Index Linked Notes [Member]
Assets:
Investment securities available for sale	0	0
Fair Value, Measurements, Recurring [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1) \| Fixed Income Securities [Member]
Assets:
Investment securities available for sale	0	7,397,000
Fair Value, Measurements, Recurring [Member] \| Significant Other Observable Inputs (Level 2)
Assets:
Money market funds	0	0
Certificates of deposit	3,469,000	3,462,000
Bonds	0	0
Investment securities available for sale	94,592,000	124,794,000
Total	98,061,000	128,256,000
Liabilities:
Fair value of derivatives embedded within convertible debt	0	0
Fair Value, Measurements, Recurring [Member] \| Significant Other Observable Inputs (Level 2) \| Marketable equity securities
Assets:
Investment securities available for sale	0	526,000
Fair Value, Measurements, Recurring [Member] \| Significant Other Observable Inputs (Level 2) \| Mutual funds invested in fixed income securities
Assets:
Investment securities available for sale	0	0
Fair Value, Measurements, Recurring [Member] \| Significant Other Observable Inputs (Level 2) \| U.S. Government securities
Assets:
Investment securities available for sale	28,132,000	35,446,000
Fair Value, Measurements, Recurring [Member] \| Significant Other Observable Inputs (Level 2) \| Corporate securities
Assets:
Investment securities available for sale	41,561,000	48,491,000
Fair Value, Measurements, Recurring [Member] \| Significant Other Observable Inputs (Level 2) \| U.S. mortgage-backed securities
Assets:
Investment securities available for sale	5,790,000	4,770,000
Fair Value, Measurements, Recurring [Member] \| Significant Other Observable Inputs (Level 2) \| Commercial mortgage-backed securities
Assets:
Investment securities available for sale	8,728,000	16,508,000
Fair Value, Measurements, Recurring [Member] \| Significant Other Observable Inputs (Level 2) \| U.S. asset backed securities
Assets:
Investment securities available for sale	8,276,000	16,955,000
Fair Value, Measurements, Recurring [Member] \| Significant Other Observable Inputs (Level 2) \| Commodity Index Linked Notes [Member]
Assets:
Investment securities available for sale	2,105,000	2,098,000
Fair Value, Measurements, Recurring [Member] \| Significant Other Observable Inputs (Level 2) \| Fixed Income Securities [Member]
Assets:
Investment securities available for sale	94,592,000	124,268,000
Fair Value, Measurements, Recurring [Member] \| Significant Unobservable Inputs (Level 3)
Assets:
Money market funds	0	0
Certificates of deposit	0	0
Bonds	0	0
Investment securities available for sale	0	0
Total	0	0
Liabilities:
Fair value of derivatives embedded within convertible debt	144,042,000	169,386,000
Fair Value, Measurements, Recurring [Member] \| Significant Unobservable Inputs (Level 3) \| Marketable equity securities
Assets:
Investment securities available for sale	0	0
Fair Value, Measurements, Recurring [Member] \| Significant Unobservable Inputs (Level 3) \| Mutual funds invested in fixed income securities
Assets:
Investment securities available for sale	0	0
Fair Value, Measurements, Recurring [Member] \| Significant Unobservable Inputs (Level 3) \| U.S. Government securities
Assets:
Investment securities available for sale	0	0
Fair Value, Measurements, Recurring [Member] \| Significant Unobservable Inputs (Level 3) \| Corporate securities
Assets:
Investment securities available for sale	0	0
Fair Value, Measurements, Recurring [Member] \| Significant Unobservable Inputs (Level 3) \| U.S. mortgage-backed securities
Assets:
Investment securities available for sale	0	0
Fair Value, Measurements, Recurring [Member] \| Significant Unobservable Inputs (Level 3) \| Commercial mortgage-backed securities
Assets:
Investment securities available for sale	0	0
Fair Value, Measurements, Recurring [Member] \| Significant Unobservable Inputs (Level 3) \| U.S. asset backed securities
Assets:
Investment securities available for sale	0	0
Fair Value, Measurements, Recurring [Member] \| Significant Unobservable Inputs (Level 3) \| Commodity Index Linked Notes [Member]
Assets:
Investment securities available for sale	0	0
Fair Value, Measurements, Recurring [Member] \| Significant Unobservable Inputs (Level 3) \| Fixed Income Securities [Member]
Assets:
Investment securities available for sale	0	$ 0
Fair Value, Measurements, Nonrecurring [Member]
Liabilities:
Long-term investments	11,189,000
Gain (loss) on long-term investment	(811,000)
Long-term investments	12,000,000
Real estate held for sale, net	4,010,000
Gain (Loss) on Real Estate	(230,000)
Real estate held for sale	3,780,000
Impairment of long-term investments	811,000
Impairment of real estate	230,000
Nonrecurring fair value measurements	14,969,000
Nonrecurring fair value measurements gain (loss)	(1,041,000)
Fair Value, Measurements, Nonrecurring [Member] \| Significant Unobservable Inputs (Level 3)
Liabilities:
Long-term investments	11,189,000
Real estate held for sale	3,780,000
Nonrecurring fair value measurements	$ 14,969,000

Investments and Fair Value Measurements Fair Value Inputs, Quantitative Information (Details) - Fair Value, Measurements, Recurring [Member] - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Fair Value Inputs, Assets And Liabilities, Quantitative Information [Line Items]
Fair value of derivatives embedded within convertible debt	$ 144,042	$ 169,386
Significant Unobservable Inputs (Level 3)
Fair Value Inputs, Assets And Liabilities, Quantitative Information [Line Items]
Fair value of derivatives embedded within convertible debt	144,042	169,386
Discounted Cash Flow [Member] \| Significant Unobservable Inputs (Level 3)
Fair Value Inputs, Assets And Liabilities, Quantitative Information [Line Items]
Fair value of derivatives embedded within convertible debt	$ 144,042	$ 169,386
Derivative Financial Instruments, Liabilities [Member] \| Discounted Cash Flow [Member] \| Significant Unobservable Inputs (Level 3)
Fair Value Inputs, Assets And Liabilities, Quantitative Information [Line Items]
Stock price (dollars per share)	$ 23.59	$ 21.31
Volatility	18.30%	16.00%
Assumed annual stock dividend	5.00%	5.00%
Assumed annual cash dividend (dollars per share)	$ 1.60	$ 1.60
Convertible trading price	114.31%	106.80%
Implied credit spread	5.25%
Discount rate		6.75%
Minimum [Member] \| Derivative Financial Instruments, Liabilities [Member] \| Discounted Cash Flow [Member] \| Significant Unobservable Inputs (Level 3)
Fair Value Inputs, Assets And Liabilities, Quantitative Information [Line Items]
Implied credit spread	5.00%
Discount rate		6.25%
Maximum [Member] \| Derivative Financial Instruments, Liabilities [Member] \| Discounted Cash Flow [Member] \| Significant Unobservable Inputs (Level 3)
Fair Value Inputs, Assets And Liabilities, Quantitative Information [Line Items]
Implied credit spread	5.50%
Discount rate		7.25%

Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
Segment Information (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting Information [Line Items]
Revenues	$ 430,330	$ 449,934	$ 416,173	$ 360,760	$ 417,590	$ 419,876	$ 406,613	$ 347,236	$ 1,657,197	$ 1,591,315	$ 1,079,921
Operating income (loss)	31,032	$ 69,367	$ 55,803	$ 43,718	47,136	62,746	$ 60,071	$ 42,485	199,920	212,438	111,186
Equity in earnings from real estate ventures									2,001	4,103	22,925
Identifiable assets	1,310,756				1,423,254	1,423,254			1,310,756	1,423,254	1,115,793
Depreciation and amortization									25,654	24,499	12,631
Capital expenditures									10,977	23,404	13,275
Equity method investments	21,495				20,484				21,495	20,484
NPM Settlement [Member]
Segment Reporting Information [Line Items]
Operating income (loss)										1,419
Litigation Judgment Expense [Member]
Segment Reporting Information [Line Items]
Operating income (loss)									20,072	2,475	1,893
Restructuring Charges [Member]
Segment Reporting Information [Line Items]
Operating income (loss)									7,257
Pension Settlement Expense [Member]
Segment Reporting Information [Line Items]
Operating income (loss)									1,607
MSA Settlements [Member]
Segment Reporting Information [Line Items]
Operating income (loss)									4,364		11,823
Engle Progeny Settlement Charge [Member]
Segment Reporting Information [Line Items]
Operating income (loss)											86,213
Tobacco [Member]
Segment Reporting Information [Line Items]
Revenues									1,017,761	1,021,259	1,014,341
Operating income (loss)									209,393	199,119	113,039
Equity in earnings from real estate ventures									0	0	0
Identifiable assets	344,033					325,870			344,033		328,084
Depreciation and amortization									11,323	10,885	9,509
Capital expenditures									3,730	9,256	9,784
E-Cigarettes [Member]
Segment Reporting Information [Line Items]
Revenues									(1,970)	8,589	0
Operating income (loss)									(13,037)	(13,124)	(1,018)
Equity in earnings from real estate ventures									0	0	0
Identifiable assets	985					8,139			985		8,950
Depreciation and amortization									0	0	0
Capital expenditures									0	0	0
Real Estate [Member]
Segment Reporting Information [Line Items]
Revenues									641,406	561,467	65,580
Operating income (loss)									24,087	42,354	15,805
Equity in earnings from real estate ventures									2,001	4,103	22,925
Identifiable assets	585,098					498,058			585,098		421,240
Depreciation and amortization									12,589	12,204	2,421
Capital expenditures									7,247	6,923	1,194
Equity method investments	217,168				163,460				217,168	163,460	128,202
Long-term Investments [Member]
Segment Reporting Information [Line Items]
Equity method investments	21,495				20,484				21,495	20,484	22,411
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Revenues									0	0	0
Operating income (loss)									(20,523)	(15,911)	(16,640)
Equity in earnings from real estate ventures									0	0	0
Identifiable assets	380,640					$ 591,187			380,640		357,519
Depreciation and amortization									1,742	1,410	701
Capital expenditures									0	7,225	2,297
Corporate and Other [Member] \| Cash [Member]
Segment Reporting Information [Line Items]
Identifiable assets	112,130				213,227				112,130	213,227	152,189
Corporate and Other [Member] \| Investment securities [Member]
Segment Reporting Information [Line Items]
Identifiable assets	181,976				269,100				181,976	269,100	119,430
Corporate and Other [Member] \| Long-term Investments [Member]
Segment Reporting Information [Line Items]
Identifiable assets	$ 62,225				$ 52,025				$ 62,225	$ 52,025	$ 42,452

Quarterly Financial Results (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Sep. 29, 2015	Sep. 26, 2014
Interim Period, Costs Not Allocable [Line Items]
Revenues	$ 430,330	$ 449,934	$ 416,173	$ 360,760	$ 417,590	$ 419,876	$ 406,613	$ 347,236	$ 1,657,197	$ 1,591,315	$ 1,079,921
Gross Profit	137,742	154,017	136,969	118,742	126,085	132,640	127,331	108,199
Operating income	31,032	69,367	55,803	43,718	47,136	62,746	60,071	42,485	199,920	212,438	111,186
Net income applicable to common shares attributed to Vector Group Ltd.	$ 7,904	$ 12,466	$ 17,607	$ 21,221	$ 12,215	$ 14,190	$ 7,917	$ 2,534	$ 59,198	$ 36,856	$ 37,300
Per basic common share:
Net income applicable to common shares (in dollars per share)	$ 0.06	$ 0.10	$ 0.14	$ 0.18	$ 0.11	$ 0.13	$ 0.07	$ 0.02	$ 0.49	$ 0.33	$ 0.36
Per diluted common share:
Net income applicable to common shares (in dollars per share)	$ 0.06	$ 0.10	$ 0.14	$ 0.18	$ 0.11	$ 0.13	$ 0.07	$ 0.02	$ 0.49	$ 0.33	$ 0.36
Stock dividend paid												5.00%	5.00%
Adoption of Equity Method [Member]
Interim Period, Costs Not Allocable [Line Items]
Operating income		$ (238)	$ (237)	$ (237)		$ (238)	$ (237)	$ (237)		$ 212,438	$ 111,186
Net income applicable to common shares attributed to Vector Group Ltd.		$ 261	$ (261)	$ 265		$ (689)	$ (8)	$ (46)		$ 36,856	$ 37,300

Condensed Consolidating Financial Information Textuals (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2015 USD ($)	Mar. 14, 2013 USD ($)	Jan. 31, 2013 USD ($)	Jan. 29, 2013 USD ($)
Condensed Financial Statements, Captions [Line Items]
Subsidiary Guarantors, Percentage Ownership	100.00%
Secured Debt [Member] \| 11% Senior Secured Notes Due 2015 [Member]
Condensed Financial Statements, Captions [Line Items]
Amount loaned		$ 78,685	$ 600,000	$ 415,000
Interest Rate			7.75%
Maximum [Member]
Condensed Financial Statements, Captions [Line Items]
EBITA Requirements for Dividend Payments	$ 75,000
Leverage Ratio Requirement	3.0
Secured Leverage Ratio Requirement	1.5
Tobacco [Member]
Condensed Financial Statements, Captions [Line Items]
Percentage Guaranteed by Domestic Subsidiaries, Cigarette Business	100.00%

Condensed Consolidating Financial Information Balance Sheets (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 240,368	$ 326,365		$ 234,466	$ 405,855
Investment securities available for sale	181,976	269,100
Accounts receivable - trade, net	23,889	23,328
Intercompany receivables	0	0
Inventories	86,516	90,323
Income taxes receivable, net	2,841	3,282
Restricted assets	9,195	2,595
Other current assets	38,954	36,404
Total current assets	583,739	751,397
Property, plant and equipment, net	75,632	84,112
Real estate held for sale, net	23,318	10,643
Long-term investments	62,726	52,723
Investments in real estate ventures	217,168	163,460
Investments in consolidated subsidiaries	0	0
Restricted assets	12,303	12,013
Goodwill and other intangible assets, net	263,959	269,972
Prepaid pension costs	20,650	25,032
Other assets	51,261	53,902
Total assets	1,310,756	1,423,254	$ 1,423,254	1,115,793
Current liabilities:
Current portion of notes payable and long-term debt	8,919	52,640
Current portion of fair value of derivatives embedded within convertible debt	0	884
Current portion of employee benefits	915	931
Intercompany payables	0	0
Income taxes payable, net	96	1,743
Litigation accruals and current payments due under the Master Settlement Agreement	52,145	29,471
Other current liabilities	154,217	126,755
Total current liabilities	216,292	212,424
Notes payable, long-term debt and other obligations, less current portion	886,249	860,711
Fair value of derivatives embedded within convertible debt	144,042	168,502
Non-current employee benefits	55,055	49,314
Deferred income taxes, net	79,429	95,904
Other liabilities, primarily litigation accruals and payments due under the Master Settlement Agreement	51,850	57,079
Total liabilities	1,432,917	1,443,934
Commitments and contingencies (Notes 10 and 15)
Stockholders' deficiency	(206,047)	(99,759)
Non-controlling interest	83,886	79,079
Total stockholders' deficiency	(122,161)	(20,680)		(50,605)	(89,070)
Total liabilities and stockholders' deficiency	1,310,756	1,423,254
Parent/Issuer [Member]
Current assets:
Cash and cash equivalents	111,470	211,751		151,342	401,344
Investment securities available for sale	131,810	202,252
Accounts receivable - trade, net	0	0
Intercompany receivables	11,293	795
Inventories	0	0
Income taxes receivable, net	8,213	1,055
Restricted assets	0	0
Other current assets	575	585
Total current assets	263,361	416,438
Property, plant and equipment, net	1,711	2,648
Real estate held for sale, net	0	0
Long-term investments	61,747	51,506
Investments in real estate ventures	0	0
Investments in consolidated subsidiaries	532,501	518,567
Restricted assets	1,713	1,707
Goodwill and other intangible assets, net	0	0
Prepaid pension costs	0	0
Other assets	37,723	40,913
Total assets	898,756	1,031,779
Current liabilities:
Current portion of notes payable and long-term debt	0	25,000
Current portion of fair value of derivatives embedded within convertible debt		884
Current portion of employee benefits	0	0
Intercompany payables	0	0
Income taxes payable, net	0	0
Litigation accruals and current payments due under the Master Settlement Agreement	0	0
Other current liabilities	38,140	36,653
Total current liabilities	38,140	62,537
Notes payable, long-term debt and other obligations, less current portion	878,509	852,560
Fair value of derivatives embedded within convertible debt	144,042	168,502
Non-current employee benefits	39,244	32,842
Deferred income taxes, net	2,675	14,176
Other liabilities, primarily litigation accruals and payments due under the Master Settlement Agreement	2,193	921
Total liabilities	1,104,803	1,131,538
Commitments and contingencies (Notes 10 and 15)
Stockholders' deficiency	(206,047)	(99,759)
Non-controlling interest	0	0
Total stockholders' deficiency	(206,047)	(99,759)
Total liabilities and stockholders' deficiency	898,756	1,031,779
Subsidiary Guarantors [Member]
Current assets:
Cash and cash equivalents	12,375	9,724		11,812	3,776
Investment securities available for sale	50,166	66,848
Accounts receivable - trade, net	15,913	18,024
Intercompany receivables	0	267
Inventories	86,516	90,323
Income taxes receivable, net	0	463
Restricted assets	7,781	1,181
Other current assets	3,747	9,133
Total current assets	176,498	195,963
Property, plant and equipment, net	54,097	61,149
Real estate held for sale, net	0	0
Long-term investments	478	519
Investments in real estate ventures	0	0
Investments in consolidated subsidiaries	0	0
Restricted assets	10,590	10,306
Goodwill and other intangible assets, net	107,511	107,511
Prepaid pension costs	20,650	25,032
Other assets	11,769	10,743
Total assets	381,593	411,223
Current liabilities:
Current portion of notes payable and long-term debt	8,733	27,248
Current portion of fair value of derivatives embedded within convertible debt		0
Current portion of employee benefits	915	931
Intercompany payables	586	0
Income taxes payable, net	5,464	0
Litigation accruals and current payments due under the Master Settlement Agreement	52,145	29,471
Other current liabilities	74,083	58,677
Total current liabilities	141,926	116,327
Notes payable, long-term debt and other obligations, less current portion	7,519	8,120
Fair value of derivatives embedded within convertible debt	0	0
Non-current employee benefits	15,811	16,472
Deferred income taxes, net	33,791	43,058
Other liabilities, primarily litigation accruals and payments due under the Master Settlement Agreement	44,982	51,775
Total liabilities	244,029	235,752
Commitments and contingencies (Notes 10 and 15)
Stockholders' deficiency	137,564	175,471
Non-controlling interest	0	0
Total stockholders' deficiency	137,564	175,471
Total liabilities and stockholders' deficiency	381,593	411,223
Subsidiary Non-Guarantors [Member]
Current assets:
Cash and cash equivalents	116,523	104,890		71,312	735
Investment securities available for sale	0	0
Accounts receivable - trade, net	7,976	5,304
Intercompany receivables	0	0
Inventories	0	0
Income taxes receivable, net	0	21
Restricted assets	1,414	1,414
Other current assets	34,632	26,686
Total current assets	160,545	138,315
Property, plant and equipment, net	19,824	20,315
Real estate held for sale, net	23,318	10,643
Long-term investments	501	698
Investments in real estate ventures	217,168	163,460
Investments in consolidated subsidiaries	0	0
Restricted assets	0	0
Goodwill and other intangible assets, net	156,448	162,461
Prepaid pension costs	0	0
Other assets	1,769	2,246
Total assets	579,573	498,138
Current liabilities:
Current portion of notes payable and long-term debt	186	392
Current portion of fair value of derivatives embedded within convertible debt		0
Current portion of employee benefits	0	0
Intercompany payables	10,707	1,062
Income taxes payable, net	4	0
Litigation accruals and current payments due under the Master Settlement Agreement	0	0
Other current liabilities	41,994	31,425
Total current liabilities	52,891	32,879
Notes payable, long-term debt and other obligations, less current portion	221	31
Fair value of derivatives embedded within convertible debt	0	0
Non-current employee benefits	0	0
Deferred income taxes, net	42,963	38,670
Other liabilities, primarily litigation accruals and payments due under the Master Settlement Agreement	4,675	4,383
Total liabilities	100,750	75,963
Commitments and contingencies (Notes 10 and 15)
Stockholders' deficiency	394,937	343,096
Non-controlling interest	83,886	79,079
Total stockholders' deficiency	478,823	422,175
Total liabilities and stockholders' deficiency	579,573	498,138
Consolidating Adjustments [Member]
Current assets:
Cash and cash equivalents	0	0		$ 0	$ 0
Investment securities available for sale	0	0
Accounts receivable - trade, net	0	0
Intercompany receivables	(11,293)	(1,062)
Inventories	0	0
Income taxes receivable, net	(5,372)	1,743
Restricted assets	0	0
Other current assets	0	0
Total current assets	(16,665)	681
Property, plant and equipment, net	0	0
Real estate held for sale, net	0	0
Long-term investments	0	0
Investments in real estate ventures	0	0
Investments in consolidated subsidiaries	(532,501)	(518,567)
Restricted assets	0	0
Goodwill and other intangible assets, net	0	0
Prepaid pension costs	0	0
Other assets	0	0
Total assets	(549,166)	(517,886)
Current liabilities:
Current portion of notes payable and long-term debt	0	0
Current portion of fair value of derivatives embedded within convertible debt		0
Current portion of employee benefits	0	0
Intercompany payables	(11,293)	(1,062)
Income taxes payable, net	(5,372)	1,743
Litigation accruals and current payments due under the Master Settlement Agreement	0	0
Other current liabilities	0	0
Total current liabilities	(16,665)	681
Notes payable, long-term debt and other obligations, less current portion	0	0
Fair value of derivatives embedded within convertible debt	0	0
Non-current employee benefits	0	0
Deferred income taxes, net	0	0
Other liabilities, primarily litigation accruals and payments due under the Master Settlement Agreement	0	0
Total liabilities	(16,665)	681
Commitments and contingencies (Notes 10 and 15)
Stockholders' deficiency	(532,501)	(518,567)
Non-controlling interest	0	0
Total stockholders' deficiency	(532,501)	(518,567)
Total liabilities and stockholders' deficiency	$ (549,166)	$ (517,886)

Condensed Consolidating Financial Information Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Condensed Financial Statements, Captions [Line Items]
Revenues	$ 430,330	$ 449,934	$ 416,173	$ 360,760	$ 417,590	$ 419,876	$ 406,613	$ 347,236	$ 1,657,197	$ 1,591,315	$ 1,079,921
Expenses:
Cost of sales									1,109,727	1,097,060	767,031
Operating, selling, administrative and general expenses									320,221	279,342	113,598
Litigation, settlement and judgment expense									20,072	2,475	88,106
Management fee expense									0	0	0
Restructuring charges									7,257	0	0
Operating (loss) income	31,032	69,367	55,803	43,718	47,136	62,746	60,071	42,485	199,920	212,438	111,186
Other income (expenses):
Interest expense									(120,691)	(160,991)	(132,147)
Changes in fair value of derivatives embedded within convertible debt									24,455	19,409	18,935
Acceleration of interest expense related to debt conversion									0	(5,205)	(12,414)
Loss on extinguishment of debt									0	0	(21,458)
Equity in earnings from real estate ventures									2,001	4,103	22,925
Equity in (losses) earnings from investments									(2,681)	3,140	3,126
Gain (loss) on sale of investment securities available for sale									11,138	(11)	5,152
Gain on acquisition of Douglas Elliman									0	0	60,842
Impairment of investment securities available for sale									(12,846)	0	0
Equity in earnings in consolidated subsidiaries									0	0	0
Management fee income									0	0	0
Other, net									6,409	9,396	4,573
Income before provision for income taxes									107,705	82,279	60,720
Income tax benefit (expense)									(41,233)	(33,165)	(23,672)
Net income									66,472	49,114	37,048
Net (income) loss attributed to non-controlling interest									(7,274)	(12,258)	252
Net income attributed to Vector Group Ltd.	$ 7,904	$ 12,466	$ 17,607	$ 21,221	$ 12,215	$ 14,190	$ 7,917	$ 2,534	59,198	36,856	37,300
Comprehensive (income) loss attributed to non-controlling interest									(7,274)	(12,258)	252
Comprehensive income									52,228	34,922	52,894
Parent/Issuer [Member]
Condensed Financial Statements, Captions [Line Items]
Revenues									0	0	0
Expenses:
Cost of sales									0	0	0
Operating, selling, administrative and general expenses									29,237	24,262	23,685
Litigation, settlement and judgment expense									0	0	0
Management fee expense									0	0	0
Restructuring charges									0
Operating (loss) income									(29,237)	(24,262)	(23,685)
Other income (expenses):
Interest expense									(115,731)	(157,321)	(130,417)
Changes in fair value of derivatives embedded within convertible debt									24,455	19,409	18,935
Acceleration of interest expense related to debt conversion										(5,205)	(12,414)
Loss on extinguishment of debt											(21,458)
Equity in earnings from real estate ventures									0	0	0
Equity in (losses) earnings from investments									(2,640)	3,122	3,126
Gain (loss) on sale of investment securities available for sale									(2,037)	(11)	(272)
Gain on acquisition of Douglas Elliman											0
Impairment of investment securities available for sale									(4,859)
Equity in earnings in consolidated subsidiaries									125,042	124,001	144,689
Management fee income									10,250	9,870	9,508
Other, net									4,016	4,178	1,462
Income before provision for income taxes									9,259	(26,219)	(10,526)
Income tax benefit (expense)									49,939	63,064	47,826
Net income									59,198	36,845	37,300
Net (income) loss attributed to non-controlling interest									0	0	0
Net income attributed to Vector Group Ltd.									59,198	36,845	37,300
Comprehensive (income) loss attributed to non-controlling interest									0	0	0
Comprehensive income									52,228	34,922	52,894
Subsidiary Guarantors [Member]
Condensed Financial Statements, Captions [Line Items]
Revenues									1,016,279	1,030,157	1,014,341
Expenses:
Cost of sales									699,440	743,032	729,393
Operating, selling, administrative and general expenses									84,437	90,208	77,780
Litigation, settlement and judgment expense									20,072	2,475	88,106
Management fee expense									10,250	9,870	9,508
Restructuring charges									7,257
Operating (loss) income									194,823	184,572	109,554
Other income (expenses):
Interest expense									(4,953)	(4,241)	(1,716)
Changes in fair value of derivatives embedded within convertible debt									0	0	0
Acceleration of interest expense related to debt conversion										0	0
Loss on extinguishment of debt											0
Equity in earnings from real estate ventures									0	0	0
Equity in (losses) earnings from investments									(41)	18	0
Gain (loss) on sale of investment securities available for sale									13,175	0	5,424
Gain on acquisition of Douglas Elliman											0
Impairment of investment securities available for sale									(7,987)
Equity in earnings in consolidated subsidiaries									0	0	0
Management fee income									0	0	0
Other, net									639	1,044	2,763
Income before provision for income taxes									195,656	181,393	116,025
Income tax benefit (expense)									(82,282)	(78,801)	(30,758)
Net income									113,374	102,592	85,267
Net (income) loss attributed to non-controlling interest									0	0	0
Net income attributed to Vector Group Ltd.									113,374	102,592	85,267
Comprehensive (income) loss attributed to non-controlling interest									0	0	0
Comprehensive income									105,456	102,536	102,344
Subsidiary Non-Guarantors [Member]
Condensed Financial Statements, Captions [Line Items]
Revenues									641,406	561,467	65,580
Expenses:
Cost of sales									410,287	354,028	37,638
Operating, selling, administrative and general expenses									207,035	165,181	12,133
Litigation, settlement and judgment expense									0	0	0
Management fee expense									0	0	0
Restructuring charges									0
Operating (loss) income									24,084	42,258	15,809
Other income (expenses):
Interest expense									(7)	(41)	(14)
Changes in fair value of derivatives embedded within convertible debt									0	0	0
Acceleration of interest expense related to debt conversion										0	0
Loss on extinguishment of debt											0
Equity in earnings from real estate ventures									2,001	4,103	22,925
Equity in (losses) earnings from investments									0	0	0
Gain (loss) on sale of investment securities available for sale									0	0	0
Gain on acquisition of Douglas Elliman											60,842
Impairment of investment securities available for sale									0
Equity in earnings in consolidated subsidiaries									0	0	0
Management fee income									0	0	0
Other, net									1,754	4,786	348
Income before provision for income taxes									27,832	51,106	99,910
Income tax benefit (expense)									(8,890)	(17,428)	(40,740)
Net income									18,942	33,678	59,170
Net (income) loss attributed to non-controlling interest									(7,274)	(12,258)	252
Net income attributed to Vector Group Ltd.									11,668	21,420	59,422
Comprehensive (income) loss attributed to non-controlling interest									(7,274)	(12,258)	252
Comprehensive income									11,668	21,420	59,422
Consolidating Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Revenues									(488)	(309)	0
Expenses:
Cost of sales									0	0	0
Operating, selling, administrative and general expenses									(488)	(309)	0
Litigation, settlement and judgment expense									0	0	0
Management fee expense									(10,250)	(9,870)	(9,508)
Restructuring charges									0
Operating (loss) income									10,250	9,870	9,508
Other income (expenses):
Interest expense									0	612	0
Changes in fair value of derivatives embedded within convertible debt									0	0	0
Acceleration of interest expense related to debt conversion										0	0
Loss on extinguishment of debt											0
Equity in earnings from real estate ventures									0	0	0
Equity in (losses) earnings from investments									0	0	0
Gain (loss) on sale of investment securities available for sale									0	0	0
Gain on acquisition of Douglas Elliman											0
Impairment of investment securities available for sale									0
Equity in earnings in consolidated subsidiaries									(125,042)	(124,001)	(144,689)
Management fee income									(10,250)	(9,870)	(9,508)
Other, net									0	(612)	0
Income before provision for income taxes									(125,042)	(124,001)	(144,689)
Income tax benefit (expense)									0	0	0
Net income									(125,042)	(124,001)	(144,689)
Net (income) loss attributed to non-controlling interest									0	0	0
Net income attributed to Vector Group Ltd.									(125,042)	(124,001)	(144,689)
Comprehensive (income) loss attributed to non-controlling interest									0	0	0
Comprehensive income									$ (117,124)	$ (123,956)	$ (161,766)

Condensed Consolidating Financial Information Statements of Cash Flows (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	$ 144,479	$ 107,376	$ 52,026
Cash flows from investing activities:
Sale of investment securities	270,576	154,615	117,021
Maturities of investment securities	5,491	930	27
Purchase of investment securities	(214,146)	(305,731)	(170,463)
Proceeds from sale or liquidation of long-term investments	1,303	2,416	10,927
Purchase of long-term investments	(10,000)	(12,000)	(5,501)
Investments in real estate ventures	(70,272)	(40,916)	(75,731)
Distributions from investments in real estate ventures	17,563	7,309	3,142
Increase in cash surrender value of life insurance policies	(1,742)	(484)	(628)
Decrease (increase) in non-current restricted assets	(6,889)	(872)	1,081
Issuance of notes receivable	(4,410)	(8,250)	(8,600)
Investments in subsidiaries	0	0	0
Proceeds from sale of fixed assets	4	4	48
Cash acquired in Douglas Elliman consolidation	0	0	116,935
Purchase of subsidiaries	0	(750)	(67,616)
Repayment of notes receivable	4,000	4,850	0
Capital expenditures	(10,977)	(23,404)	(13,275)
Purchase of preferred securities	0	(1,000)	0
Proceeds from sale of preferred securities	1,000	0	0
Investments in real estate held for sale	(12,603)	0	0
Pay down of investment securities	8,739	1,849	681
Net cash used in investing activities	(22,363)	(221,434)	(91,952)
Cash flows from financing activities:
Proceeds from issuance of debt	2,105	413,914	457,767
Deferred financing charges	(624)	(12,360)	(11,750)
Repayments of debt	(6,684)	(12,601)	(422,581)
Borrowings under revolver	153,361	886,130	978,788
Repayments on revolver	(167,915)	(898,788)	(977,794)
Capital contributions received	0	0	0
Intercompany dividends paid	0	0	0
Dividends and distributions on common stock	(188,151)	(167,328)	(144,711)
Distributions to non-controlling interest	(3,280)	(9,339)	(11,764)
Contributions from non-controlling interest	813	0	0
Proceeds from exercise of Vector options	1,441	5,151	544
Tax benefit of options exercised	821	1,178	38
Net cash (used in) provided by financing activities	(208,113)	205,957	(131,463)
Net increase (decrease) in cash and cash equivalents	(85,997)	91,899	(171,389)
Cash and cash equivalents, beginning of year	326,365	234,466	405,855
Cash and cash equivalents, end of year	240,368	326,365	234,466
Parent/Issuer [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	136,370	61,779	71,730
Cash flows from investing activities:
Sale of investment securities	256,161	154,615	110,419
Maturities of investment securities	5,491	930	27
Purchase of investment securities	(207,822)	(299,417)	(159,463)
Proceeds from sale or liquidation of long-term investments	1,106	2,367	10,847
Purchase of long-term investments	(10,000)	(12,000)	(5,000)
Investments in real estate ventures	0	0	0
Distributions from investments in real estate ventures	0	0	0
Increase in cash surrender value of life insurance policies	(1,257)	0	(144)
Decrease (increase) in non-current restricted assets	(6)	188	3
Issuance of notes receivable	0	(35,000)	0
Investments in subsidiaries	(103,174)	(85,278)	(155,961)
Proceeds from sale of fixed assets	0	0	35
Cash acquired in Douglas Elliman consolidation			0
Purchase of subsidiaries		0	0
Repayment of notes receivable	0	35,000
Capital expenditures	0	(15)	(2,297)
Purchase of preferred securities		0
Proceeds from sale of preferred securities	0
Investments in real estate held for sale	0
Pay down of investment securities	8,739	1,849	681
Net cash used in investing activities	(50,762)	(236,761)	(200,853)
Cash flows from financing activities:
Proceeds from issuance of debt	0	408,750	450,000
Deferred financing charges	0	(12,360)	(11,750)
Repayments of debt	0	0	(415,000)
Borrowings under revolver	0	0	0
Repayments on revolver	0	0	0
Capital contributions received	0	0	0
Intercompany dividends paid	0	0	0
Dividends and distributions on common stock	(188,151)	(167,328)	(144,711)
Distributions to non-controlling interest	0	0	0
Contributions from non-controlling interest	0
Proceeds from exercise of Vector options	1,441	5,151	544
Tax benefit of options exercised	821	1,178	38
Net cash (used in) provided by financing activities	(185,889)	235,391	(120,879)
Net increase (decrease) in cash and cash equivalents	(100,281)	60,409	(250,002)
Cash and cash equivalents, beginning of year	211,751	151,342	401,344
Cash and cash equivalents, end of year	111,470	211,751	151,342
Subsidiary Guarantors [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	172,065	83,671	115,829
Cash flows from investing activities:
Sale of investment securities	14,415	0	6,602
Maturities of investment securities	0	0	0
Purchase of investment securities	(6,324)	(6,314)	(11,000)
Proceeds from sale or liquidation of long-term investments	0	0	0
Purchase of long-term investments	0	0	(501)
Investments in real estate ventures	0	0	0
Distributions from investments in real estate ventures	0	0	0
Increase in cash surrender value of life insurance policies	(485)	(484)	(484)
Decrease (increase) in non-current restricted assets	(6,883)	(371)	1,078
Issuance of notes receivable	0	0	0
Investments in subsidiaries	0	0	0
Proceeds from sale of fixed assets	4	4	13
Cash acquired in Douglas Elliman consolidation			0
Purchase of subsidiaries		0	0
Repayment of notes receivable	0	0
Capital expenditures	(3,730)	(16,466)	(9,784)
Purchase of preferred securities		0
Proceeds from sale of preferred securities	0
Investments in real estate held for sale	0
Pay down of investment securities	0	0	0
Net cash used in investing activities	(3,003)	(23,631)	(14,076)
Cash flows from financing activities:
Proceeds from issuance of debt	1,799	40,164	4,687
Deferred financing charges	(624)	0	0
Repayments of debt	(6,362)	(43,724)	(7,466)
Borrowings under revolver	153,361	886,130	978,788
Repayments on revolver	(167,915)	(898,788)	(977,794)
Capital contributions received	33,658	15,270	13,950
Intercompany dividends paid	(181,825)	(61,180)	(105,882)
Dividends and distributions on common stock	0	0	0
Distributions to non-controlling interest	0	0	0
Contributions from non-controlling interest	0
Proceeds from exercise of Vector options	0	0	0
Tax benefit of options exercised	1,497	0	0
Net cash (used in) provided by financing activities	(166,411)	(62,128)	(93,717)
Net increase (decrease) in cash and cash equivalents	2,651	(2,088)	8,036
Cash and cash equivalents, beginning of year	9,724	11,812	3,776
Cash and cash equivalents, end of year	12,375	9,724	11,812
Subsidiary Non-Guarantors [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	45,715	62,656	(16,239)
Cash flows from investing activities:
Sale of investment securities	0	0	0
Maturities of investment securities	0	0	0
Purchase of investment securities	0	0	0
Proceeds from sale or liquidation of long-term investments	197	49	80
Purchase of long-term investments	0	0	0
Investments in real estate ventures	(70,272)	(40,916)	(75,731)
Distributions from investments in real estate ventures	17,563	7,309	3,142
Increase in cash surrender value of life insurance policies	0	0	0
Decrease (increase) in non-current restricted assets	0	(689)	0
Issuance of notes receivable	(4,410)	(8,250)	(8,600)
Investments in subsidiaries	0	0	0
Proceeds from sale of fixed assets	0	0	0
Cash acquired in Douglas Elliman consolidation			116,935
Purchase of subsidiaries		(750)	(67,616)
Repayment of notes receivable	4,000	4,850
Capital expenditures	(7,247)	(6,923)	(1,194)
Purchase of preferred securities		(1,000)
Proceeds from sale of preferred securities	1,000
Investments in real estate held for sale	(12,603)
Pay down of investment securities	0	0	0
Net cash used in investing activities	(71,772)	(46,320)	(32,984)
Cash flows from financing activities:
Proceeds from issuance of debt	306	0	3,080
Deferred financing charges	0	0	0
Repayments of debt	(322)	(3,877)	(115)
Borrowings under revolver	0	0	0
Repayments on revolver	0	0	0
Capital contributions received	69,516	70,008	142,011
Intercompany dividends paid	(29,343)	(39,550)	(13,412)
Dividends and distributions on common stock	0	0	0
Distributions to non-controlling interest	(3,280)	(9,339)	(11,764)
Contributions from non-controlling interest	813
Proceeds from exercise of Vector options	0	0	0
Tax benefit of options exercised	0	0	0
Net cash (used in) provided by financing activities	37,690	17,242	119,800
Net increase (decrease) in cash and cash equivalents	11,633	33,578	70,577
Cash and cash equivalents, beginning of year	104,890	71,312	735
Cash and cash equivalents, end of year	116,523	104,890	71,312
Consolidating Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	(209,671)	(100,730)	(119,294)
Cash flows from investing activities:
Sale of investment securities	0	0	0
Maturities of investment securities	0	0	0
Purchase of investment securities	0	0	0
Proceeds from sale or liquidation of long-term investments	0	0	0
Purchase of long-term investments	0	0	0
Investments in real estate ventures	0	0	0
Distributions from investments in real estate ventures	0	0	0
Increase in cash surrender value of life insurance policies	0	0	0
Decrease (increase) in non-current restricted assets	0	0	0
Issuance of notes receivable	0	35,000	0
Investments in subsidiaries	103,174	85,278	155,961
Proceeds from sale of fixed assets	0	0	0
Cash acquired in Douglas Elliman consolidation			0
Purchase of subsidiaries		0	0
Repayment of notes receivable	0	(35,000)
Capital expenditures	0	0	0
Purchase of preferred securities		0
Proceeds from sale of preferred securities	0
Investments in real estate held for sale	0
Pay down of investment securities	0	0	0
Net cash used in investing activities	103,174	85,278	155,961
Cash flows from financing activities:
Proceeds from issuance of debt	0	(35,000)	0
Deferred financing charges	0	0	0
Repayments of debt	0	35,000	0
Borrowings under revolver	0	0	0
Repayments on revolver	0	0	0
Capital contributions received	(103,174)	(85,278)	(155,961)
Intercompany dividends paid	211,168	100,730	119,294
Dividends and distributions on common stock	0	0	0
Distributions to non-controlling interest	0	0	0
Contributions from non-controlling interest	0
Proceeds from exercise of Vector options	0	0	0
Tax benefit of options exercised	(1,497)	0	0
Net cash (used in) provided by financing activities	106,497	15,452	(36,667)
Net increase (decrease) in cash and cash equivalents	0	0	0
Cash and cash equivalents, beginning of year	0	0	0
Cash and cash equivalents, end of year	$ 0	$ 0	$ 0

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	$ 13,105	$ 10,867	$ 10,954
Additions Charged to Costs and Expenses	34,207	32,718	29,424
Deductions	35,111	30,480	29,511
Balance at End of Period	12,201	13,105	10,867
Doubtful Accounts [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	37	192	318
Additions Charged to Costs and Expenses	75	31	198
Deductions	0	186	324
Balance at End of Period	112	37	192
Cash Discounts [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	415	241	259
Additions Charged to Costs and Expenses	25,616	25,801	25,207
Deductions	25,664	25,627	25,225
Balance at End of Period	367	415	241
Deferred Tax Valuation Allowance [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	4,933	6,014	6,310
Additions Charged to Costs and Expenses	0	0	0
Deductions	1,033	1,081	296
Balance at End of Period	3,900	4,933	6,014
Sales Returns [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	7,720	4,420	4,067
Additions Charged to Costs and Expenses	8,516	6,886	4,019
Deductions	8,414	3,586	3,666
Balance at End of Period	$ 7,822	$ 7,720	$ 4,420

Employee Benefit Plans Pension Plan Assets Fair Value Measurements (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Fair Value [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	$ 106,620	$ 134,017
Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	33,863	50,365
Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	69,343	76,828
Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	3,414	6,824	$ 9,031
Insurance contracts [Member] \| Fair Value [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	1,760	1,762
Insurance contracts [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	0	0
Insurance contracts [Member] \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	1,760	1,762
Insurance contracts [Member] \| Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	0	0
Cash [Member] \| Fair Value [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	5,429
Cash [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	5,429
Cash [Member] \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	0
Cash [Member] \| Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	0
Cash, mutual funds, and common stock [Member] \| Fair Value [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		8,319
Cash, mutual funds, and common stock [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		8,319
Cash, mutual funds, and common stock [Member] \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		0
Cash, mutual funds, and common stock [Member] \| Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets		0
Marketable equity securities \| Fair Value [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	28,434	42,046
Marketable equity securities \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	28,434	42,046
Marketable equity securities \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	0	0
Marketable equity securities \| Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	0	0
Common collective trusts [Member] \| Fair Value [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	56,327	61,877
Common collective trusts [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	0	0
Common collective trusts [Member] \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	56,327	61,877
Common collective trusts [Member] \| Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	0	0
Investment partnership [Member] \| Fair Value [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	14,670	20,013
Investment partnership [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	0	0
Investment partnership [Member] \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	11,256	13,189
Investment partnership [Member] \| Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	$ 3,414	$ 6,824